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ABSTRACT OF THE DISSERTATION 
 
Discrimination between Neutral and Unsafe 
 Stimuli, Return of Fear, and Anxiety 
by 
Lindsay Katharine Staples, M.A., C.Phil 
University of California, Los Angeles 
Professor Michelle Craske, Chair 
 
Abnormalities in basic fear conditioning and extinction processes may contribute 
to the development and maintenance of anxiety disorders. Specifically, the ability to 
distinguish between a stimulus that predicts an aversive outcome and a stimulus that 
predicts its absence may impact fear conditioning, extinction, and return of fear. This 
dissertation will include three papers investigating the role of discrimination between 
neutral and unsafe stimuli in the development and maintenance of conditional fear. 
Anxiety has been linked to discrimination (e.g., Jovanovic et al., 2013; Lissek et al., 
2014), however it is unknown whether discrimination may explain the link between trait 
anxiety and return of fear. Study 1 examines whether discrimination mediates the 
relationship between trait anxiety and return of fear in a classical conditioning 
paradigm. There is little evidence examining whether discrimination between neutral 
and unsafe stimuli can be manipulated. Study 2 examines whether a positive or 
negative mood induction may impact discrimination and therefore impact extinction and 
		 iii	
return of fear. Study 3 investigates whether there exist functional differences when 
participants are presented the CS+ versus the CS-, and whether these differences 
accompany anxiety symptoms, altered fear extinction and extinction recall. No previous 
research has investigated this. In sum, we will determine whether the ability to 
distinguish between a neutral stimulus and an unsafe stimulus is related to trait anxiety 
and return of fear, whether this discrimination can be manipulated by mood, and 
whether the phenomenon of discrimination impacting return of fear can be observed 
using neuroimaging methods. 
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INTRODUCTION 
Anxiety disorders can be conceptualized as disorders of false alarms. 
Indeed, difficulty with identifying neutral stimuli in the environment as 
nonthreatening is a commonly observed characteristic of anxiety disorders (Duits et 
al., 2015). Basic Pavlovian fear conditioning paradigms are commonly employed to 
examine the learning mechanisms that underlie these deficits. In differential 
Pavlovian fear conditioning paradigms, two conditional stimuli (CS) are used: a CS+ 
which predicts the aversive unconditional stimulus (US) and a CS- which predicts 
its absence. Over the course of fear acquisition, individuals who discriminate 
between each CS successfully will come to anticipate the US when presented with 
the CS+ and anticipate its absence when presented with the CS-. Individuals with 
anxiety disorders, however, show elevated fear responding to the CS- (e.g., 
Jovanovic et al., 2013; Lissek et al., 2014; Lissek & Grillon, 2012). 
Indeed, overgeneralization of conditional fear from a CS+ to a CS- as 
measured by startle has been observed in panic disorder (Lissek et al., 2010). Fear 
responding to neutral stimuli has also been linked to generalized anxiety disorder 
(Lissek, 2014) and posttraumatic stress disorder (Lissek & Grillon, 2012). Similarly, 
difficulties with discriminating between a CS+ and a CS- have been observed in 
anxiety disorders (e.g., Jovanovic et al., 2013; Lissek et al., 2014) and impact 
retention of fear extinction memories (Dibbets, van den Broek, & Evers, 2015; 
Grillon, 2002; Grillon & Morgan, 1999). Notably, a meta analysis did not find 
significant differences between anxiety patients and controls in discrimination 
learning, however did find elevated fear responding to the CS- (Duits et al., 2015). 
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State anxiety has been linked with the ability to learn the relationship between the 
CS+ and the US, and difficulties with learning this contingency have been 
associated with increased contextual anxiety during a Pavlovian fear conditioning 
paradigm (Prenoveau, Craske, Liao, & Ornitz, 2011). 
Following fear acquisition, extinction is performed, in which each CS is 
presented in the absence of the US and the organism learns safety. Following 
extinction, fear memories can sometimes return (Craske & Mystkowski, 2006). Fear 
memories return in the phenomena of spontaneous recovery and context renewal, 
suggesting that extinction is not erasure of the original fear memory but rather new, 
inhibitory learning (e.g., Bouton, 1993). In spontaneous recovery, fear returns over 
the passage of time following extinction learning, with full spontaneous recovery 
occurring at 14 days in rodent samples (Quirk, 2002). In context renewal, fear 
responding to the CS returns when the CS is presented in a context other than the 
extinction context (Bouton, 1993).  
Currently, it is unknown whether the ability to discriminate between a CS+ and 
CS- may mediate the relationship between trait anxiety and return of fear. 
Additionally, no research has investigated whether discrimination can be 
manipulated using a positive or negative mood induction. Finally, it is unknown 
whether decreased discrimination as measured by functional activation in regions 
associated with fear conditioning accompanies increased anxiety, and whether this 
discrimination impacts extinction learning and retention. The aim of the current 
investigation is threefold: 1) To determine whether trait anxiety is related to 
discrimination and if that in turn is accompanied by changes in return of fear, 2) To 
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determine whether a positive or negative mood induction can impact discrimination 
between a CS+ and a CS- and affect extinction learning and retention, and 3) To 
examine whether differential activation in particular brain regions accompanies 
anxiety and decreased extinction learning and recall. 
 
Study 1: Discrimination as a Mediator of the Relationship Between Trait 
Anxiety and Return of Fear 
 Trait anxiety may be associated with increased return of fear. If so, this 
relationship may be explained in part by impaired ability to distinguish between 
neutral and unsafe stimuli. Disorders of anxiety have indeed been associated with 
increased return of fear following successful fear extinction, however there is a 
dearth of evidence on the relationship between trait anxiety and return of fear. 
Anxiety may be linked to impaired discrimination, however findings on this are 
mixed. In a few studies, impaired discrimination has been associated with elevated 
return of fear. Each of these relationships should be confirmed and the possible 
mediating role of discrimination in the relationship between trait anxiety and return 
of fear should be investigated. 
Increased anxiety may be associated with increased return of fear.  While it 
is unknown whether increased trait anxiety accompanies increased return of fear, 
return of fear is frequently observed among individuals with anxiety disorders. 
Indeed, a significant portion of patients show a resurgence of symptoms following 
treatment (Arch & Craske, 2009). The basis for this return of fear lies within 
Pavlovian fear conditioning and extinction processes. Following exposure therapy, 
		 4	
the clinical analogue of fear extinction, fear can return over time in a phenomenon 
known as spontaneous recovery (Baum, 1988). Additionally, when individuals enter 
contexts outside the therapy context, fear can return in a phenomenon known as 
context renewal (Bouton, 1993).  
While these forms of return of fear are the basis for the resurgence of 
symptoms seen in clinical populations, few studies have examined return of fear in 
the context of basic fear conditioning paradigms among clinical populations. Some 
disorders associated with anxiety have been linked with failure to recall extinction 
learning (i.e., return of fear). For example, individuals with posttraumatic stress 
disorder (PTSD) show elevated skin conductance responding at test of extinction 
recall compared to healthy controls, indicating poor retention of extinction memories 
and elevated return of fear (e.g., Milad et al., 2008; Milad et al., 2009). Individuals 
with obsessive compulsive disorder have also shown impaired recall of extinction 
memories in a basic fear conditioning paradigm (McLaughlin et al., 2015). Whether 
this increased return of fear can be detected among individuals with elevated trait 
anxiety is not yet certain. 
Increased anxiety may be associated with decreased discrimination between 
a CS+ and CS-. Again, we first look to individuals with anxiety disorders, among 
whom increased responding to the CS- has been observed (Duits et al., 2015). This 
increased responding has also been identified in individuals with high trait anxiety 
(Gazendam, Kamphuis, & Kindt, 2013). State anxiety has been associated with 
awareness of the association between the CS+ and the US (Prenoveau, Craske, 
Liao, & Ornitz, 2011). Trait anxiety has also been associated with the ability to 
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distinguish between a CS+ and a CS+ accompanied by a safety signal (Chan & 
Lovibond, 1996). This may signal a relationship between anxiety and failure to 
identify nonthreatening cues in the environment and distinguish them from danger 
cues. However, a recent meta analysis of several conflicting studies did not detect 
an overall difference between anxious and control participants in their ability to 
discriminate between the CS+ and CS- (Duits et al., 2015). Further research should 
disambiguate the relationship between anxiety and discrimination. 
Finally, decreased discrimination may be related to increased return of fear. 
It has indeed been shown that individuals who are less able to discriminate 
between a CS+ and a CS- show more return of fear as measured by startle 
response at follow-up (Grillon, 2002). In a differential fear conditioning paradigm, 
only participants who were aware of the CS+-US contingency showed differential 
conditional responding while the unaware participants who did not show this 
discrimination showed increased fear at test (Grillon, 2002). This indicates that 
reduced discrimination may be associated with increased spontaneous recovery, 
however the impact of discrimination on context renewal is unknown. 
 
Study 2: Mood Induction, Discrimination, and Return of Fear 
 Induction of positive or negative mood may impact discrimination between 
neutral and unsafe stimuli. Emotional categorization theory predicts that mood 
induction will impact the extent to which the individual perceives two stimuli as 
similar. In brief, this theory states that individuals use emotional response 
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categories when they are experiencing emotion (Niedenthal, Innes-Ker, & 
Halberstadt, 1999).  
Humans group stimuli into categories. For example, a husky, a dachshund, 
and a dalmatian may all be categorized as dogs based on particular features such 
as fur, tails, legs and snouts. However, categories are determined by factors not 
only related to the object itself but also related to the individual perceiving the 
object, including goals, memories, and histories. For example, a husky may be 
assigned the category of “dog” or, alternatively, of “things from my childhood home.” 
Thus, what may appear to one person as a list of unrelated objects such as a 
necklace, a beach in Maine, a hairbrush, and an armchair may to another person 
fall in the emotional category of “things that remind me of my mother”. Emotional 
categorization theory asserts that, when the individual is in an emotional state, 
objects are more likely to be categorized based on their emotional value rather than 
on their other properties (e.g., categorizing a necklace as “something that reminds 
me of my mother” rather than as “a type of jewelry”). 
Specific emotions give rise to specific categories. For example, a lion, a 
precipice, and a particularly difficult statistics exam may all fall into the category of 
fear-provoking items. Experiencing the emotion of fear activates a tendency to 
categorize stimuli as being related to fear. In lexical decision studies by Niedenthal, 
Halberstadt, and Setterlund (1997), participants were induced to feel specific 
emotions and then asked to make word/nonword judgments about a series of word 
and nonword letter strings. Emotion-congruent words were facilitated more than 
emotion-incongruent words. (e.g., words related to happiness were more likely to 
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be identified correctly for participants in the happy condition). This suggests that 
emotional response categories are grounded in specific emotional states. Because 
specific emotions differentially facilitate categorization of emotion-related stimuli, it 
is possible that individuals in a negative mood induction will be more likely to rate 
fear-related stimuli (i.e., conditional stimuli) as more similar than individuals in a 
positive mood induction. 
Specific emotions give rise to specific categories, but emotional 
categorization may not be contingent on the experience of a particular emotion. 
While specific emotional states may differentially facilitate particular categorizations, 
Emotional Categorization Theory argues that any emotional state will increase the 
use of all emotional response categories; an individual will be more likely to 
categorize the necklace as “something that reminds me of my mother” when he or 
she is experiencing emotion more than if he or she is neutral regardless of whether 
the emotion is sadness, anger, or happiness. An empirical study by Niedenthal, 
Innes-Ker, & Halberstadt, (1999) supports this perspective. In this study, individuals 
were randomized to a happy, sad, or neutral mood induction. They then categorized 
happy and sad words as more similar to an emotion concept or a non-emotion 
concept. Individuals in emotional conditions grouped happy concepts together and 
sad concepts together more than those in the neutral condition. Furthermore, 
individuals in the happy condition grouped happy concepts together and sad 
concepts together to the same degree that those in the sad condition did. It is 
possible that only a negative mood induction will cause individuals to perceive fear-
related stimuli as more similar, but because any emotional state can increase the 
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use of all emotional response categories, it is possible that both positive and 
negative mood states will cause the individual to perceive a CS+ and a CS- as 
more similar. Individuals will be more likely, when in an emotional state, to 
categorize a CS+ and a CS- as “stimuli that scare me” rather than “pictures of 
faces”.  
Emotional Categorization Theory offers an explanation for these 
phenomena. It suggests that, during the experience of emotion, individuals attend 
to their emotional responses to stimuli, and therefore weight emotion more greatly 
in responding to stimuli. In models of categorization and category learning (e.g., 
Kruschke, 1992; Medin & Schaffer, 1978; Nosofsky, 1986, 1992; Smith 1989), 
selective attention towards a particular feature of a stimulus decreases attention to 
other features of the stimulus. If one is attending to the emotional significance of an 
object, one is not attending to its other features. Due to this attention being 
allocated toward a stimulus’ emotional value and away from its discrete features, 
Niedenthal, Innes-Ker and Halberstadt (1999) claim that one is more likely to 
perceive stimuli as more similar when in an emotional state. This suggests that 
individuals in both a positive and negative mood condition will perceive a CS+ and 
CS- as being more similar than individuals in a control condition and will show 
decreased discrimination. 
Running counter to the predictions of this theory, prior research has linked 
low amounts of positive affect with decreased ability to discriminate (Meulders, 
Meulders, & Vlaeyen, 2014). This study examined whether positive affect and trait 
anxiety impact fear inhibition to a neutral stimulus during extinction. Results 
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indicated that individuals who show low levels of positive affect show failure of fear 
inhibition to the CS-. Additionally, trait anxiety was associated with elevated fear in 
response to the CS-. Importantly, this study examined trait positive affect rather 
than state positive affect. This study suggests that individuals experiencing less 
positive emotion are less likely to discriminate successfully between an CS+ and a 
CS-. It is possible that increased state positive affect may increase discrimination. 
Additionally, trait anxiety, or the tendency to experience the negative emotion of 
fear, may be related to decreased discrimination. 
Based on this collection of evidence, it is possible that only negative mood 
induction will decrease discrimination and positive mood induction will have no 
impact, that a positive mood induction will facilitate discrimination and a negative 
mood induction will decrease discrimination, or that both positive and negative 
mood inductions will decrease discrimination. Thus, the aim of the current study is 
to examine the impact of positive, negative, and neutral mood inductions on the 
ability to discriminate between a CS+ and a CS-. Additionally, this study seeks to 
confirm a negative relationship between discrimination and fear following extinction, 
at spontaneous recovery, and at context renewal.  
 
Study 3: Differential Brain Activation in Response to Neutral and Unsafe 
Stimuli and Extinction Learning and Recall 
Fear conditioning activates a consistent network of brain regions or “fear 
network” (Fullana et al., 2016). Discrimination between neutral and unsafe stimuli 
may be related to areas in this network inhibiting responding to the CS-. 
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Alternatively, hyperresponsivity to the CS+ may be responsible for decreased 
discrimination.  
In a meta analysis of neuroimaging studies of fear conditioning, Fullana et al. 
(2016) identified several areas that show greater deactivation in the presence of the 
CS- relative to the CS+, including (1) lateral and midline primary somatosensory 
cortex and dorsal posterior insular cortex, (2) dorsal anterior prefrontal cortex, (3) 
ventromedial prefrontal cortex, (4) posterior cingulate cortex, including the 
retrosplenial cortex, hippocampus and lateral inferior and middle temporal cortex; 
(5) lateral OFC, 6) inferior parietal cortex, (7) lateral retrosplenial cortex, (8) 
posterior cerebellum, (9) dorsal caudate nucleus, and (10) dorsal–posterior 
precuneus (Fullana et al., 2016). These regions are likely to be responsible for 
processing of the CS- as a nonthreatening signal (Fullana et al., 2016). Regions 
such as the hippocampus responsible for the encoding of episodic memory may be 
linked to the encoding of an episodic memory representation during processing of 
the CS- (Fullana et al., 2016). Alternatively, these regions may be associated with 
relief related to the absence of the US (Leknes, Lee, Berna, Andersson, & Tracey, 
2011). Individuals who show impaired discrimination may show limited deactivation 
of these brain regions. 
Regions that show significant functional activation when presented with the 
CS+ relative to the CS- included (1) the anterior insular cortex, (2) the ventral 
striatum and major thalamic nuclei, (3) pre-supplementary and supplementary 
motor areas, the dorsal anterior cingulate cortex and the dorsal–anterior precuneus, 
(4) the second somatosensory cortex/parietal operculum, (5) the dorsolateral 
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prefrontal cortex (6) the lateral premotor cortex, (7) the ventral–posterior precuneus, 
and (8) the lateral cerebellum. Overall, several of these regions reflect processes 
related to autonomic and behavioral regulation, including monitoring of the 
physiological condition of the body and subjective emotional awareness (Cameron, 
2009; Craig, 2009; Critchley & Harrison, 2013; Saper, 2002). Among these regions, 
the anterior insular cortex and dorsal anterior cingulate cortex are hypothesized to 
be two major components, in which the anterior insular cortex is responsible for 
awareness of one’s cognitive, emotional, and physical state which is conveyed to 
the dorsal anterior cingulate cortex in order to facilitate physiological and behavioral 
responses in the interest of homeostasis (Craig, 2009; Medford & Critchley, 2010). 
These areas may be hyperresponsive in individuals who show poor discrimination.  
The amygdala is an important area in fear conditioning processes. Early 
animal research on the role of the amygdala in fear conditioning demonstrated its 
crucial role in fear learning. In one study, rats with lesions to the amygdala failed to 
avoid a CS and failed to show freezing behavior (Blanchard & Blanchard, 1972). 
Today, fear conditioning is known to depend on the central nucleus of the amygdala 
in rats (Zimmerman, Rabinak, McLachlan, & Maren, 2007). This structure has been 
shown to be necessary for learning not only about discrete stimuli but also 
contextual stimuli (Phillips & Ledoux, 1992). The amygdala is involved in both the 
learning of fear and the expression of fear responses in humans (Cheng, Knight, 
Smith, & Helmstetter, 2006). The amygdala shows increased activation in humans 
when an aversive event is predicted compared to when it is unpredictable (Carlsson 
et al., 2006) and regional cerebral blood flow to the amygdala is shown to increase 
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following conditioning (Doronbekov et al., 2005). Amygdala activation increases 
with the rate of reinforcement during fear conditioning; the more often the US 
follows the CS, the greater the amygdala activation (Dunsmoor, Bandettini, & 
Knight, 2007) For example, Cheng et al. (2003) found that subjects receiving paired 
CS-US presentations showed greater amygdala activity than those receiving 
unpaired shocks and CS presentations. It is important to note that the amygdala 
habituates quickly, thus responses toward the beginning of conditioning may be the 
most informative (Breiter et al., 1996). The amygdala is important for generating 
conditional responses (Cheng, Richards, & Helmstetter, 2007). Differential 
amygdala activity has been demonstrated during differential Pavlovian fear 
conditioning paradigms in animals (Collins & Paré, 2000) and humans (Buchel et 
al., 1998; Buchel et al., 1999; LaBar et al., 1998; Cheng, Knight, Smith, & 
Helmstetter, 2006) such that responding is increased during presentation of the 
CS+ relative to the CS-. Whether the magnitude of this difference is related to 
anxiety or predicts extinction and return of fear is unknown. 
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STUDY 1 
DISCRIMINATION AS A MEDIATOR OF THE RELATIONSHIP BETWEEN TRAIT 
ANXIETY AND RETURN OF FEAR 
 
Study 1 has been published in the journal Cognition and Emotion:  
Staples-Bradley, L. K., Treanor, M., & Craske, M. G. (2016). Discrimination 
between safe and unsafe stimuli mediates the relationship between trait anxiety and 
return of fear. Cognition and Emotion. Advance online publication. doi: 
http://dx.doi.org/10.1080/02699931.2016.1265485. 
 
Introduction 
Abnormalities in basic fear conditioning and extinction processes may 
contribute to the development and maintenance of anxiety disorders. Exposure 
therapy for anxiety disorders applies principles of extinction learning to reduce 
symptoms and improve functioning. However, despite its well-established 
effectiveness, a portion of individuals do not respond and many who do respond 
experience symptom relapse following treatment (Vervliet, Craske, & Hermans, 
2013). The relapse of symptoms may be due to several phenomena. For instance, 
following successful extinction learning, a resurgence of fear known as 
spontaneous recovery occurs over the passage of time, with full spontaneous 
recovery occurring at 14 days in rodent samples (Quirk, 2002). In a separate 
phenomenon known as context renewal, fear responding to a conditional stimulus 
(CS) returns when the CS is presented in a context other than the extinction context 
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(Bouton, 1993). These processes may explain 1) relapse in the weeks and months 
following exposure therapy and 2) the resurgence of symptoms when the individual 
is confronted with a previously feared stimulus in a novel environment.  However, it 
is unclear what factors contribute to increased spontaneous recovery and context 
renewal in individuals with anxiety disorders.  
In differential conditioning paradigms, which are an experimental analogue of 
fear acquisition, one CS (the CS+) predicts the unconditional stimulus (US) and the 
other (the CS-) predicts its absence. Discrimination between the CS+ and CS- is an 
index of associative processes and is measured by strength of fear responding 
(such as skin conductance) and strength of perceived association with the US (such 
as US expectancy).  
Usually, non-anxious individuals successfully discriminate as evident by 
stronger fear arousal and US expectancy to the CS+ than the CS- . This 
discrimination is often used as an indicator of successful fear learning. Individuals 
with anxiety disorders, however, have shown deficits in the differentiation between 
CS+ and CS- and elevated threat responding to neutral cues (e.g., Duits et al., 
2015; Jovanovic et al., 2013; Lissek et al., 2014). Additionally, individuals who are 
unaware of the relationship between the CS+ and the US show elevated state 
anxiety (Prenoveau, Craske, Liao, & Ornitz, 2011).  
  Superior discrimination has been associated with decreased return of 
conditional fear at spontaneous recovery (Grillon, 2002), but linkages between 
discrimination and context renewal remain unknown. On the one hand, greater 
discrimination between a CS+ and a CS- may lead to increased context renewal 
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due to enhanced observation of novel elements of contextual stimuli. Throughout 
extinction, the individual searches the environment for cues in order to resolve the 
ambiguity of the CS+ because the absence of the US violates its prior predictive 
association with the US (Bouton, 1993). Those who more easily discriminate 
between a CS+ and a CS- may show greater attention to novel elements of stimuli 
in general, which may in turn correspond with enhanced attention towards novel 
contextual elements during extinction, resulting in a stronger contextual 
representation. Enhanced attention to novel elements of stimuli and contexts may 
amplify the difference between the extinction context and a renewal context at test, 
leading to greater context renewal. On the other hand, individuals with greater 
discrimination may simply show greater attention toward the CS+ rather than 
greater attention to novel elements in general, thereby diverting attention from the 
surrounding environment and decreasing context renewal. 
  Previous research has examined the impact of trait anxiety on extinction 
learning (Indovina, Robins, Núñez-Elizalde, Dunn, & Bishop, 2011; Sehlmeyer et 
al., 2011), and impaired discrimination (Lissek et al., 2014), however the impact of 
trait anxiety on spontaneous recovery and context renewal is unknown. Previous 
studies have linked disorders of anxiety such as PTSD to return of extinguished 
fear memories, (e.g., Milad et al., 2009), however previous findings have failed to 
establish a link between trait anxiety and return of fear (Haaker et al., 2015).  
The aim of the current study is to evaluate whether discrimination between 
the CS+ (cuing danger) and CS- (cuing the absence of danger) during fear 
acquisition mediates the relationship between trait anxiety and a) spontaneous 
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recovery and b) context renewal of fear. Given the evidence to suggest that anxiety 
is associated with impaired discrimination and that impaired discrimination is 
associated with increased spontaneous recovery, it is hypothesized that 
discrimination between the CS+ and CS- during acquisition mediates the 
relationship between trait anxiety and spontaneous recovery. Given the dearth of 
prior research, no specific hypotheses are made regarding the role of discrimination 
in the relationship between anxiety and context renewal. The current study utilizes 
data from an investigation examining the effect of multiple contexts during 
extinction. Thus, the findings represent secondary analyses. 
Methods 
  Twenty-nine participants (mean age = 19.3 years, SD =1.47, 79% female, 
37% Caucasian, 31% Asian, 24% Hispanic or Latino, 3% Other) were recruited 
from a student subject pool at a local university and received either monetary 
compensation or partial course credit for their participation. Participants were 
excluded if they were currently undergoing treatment for a psychiatric disorder other 
than an anxiety disorder, if they were pregnant, under the age of 18, unable to 
speak or understand English, or if they had a serious medical condition, hearing 
difficulties, or a physician’s recommendation to avoid stressful situations.  
Apparatus and Stimuli 
  Stimuli were presented on a desktop computer using E-prime software 
(Psychology Software Tools, Pittsburgh, PA). Each CS was a picture of one of two 
faces (one Asian female, one Caucasian male) selected from the NimStim set 
(Tottenham et al., 2009).  The CS was superimposed on an image of a context (a 
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living room, a mall, a staircase, an outdoor seating area, or a laundry room). 
Context as well as which CS was selected as the CS+ versus the CS- were 
counterbalanced across participants. Each CS lasted 8 seconds and was presented 
in pseudo-random order, such that there were no more than two consecutive trials 
of either CS.  The US was a 1-second 100 decibel scream presented via 
headphones that co-terminated with the CS+ (Joos, Vansteenwegen, & Hermans, 
2012). Inter-trial intervals were set to 20, 25, and 30-seconds in randomized order, 
during which a fixation cross was displayed.  
Measures 
  Participants completed the Behavioral Inhibition System scale (BIS; 
M=23.24, SD=2.86; Carver & White, 1994) as a measure of trait anxiety or 
vulnerability to anxiety. Additionally, they completed a demographics questionnaire 
and an eligibility questionnaire.  
  The primary dependent variables were ratings of US Expectancy and CS 
Fear, which are valid measures of fear conditioning (Boddez et al., 2013). 
Participants rated how certain they were that they would receive the US on each 
trial. Ratings were made using a box with a sliding switch. One end of the box was 
labeled “Certain Noise”, the opposite end was labeled “Certain No Noise”, and the 
middle was labeled “Uncertain”.  These subjective responses were measured in 
arbitrary units; the software value default assigned to the far end of the dial labeled 
“Certain No Noise” was -29.6, the value assigned to the end of the dial labeled 
“Certain Noise” was 9.56, and the midpoint fell at -19.58. Data were centered for 
ease of interpretation. On each trial, participants were asked to rate how much they 
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expected to hear the scream sound in the next few moments. At the midpoint of 
each trial, participants received a prompt (i.e., the words “Scream Sound?”) at the 
bottom of the screen to remind them to continuously rate their expectancy of the 
US. US Expectancy was calculated by taking the maximum value of US Expectancy 
ratings during each trial. Discrimination (M=30.07, SD=13.67) during Acquisition 
was assessed by subtracting the average US Expectancy to the CS- from the 
average US Expectancy to the CS+ throughout Acquisition.   
  After each phase (Habituation, Acquisition, Extinction, Spontaneous 
Recovery, and Context Renewal – detailed below), participants rated each CS 
(without context) using a 7-point likert scale of Fear (1=very low fear, 7=very high 
fear). The original paradigm included a measure of skin conductance, but due to 
technical error, skin conductance data were not analyzable. 
Procedure 
  On Day 1, participants provided informed consent and were instructed to sit 
at the computer where stimuli were presented. Participants were instructed that 
they would see various images and that they may hear a loud scream sound at 
certain times. The experimenter explained the US Expectancy ratings box and 
instructed participants to continuously rate the extent to which they expected to 
hear the scream sound. During Habituation, four presentations of each CS occurred 
in either the Acquisition context or the Extinction context, counterbalanced. No US 
Expectancy ratings were collected during Habituation to minimize development of 
an expectation of the US that would interfere with conditioning. During the 
Acquisition phase, the CS+ and the CS- were each presented 8 times in one of the 
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contexts, and the CS+ was always followed by the US. In the Extinction phase, 
participants viewed 24 presentations of the CS+ and the CS- in a context that 
differed from the Acquisition context.  The initial study design compared two groups: 
a Control group (n=17) received only one context and a Multiple Context group 
(n=12) received three contexts during the Extinction phase. The groups did not 
significantly differ on CS Discrimination during Acquisition (t(27)=-.916, p=.368). 
Furthermore, the groups did not significantly differ on US Expectancy for CS+ at 
Spontaneous Recovery or Renewal, or US Expectancy for CS- at Extinction, 
Spontaneous Recovery, or Renewal (all p’s >.052). However, since Groups were 
significantly different on US Expectancy for CS+ at Extinction (t(27)=-2.158, 
p=.040), Group was added as a covariate in all analyses. 
  Seven days later, participants returned to the laboratory for a second visit. 
They were instructed that throughout the experiment they may hear the scream 
sound at certain times. At this time, they completed questionnaires and were tested 
for Spontaneous Recovery, where they viewed four presentations each of the CS+ 
and the CS- in the Extinction context. For individuals who viewed multiple contexts 
during Extinction, the context presented during Spontaneous Recovery was the 
context presented during the final one third of Extinction trials. In the Context 
Renewal phase, participants viewed four presentations each of the CS+ and the 
CS- in a novel context. The order of these test phases was counterbalanced across 
participants.  
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Data Analytic Plan 
  We first analyzed data indicative of Acquisition, Extinction, Context Renewal 
and Spontaneous Recovery of expectancy and fear, using repeated measures 
ANOVA. US Expectancy was averaged over the first two trials of both Spontaneous 
Recovery and Context Renewal based upon previous research demonstrating this 
method as a dependable measure of return of fear (e.g., Hermann, Stark, Milad, & 
Merz, 2016).  
  We also assessed for order effects between Spontaneous Recovery and 
Context Renewal using repeated measures ANOVAs. To examine the relationship 
between trait anxiety and return of fear, correlations were performed between BIS 
and a) US Expectancy at Spontaneous Recovery, b) US Expectancy at Context 
Renewal, and c) Fear ratings following both Spontaneous Recovery and d) Context 
Renewal.  
  Next, we examined whether Discrimination mediated the relationship 
between trait anxiety (as measured by the BIS) and Spontaneous Recovery and 
Context Renewal using PROCESS, a conditional modeling program. This program 
utilizes an ordinary least squares framework to test direct and indirect effects 
(Hayes, 2012). The present analyses utilized PROCESS Model 4 and bootstrap 
analyses for mediation. Due to small sample size, bootstrap estimates used 50,000 
repetitions to construct 95% bias-corrected confidence intervals. We utilized current 
methods for establishing mediation based upon MacKinnon and colleagues 
(MacKinnon, 2007; MacKinnon & Fairchild, 2009). This method allows 
demonstration of more nuanced mediation models such as inconsistent mediation 
		 21	
or indirect-only mediation (Zhao, Lynch, & Chen, 2010), in which mediation occurs 
in the absence of total effects. 
  Finally, for a more precise measure of Discrimination we recalculated 
Discrimination as CS+/(CS+ + CS-), which yields a 0 to 1 proportion. Mediation 
analyses were rerun with this recalculated Discrimination variable. 
Results 
Acquisition, Extinction, Spontaneous Recovery, and Context Renewal 
  Acquisition, Extinction, Spontaneous Recovery and Context Renewal were 
analyzed using a 2 (CS +, CS-) x 5 (Phase: beginning of Acquisition, end of 
Acquisition, end of Extinction, Context Renewal, and Spontaneous Recovery) 
repeated measures ANOVA. In instances were sphericity was violated, results are 
reported with the Greenhouse-Geisser correction. For US Expectancy, there was a 
main effect of phase (F(2.67,72.04)=28.80, p<.001, ηp2 =.52),  CS type 
(F(1,27)=82.82, p<.001, ηp2 =.75 ) and a Phase X CS type interaction 
(F(2.17,58.71)=59.21, p<.001, ηp2 = .69; see Figure 1). Planned comparisons 
indicated a significant increase in US Expectancy to the CS+ from the beginning to 
the end of Acquisition, and a significant decrease in US Expectancy to the CS+ by 
the end of Extinction (all ps<.001). There was a significant return of fear to the CS+ 
and CS- from the end of Extinction to Renewal and Spontaneous Recovery 
(ps<.001). However, return of fear was specific, as responding was greater to the 
CS+ than the CS- in Context Renewal (p<.01) and trended in the same direction for 
Spontaneous Recovery (p=.055), and US Expectancy to the CS+ was higher during 
Renewal compared to Spontaneous Recovery (p<.05). For Fear ratings, there was 
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significant effect of phase (F(2.78,75.02)=9.41, p<.001, ηp2 =.26), but no effect of 
CS type or phase by CS type interaction (ps>.50). Planned comparisons indicated a 
significant increase in fear to conditional stimuli from the beginning to the end of 
Acquisition, and a significant decrease in fear by the end of Extinction (all ps<.001). 
However, there was no significant renewal or spontaneous recovery of fear 
(ps>.30). 
  Order effects of Spontaneous Recovery versus Context Renewal were 
evaluated using a 2 (Order: Spontaneous Recovery First, Context Renewal First) X 
2 (CS Type: CS+, CS-) repeated measures ANOVA. For both Context Renewal and 
Spontaneous Recovery, there was no main effect of order or significant Order X CS 
Type interaction (ps>.14). There was also no difference in acquisition, extinction, or 
test phases between participants who underwent habituation in the acquisition 
context versus the extinction context (all p’s > .213).  
Mediation Analyses 
(a) CS+ US Expectancy. 
  Discrimination during Acquisition was significantly negatively correlated with 
US Expectancy at Spontaneous Recovery (r(29)=-.57, p=.001) and Context 
Renewal (r(29)=-.442, p=.02. BIS was not significantly correlated with US 
Expectancy at Spontaneous Recovery (r(29)=.20, p=.297) or Context Renewal 
(r(29)=.02, p=.924). However, given that a significant total effect is not necessary to 
demonstrate mediation, we proceeded with mediation analyses (MacKinnon & 
Fairchild, 2009).  
		 23	
Statistics for all mediation analyses are listed in Tables 1 and 2 (see 
supplemental materials). BIS significantly predicted Discrimination and, when 
controlling for BIS, Discrimination significantly predicted US Expectancy at 
Spontaneous Recovery and Context Renewal. All total effects were nonsignificant. 
Direct effects of BIS on Spontaneous Recovery and Context Renewal were 
nonsignificant, indicating full mediation of Discrimination on these relationships.  
(b) CS- US Expectancy. 
  Discrimination was significantly negatively correlated with US Expectancy at 
Spontaneous Recovery (r(29)=-.62, p<.001) and Context Renewal (r(29)=-.50, 
p<.001). BIS was not significantly correlated with US Expectancy at Spontaneous 
Recovery (r(29)=.18, p=.345) or Context Renewal (r(29)=.08, p=.691).  
BIS significantly predicted Discrimination and, when controlling for BIS, 
Discrimination significantly predicted US Expectancy at Spontaneous Recovery and 
Context Renewal. All total effects were nonsignificant. Direct effects of BIS on 
Spontaneous Recovery and Context Renewal were nonsignificant, indicating full 
mediation of Discrimination on these relationships.  
(c) Fear Ratings to the CS+. 
  Discrimination was significantly negatively correlated with fear ratings at 
Spontaneous Recovery (r(29)=-.52, p=.004) and Context Renewal (r(29)=-.57, 
p=.001). BIS was not significantly correlated with fear ratings following 
Spontaneous Recovery (r(29)=.10, p=.611) or Context Renewal (r(29)=.13, p=.499).  
BIS significantly predicted Discrimination and, when controlling for BIS, 
Discrimination significantly predicted fear ratings to the CS+ at Spontaneous 
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Recovery and Context Renewal. Again, all total effects were nonsignificant. The 
direct effects of BIS on Spontaneous Recovery and Context Renewal were 
nonsignificant, indicating full mediation.  
(d) Fear Ratings to the CS-. 
  Discrimination was negatively correlated with fear ratings at Spontaneous 
Recovery (r(29)=-.52, p=.004) and Context Renewal (r(29)=-.53, p=.003). BIS was 
not correlated with fear ratings following Spontaneous Recovery (r(29)=.03, p=.873) 
or Context Renewal (r(29)=.09, p=.643).  
BIS significantly predicted Discrimination and, when controlling for BIS, 
Discrimination significantly predicted fear ratings to the CS- at Spontaneous 
Recovery and Context Renewal. Again, all total effects were nonsignificant. The 
direct effects of BIS on Spontaneous Recovery and Context Renewal were 
nonsignificant, indicating full mediation.  
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Figure 1.  
Mediation of the relationship between BIS and US Expectancy at Spontaneous 
Recovery. 
 
Figure 2. 
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Changes in US Expectancy demonstrating fear acquisition, extinction, 
spontaneous recovery, and context renewal.
 
 
Table 1.  
US Expectancy Ratings: Analyses of discrimination mediating the relationship 
between Behavioral Inhibition System (BIS) scores and Spontaneous Recovery 
(SR) and Context Renewal (CR). LLCI=Lower Limit 95% Confidence Interval, ULCI 
= Upper Limit 95% Confidence Interval.  
 b SE LLCI ULCI sig 
A Path       
     BIS à  Discrimination (a path)  -2.09 .83 -3.80 -.40 * 
US Expectancy during CS+        
Spontaneous Recovery      
     Discrimination à  SR (b path) -.43 .14 -.71 -.14 * 
     BIS àDiscrimination à  SR (Indirect Effect) .89 .38 .29 1.79 * 
     BISà  SR (Direct Effect) -.21 .65 -1.54 1.12  
     BISà  SR (Total Effect) .68 .67 -.69 2.06  
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Context Renewal      
     Discrimination à  CR (b path) -.31 .12 -.56 -.06 * 
     BIS àDiscrimination à  CR (Indirect Effect) .66 .26 .23 1.27 * 
     BISà  CR (Direct Effect) -.65 .57 -1.82 .53  
     BISà  CR (Total Effect) .01 .56 -1.15 1.17  
US Expectancy during CS-       	
Spontaneous Recovery      
     Discrimination à  SR (b path) -.51 .14 -.80 -.23 * 
     BIS àDiscrimination à  SR (Indirect Effect) 1.08 .45 .35 2.16 * 
     BISà  SR (Direct Effect) -.42 .65 -1.77 .92  
     BISà  SR (Total Effect) .66 .71 -.81 2.12  
Context Renewal      
     Discrimination à  CR (b path) -.32 .11 -.54 -.09 * 
     BIS àDiscrimination à  CR (Indirect Effect) .67 .29 .20 1.37 * 
     BISà  CR (Direct Effect) -.48 .51 -1.54 .58  
     BISà  CR (Total Effect) .18 .52 -.89 1.25  
 
 
 
 
 
 
Table 2.  
Fear Ratings: Analyses of discrimination mediating the relationship between 
Behavioral Inhibition System (BIS) scores and Spontaneous Recovery (SR) and 
Context Renewal (CR). LLCI=Lower Limit 95% Confidence Interval, ULCI = Upper 
Limit 95% Confidence Interval.  
 b SE LLCI ULCI sig 
CS+ Fear Ratings 
A Path 
      
     BIS à  Discrimination (a path)  -2.10 .83 -3.80 -.40 * 
Spontaneous Recovery       
     Discrimination à  SR (b path) -.07 .02 -.12 -.03 *  
     BIS àDiscrimination à  SR (Indirect Effect) .15 .06 .05 .31 *  
     BISà  SR (Direct Effect) -.10 .11 -.32 .12   
     BISà  SR (Total Effect) .06 .11 -.18 .29   
Context Renewal       
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     Discrimination à CR (b path) -.08 .02 -.12 -.03 *  
     BIS àDiscrimination à  CR (Indirect Effect) .16 .07 .06 .32 *  
     BISà CR (Direct Effect) -.09 .10 -.30 .12   
     BISà CR  (Total Effect) .07 .11 -.15 .30   
CS- Fear Ratings       
Spontaneous Recovery       
     Discrimination à  SR (b path) -.07 .02 -.12 -.03 *  
     BIS àDiscrimination à  SR (Indirect Effect) .15 .07 .04 .30 *  
     BISà  SR (Direct Effect) -.14 .10 -.35 .07   
     BISà  SR (Total Effect) .01 .11 -.21 .24   
Context Renewal       
     Discrimination à CR (b path) -.07 .02 .-12 -.03 *  
     BIS àDiscrimination à  CR (Indirect Effect) .15 .06 .05 .29 *  
     BISà CR (Direct Effect) -.10 .10 -.32 .11   
     BISà CR  (Total Effect) .05 .11 -.18 .27   
 
 
 
 
Results: Secondary Mediation Analysis Recalculating Discrimination 
(e) CS+ US Expectancy. 
  Recalculated Discrimination during Acquisition was significantly negatively 
correlated with US Expectancy at Spontaneous Recovery (r(29)=-.60, p=.001) and 
Context Renewal (r(29)=-.48, p=.008). BIS was not significantly correlated with US 
Expectancy at Spontaneous Recovery (r(29)=.20, p=.297) or Context Renewal 
(r(29)=.02, p=.924). However, given that a significant total effect is not necessary to 
demonstrate mediation, we proceeded with mediation analyses (MacKinnon & 
Fairchild, 2009).  
Statistics for all mediation analyses are listed in Tables 3 and 4. BIS 
significantly predicted Recalculated Discrimination and, when controlling for BIS, 
Recalculated Discrimination significantly predicted US Expectancy at Spontaneous 
Recovery and Context Renewal. All total effects were nonsignificant. Direct effects 
		 29	
of BIS on Spontaneous Recovery and Context Renewal were nonsignificant, 
indicating full mediation of Recalculated Discrimination on these relationships.  
(f) CS- US Expectancy. 
  Recalculated Discrimination was significantly negatively correlated with US 
Expectancy at Spontaneous Recovery (r(29)=-.64, p<.001) and Context Renewal 
(r(29)=-.49, p=.007). BIS was not significantly correlated with US Expectancy at 
Spontaneous Recovery (r(29)=.18, p=.345) or Context Renewal (r(29)=.08, p=.691).  
BIS significantly predicted Recalculated Discrimination and, when controlling 
for BIS, Recalculated Discrimination significantly predicted US Expectancy at 
Spontaneous Recovery and Context Renewal. All total effects were nonsignificant. 
Direct effects of BIS on Spontaneous Recovery and Context Renewal were 
nonsignificant, indicating full mediation of Recalculated Discrimination on these 
relationships.  
 
 
(g) Fear Ratings to the CS+. 
  Recalculated Discrimination was significantly negatively correlated with fear 
ratings at Spontaneous Recovery (r(29)=-.53, p=.003) and Context Renewal 
(r(29)=-.58, p=.001). BIS was not significantly correlated with fear ratings following 
Spontaneous Recovery (r(29)=.10, p=.611) or Context Renewal (r(29)=.13, p=.499).  
BIS significantly predicted Recalculated Discrimination and, when controlling 
for BIS, Recalculated Discrimination significantly predicted fear ratings to the CS+ 
at Spontaneous Recovery and Context Renewal. Again, all total effects were 
		 30	
nonsignificant. The direct effects of BIS on Spontaneous Recovery and Context 
Renewal were nonsignificant, indicating full mediation.  
(h) Fear Ratings to the CS-. 
  Recalculated Discrimination was negatively correlated with fear ratings at 
Spontaneous Recovery (r(29)=-.50, p=.006) and Context Renewal (r(29)=-.53, 
p=.003). BIS was not correlated with fear ratings following Spontaneous Recovery 
(r(29)=.03, p=.873) or Context Renewal (r(29)=.09, p=.643).  
BIS significantly predicted Recalculated Discrimination and, when controlling 
for BIS, Recalculated Discrimination significantly predicted fear ratings to the CS- at 
Spontaneous Recovery and Context Renewal. Again, all total effects were 
nonsignificant. The direct effects of BIS on Spontaneous Recovery and Context 
Renewal were nonsignificant, indicating full mediation.  
 
 
 
Table 3.  
US Expectancy Ratings: Analyses of Recalculated Discrimination mediating 
the relationship between Behavioral Inhibition System (BIS) scores and 
Spontaneous Recovery (SR) and Context Renewal (CR). LLCI=Lower Limit 
95% Confidence Interval, ULCI = Upper Limit 95% Confidence Interval.  
 
                      b SE LLCI ULCI sig 
A Path       
     BIS à  Discrimination (a path)  -.03 .01 -.05 -.01 * 
US Expectancy during CS+        
Spontaneous Recovery      
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     Recalculated Discrimination à  SR (b path) -36.12 10.31 -57.34 -14.89 * 
     BIS àRecalculated Discrimination à  SR (Indirect Effect) 1.14 .43 .41 2.14 * 
     BISà  SR (Direct Effect) -.46 .65 -1.79 .87  
     BISà  SR (Total Effect) .68 .67 -.69 2.06  
Context Renewal      
     Recalculated Discrimination à  CR (b path) -28.07 8.99 -46.59 -9.54 * 
     BIS à Recalculated Discrimination à  CR (Indirect Effect) .89 .30 .38 1.61  * 
     BISà  CR (Direct Effect) -.87 .56 -2.04 .29  
     BISà  CR (Total Effect) .01 .56 -1.15 1.17  
US Expectancy during CS-       	
Spontaneous Recovery      
     Recalculated Discrimination à  SR (b path) -42.80 10.33 -64.08 -21.51 * 
     BIS àRecalculated Discrimination à  SR (Indirect Effect) 1.35 .53 .48 2.58 * 
     BISà  SR (Direct Effect) -.69 .65 -2.03 .64  
     BISà  SR (Total Effect) .66 .71 -.81 2.12  
Context Renewal      
     Recalculated Discrimination à  CR (b path) -24.75 8.50 -42.25 -7.25 * 
     BIS àRecalculated Discrimination à  CR (Indirect Effect) .78 .34 .21 1.58 * 
     BISà  CR (Direct Effect) -.60 .53 -1.70 .50  
     BISà  CR (Total Effect) .18 .52 -.89 1.25  
 
 
 
 
 
Table 4.  
Fear Ratings: Analyses of Recalculated Discrimination mediating the 
relationship between Behavioral Inhibition System (BIS) scores and 
Spontaneous Recovery (SR) and Context Renewal (CR). LLCI=Lower Limit 
95% Confidence Interval, ULCI = Upper Limit 95% Confidence Interval.  
 
 b SE LLCI ULCI sig 
CS+ Fear Ratings 
A Path 
      
     BIS à  Recalculated Discrimination (a path)  -.03 .01 -.05 -.01 * 
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Spontaneous Recovery       
     Recalculated Discrimination à  SR (b path) -5.96 1.75 -9.56 -2.35 *  
     BIS àRecalculated Discrimination à  SR (Indirect Effect) .19 .08 .07 .38 *  
     BISà  SR (Direct Effect) -.13 .11 -.36 .09   
     BISà  SR (Total Effect) .06 .11 -.18 .29   
Context Renewal       
     Recalculated Discrimination à CR (b path) -6.37 1.66 -9.80 -2.95 *  
     BIS àRecalculated Discrimination à  CR (Indirect Effect) .20 .08 .08 .38 *  
     BISà CR (Direct Effect) -.13 .10 -.34 .09   
     BISà CR  (Total Effect) .07 .11 -.15 .30   
CS- Fear Ratings       
Spontaneous Recovery       
     Recalculated Discrimination à  SR (b path) -5.56 1.71 -9.08 -2.04 *  
     BIS àRecalculated Discrimination à  SR (Indirect Effect) .18 .08 .05 .35 *  
     BISà  SR (Direct Effect) -.16 .11 -.38 .06   
     BISà  SR (Total Effect) .01 .11 -.21 .24   
Context Renewal       
     Recalculated Discrimination à CR (b path) -5.62 1.72 -9.16 -2.09 *  
     BIS àRecalculatedDiscrimination à  CR (Indirect Effect) .18 .07 .06 .35 *  
     BISà CR (Direct Effect) -.13 .11 -.35 .09   
     BISà CR  (Total Effect) .05 .11 -.18 .27   
 
 
Discussion 
Overall, this study confirms previous findings showing that individuals high in 
anxiety show impairments in discrimination between neutral and threatening stimuli. 
It extends upon those findings by demonstrating that impaired discrimination 
mediates the relationships between trait anxiety and phenomena that are related to 
the return of fear – spontaneous recovery and context renewal.  
Individuals with higher trait anxiety, measured using the Behavioral Inhibition 
System scale, displayed impaired ability to distinguish between a CS+ and a CS- 
during fear conditioning. This effect is consistent with previous studies which 
demonstrate impairments in discrimination between neutral and threatening stimuli 
among individuals with anxiety disorders (e.g., Lissek et al., 2014).  
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At spontaneous recovery, discrimination during fear acquisition was 
negatively correlated with US expectancy and fear ratings to the CS+. This effect is 
consistent with previous findings that poor associative distinction between a CS+ 
and a CS- is associated with greater return of fear (Grillon, 2002). Discrimination 
was also negatively correlated with US expectancy and fear to the CS- at 
spontaneous recovery, further suggesting that individuals with poor discrimination 
have impaired learning of the neural properties of the CS-. Discrimination during 
acquisition mediated the relationships between trait anxiety and US Expectancy 
and fear to both the CS+ and CS- at spontaneous recovery. Conceivably, 
discrimination mediates between trait anxiety and spontaneous recovery because 
better discrimination reflects greater attentional control, which enhances the 
salience of the CS+, and in turn leads to more robust extinction learning and less 
return of fear. Indeed, attentional allocation can impact the rate of fear extinction 
(Barry, Vervliet, & Hermans, 2016). Furthermore, individuals with anxiety show 
deficits in attentional control (Eysenck, 2010), and individuals with less self-reported 
attentional control show impaired contingency awareness in context conditioning 
(Baas, 2013).  
At context renewal, discrimination during acquisition was also negatively 
associated with US expectancy and fear ratings to the CS+, suggesting attenuated 
context renewal among individuals who more successfully discriminate during fear 
acquisition. Individuals who discriminated poorly also showed increased US 
expectancy and fear in response to the CS- at context renewal. Discrimination 
mediated the relationship between trait anxiety and US Expectancy and fear ratings 
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to both the CS+ and CS- at context renewal. Attenuated context renewal in 
individuals who successfully discriminate, characteristic of those with lower trait 
anxiety, may reflect greater attention to conditional stimuli compared to the 
surrounding environment, thereby reducing the association of the conditional stimuli 
and the extinction context. Reduced contextualization of extinction learning may 
allow extinction to generalize more readily across contexts, mitigating context 
renewal. An alternative explanation is that individuals with “poor discrimination” are 
generally more reactive to experimental stimuli following US delivery. However, that 
CS+ expectancy was greater than CS- expectancy at both spontaneous recovery 
and context renewal suggests that deficits in discrimination are due to associative 
processes rather than simple reactivity to study stimuli. Further evidence for 
associative mechanisms is derived from higher US expectancy ratings during the 
context renewal phase when compared to spontaneous recovery. If impaired 
discrimination was simply related to greater overall reactivity, we would not expect 
to see differences consistent with associative learning such as differential 
expectancy to the CS+ compared to CS-, and greater context renewal compared to 
spontaneous recovery.  
The mediation effects occurred in the absence of total effects (i.e., the direct 
correlation between BIS and each outcome). This can occur when a) the sign of 
the indirect effect differs from the sign of the direct effect, resulting in the total 
effect equaling zero (inconsistent mediation; MacKinnon, Fairchild, & Fritz, 2007; 
MacKinnon & Fairchild, 2009), b) when additional unexplored mediators that differ 
in the direction from the current indirect effect result in no total direct effect (Hayes, 
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2009), or c) when there is “indirect-only” mediation (Zhao et al., 2010). Regardless, 
recent statistical techniques allow for a more nuanced examination of indirect 
effects such as the full mediation of trait anxiety on fear renewal through 
discrimination examined in the current study.  
The present study has some important limitations. First, it is possible that the 
contexts utilized did not adequately simulate contexts in fear learning. Processing 
context may be hippocampus dependent while processing a CS is not (Huff et al., 
2011). Evidence that the hippocampus is necessary for processing context is not, 
however, evidence that it is sufficient for processing context. When the 
hippocampus is damaged, for example, compensating structures acquire learning 
about simple, elemental cues, and minimum processing time is necessary for 
context conditioning to occur but not for elemental cues (Wiltgen, Sanders, 
Anagnostaras, Sage, & Fanselow, 2006). Therefore, one way to determine whether 
study stimuli represented contexts or discrete cues is to determine whether a 
minimum processing time is necessary for conditioning to occur. The present study 
did not make this determination.  
Additional limitations included small sample size. Psychophysiological 
measurements were not analyzed due to technical error. Because spontaneous 
recovery and context renewal fear ratings were taken at the end of each test phase 
during which re-extinction had taken place, these measures failed to capture peak 
fear and return of fear was not demonstrated. However, these ratings provided 
enough variance for discrimination to predict, and fear ratings following re-extinction 
are still informative. While attentional control is one proposed mechanism of 
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impaired discrimination, attentional control was not directly assessed. Future 
research should investigate the relationship between discrimination and attentional 
control, perhaps by using eye tracking to measure of attention during differential 
fear conditioning paradigms. Additionally, generalization of the findings to clinical 
samples warrants investigation. Finally, future studies should investigate whether 
discrimination can be trained in highly anxious individuals and whether this impacts 
fear extinction and return of fear. 
In sum, this study demonstrates that the ability to distinguish between neutral 
and threatening stimuli is an important mechanism through which trait anxiety 
impacts return of fear. It is the first study to show this mediation and is the first 
study to directly investigate the impact of trait anxiety on spontaneous recovery and 
context renewal.  
 
 
STUDY 2 
MOOD INDUCTION, DISCRIMINATION, AND RETURN OF FEAR 
Introduction 
Decreased ability to distinguish between a CS+ and a CS- during fear 
acquisition has been linked with anxiety (e.g., Jovanovic et al., 2013; Lissek et al., 
2014), however the factors impacting this ability are unknown. One factor impacting 
CS+/CS- discrimination may be the mood state of the individual. State affect may 
influence certain processes within fear conditioning. Previous research has 
examined whether induction of positive mood can impact fear conditioning, 
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suggesting that mood induction before extinction learning reduces reinstatement of 
fear (Zbozinek, Holmes, & Craske, 2015). It is thought that positive mood induction 
activates brain regions that are important for extinction learning such as 
ventromedial/medial prefrontal cortex and anterior cingulate cortex (Phan, Wager, 
Taylor, & Liberzon, 2002). Trait positive affect may aid in preventing 
overgeneralization of fear and may bolster the effects of exposure treatment 
(Meulders, Meulders, & Vlaeyen, 2014). Low levels of trait positive affect have been 
associated with a decrease in discrimination between neutral and unsafe stimuli 
(Meulders, Meulders & Vlaeyen, 2014). However, whether positive mood induction 
prior to conditioning affects generalization of fear to neutral stimuli is unknown.  
It has been demonstrated that stress exposure decreases eyeblink 
conditional discrimination (Wolf, Soria Bauser, & Daum, 2012), however whether 
this effect can be attributed to induction of negative affect is unclear. Additionally, 
whether the impact of positive versus negative mood induction on discrimination 
differs has not yet been studied. Emotional response categorization theory predicts 
that, when in an emotional state, individuals will view emotionally valenced stimuli 
as more similar (Niedenthal, Halberstadt, & Innes-Ker, 1999). This is supported by 
Cavanagh and Davey (2001), who found that individuals both in positive and 
negative mood induction groups overestimated the likelihood that a US would 
occur.  
The present study seeks to determine whether mood induction prior to 
conditioning may affect discrimination learning and thereby impact extinction, 
spontaneous recovery, and context renewal. We present two competing 
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hypotheses: First, negative mood induction may impair discrimination, in line with 
prior research that stress induction is associated with decreased discrimination 
(Wolf, Soria Bauser, & Daum, 2012). Additionally, prior research has linked low 
positive affect with decreased ability to discriminate (Meulders, Meulders, & 
Vlaeyen, 2014); it is possible that increased state positive affect may increase 
discrimination. Alternatively, both negative and positive mood inductions may impair 
discrimination, in line with emotional response categorization theory (Niedenthal, 
Halberstadt, & Innes-Ker, 1999), which predicts that any state of emotional arousal 
will lead individuals to perceive emotionally valenced stimuli as more similar.  
 
Method 
Participants 
Participants were undergraduate volunteers who received course credit. 
Participants were excluded under the following conditions: presence of a serious 
medical condition, current treatment for a psychiatric disorder other than an anxiety 
disorder, pregnancy, inability to speak or understand the English language, age 
below 18, hearing difficulties, clinically significant depression (BDI>17), or a 
physician’s recommendation to avoid stressful situations.  
Apparatus and Stimuli 
A picture of a Caucasian male and an Asian female from the NimStim set 
(Tottenham et al., 2009) served as CS’s. Stimuli were presented within a white 
backdrop. Three contexts were used: a “red room”, a “green room,” and a “blue 
room”. Contexts were represented by changing a colored backdrop behind the 
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computer, a colored light providing ambient light, ambient noise (city noises, ocean 
noises, rainforest noises), and objects placed on the desk such as vases and 
plants. Habituation and Acquisition were completed in Context A, Extinction was 
completed in Context B, Spontaneous Recovery was completed in Context B, and 
Context Renewal was completed in a novel Context C. Both context selection and 
selection of which face served as the CS+/CS- were counterbalanced. Each CS 
was presented for 8 seconds and coterminated with the US, which was a 1-second 
scream sound (100 decibels). Stimuli were presented using E-prime software 
(Psychology Software Tools, Inc). Participants were randomized to one of three 
conditions: a positive mood induction, negative mood induction, or neutral condition. 
Mood inductions consisted of 12 commercials designed to elicit positive, negative, 
or neutral affect.  
 
 
Measures 
Participants initially completed the Beck Depression Inventory (BDI; Beck, 
Ward, Mendelson, Mock, & Erbaugh, 1961), however one item regarding suicidal 
ideation was omitted. Participants also completed the Behavioral Inhibition System 
and Behavioral Activation System scales (BIS/BAS), which measure nervous 
anticipation of aversive stimuli, responsiveness to reward, and drive (Carver & 
White, 1994). The Positive and Negative Affect Scale- Expanded Form (PANAS-X), 
which measures trait or state experiences of positive and negative affect was 
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administered initially and following mood induction (Watson, Clark, & Tellegen, 
1988). Finally, a demographics and eligibility questionnaire was administered.  
Participants provided several subjective ratings throughout the experiment. 
To provide US Expectancy ratings, participants used a sliding switch with “Certain 
Noise” on one end, “Certain No Noise” on the other, and “Uncertain” in the center. 
Participants continuously rated the extent to which they expected to hear the US in 
the next few moments, and were instructed to move the switch any time their 
expectancy changed. After each phase, participants provided ratings of fear, 
valence, and arousal in response to each CS on a 0 to 7 likert scale (7= most fear, 
most positive valence, highest arousal).  
Skin conductance response (SCR) was measured using a Biopac MP150 
unit and Acqknowledge 4.3 software (Biopac Systems, Inc., Goleta, CA). Two 
disposable EDA Isotonic Gel electrodes were placed on the intermediate phalanx of 
the index and middle fingers of the non-dominant hand. Baseline SCRs were 
calculated as the average skin conductance (measured in microsiemens) during the 
2 seconds prior to CS presentation, with the peak calculated as the maximum skin 
conductance 1-6 seconds after CS onset. SCRs were range-corrected using the 
highest SCR to the US. Two disposable 1cm Ag-AgCl ECG electrodes were placed 
to monitor participant heart rate. The positive electrode was placed at the bottom-
most rib on the participant’s left side and the negative electrode was placed 
beneath the collarbone of the participant’s right side. Data were acquired at 1000 
samples per second at a line frequency of 60 hz. 
Procedure 
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Study procedures included two visits seven days apart. On Day 1, 
participants initially provided informed consent. They were instructed to sit in front 
of a computer monitor, and electrodes to measure SCR and heart rate were 
attached. Participants were then shown the expectancy ratings dial and instructed 
to rate the extent to which they expected to hear the US in the next few moments, 
and move the dial any time their expectancy changed. The task began with a 2-
minute adjustment period, during which a white screen was presented. Next, the 
Habituation phase was presented, during which each CS was presented 2 times in 
the absence of the US. Throughout the experiment, all CSs were presented in 
random order with the caveat that no stimulus was ever presented more than twice 
in a row. To eliminate impact of ratings on US expectancy prior to acquisition, no 
expectancy ratings were collected during Habituation.  Participants then completed 
questionnaires including the BDI, BISBAS, a demographics questionnaire, and the 
PANAS-X as an index of baseline mood. Participants then viewed 12 commercials 
from one of three conditions: Positive mood induction, Negative mood induction, or 
Neutral. Participants will again complete the PANAS-X as an index of mood 
following the mood induction. Participants then completed the Acquisition phase. 
During the Acquisition phase, each CS was presented 8 times and the CS+ was 
always followed by the US. Participants completed the PANAS-X a third time at this 
stage. During the Extinction phase, each CS was presented 12 times and no USs 
were presented. Participants again completed the PANAS-X following Extinction. 
On Day 8, electrodes were placed again and participants placed the 
headphones around their ears. Participants completed the PANAS-X. They were 
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reminded how to use the ratings box, and the 2-minute baseline period was 
repeated. The Spontaneous Recovery and Context Renewal periods followed, and 
the order of these phases was counterbalanced. During Spontaneous Recovery, 
each CS was presented four times in the same context where Extinction took place. 
During Context Renewal, each CS was presented four times in a novel context.  
Analyses 
 We examined whether groups differed on BDI, BIS, and age using one-way 
ANOVA. Skin conductance values were range-corrected to the maximum SCR to 
the US and square-root transformed. Heart rate was range-corrected to the mean 
heart rate during Habituation. The average of the first 2 trials of Context Renewal 
and Spontaneous Recovery were used. A 2 (CS type: CS+, CS-) x 5 (Phase: 
Beginning of Acquisition, End of Acquisition, End of Extinction, Spontaneous 
Recovery, Context Renewal) repeated measures ANOVA assessed for differential 
acquisition, extinction, spontaneous recovery, and context renewal. To assess for 
mood induction, a paired samples t test was run comparing the PANAS-X pre-mood 
induction to the PANAS-X post mood induction within each group.  
 Discrimination was calculated as CS+/(CS+ + CS-). To assess whether 
discrimination was related to Extinction, Spontaneous Recovery, and Context 
renewal, correlations between discrimination and a) Extinction, b) Spontaneous 
Recovery, and c) Context Renewal were run. One-way ANOVAs were used to 
assess whether groups differed on discrimination and Extinction, Spontaneous 
Recovery, and Context Renewal. 
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 Using PROCESS, a conditional modeling program which utilizes an ordinary 
least squares framework to test direct and indirect effects, we assessed whether 
discrimination mediates the relationship between group and 1) Extinction, 2) 
Spontaneous Recovery, and 3) Context Renewal (Hayes, 2012). The present 
analyses utilized PROCESS Model 4 and bootstrap analyses for mediation. 
Bootstrap estimates used 50,000 repetitions to construct 95% bias-corrected 
confidence intervals. Also using PROCESS, we examined whether discrimination 
mediates the relationship between change in the PANAS-X from Pre-mood 
induction to Post-mood induction and 1) Extinction, 2) Spontaneous Recovery, and 
3) Context Renewal. Finally, correlations were run between PANAS-X scores at the 
end of Extinction and on Day 8 to determine whether they correlate with SCR, Heart 
Rate, US Expectancy, and Fear, Valence, and Arousal ratings following Extinction 
and at Spontaneous Recovery or Context Renewal.  
 Follow up analyses included correlations to examine whether discrimination 
is associated with positive or negative mood change from the beginning of 
Acquisition to the end of Acquisition. Follow up mediation analyses assessed 
whether discrimination mediated between mood change from the beginning of 
Acquisition to the end of Acquisition and Extinction, Context Renewal, and 
Spontaneous Recovery 
Results 
Questionnaires and Age 
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 Differences between groups on questionnaires and age were assessed 
using one-way ANOVA. Groups did not significantly differ on BDI (F(2,91)=.191, 
p=.826), BIS (F(2,91)=1.300, p=.278), or Age (F(2,91)=.479, p=.621).  
Acquisition, Extinction, Spontaneous Recovery, and Context Renewal 
Acquisition, Extinction, Context Renewal, and Spontaneous Recovery were 
analyzed using a 2 (CS+, CS-) x 5 (Phase: beginning of Acquisition, end of 
Acquisition, end of Extinction, Context Renewal, and Spontaneous Recovery) 
repeated measures ANOVA. In instances where sphericity was violated, results are 
reported with the Greenhouse-Geisser correction.  
 Skin conductance. 
 For SCR, there was a main effect of phase (F(2.799, 148.357)= 9.835, 
p<.001, ηp2=.157) and a Phase x CS type interaction (F(2.049, .190)=2.622, 
p=.036, ηp2 = .047). There was no main effect of CS type (F(1, 53)=3.963, 
p=.052, ηp2 =.070), however planned comparisons revealed that SCR to the 
CS+ (M=.304, SE=.026) was significantly higher than SCR to the CS- 
(M=.265, SE=.032) at the end of Acquisition (p=.002). Planned comparisons 
indicated no significant increase in SCR to the CS+ from the beginning to the 
end of Acquisition (p=.401), however there was a significant decrease in SCR 
to the CS+ between the end of Acquisition and the end of Extinction (p<.001). 
There was also a significant decrease in SCR to the CS+ between the 
beginning of Acquisition and the end of Extinction (p<.001). There was a 
significant return of fear to the CS+ from the end of Extinction to Renewal 
(p=.006) and Spontaneous Recovery (p=.004).  Return of fear was specific, 
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as there was no significant return of fear to the CS- between the end of 
Extinction and Renewal (p=.071) or Spontaneous Recovery (p=.502).  
Figure 1: SCR 
 
 Expectancy. 
 For US Expectancy ratings, there was a main effect of phase (F(3.185, 
187.94)= 75.948, p<.001 ηp2=.563), a main effect of CS type (F(1,59)= 101.522, 
p<.001, ηp2=.632), and a Phase x CS type interaction (F(71.816, 186.721)= 81.555, 
p<.001, ηp2=.580). Planned comparisons indicated that there was a significant 
increase in US Expectancy to the CS+ from the beginning of Acquisition to the end 
of Acquisition (p<.001) and a decrease in US Expectancy to the CS+ from the end 
of Acquisition to the end of Extinction (p<.001). There was a significant return of 
fear to the CS+ and CS- from the end of Extinction to Renewal (p<.001) and 
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Spontaneous Recovery (ps<.001). However, return of fear was specific, as 
responding was greater to the CS+ than the CS- in Renewal (p<.001) and in 
Spontaneous Recovery (p<.001).  
Figure 2: US Expectancy 
 
 Heart rate. 
 For Heart Rate, there was no main effect of Phase (F(1.646, 88.863)=.717, 
p=.465, ηp2= .013), no main effect of CS Type (F(1, 54)= 2.000, p=.163, ηp2= .036), 
or Phase x CS Type interaction (F(2.289, 123.623)= .612, p=.565, ηp2=.011).  
Figure 3: Heart Rate 
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 Fear, valence, and arousal ratings.  
 For Fear ratings, there was a main effect of Phase (F(3.459, 238.641)= 
20.715, p<.001, ηp2=.231), a main effect of CS Type (F(1,69)= 61.339, p<.001, 
ηp2=.471), and a Phase x CS Type interaction (F(3.207, 221.294)= 35.578, p<.001, 
ηp2= .340). Planned comparisons indicated that there was a significant increase in 
Fear ratings to the CS+ from the beginning of Acquisition to the end of Acquisition 
(p<.001) and a decrease in Fear ratings to the CS+ from the end of Acquisition to 
the end of Extinction (p<.001). There was a significant return of fear from the end of 
Extinction to Renewal (p=.012) but no significant return of fear from the end of 
Extinction to Spontaneous Recovery (p=.121). Return of fear was not specific, as 
Fear ratings were significantly higher for the CS+ compared to the CS- at the end of 
Renewal (p<.001) and Spontaneous Recovery (p<.001). 
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 For Valence ratings, there was a main effect of Phase (F(3.425, 229.479)= 
25.625, p<.001, ηp2=.277), a main effect of CS Type (F(1,67)= 68.682, p<.001, ηp2= 
.506), and a Phase x CS Type interaction (F(2.361,158.211)= 61.077, p<.001, ηp2= 
.477). Planned comparisons indicated participants rated the CS+ as significantly 
more negative at the end of Acquisition compared to the beginning of Acquisition 
(p<.001), and as significantly less negative at the end of Extinction compared to the 
end of Acquisition (p<.001). There was no significant change in Valence ratings 
from the end of Extinction to Renewal (p=.780) or Spontaneous Recovery (p=.885).  
 For Arousal ratings, there was a main effect of Phase (F(4, 272)= 10.954, 
p<.001, ηp2=.139), a main effect of CS Type (F(1,68)= 52.584, p<.001, ηp2=.436), 
and a Phase x CS Type interaction (F(2.628, 178.712)= 31.493, p<.001, ηp2=.317).  
Planned comparisons indicated that there was a significant increase in Arousal 
ratings to the CS+ from the beginning of Acquisition to the end of Acquisition 
(p<.001), and a significant decrease from the end of Acquisition to the end of 
Extinction (p<.001). There was a significant increase in Arousal ratings to the CS+ 
from the end of Extinction to Renewal (p=.016), and Spontaneous Recovery 
(p=.015). There was also a significant increase in Arousal ratings to the CS- 
between the end of Extinction and Renewal (p=.001) and Extinction and 
Spontaneous Recovery (p=.036). However, return of fear was specific, as Arousal 
ratings to the CS+ were significantly higher than Arousal ratings to the CS- for 
Renewal (p=.001) and Spontaneous Recovery (p<.001).  
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Figure 4: Fear Ratings 
 
 
 
Figure 5: Valence Ratings 
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Figure 6: Arousal Ratings 
 
Mood Induction 
 Mood induction was assessed using paired samples t tests. Within the 
Negative group, scores on the sum of the negative subscales of the PANAS-X 
increased from pre-mood induction to post-mood induction (t(28)=-3.914, p=.001). 
Scores on the sum of the positive subscales of the PANAS-X decreased from pre-
mood induction to post-mood induction (t(28)=4.933, p<.001).   
 Within the Neutral group, scores on the sum of the negative subscales of the 
PANAS-X significantly decreased from pre-mood induction to post-mood induction 
(t(29)=4.289, p<.001). Scores on the sum of the positive subscales of the PANAS-X 
did not significantly change from pre-mood induction to post-mood induction 
(t(29=1.621, p=.116).  
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 Within the Positive group, scores on the sum of the negative subscales of 
the PANAS-X significantly decreased from pre-mood induction to post-mood 
induction (t(30)=6.094, p<.001). Scores on the sum of the positive subscales of the 
PANAS-X increased from pre-mood induction to post-mood induction (t(30)=-2.312, 
p=.028).  
 Using one-way ANOVA, the sum of the negative subscales of the PANAS-X 
significantly differed between groups (F(2,89)=25.708, p<.001).  Planned 
comparisons indicated that the Negative group showed significantly greater 
negative affect than the Neutral group or the Positive group (ps<.001).  The Neutral 
and Positive groups were not significantly different in negative affect (p=.393). The 
sum of the positive subscales of the PANAS-X differed between groups 
(F(2,89)=6.009, p=.004). Planned comparisons indicated that the Positive group 
showed significantly higher positive affect than the Negative group (p=.002), and 
the Neutral group (p=.010).  
 Finally, groups did not differ on the sum of the negative subscales of the 
PANAS-X (F(2,90)=.977, p=.381) or the sum of the positive subscales of the 
PANAS-X (F(2,90)=.352, p=.705) following acquisition.  
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Figure 7: Mood Induction 
 
Discrimination and Extinction, Spontaneous Recovery, and Context Renewal 
 Skin conductance. 
 Discrimination on SCR was not significantly correlated with SCR to the CS+ 
at the end of Extinction (r(78)=-.182, p=.110) or the first two trials of Renewal 
(r(54)=-.228, p=.098). It was not associated with SCR to the CS+ during trials 1, 3, 
or 4 of Renewal (al ps > .137). It was marginally negatively correlated with Renewal 
when averaging across all four trials (r(54)=-.262, p=.055) and was significantly 
negatively correlated when examining the second trial of Renewal (r(54)=-.277, 
p=.042). It was significantly negatively correlated with the first two trials of 
Spontaneous Recovery (r(53)=-.479, p<.001), when averaging all four trials of 
Spontaneous Recovery (r(53)=-.367, p=.007), and when examining trial 1 (r(53)=-
.448, p=.001) and trial 2 (r(53)=-.326, p=.017) of Spontaneous Recovery. It was not 
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significantly correlated with either the 3rd or 4th trial of Spontaneous Recovery (all ps 
> .233).  
It was not significantly correlated with SCR to the CS- at the end of 
Extinction (r(76)=-.005, p=.966). It was negatively correlated with SCR to the first 
two trials of Renewal (r(53)=-.408, p=.002), when averaging all four trials of 
Renewal (r(53)=-.383, p=.004),  when examining the 1st (r(54)=-.357, p=.008),  and 
marginally 3rd trials of Renewal (r(54)=-.255, p-.063). It was not significantly 
correlated with trials 2 or 4 of Renewal (all ps >.220). It was significantly correlated 
with SCR to the average of all 4 trials of Spontaneous Recovery (r(53)=-.351, 
p=.010) and trials 1 (r(53)=-.310, p=.024), 2 (r(53)=-.288, p=.037), marginally 3 
(r(52)=-.265, p=.058, and 4 (r(53)=-.338, p=.013). It was not significantly correlated 
with the first 2 averaged trials of Spontaneous Recovery (r(51)=-.120, p-.402).  
 Expectancy. 
 Discrimination on Expectancy was significantly positively correlated with 
Expectancy to the CS+ at the end of Extinction (r(84)=.277, p=.011). It was not 
significantly correlated with the average of the first 2 trials of Spontaneous 
Recovery, the average of all trials of Spontaneous Recovery, or any individual trial 
(all ps > .356).  It was marginally positively correlated with the first 2 trials of 
Renewal (r(61)=.223, p=.084) and trial 1 of Renewal (r(61)=.341, p=.007), but was 
not correlated with the average of all 4 trials or trials 2, 3, or 4 of Renewal (all ps 
>.113).  
Discrimination on Expectancy was significantly positively correlated with 
Expectancy to the CS- at the end of Extinction (r(84)=.442, p<.001). It was 
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negatively correlated with Expectancy to the CS- for the first 2 trials of Spontaneous 
Recovery (r(60)=-.334, p=.009), all four averaged trials of Spontaneous Recovery 
(r(60)=-.402, p=.001), and trials 2, (r(60)=-.511, p<.001), 3, (r(60)=-.314, p=.015), 
and 4 (r(60)=-.369, p=.004). It was not significantly correlated with trial 1 of 
Spontaneous Recovery (r(60)=-.119, p=.364). It was significantly negatively 
correlated with trial 4 of Renewal (r(61)=-.323, p=.011) and marginally correlated 
with trial 3 (r(61)=-.231, p=.074). It was not significantly correlated with the first 2 
averaged trials of Renewal, all 4 averaged trials, or trials 1 or 2 (all ps >.207). 
Heart rate. 
 Discrimination on Heart Rate was not significantly correlated with Heart Rate 
to the CS+ at the end of Extinction, the first two trials of Renewal, the first two trials 
of Spontaneous Recovery, the average of all four trials of Renewal or Spontaneous 
Recovery, or any individual trial of Renewal or Spontaneous Recovery (all ps > 
.476) with the exception of a marginal positive correlation with Heart Rate to the 
CS+ at trial 2 of Renewal (r(56)=.236, p=.079).   
 Discrimination on Heart Rate was not significantly correlated with Heart Rate 
to the CS- at the end of Extinction, the first two trials of Renewal, the first two trials 
of Spontaneous Recovery, the average of all four trials of Renewal or Spontaneous 
Recovery, or any individual trial of Renewal or Spontaneous Recovery (all ps > 
.280).  
 Fear, valence, and arousal ratings.  
 Discrimination on Fear ratings was not significantly correlated with Fear 
ratings to the CS+ at the end of Extinction (r(90)=-.173, p=.102), Renewal (r(70)=-
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.031, p=.801),  or Spontaneous Recovery (r(70)=-.192 p=.111). It was significantly 
negatively correlated with Fear ratings to the CS- at the end of Extinction (r(90)=-
.531, p<.001), Renewal (r(70)=-.272, p=.023), and Spontaneous Recovery (r(70)=-
.466, p<.001).  
 Discrimination on Valence ratings was significantly positively correlated with 
Valence ratings to the CS+ at Renewal (r(70)=.245, p=.041). It was not significantly 
correlated with Valence ratings to the CS+ at the end of Extinction (r(90)=.065, 
p=.546) or Spontaneous Recovery (r(70)=-.034 p=.779). It was significantly 
negatively correlated with Valence ratings to the CS- at the end of Extinction 
(r(90)=-.278, p=.008) and Spontaneous Recovery (r(70)=-.285, p=.017). It was not 
significantly correlated with Valence ratings at Renewal (r(70)=-.51, p=.675).  
 Discrimination on Arousal ratings was negatively correlated with Arousal 
ratings to the CS+ at the end of Extinction (r(90)=-.247, p=.019). It was not 
significantly correlated with Arousal ratings at Renewal (r(70)=-.089, p=.462) or 
Spontaneous Recovery (r(79)=.060, p=.624). It was significantly negatively 
correlated with Arousal ratings to the CS- at the end of Extinction (r(90)=-.393, 
p<.001). It was not significantly correlated with Arousal ratings to the CS- at 
Renewal (r(70)=-.165, p=.171) or Spontaneous Recovery (r(70)=-.123, p=.309).  
 
Group Differences in Extinction, Spontaneous Recovery, and Context 
Renewal 
 Skin conductance. 
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 Using one-way ANOVA, groups did not differ on SCR to the CS+ at the end 
of Extinction, the first two trials of Renewal, the first two trials of Spontaneous 
Recovery, when averaging across all four trials of Renewal and Spontaneous 
Recovery, or when examining each trial individually (all ps>.268).  
 Groups marginally differed on SCR to the CS- at the end of Extinction (F(2, 
82)=3.068, p=.052). The Negative group showed marginally greater SCR than the 
Neutral group (p=.053) and significantly greater SCR than the Positive group 
(p=.024). Neutral and Positive groups did not differ on SCR at the end of Extinction 
(p=.706). Groups did not differ on SCR to the CS- across the first two trials of 
Renewal, the first two trials of Spontaneous Recovery, when averaging across all 
four trials of Renewal and Spontaneous Recovery, or when examining each trial 
individually (all ps > .165).  
 Paired samples t tests showed that the average SCR to CS+ at Habituation 
(M=.30, SE=.02) was significantly lower than SCR to CS+ at the beginning of 
Acquisition (M=.39, SE=.03, t(86)=-3.183, p=.002) and SCR to CS+ at the end of 
Acquisition (t(86)=-2.511, p=.014). Average SCR to the CS- at Habituation (M=.32, 
SE=.03) was significantly lower than SCR to CS- at the beginning of Acquisition 
(M=.45, SE=.04, t(86)=-3.011, p=.003) and significantly higher than SCR to CS- at 
the end of Acquisition (M=.26, SE=.03, t(86)=2.053, p=.043).   
Expectancy. 
Using one-way ANOVA, groups did not differ on Expectancy to the CS+ or 
CS- at the end of Extinction, the first two trials of Renewal, the first two trials of 
Spontaneous Recovery, when averaging across all four trials of Renewal and 
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Spontaneous Recovery, or when examining each trial individually (all ps> .119), 
with the exception of a marginal difference among groups during the first trial of 
Renewal for the CS- (F(2, 60)=2.449, p=.095). The Negative group showed 
marginally higher Expectancy than the Positive group (p=.053) and the Positive 
group showed marginally higher Expectancy than the Neutral group (p=.065). The 
Negative and Neutral groups did not show significantly different Expectancy to the 
CS- (p=.821). 
 Heart rate. 
 Using one-way ANOVA, groups differed on Heart Rate to the CS+ at the end 
of Extinction (F(2,80)=3.426, p=.037). The Negative group showed significantly 
lower heart rate than the Positive group (p=.014) and the Neutral group showed 
marginally lower heart rate than the Positive group (p=.066). The Negative group 
did not show significantly different heart rate than the Neutral group (p=.489).  Heart 
Rate to the CS+ and CS- did not otherwise differ among groups for Extinction, the 
first 2 trials of Renewal or Spontaneous Recovery, all averaged trials of Renewal or 
Spontaneous Recovery, or any individual trial of Renewal or Spontaneous 
Recovery (all ps > .252).  
 Fear, valence, and arousal ratings.  
 Using one-way ANOVA, groups did not differ on Fear ratings to the CS+ or 
CS- at the end of Extinction, Renewal, or Spontaneous Recovery (all ps >.179).  
Groups did not differ on Valence ratings to the CS+ or CS- at the end of Extinction, 
Renewal, or Spontaneous Recovery (all ps > .486). Groups did not differ on Arousal 
ratings to the CS+ or CS- at the end of Extinction, Renewal, or Spontaneous 
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Recovery (all ps > .206), with the exception of Arousal to the CS- at Extinction (F(2, 
89)=2.931, p=.059. Positive group participants showed increased arousal to the 
CS- at the end of Extinction compared to the Negative group (p=.018). The 
Negative and Neutral groups did not differ, and the Neutral and Positive groups did 
not differ (all ps > .187).  
Mediation Analyses 
Cases in which Discrimination significantly predicted outcomes are listed in tables 1 
and 2. See appendices for tables for mediation results. 
 
Table 1: Discrimination predicting outcomes: CS+ x= n.s. neg = negative 
prediction pos = positive prediction - = no analysis 
 Skin 
Conductance Expectancy 
Heart 
Rate 
Fear 
Ratings 
Valence 
Ratings 
Arousal 
Ratings 
Extinction  
CS+ X Pos X X X Neg 
Context Renewal 
Averaged CS+ X X X X Pos X 
Context Renewal 
Trial 1 CS+ X Pos X - - - 
Context Renewal 
Trial 2 CS+ X X X - - - 
Context Renewal 
Trial 3 CS+ X X X - - - 
Context Renewal 
Trial 4 CS+ X X X - - - 
Spontaneous Recovery 
Averaged CS+ Neg X X X X X 
Spontaneous Recovery 
Trial 1 CS+ Neg X X - - - 
Spontaneous Recovery 
Trial 2 CS+ Neg X X - - - 
Spontaneous Recovery 
Trial 3 CS+ X X X - - - 
Spontaneous Recovery 
Trial 4 CS+ X X X - - - 
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Table 2: Discrimination predicting outcomes: CS- x= n.s. neg = negative 
prediction pos = positive prediction - = no analysis 
 Skin 
Conductance Expectancy 
Heart 
Rate 
Fear 
Ratings 
Valence 
Ratings 
Arousal 
Ratings 
Extinction  
CS- X Pos X Neg Neg Neg 
Context Renewal 
Averaged CS- Neg X X X X X 
Context Renewal 
Trial 1 CS- Neg X X - - - 
Context Renewal 
Trial 2 CS- X X X - - - 
Context Renewal 
Trial 3 CS- X X X - - - 
Context Renewal 
Trial 4 CS- X Neg X - - - 
Spontaneous Recovery 
Averaged CS- Neg Neg X Neg Neg X 
Spontaneous Recovery 
Trial 1 CS- Neg X X - - - 
Spontaneous Recovery 
Trial 2 CS- Neg Neg X - - - 
Spontaneous Recovery 
Trial 3 CS- X Neg X - - - 
Spontaneous Recovery 
Trial 4 CS- Neg Neg X - - - 
 
 
Group and extinction, spontaneous recovery, and context renewal. 
 Skin conductance. 
 Mediation analyses indicated that SCR Discrimination did not mediate the 
relationship between Group and SCR to the CS+ or CS- at Extinction, Context 
Renewal, or Spontaneous Recovery. All indirect effects were nonsignificant with the 
exception of some indirect effects detected for Spontaneous Recovery. In the 
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absence of significant a paths, these indirect effects reflect a type I error. 
Throughout each phase, Discrimination occasionally negatively predicted SCR. 
Rare significant direct and total effects reflect Type I error.   
Expectancy. 
 Expectancy Discrimination did not mediate the relationship between Group 
and Expectancy to the CS+ or CS- at Extinction, Context Renewal, or Spontaneous 
Recovery. All indirect, direct, and total effects were nonsignificant. Throughout each 
phase, Discrimination occasionally negatively or positively predicted Expectancy.  
Heart rate. 
Heart Rate Discrimination did not mediate the relationship between Group 
and Heart Rate to the CS+ or CS- at Extinction, Context Renewal, or Spontaneous 
Recovery. All indirect, direct, and total effects were nonsignificant with rare 
exceptions that represent Type I error. Discrimination did not predict Heart Rate at 
any phase. 
Fear, valence, and arousal ratings.  
 Fear, Valence, and Arousal ratings Discrimination did not mediate the 
relationship between Group and ratings to the CS+ or CS- at Extinction, Context 
Renewal, or Spontaneous Recovery. All indirect, direct, and total effects were 
nonsignificant with rare exceptions that represent a Type I error. Discrimination 
occasionally negatively predicted Fear and Arousal ratings-, and positively or 
negatively predicted Valence ratings.  
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Mood change from pre to post mood induction and extinction, 
spontaneous recovery, and context renewal. 
 Skin conductance. 
SCR Discrimination did not mediate the relationship between Positive or 
Negative Mood Change and SCR at Extinction, Spontaneous Recovery, or Context 
Renewal for the CS+ or CS-. Total, indirect, and direct effects were nonsignificant. 
Discrimination occasionally negatively predicted SCR. 
Expectancy. 
Expectancy Discrimination did not mediate the relationship between Positive 
or Negative Mood Change and Expectancy at Extinction, Spontaneous Recovery, 
or Context Renewal for the CS+ or CS-. Total, indirect, and direct effects were 
nonsignificant. Discrimination occasionally positively or negatively predicted 
Expectancy. 
 Heart rate. 
Heart Rate Discrimination did not mediate the relationship between Positive 
or Negative Mood Change and Heart Rate at Extinction, Spontaneous Recovery, or 
Context Renewal for the CS+ or CS-. Total, indirect, and direct effects were 
nonsignificant. Discrimination rarely positively predicted Heart Rate. 
 Fear, valence, and arousal ratings.  
Fear, Valence, and Arousal ratings Discrimination did not mediate the 
relationship between Positive or Negative Mood Change and ratings at Extinction, 
Context Renewal, or Spontaneous Recovery for the CS+ or CS-. All total, direct, 
and indirect effects were nonsignificant. Discrimination occasionally negatively 
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predicted Fear and Arousal ratings, and occasionally negatively or positively 
predicted Valence ratings.  
 
Mood and Outcomes Correlations 
 Skin conductance. 
 The sum of the Positive subscales of the PANAS-X at the end of Extinction 
was not correlated with SCR for the CS+ or CS- at the end of Extinction, for the first 
2 trials of Context Renewal, for the first 2 trials of Spontaneous Recovery, all trials 
of Context Renewal, all trials of Spontaneous Recovery, or any individual trial of 
Context Renewal or Spontaneous Recovery (all ps>.208), with the exception of a 
marginal positive correlation with SCR to the CS- at the end of extinction (r(85)=.24, 
p=.027). None of these measures correlated with the sum of the Negative 
subscales of the PANAS-X at the end of Extinction (all ps>.094). 
 The sum of Positive subscales of the PANAS-X on Day 8 was marginally 
negatively correlated with SCR at the first trial of Spontaneous Recovery for the 
CS- (r(57)=-.239, p=.074) and SCR at the average of all four trials of Context 
Renewal for the CS+ (r(57)=-.239, p=.071). With these exceptions, the sum of the 
Positive subscales of the PANAS-X on Day 8 was not significantly correlated with 
SCR for the CS+ or CS- at the end of Extinction, for the first 2 trials of Context 
Renewal, for the first 2 trials of Spontaneous Recovery, all trials of Context 
Renewal, all trials of Spontaneous Recovery, or any other individual trial of Context 
Renewal or Spontaneous Recovery (all ps>.096).  
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 The sum of the Negative subscales of the PANAS-X at Day 8 was not 
correlated with SCR for the CS+ or CS- at the end of Extinction, for the first 2 trials 
of Context Renewal, for the first 2 trials of Spontaneous Recovery, all trials of 
Context Renewal, all trials of Spontaneous Recovery, or any individual trial of 
Context Renewal or Spontaneous Recovery (all ps>.325). 
 Expectancy. 
 The sum of the Positive subscales of the PANAS-X at the end of Extinction 
was marginally negatively correlated with Expectancy at the third trial of 
Spontaneous Recovery for the CS+ (r(60)=-.249, p=.055). With this exception, the 
sum of the Positive subscales of the PANAS-X at the end of Extinction was not 
correlated with Expectancy for the CS+ or CS- at the end of Extinction, for the first 2 
trials of Context Renewal, for the first 2 trials of Spontaneous Recovery, all trials of 
Context Renewal, all trials of Spontaneous Recovery, or any individual trial of 
Context Renewal or Spontaneous Recovery (all ps>.088). None of these measures 
correlated significantly with the sum of the Negative subscales of the PANAS-X at 
the end of Extinction (all ps>.151). 
The sum of the Positive subscales of the PANAS-X at Day 8 was not 
correlated with Expectancy for the CS+ or CS- at the end of Extinction, for the first 2 
trials of Context Renewal, for the first 2 trials of Spontaneous Recovery, all trials of 
Context Renewal, all trials of Spontaneous Recovery, or any individual trial of 
Context Renewal or Spontaneous Recovery (all ps>.146).  
The sum of the Negative subscales of the PANAS-X at Day 8 was marginally 
positively correlated with Expectancy to the CS+ at the average of all four trials of 
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Spontaneous Recovery (r(60)=.246, p=.058), and at the third (r(60)=.283, p=.028) 
and fourth (r(60)=.392, p=.002) trials of Spontaneous Recovery. The sum of the 
Negative subscales of the PANAS-X at Day 8 was not correlated with Expectancy 
for the CS+ or CS- at the end of Extinction, for the first 2 trials of Context Renewal, 
for the first 2 trials of Spontaneous Recovery, all trials of Context Renewal, all trials 
of Spontaneous Recovery, or any individual trial of Context Renewal or 
Spontaneous Recovery (all ps>.082).  
 Heart rate. 
The sum of the Positive subscales of the PANAS-X at the end of Extinction 
was not correlated with Heart Rate for the CS+ or CS- at the end of Extinction, for 
the first 2 trials of Context Renewal, for the first 2 trials of Spontaneous Recovery, 
all trials of Context Renewal, all trials of Spontaneous Recovery, or any individual 
trial of Context Renewal or Spontaneous Recovery (all ps>.175). 
The sum of the Negative subscales of the PANAS-X at the end of Extinction 
was not correlated with Heart Rate for the CS+ or CS- at the end of Extinction, for 
the first 2 trials of Context Renewal, for the first 2 trials of Spontaneous Recovery, 
all trials of Context Renewal, all trials of Spontaneous Recovery, or any individual 
trial of Context Renewal or Spontaneous Recovery (all ps>.086). 
The sum of the Positive subscales of the PANAS-X at Day 8 was not 
correlated with Heart Rate for the CS+ or CS- at the end of Extinction, for the first 2 
trials of Context Renewal, for the first 2 trials of Spontaneous Recovery, all trials of 
Context Renewal, all trials of Spontaneous Recovery, or any individual trial of 
Context Renewal or Spontaneous Recovery (all ps>.216). 
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The sum of the Negative subscales of the PANAS-X at Day 8 was not 
correlated with Heart Rate for the CS+ or CS- at the end of Extinction, for the first 2 
trials of Context Renewal, for the first 2 trials of Spontaneous Recovery, all trials of 
Context Renewal, all trials of Spontaneous Recovery, or any individual trial of 
Context Renewal or Spontaneous Recovery (all ps>.420). 
 Fear, valence, and arousal ratings.  
 The sum of the Positive subscales of the PANAS-X at the end of Extinction 
was positively correlated with Valence ratings to the CS- at the end of Extinction 
(r(90)=.360, p=.001), Valence ratings to the CS+ at the end of Extinction 
(r(90)=.386, p<.001), negatively correlated with Fear ratings to the CS+ at the end 
of Extinction (r(90)=-.222, p=.386, p<.001), and positively correlated with Valence 
ratings to the CS+ at Context Renewal (r(70)=.253, p=.035). With those exceptions, 
ratings for Fear, Valence, and Arousal to the CS+ or CS- at any phase were not 
correlated with the sum of the Positive subscales of the PANAS-X  at the end of 
Extinction (all ps>.112). The sum of the Negative subscales of the PANAS-X at the 
end of Extinction was not correlated with any Fear, Valence, or Arousal ratings to 
the CS+ or CS- at any phase (all ps>.112). 
 The sum of the Positive subscales of the PANAS-X at Day 8 was 
significantly negatively correlated with Fear ratings to the CS- at the end of 
Extinction (r(70)=-.258, p=.031), Fear ratings to the CS+ at the end of Extinction 
(r(70)=-.292, p=.014), positively correlated with Valence ratings to the CS- at the 
end of Extinction (r(70)=.287, p=.016), and positively correlated with Valence 
ratings to the CS- at Spontaneous Recovery (r(67)=.325, p=.007). It was marginally 
		 66	
positively correlated with Valence ratings to the CS+ at Context Renewal 
(r(67)=.225, p=.067). No other correlations between the sum of the Positive 
subscales of the PANAS-X at Day 8 and Fear, Valence, or Arousal ratings at any 
phase emerged (all ps>.124). The sum of the Negative subscales of the PANAS-X 
was negatively correlated with Valence ratings to the CS+ at Spontaneous 
Recovery (r(67)=-.292, p=.017), positively correlated with Fear ratings to the CS+ at 
Spontaneous Recovery (r(67)=.271, p=.027), and positively correlated with Arousal 
ratings to the CS+ at Spontaneous Recovery (r(67)=.317, p=.009). With these 
exceptions, the sum of the Negative subscales of the PANAS-X was not correlated 
with Fear, Valence, or Arousal ratings at any phase (all ps>.088).  
 
Follow Up Analyses: Correlations Between Mood Change and Discrimination 
 Correlations revealed that change in the sum of the Positive subscales of the 
PANAS-X from pre to post mood induction was not correlated with any measure of 
discrimination (all ps>.439). Change in the sum of the Negative subscales of the 
PANAS-X from pre to post mood induction was not correlated with any measure of 
discrimination (all ps>.122). 
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Follow Up Analyses: Mediation of Discrimination Between Change in Affect 
from the Beginning of Acquisition to the End of Acquisition and Extinction, 
Context Renewal, and Spontaneous Recovery  
Skin conductance. 
SCR Discrimination did not mediate the relationship between Positive or 
Negative Acquisition mood change and SCR at Extinction, Context Renewal, or 
Spontaneous Recovery for the CS+ or CS-. All total, and direct effects were 
nonsignificant. Discrimination occasionally negatively predicted SCR. 
Expectancy. 
Expectancy Discrimination did not mediate the relationship between Positive 
or Negative Acquisition mood change and Expectancy at Extinction, Context 
Renewal, or Spontaneous Recovery for the CS+ or CS-. All total, and direct effects 
were nonsignificant. Discrimination occasionally positively or negatively predicted 
Expectancy. 
Heart rate. 
Heart Rate Discrimination did not mediate the relationship between Positive 
or Negative Acquisition Mood Change and Heart Rate at Extinction, Context 
Renewal, or Spontaneous Recovery for the CS+ or CS-. All total, and direct effects 
were nonsignificant. Discrimination occasionally negatively or positively predicted 
Heart Rate. 
Fear, valence, and arousal ratings.  
Fear, Valence, and Arousal ratings Discrimination did not mediate the 
relationship between Positive or Negative Acquisition Mood Change and ratings at 
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Extinction, Context Renewal, or Spontaneous Recovery for the CS+ or CS-. All 
total, direct, and indirect effects were nonsignificant. Discrimination occasionally 
negatively or positively predicted ratings. 
 
Fear, Valence, and Arousal Correlations 
 At Habituation, for the CS-, Fear and Arousal ratings were positively 
correlated (r(93)=.261, p=.012), Fear and Valence ratings were not correlated 
(r(93)=-.144, p=.165), and Arousal and Valence ratings were positively correlated 
(r(93)= .225, p=.030). For the CS+, Fear and Arousal ratings were positively 
correlated (r(93)=.336, p=.001), Fear and Valence Ratings were negatively 
correlated (r(93)=-.368, p<.001), and Arousal and Valence ratings were not 
correlated (r(93)=.015, p=.889). 
 At Acquisition, for the CS-, Fear and Arousal ratings were positively 
correlated (r(93)=.664, p<.001), Fear and Valence ratings were negatively 
correlated (r(93)=-.564, p<.001), and Arousal and Valence ratings were negatively 
correlated (r(93)=-.580, p<.001). For the CS+, Fear and Arousal ratings were 
positively correlated (r(93)=.508, p<.001), Fear and Valence Ratings were 
negatively correlated (r(93)=-.568, p<.001), and Arousal and Valence ratings were 
negatively correlated (r(93)=-.384, p<.001). 
 At Extinction, for the CS-, Fear and Arousal ratings were positively correlated 
(r(93)=.573, p<.001), Fear and Valence ratings were negatively correlated (r(93)=-
.381, p<.001), and Arousal and Valence ratings were negatively correlated (r(93)=-
.298, p=.004). For the CS+, Fear and Arousal ratings were positively correlated 
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(r(93)=.656, p<.001), Fear and Valence Ratings were negatively correlated (r(93)=-
.375, p<.001), and Arousal and Valence ratings were negatively correlated (r(93)=-
.318, p=.002). 
 At Spontaneous Recovery, for the CS-, Fear and Arousal ratings were 
positively correlated (r(71)= .399, p=.001), Fear and Valence ratings were 
negatively correlated (r(71)=-.312, p=.008, and Arousal and Valence ratings were 
not correlated (r(71)=-.009, p=.942). For the CS+, Fear and Arousal ratings were 
positively correlated (r(71)= .543, p<.001), Fear and Valence Ratings were 
negatively correlated (r(71)=-.525, p<.001), and Arousal and Valence ratings were 
negatively correlated (r(71)= -.302, p=.011). 
 At Context Renewal, for the CS-, Fear and Arousal ratings were positively 
correlated (r(71)=.362, p=.002), Fear and Valence ratings were negatively 
correlated (r(71)= -.313, p=.008), and Arousal and Valence ratings were not 
correlated (r(71)=.077, p=.525). For the CS+, Fear and Arousal ratings were 
positively correlated (r(71)=.551, p<.001), Fear and Valence Ratings were 
negatively correlated -.493, p<.001), and Arousal and Valence ratings were 
negatively correlated (r(71)=-.359, p=.002). 
 
Discussion 
The present study examined whether a mood induction prior to conditioning 
is associated with discrimination learning, and whether discrimination learning 
impacts extinction, spontaneous recovery, and context renewal. Our competing 
hypotheses were 1) negative mood induction would impair discrimination, or 2) both 
		 70	
negative and positive mood inductions would impair discrimination. Neither of our 
competing hypotheses was supported: mood induction was not associated with 
discrimination and, while there was limited and inconsistent support for a 
relationship between discrimination and fear at extinction, context renewal, and 
spontaneous recovery, neither positive nor negative mood prior to acquisition 
impacted these outcomes.  
Ratings data provided inconsistent evidence of acquisition, extinction, and 
return of fear. Ratings of US expectancy and arousal ratings revealed clear fear 
acquisition, extinction, context renewal, and spontaneous recovery. For fear ratings, 
however, while acquisition, extinction, and context renewal were demonstrated, 
spontaneous recovery was not. Similarly, valence ratings revealed significant 
acquisition and extinction but not context renewal or spontaneous recovery. Return 
of fear was not reliably observed among subjective ratings. This may be due to re-
extinction during test phases as fear, valence, and arousal ratings were taken at the 
end of context renewal and spontaneous recovery. Additionally, it should be noted 
that measures of fear, valence, and arousal were correlated across all study phases 
and may represent the same construct. 
Physiological indices produced more complex findings regarding 
conditioning, extinction, and return of fear. For SCR, no significant difference from 
the beginning to the end of acquisition was observed, although SCR to the CS+ 
was greater than SCR to the CS- at the end of acquisition. This may reflect failure 
of the CS+ to evoke a fear response by the end of extinction, however skin 
conductance at the beginning of acquisition was significantly higher than skin 
		 71	
conductance at the end of extinction; this suggests that skin conductance was 
elevated before fear learning ever took place. This consistently elevated 
physiological responding prior to formal fear conditioning may be explained by the 
demand characteristics of the study: participants were informed they would receive 
an aversive stimulus at some point in the task, potentially producing an immediate 
increase in physiological reactivity before associative learning. Skin conductance 
was lower at habituation than at the beginning of acquisition for both the CS+ and 
CS-, which does not support this explanation, however participants did not have 
headphones on during habituation and elevated reactivity due to task demands may 
not have occurred until participants placed the headphones on. 
 Extinction was demonstrated through a decrease in SCR from the end of 
acquisition to the end of extinction. It should be noted that not only was skin 
conductance significantly higher at the end of acquisition compared to the end of 
extinction but also higher at the beginning of acquisition compared to the end of 
extinction. While there was no main effect of CS type (which would indicate 
differential learning at the task level) SCR to the CS+ was greater than SCR to the 
CS- at the end of acquisition, indicating differential acquisition. This planned 
comparison should be interpreted with caution in the absence of a main effect of CS 
type. A measure of Heart Rate did not demonstrate significant acquisition, 
extinction, or return of fear, thus Heart Rate results should be interpreted with 
caution. 
Mood inductions within each group were successful with a few caveats. For 
the Negative group, negative affect increased from pre-mood induction to post-
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mood induction, however this was not specific to negative affect: positive affect 
decreased from pre-mood induction to post-mood induction. For the Positive group, 
negative affect decreased and positive affect increased. For the Neutral group, a 
decrease in negative affect was observed, calling into question whether this 
condition differed from the Positive group. Follow-up comparisons did not reveal 
significant differences between the Neutral group and the Positive group on overall 
negative affect, however individuals in the Positive group showed significantly 
higher positive affect than those in the Neutral or Negative groups, thus we 
proceeded with group comparisons. 
Analyses of skin conductance, US expectancy, heart rate, and fear, valence, 
and arousal ratings revealed no significant differences between groups on 
extinction, context renewal, or spontaneous recovery, with the following exceptions: 
The Negative group showed significantly lower heart rate than the Positive group at 
the end of Extinction, and participants in the negative group showed higher SCR at 
the end of extinction than participants in the positive group.  
Analyses investigating whether discrimination between the CS+ and CS- 
predicted extinction and return of fear were inconclusive. Discrimination on each 
index occasionally negatively predicted these outcomes. Based on this limited 
support for an association between discrimination and extinction, context renewal, 
and spontaneous recovery, we proceeded with mediation analyses.  
Mediation analyses revealed that discrimination did not mediate between 
group and extinction, context renewal, or spontaneous recovery. Furthermore, 
discrimination did not mediate between mood change from pre-mood induction to 
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post-mood induction and these outcomes. Under some circumstances, when 
controlling for group or mood change, discrimination predicted extinction, context 
renewal, and spontaneous recovery, however this effect was not consistent. Finally, 
mood following extinction was not associated with any of these outcomes, with few 
exceptions. For example, positive mood at the end of extinction was positively 
correlated with valence ratings to the CS+ and CS- at the end of extinction and 
negatively correlated with fear ratings to the CS+ at the end of extinction. 
Additionally, with few exceptions, mood on day 8 was not associated with these 
outcomes.  
At first glance, these results appear to suggest that affect does not impact 
discrimination between a CS+ and CS-. However, it is possible that the process of 
fear conditioning itself acted as a negative mood induction, eliminating the impact of 
viewing positive or negative videos prior to acquisition. Indeed, prior research 
shows that exposure to the US over several trials is experienced as aversive, and, 
by this mechanism, perceptual accuracy is impaired and discrimination is 
decreased (e.g., Struyf, Zaman, Vervliet, & Van Diest, 2015). For example, previous 
studies have demonstrated that aversive conditioning using a variety or USs 
impacts the ability to distinguish between a CS+ (such as a tone) and similar neutral 
stimuli (such as tones of a similar but different frequency), suggesting a relationship 
between affect and discrimination (Laufer & Paz, 2012; Resnik et al., 2011; 
Schechtman et al., 2010).  
In support of this, while group differences in affect were observed 
immediately following the mood induction, different groups showed similar affect 
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immediately following acquisition. We investigated whether positive or negative 
mood change during acquisition was associated with any measure of 
discrimination, however no relationship was found. Discrimination did not mediate 
between mood change from pre-acquisition to post-acquisition and extinction, 
spontaneous recovery, or context renewal. This may be due to limited variability on 
subjective indices of conditioning or mood change. 
Additionally, while the present study utilized several elements to simulate 
context, it was not determined whether these cues were processed as context or as 
discrete cues using a test of immediate shock deficit (Wiltgen, Sanders, 
Anagnostaras, Sage, & Fanselow, 2006). 
In sum, the current findings suggest that, while discrimination between a 
CS+ and CS- may be associated with changes in extinction and return of fear, 
affect may or may not impact this discrimination and thus impact extinction and 
return of fear. However, affect prior to fear conditioning does not impact these 
outcomes due to the mood change induced by the experience of the US.  
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STUDY 3 
DIFFERENTIAL BRAIN ACTIVATION IN RESPONSE TO NEUTRAL AND 
UNSAFE STIMULI, EXTINCTION LEARNING AND RECALL  
Introduction 
Previous studies have examined the neural underpinnings of Pavlovian fear 
conditioning. Few studies, however, have examined the neural underpinnings of 
differentiation between neutral and unsafe stimuli during fear conditioning and their 
relationship with self-reported fear, extinction and return of fear as measured by 
physiological indices.  
A network of brain regions may be responsible for differentially processing 
the CS- as a neutral cue and the CS+ as a cue signaling danger. These regions 
may include the insular cortex, hippocampus, dorsal anterior cingulate cortex, and 
ventromedial prefrontal cortex (Fullana et al., 2016). According to Fullana et al. 
(2016), insula and dACC may show higher activation to the CS+ relative to the CS- 
while hippocampus and vmPFC may show higher activation to the CS- relative to 
the CS+. Whether this differentiation may mediate the relationship between fear 
symptoms and extinction and return of fear as measured by physiological indices 
has not yet been studied.  
The amygdala is a structure that is essential in fear conditioning processes 
(e.g., Zimmerman, Rabinak, McLachlan, & Maren, 2007). During differential 
Pavlovian fear conditioning, differential amygdala activity has been demonstrated in 
animals (Collins & Paré, 2000) and humans such that activation is greater in the 
presence of the CS+ than the CS- (Buchel et al., 1998; Buchel et al., 1999; Cheng, 
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Knight, Smith, & Helmstetter, 2006; LaBar et al., 1998). It is unknown whether the 
magnitude of this difference is predicted by anxiety or predicts extinction and return 
of fear.  
This investigation examined whether smaller differences in brain activation 
when presented the CS+ versus the CS- (i.e., decreased discrimination) 
accompany greater fear symptoms. Additionally, this study investigated whether 
this differentiation between the CS+ and the CS- can predict extinction learning and 
recall as measured by skin conductance to determine whether poor discrimination 
predicts poorer extinction and greater return of fear. We hypothesized that the 
following regions will show greater activation in the presence of the CS+ relative to 
the CS- and that smaller differences will accompany greater anxiety symptoms: 1) 
amygdala, 2) dorsal anterior cingulate cortex, and 3) insula. 
We hypothesized that regions showing greater deactivation in the presence 
of the CS- relative to the CS+ would include 1) ventromedial prefrontal cortex, and 
2) hippocampus. We predicted that smaller deactivation would accompany greater 
anxiety symptoms. Finally, it was predicted that that the magnitude of these 
differences will positively predict decrease in skin conductance response to the CS+ 
from the beginning to the end of extinction and negatively predict skin conductance 
response to the CS+ at test of extinction recall.  
These regions were selected based on a meta analysis by Fullana et al., 
(2016) as well as previous work implicating the amygdala, (e.g., Zimmerman, 
Rabinak, McLachlan, & Maren, 2007) dorsal anterior cingulate cortex, insula (e.g., 
Linnman, Rougemont-Bücking, Beucke, Zeffiro, & Milad, 2011), ventromedial 
		 77	
prefrontal cortex, and hippocampus (e.g., Moustafa et al., 2013) in anxiety and fear 
conditioning processes.  
Methods 
Participants 
Participants were right-handed young adults aged 18-19 recruited via 
advertisements and social media. Exclusion criteria included contraindications to 
fMRI (i.e., claustrophobia, irremovable metal), smoking cigarettes, consumption of 
more than 10 caffeinated beverages per day, traumatic brain injury, psychosis, and 
severe substance abuse. To increase the probability of elevated scores on anxiety 
measures, participants were oversampled for neuroticism.  
Apparatus and Stimuli 
Participants completed a widely-utilized differential Pavlovian Fear Learning 
Task (Milad et al., 2009; Milad et al., 2007). Stimuli were presented using E-prime 
software (Schneider, Eschman, & Succolotto, 2002). Participants were presented 
with a context picture of an office containing a lamp, which changes colors to 
represent each CS. Three colors of the lamp served as CSs: A CS+U which 
predicted the US 60% of the time and was never extinguished, a CS+E which 
predicted the US 60% of the time and is extinguished, and a CS- which never 
predicted the US. The colors that represent the CS+U, CS+E and CS- were 
counterbalanced. The US was a shock that will be calibrated to each individual 
participant to reach a level the participant rates his or her discomfort as a 7 out of 
10. Participants received a total of 10 pulses of 1ms pulse duration delivered at 
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20Hz frequency (total shock duration = 500ms). Shocks were delivered using a 
DS7a constant current high voltage stimulator (Digitimer Ltd, England).   
Measures 
A Prisma 3.0 Tesla MRI scanner with a 64-channel gradient head coil 
was used (Siemens Medical Systems, Iselin, New Jersey). We acquired high 
resolution structural images (T1-weighted) using a magnetized prepared rapid 
acquisition gradient echo (MPRAGE) sequence containing 0.8mm isotropic 
voxels, TR/TE/flip angle=2300ms/2.99ms/7°, FOV= 256mm2, 208 slices.  
Using the Siemens AutoAlign function, blood oxygenation level-dependent 
(BOLD, T2*-weighted) functional images were acquired parallel to the AC-PC 
line, containing 2mm isotropic voxels, TR/TE/flip angle=2000ms/25ms/80°, 
FOV = 208mm2, 64 slices, 380 volumes (per task phase). 
Skin conductance response (SCR)  and heart rate (HR) were measured 
using a Biopac MP100A-CE unit with one GSR100C amplifier and one pulse 
oximeter OXY100C amplifier attached, and Acqknowledge 3.9.2 software (Biopac 
Systems, Inc., Goleta, CA). Two disposable EDA Isotonic Gel electrodes were 
placed on the medial phalanx of the index and middle fingers of the non-dominant 
hand. Baseline SCRs were calculated as the average skin conductance (measured 
in microsiemens) during the 2 seconds prior to CS presentation, with the peak 
calculated as the maximum skin conductance during CS presentation. Skin 
conductance values were range-corrected to the maximum SCR to the US and 
square-root transformed. The GSR amplifier was set to direct current and has a 
sensitivity of 5 microohms/V, with a 1.0-Hz low-pass filter.  A pulse oximeter was 
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placed on the ring finger of the non dominant hand. Data were acquired at 2000 
samples per second. Heart rate was calculated as the mean heart rate in the 6 
seconds following CS presentation. Heart rate response was calculated as the 
change in heart rate following stimulus onset.   
We examined whether discrimination was associated with the Fear index 
from the tri-level model (Prevoneau et al., 2010), which is calculated using items 
from the Social Phobia Scale (Mattick & Clarke, 1998; items 5, 7, 9), the Fear 
Survey Schedule (Geer, 1965; items 4, 5, 6) and the Albany Panic and Phobia 
Questionnaire (items 6, 10, 21; Rapee, Craske, & Barlow, 1994/1995). This 
measure of fear provides a transdiagnostic measure of what is common to social 
fears, anxious arousal, interoceptive/agoraphobia fears, specific fears, and worry 
independent of general distress and anhedonia-apprehension. Further information 
on the tri-level model can be found in Prevoneau et al. (2010).  
Procedure 
Study procedures occurred over 2 separate visits. On Day 1, shock 
electrodes were placed on the participant’s bicep and skin conductance electrodes 
were placed on the medial phalanx of the non-dominant hand. A pulse oximeter 
was placed on the participant’s non-dominant ring finger. Across all phases of the 
study, the context was presented for 9 seconds overall: 6 seconds in the absence 
of the CS and 3 seconds with the CS presented within the context. The mean inter-
trial interval was 15 seconds (range: 12-18 seconds). 
Participants first completed the Habituation phase, which consisted of 4 
presentations of the CS+U, CS+E, and CS- either in the Acquisition context or the 
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Extinction context. In the Acquisition phase, the Acquisition context was presented 
and the CS+ and CS+E predict the shock 60% of the time while the CS- never 
predicted the shock. The US was presented immediately after the offset of the CS+ 
and CS+E. The Acquisition phase included 8 CS+ trials, 8 CS+E trials, and 16 CS- 
trials. Subsequently, participants completed the Extinction phase, in which the 
CS+E and the CS- were each presented 16 times in the absence of the US. 
Participants then provided ratings of each CS, rating whether the risk of shock 
following each CS was low, moderate, or high. 
On Day 2, participants returned and completed Extinction Recall, in which 8 
CS+E, 8 CS+, and 16 CS- were presented in the extinction context. No shocks 
were delivered during the Extinction Recall phase. Participants repeat ratings of 
each CS, rating whether the risk of shock following each CS was low, moderate, or 
high.  
Analysis 
Prior to analysis of fMRI data, raw dicom files were converted to NIFTI 
format using dcm2nii (MRIcroN, 
http://www.cabiatl.com/mricro/mricron/dcm2nii.html). Data was processed and 
analyzed using FSL (FMRIB’s Software Library, www.fmrib.ox.ac.uk/fsl). 
Using FAST, (FMRIB’s Automated Segmentation Tool) (Zhang, Brady, & 
Smith, 2001). We corrected structural data for spatial intensity variations (bias 
field correction) and, using optiBET (optimized brain extraction), performed 
brain extraction (Lutkenhoff et al., 2014).  
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Following brain extraction, we excluded runs with >10% outliers (75th 
percentile + 1.5 times interquartile range) from group analysis. To identify 
outliers, we assessed functional data for outlier volumes (75th percentile +1.5 
times interquartile range) based on framewise displacement (average of 
rotation and translation parameter differences, using weighted scaling 
(Power, Barnes, Snyder, Schlaggar, & Petersen, 2012) as implemented in the 
fsl motion outliers function (FSL). We censored outlier volumes in first level 
analyses by including a regressor with a single time point corresponding to 
each outlying volume. Functional data was brain extracted using BET (Brain 
Extraction Tool, FSL) (Smith, 2002) and bias field corrected using N4 Bias 
Field Correction, run twice (ANTS registration suite (Tustison et al., 2010)).  
We completed fMRI data processing using FEAT (FMRI Expert 
Analysis Tool) Version 6.00. Registration to high resolution structural space 
images was completed using FLIRT (Jenkinson, Bannister, Brady, & Smith, 
2002; Jenkinson & Smith, 2001). We further refined registration from high 
resolution structural to space using FNIRT nonlinear registration (Andersson, 
Jenkinson, & Smith, 2007a, 2007b). We completed the following pre-statistics 
processing steps: motion correction using MCFLIRT (Jenkinson et al., 2002), 
slice-timing correction using Fourier-space time-series phase-shifting, spatial 
smoothing using a Gaussian kernel of FWHM 4.0mm, grand-mean intensity 
normalisation of the entire 4D dataset by a single multiplicative factor, and 
high-pass temporal filtering (0.01Hz) to remove low frequency artifacts.   
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In first-level analyses, we included regressors of interest and temporal 
derivatives, six motion regressors and additional regressors to censor outlying 
volumes. Regressors of interest included CS+, CS-, Context, and Shock.  
We selected a priori ROIs as follows: 1) Predicting increased activation to 
the CS+ relative to the CS-: amygdala, dorsal anterior cingulate cortex, and insula, 
and 2) Predicting deactivation to the CS- relative to the CS+: ventromedial 
prefrontal cortex and hippocampus. The amygdala, insula, dorsal anterior cingulate, 
and hippocampus were anatomically defined using the Harvard-Oxford Anatomical 
Atlas. Masks were thresholded at >50% probability and binarized. Data extraction 
was performed by first registering each ROI mask into subject space. 
Transformation matrices from whole brain registration were used to generate sets 
of subject-specific ROIs using FLIRT (FSL), which were subsequently thresholded 
at 0.5 and re-binarized. The command FSLSTATS was then used to extract the 
mean zstat for each ROI for each subject.  The ventromedial prefrontal cortex was 
defined functionally and was obtained from a whole-brain mask from Fullana et al., 
2016, using a 5mm sphere and a 10mm sphere (MNI coordinates: -2, 56, -14). For 
mediation analysis using vmPFC activation as an outcome, the last 4 trials of 
extinction and the first 4 trials of recall were used. 
A 2 (CS type: CS+, CS-) x 4 (Phase: Beginning of Acquisition, End of 
Acquisition, End of Extinction, Recall) repeated measures ANOVA assessed for 
differential acquisition, extinction, and recall. Discrimination was calculated as 
CS+/(CS+ + CS-) for regions in which CS+ activation exceeded CS- activation and 
as CS-/CS+ + CS-) for regions in which CS- activation exceeded CS+ activation. 
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Correlations between ROI activation/deactivation and Fear scores were run in 
addition to correlations between ROI activation/deactivation and SCR and heart 
rate at the last trial of extinction and over the average of the first two trials of 
extinction recall. Additionally, vmPFC activation to CS+ and CS- relative to implicit 
baseline at the end of extinction (last 4 trials) and the beginning of recall (first 4 
trials) was examined as an outcome, in line with research implicating vmPFC in 
extinction learning (Linnman et al., 2012a). Finally, mediation analyses using 
PROCESS (Hayes, 2009; 2012) determined whether discrimination in each region 
of interest mediated the relationship between Fear and Extinction or the relationship 
between Fear and Extinction Recall. The present analyses utilized PROCESS 
Model 4 and bootstrap analyses for mediation. Bootstrap estimates used 50,000 
repetitions to construct 95% bias-corrected confidence intervals. 
 
Results 
Acquisition, Extinction, and Fear Recall 
 Contingency Awareness. 
A paired samples t test on contingency ratings showed that participants rated 
the CS+ as more predictive of shock than the CS- (M=2.76, SE=.047) both for the 
unextinguished CS+ (M=1.64, SE=.057, t(126)=-14.538, p<.001) and for the 
extinguished CS+ (M=1.87, SE=.047, t(126)=-12.105, p<.001). 
Skin Conductance. 
For SCR, there was no main effect of CS type (F(1, 75)=.021, p=.886, 
ηp2 = .000). There was a main effect of phase (F(2.040, 153.033)=14.351, 
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p<.001, ηp2 =.161). There was a CS type x phase interaction (F(2.349, 
176.191)=10.720, p<.001, ηp2 =.125).  
Planned comparisons showed that SCR to the CS+ at the beginning of 
Acquisition (M=.1030, SE=.007) was significantly lower than SCR to the CS- 
at the beginning of Acquisition (M=1.057, SE=.012, p=.003). Additionally, at 
Recall, SCR to the CS+ (M=1.065, SE=.013) was significantly higher than 
SCR to the CS- (M=1.041, SE=.010, p=.006). Other CS+/- comparisons at 
each phase were nonsignificant (p’s>.285).  
SCR to the CS+ was significantly greater at the beginning of 
Acquisition (M=1.030, SE=.007) than at the end of Acquisition (1.010, 
SE=.004, p=.004). SCR to the CS+ was significantly greater at the end of 
Acquisition than at the end of Extinction (M=1.002, SE=.002, p=.003). SCR to 
the CS+ was significantly lower at the end of Extinction than at Recall 
(M=1.065, SE=.013, p<.001). 
SCR to the CS- was significantly higher at the beginning of Acquisition 
(M=1.057, SE=.012) than at the end of Acquisition (=1.004, SE=.004, 
p<.001). SCR to the CS- at the end of Acquisition was not significantly 
different from SCR to the CS- at the end of Extinction (p=.725). SCR to the 
CS- at the end of Extinction (=1.007, SE=.006) was significantly lower than 
SCR to the CS- at Recall (M=1.041, SE=.010, p=.003).  
 
 
		 85	
 
 
 
Figure 1: SCR 
 
 
Due to error, the first 2 trials viewed by participants were always the CS-. We 
therefore reran fear conditioning analyses dropping these first 2 trials of the CS-. In 
this case, there was a main effect of CS type (F(1, 75)=12.387, p=.001, ηp2 =.142), 
a main effect of phase (F(1.553, 116.483)=14.833, p<.001, ηp2 =.165), and a CS 
type x phase interaction (F(3, 225)=5.632, p=.001, ηp2 =.070).  
Planned comparisons showed that at the beginning of Acquisition, SCR to 
the CS+ (M=1.030, SE=.007) was significantly greater than SCR to the CS- 
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(M=1.008, SE=.005, p=.001). At Recall, SCR to the CS+ (M=1.065, SE=.013) was 
also greater than SCR to the CS- (M=1.041, SE=.010, p<.001). Other CS+/- 
comparisons were nonsignificant (p’s>.285).  
For the CS+, SCR at the beginning of Acquisition (M=1.030, SE=.007) was 
significantly higher than SCR at the end of Acquisition (M=1.010, SE=.004, p=.004). 
SCR at the end of Acquisition was significantly higher than SCR at the end of 
Extinction (M=1.002, SE=.002, p=.021). SCR at the end of Extinction was 
significantly lower than SCR at Recall (M=1.065, SE=.013, p<.001).  
For the CS-, SCR at the beginning of Acquisition was not significantly 
different from SCR at the end of Acquisition (p=.531). SCR at the end of Acquisition 
was not significantly different from SCR at the end of Extinction (p=.725). SCR at 
the end of Extinction (M=1.007, SE=.006) was significantly lower than SCR at 
Recall (M=1.041, SE=.010, p<.001). Because this change does not demonstrate 
improved evidence of fear acquisition, all trials were used in further analyses.  
Figure 2: SCR not including first 2 trials of CS- 
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Heart Rate.  
For Heart Rate, there was no main effect of CS type (F(1, 52)=.145, 
p=.705, ηp2 =.003). There was a main effect of phase (F(3, 156)=6.474, 
p<.001, ηp2 =.111) and a CS type x phase interaction (F(2.465, 2.465, 
128.159)=3.808, p=.017, ηp2 =.068).  
At the beginning of Acquisition, heart rate response to the CS+ (M=-
.956, SE=.325) was significantly greater than heart rate response to the CS- 
(M=.512, SE=.328, p=.001). At recall, heart rate response to the CS+ (M=-
.366, SE=.343) was significantly higher than heart rate response to the CS- 
(M=-1.656, SE=.424, p=.012). Other CS+/- comparisons were nonsignificant 
(p’s>.353).  
For the CS+, heart rate response was marginally lower at the 
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beginning of Acquisition (M=-.956, SE=.325) than at the end of Acquisition 
(M=.032, SE=.468, p=.091). It was not significantly different from the end of 
Acquisition to the end of Extinction (p=.232) but was marginally higher at the 
end of Extinction (M=1.004, SE=.729) than at Recall (M=-.366, SE=.343, 
p=.088).  
For the CS-, heart rate response at the beginning of Acquisition 
(M=.512, SE=.328) was significantly higher than heart rate response at the 
end of Acquisition (M=-.551, SE=.468, p=.046). It was significantly lower at 
the end of Acquisition than at the end of Extinction (M=.912, SE=.417, 
p=.020). It was significantly higher at the end of Extinction than at Recall (M=-
1.656, SE=.424, p<.001).  
Figure 3: Heart Rate 
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Due to error, the first 2 trials viewed by participants were always the CS-. We 
therefore reran fear conditioning analyses dropping these first 2 trials of the CS-. In 
this case, there was a main effect of CS type (F(1, 52)=4.093, p=.048, ηp2 = .073), a 
main effect of phase (F(3, 156)=8.707, p<.001, ηp2 =.143). There was no CS type x 
phase interaction (F(2.538, 131.967)=.624, p=.574, ηp2 =.012).  
There were no differences in CS+/CS- at any phase with the exception of 
Recall, where heart rate response to the CS+ (M=-.366, SE=.343) was significantly 
higher than heart rate response to the CS- (M=-1.656, SE=.424, p=.012).  
For the CS+, heart rate response was marginally lower at the beginning of 
Acquisition (M=-.956, SE=.325) compared to the end of Acquisition (M=.032, 
SE=.468, p=.091). Heart rate response was not significantly different from the end 
of Acquisition to the end of Extinction (p=.232). It was marginally higher at the end 
of Extinction (M=1.004, SE=.729) compared to Recall (M=-.366, SE=.343, p=.088).  
For the CS-, heart rate response was not significantly different from the 
beginning of Acquisition to the end of Acquisition (p=.140). It was significantly lower 
at the end of Acquisition (M=-.551, SE=.468) compared to the end of Extinction 
(M=.912, SE=.417, p=.020). It was significantly higher at the end of Extinction 
compared to Recall (M=-1.656, SE=.424, p<.001). ). Because this change does not 
demonstrate improved evidence of fear acquisition, all trials were used in further 
analyses.  
 
 
Figure 4: Heart Rate Not Including First 2 Trials of CS- Acquisition  
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Discrimination 
Paired samples t tests were run to determine whether significant 
discrimination occurred in each ROI. In left amygdala, the CS+ (M=-.20, SE=.043) 
showed greater deactivation relative to implicit baseline than the CS- (M=-.10, 
SE=.043, t(105)=-2.354, p=.020). In right amygdala, the CS+ ((M=-.20, SE=.049) 
showed greater deactivation relative to implicit baseline than the CS- (M=-.01, 
SE=.045, t(105)=-4.601, p<.001). Due to failure to demonstrate CS+>CS- activation 
in amygdala in line with previous research, (Buchel et al., 1998; Buchel et al., 1999; 
LaBar et al., 1998; Cheng, Knight, Smith, & Helmstetter, 2006), meditational 
analyses of discrimination in the amygdala are omitted. 
In left insula, the CS+ (M=.17, SE=.052) showed greater activation than the 
CS- (M=.05, SE=.041, t(105)=2.339, p=.021). In right insula, the CS+ (M=.14, 
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SE=.051) showed marginally greater activation than the CS- (M=.05, SE=.040, 
t(105)=1.857, p=.066). In dACC, the CS+ (M=.30, SE=.-66) showed greater 
activation than the CS- (M=-.03, SE=.048, t(105)=5.324, p<.001). In left 
hippocampus, the CS+ showed greater deactivation (M=-.25, SE=.043) than the 
CS- (M=.00, SE=.043, t(105)=-6.293, p<.001). In right hippocampus, the CS+ (M=-
.29, SE=.042) showed greater deactivation than the CS- (M=-.02, SE=.037, t(105)=-
7.054, p<.001). In 5mm vmPFC, the CS+ (M=-.62, SE=.088) showed greater 
deactivation than the CS- (M=-.17, SE=.074, t(105)=-5.388, p<.001). In 10mm 
vmPFC, the CS+ (M=-.42, SE=.061) showed greater deactivation than the CS- (M=-
.17, SE=.054, t(105)=-4.602, p<.001).  
To determine whether discrimination in each region of interest was driven by 
activation to CS+ or CS-, a median split followed by independent samples t tests on 
discrimination were run. In left amygdala, individuals who showed activation to the 
CS+ above the median (M=.498, SE=.001) showed significantly lower CS->CS+ 
discrimination than those who showed left amygdala activation to the CS+ (M=	
0.507, SE=.001, t(104)=-4.918, p<.001). Individuals who showed activation to the 
CS- above the median (M=.507, SE=.001) showed significantly higher 
discrimination than those who showed activation to CS- below the median (M=.499, 
SE=.001, t(104)=3.997, p<.001).  
In right amygdala, individuals who showed activation to CS+ above the 
median (M=.501, SE=.001) showed significantly lower CS->CS+ discrimination than 
individuals who showed activation to CS+ below the median (M=.509, SE=.002, 
t(104)=-4.339, p<.001). Individuals who showed activation to CS- above the median 
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(M=.509, SE=.001) showed significantly higher discrimination than individuals who 
showed activation to CS- below the median (M=.501, SE=.002, t(93.014)=3.740, 
p<.001).  
In left insula, individuals who showed CS+ activation above the median 
(M=.510, SE=.001) showed significantly higher discrimination than individuals who 
showed CS+ activation below the median (M=.495, SE=.002, t(104)=-7.077, 
p<.001). Individuals who showed activation to CS- above the median (M=.498, 
SE=.001) showed significantly lower discrimination than individuals how showed 
activation to CS- below the mean (M=.507, SE=.002, t(104)=3.626, p<.001).   
In right insula, individuals who showed CS+ activation above the median 
(M=.509, SE=.001) showed significantly higher discrimination than individuals who 
showed CS+ activation below the median (M=.495, SE=.01, t(104)=-7.33, p<.001).  
Individuals who showed CS- activation above the median (M=.498, SE=.001) 
showed significantly lower discrimination than individuals who showed CS- 
activation below the median (M=.506, SE=.002, t(104)=3.397, p=.001).  
In dACC, individuals who showed activation to the CS+ above the median 
(M=.515, SE=.002) showed significantly higher discrimination than individuals who 
showed activation to the CS+ below the median (M=.500, SE=.002, t(97.864)=-
5.802, p<.001). Individuals who showed activation to the CS- above the median 
(M=.505, SE=.002) showed significantly lower discrimination than individuals who 
showed activation to CS- below the median (M=.511, SE=.002, t(104)=2.094, 
p=.039).   
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In left hippocampus, individuals who showed activation to CS+ above the 
median (M=.501, SE=.001) showed significantly lower discrimination than 
individuals who showed activation to the CS+ below the median (M=.512, SE=.001, 
t(104)=6.128, p<.001). Individuals who showed activation to CS- above the median 
(M=.509, SE=.001) showed significantly higher discrimination than individuals who 
showed activation to CS- below the median (M=.504, SE=.001, t(104)=-2.644, 
p=.009).  
In right hippocampus, individuals who showed activation to CS+ above the 
median (M=.502, SE=.001) showed significantly lower discrimination than 
individuals who showed activation to the CS+ below the median (M=.512, SE=.001, 
t(104)=5.385, p<.001). Individuals who showed activation to CS- above the median 
(M=.509, SE=.001) showed significantly higher discrimination than individuals who 
showed activation to CS- below the median (M=.504, SE=.001, t(104)=-2.494, 
p=.014).  
In vmPFC using a 5mm sphere, individuals who showed activation to CS+ 
above the median (M=.500, SE=.002) showed significantly lower discrimination 
than individuals who showed activation to CS+ below the median (M= .524, 
SE=.003, t(104)=6.337, p<.001). Individuals who showed activation to CS- above 
the median (M=.520, SE=.003) showed significantly higher discrimination than 
individuals who showed activation to CS- below the median (M=.504, SE=.003, 
t(104)=-3.936, p<.001).  
In vmPFC using a 10mm sphere, individuals who showed activation to CS+ 
above the median (M=.498, SE=.002) showed significantly lower discrimination 
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than individuals who showed activation to CS+ below the median (M=.515, 
SE=.002, t(104)=5.878, p<.001). Individuals who showed activation to CS- above 
the median (M=.513, SE=.002) showed significantly higher discrimination than 
individuals who showed activation to CS- below the median (M=.500, SE=.002, 
t(104)=-4.846, p<.001).  
Correlations 
Fear. 
The Fear index was marginally positively correlated with discrimination in 
dACC (r(103)=.192, p=.052). All other ROI discrimination correlations with Fear 
were nonsignificant (all p’s > .221).  
SCR. 
SCR to the CS+ at the end of Extinction was not significantly correlated with 
any ROI discrimination (all p’s > .506). SCR to the CS- at the end of Extinction was 
not significantly correlated with any ROI discrimination (all p’s > .509). 
SCR to the CS+ at Recall was significantly positively correlated with higher 
CS->CS+ discrimination in vmPFC using a 10mm sphere (r(66)=.246, p=.047) and 
marginally positively correlated with CS->CS+ discrimination in vmPFC using a 
5mm sphere (r(66)=.235, p=.058). All other ROI discrimination correlations with 
SCR to the CS+ at Recall were nonsignificant (all p’s>.385). SCR to the CS- was 
not correlated with any ROI discrimination (all p’s > .484). 
Heart Rate. 
Heart rate to the CS+ at the end of Extinction was significantly positively 
correlated with CS->CS+ discrimination in right hippocampus (r(71)=.260, p=.029). 
		 95	
All other correlations between heart rate to the CS+ at the end of Extinction and 
ROI discrimination were nonsignificant (all p’s >.099). Heart rate to the CS- at the 
end of Extinction was marginally positively correlated with dACC discrimination 
(r(71)=.209, p=.081). Heart rate to the CS- at the end of Extinction was not 
correlated with any other ROI discrimination (all p’s > .247). 
Heart rate to the CS+ at recall was marginally negatively correlated with CS-
>CS+ discrimination in left hippocampus (r(73)=-.212, p=.071). Heart rate to the 
CS+ at Recall was not correlated with any other ROI discrimination (all p’s > .139). 
Heart rate to the CS- was not correlated with any ROI discrimination (all p’s > .228).  
 
Discrimination Mediation between Fear and Extinction/Recall 
There was no mediation of CS+>CS- or CS->CS+ discrimination in any ROI 
on the relationship between fear and SCR or Heart Rate at the end of Extinction or 
at Recall for the CS+ or for the CS-. There was also no mediation when testing 
CS+>CS- and CS->CS+ contrasts as mediators of the relationship between fear 
and these outcomes.  
Discussion 
The current study sought to demonstrate whether discrimination between a 
CS+ and CS- as reflected by differential activation in particular regions of interest 
may be associated with fear, extinction, and retention of extinction learning. There 
was no evidence for a relationship between fear and discrimination, discrimination 
and extinction or extinction retention, or between fear and extinction or extinction 
retention.  
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Evidence for successful fear conditioning, extinction, and return of fear was 
inconsistent. Successful fear acquisition was supported by contingency awareness 
ratings, which showed increased expectancy of the shock in response to the CS+ 
relative to the CS-. However, differentiation between CS+ and CS- at the end of 
acquisition was not reflected in either skin conductance response or heart rate. Skin 
conductance response to the CS+ declined across acquisition, potentially reflecting 
habituation to the US and to the fMRI environment. This may suggest insufficient 
fear learning, as only 60% of trials were reinforced. This explanation is contradicted 
by evidence for CS+/- discrimination in regions of interest and in contingency ratings. 
Alternatively, participants may have exhibited a fear response to context onset prior 
to the onset of the CS+ or CS, reflecting context conditioning regardless of the CS 
presented (Marschner et al., 2008). A design maintaining context throughout 
acquisition rather than an intermittent fixation cross may prevent this in future 
studies. Heart rate marginally increased across acquisition, and contingency 
awareness ratings for CS+ exceeded ratings for CS-, providing evidence for 
successful fear conditioning. Decline in skin conductance may therefore represent 
ambient temperature or decreased skin conductance following limited movement in 
the scanner. A programming error leading to consistent presentation of the CS- at 
the beginning of the task may provide an explanation for these results, however 
follow-up analyses excluding early trials did not produce notably different results. 
Overall, while subjective ratings demonstrate clear learning, results of physiological 
measures should be interpreted with caution. Skin conductance response to the CS+ 
was increased at the end of acquisition compared to the end of extinction, providing 
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support for successful extinction. However, heart rate did not reflect fear extinction. 
Skin conductance data showed increased response to the CS+ at recall compared to 
the end of extinction, demonstrating return of fear. Heart rate data, however, did not 
provide support for return of fear.   
Evidence for hypothesized CS+/CS- discrimination was mixed. Both left and 
right amygdala showed deactivation to both the CS+ and CS- during acquisition 
relative to implicit baseline, and deactivation to the CS+ was greater than 
deactivation to the CS-. It is possible that this reflects uncertainty in response to the 
CS- or insufficient reinforcement (Dunsmoor, Bandettini, & Knight, 2007).  
Left and right insula, which are associated with excitation of fear (Sehlmeyer 
et al., 2009; Fullana et al., 2016), showed increased activation in response to the 
CS+ relative to the CS-.  Additionally, dACC showed increased activation in 
response to the CS+ relative to the CS-, consistent with previous findings that dACC 
may have a role in fear expression (Milad et al., 2007). Examining participants 
whose activation fell above and below the median suggested that, for regions in 
which activation to CS+ exceeded activation to CS-, individuals with greater 
activation to CS+ showed greater discrimination and individuals with lesser 
activation to CS- showed greater discrimination. For regions in which activation to 
CS- is hypothesized to exceed activation to CS+, individuals with lesser activation to 
CS+ showed greater discrimination and individuals with greater activation to CS- 
showed greater discrimination. From this evidence we are unable to conclude 
whether greater discrimination is driven primarily by hyperactivation to CS+ or 
hypoactivation to CS-.  
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Consistent with the findings of Fullana et al (2016), hippocampus and vmPFC 
each showed greater deactivation to the CS- relative to the CS+. This may represent 
increased default network activity in the presence of a neutral cue relative to a 
danger cue, which may provide support for contextualization of safety memories, 
constrain fear generalization, and increase adaptive fear learning (Marstaller, 
Burianova, & Reutens, 2017).  
Our results did not provide support for a meditational role for discrimination 
between fear and extinction and extinction recall. Occasional significant a and b 
paths occurred in less than 5% of analyses and likely represent Type I error. Fear 
did not predict discrimination and discrimination did not predict outcomes of interest. 
The lack of evidence suggesting that the fear index of the trilevel model (Prevoneau 
et al., 2010) may represent Type II error, or may suggest that a more specific 
measure is needed to capture the relationship between fear and discrimination.  
One important limitation of the present study is that it did not provide evidence 
that the stimuli used to represent context were indeed processed as contexts and 
not as discrete stimuli. For example, hippocampus may be necessary but not 
sufficient for processing context while the discrete stimuli are processed by other 
structures (Huff et al., 2011). For example, structures compensating for hippocampal 
damage acquire learning discrete cues (Wiltgen, Sanders, Anagnostaras, Sage, & 
Fanselow, 2006). In a phenomenon known as immediate shock deficit, a minimum 
processing time is necessary for context conditioning to occur but not for elemental 
cues (Wiltgen, Sanders, Anagnostaras, Sage, & Fanselow, 2006). Therefore, to 
determine whether these stimuli represent contexts, we would need to determine 
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whether a minimum processing time is necessary for conditioning to occur. The 
present study did not test this. 
In sum, the present study provides some support for differentiation between a 
CS+ and CS- in the hypothesized direction for particular regions of interest. 
However, limitations include potential confounding variables on physiological indices 
including ambient temperature and habituation. Additionally, further research should 
clarify the conditions under which amygdala deactivation may occur during 
acquisition and potential explanations for increased deactivation to CS+ relative to 
CS-. Finally, future studies should continue explore correlates of discrimination in 
both fear network and default mode network regions of interest.  
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DISCUSSION 
 This set of studies provides information regarding the role of discrimination 
between a CS+ and a CS- in fear learning and potential factors that may predict the 
ability to discriminate. The results of Study 1 demonstrate a relationship between 
trait anxiety and discrimination and the potential ability of increased discrimination 
to facilitate extinction and retention of extinction learning. Study 2 provides limited 
confirmation of the relationship between discrimination and fear learning and 
demonstrates that a mood induction prior to acquisition does not impact the ability 
to differentiate between an CS+ and a CS-. Study 3 provides evidence of 
differentiation between a CS+ and CS- both in regions that have been associated 
with the learning and expression of fear and in default mode network regions that 
may be associated with processing safety or neutral cues.  
 Each study examined variables that may be associated with discrimination 
between a CS+ and CS-. Consistent with previous research (Lissek et al., 2014), 
Study 1 demonstrates that trait anxiety as measured by the BIS is associated with 
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the extent to which an individual can differentiate between a danger cue and a 
neutral cue. Study 2 shows that, while negative mood arising from exposure to an 
aversive US may potentially decrease discrimination, no mood induction prior to 
fear acquisition appears to be associated with discrimination. Acquisition itself may 
serve as a negative mood induction and impact discrimination. Differences in 
positive and negative mood prior to acquisition were no longer present following 
acquisition, suggesting that acquisition acts as a negative mood induction, however 
there was no relationship between mood change during acquisition and 
discrimination. Additionally, mood following extinction or at recall was not related to 
fear in response to the CS+ or CS-. Study 3 measured fear based on the trilevel 
model (Prevoneau et al., 2010), which provides a transdiagnostic measure of what 
is common to social fears, anxious arousal, interoceptive/agoraphobia fears, 
specific fears, and worry independent of general distress and anhedonia-
apprehension. This study failed to demonstrate a link between this measure and 
discrimination; there was no association between fear and the ability to distinguish 
between a CS+ and CS-. It is possible that this fear measure is too broad to capture 
this particular phenomenon, which may be specific to particular types of fear such 
as those associated with panic disorder (Lissek et al., 2010).  
 All three studies examined the relationship between discrimination and fear 
learning-related outcomes such as extinction and return of fear. Study 1 
demonstrated a link between discrimination and two types of return of fear: 
spontaneous recovery and context renewal. This study also demonstrated that 
increased discrimination is associated with lower fear ratings not only for the CS+ 
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but also for the CS-. This suggests that individuals who show increased ability to 
discriminate between a neutral and an unsafe cue may be less likely to show 
inappropriate fear in response to neutral cues. Study 2 provided limited confirmation 
of the association between increased discrimination and decreased fear following 
extinction; US expectancy and skin conductance among individuals with higher 
discrimination were decreased among individuals with higher discrimination during 
acquisition than among individuals with lower discrimination. Study 3 examined 
regions that have been implicated in CS+>CS- discrimination including amygdala, 
insula, and dACC (Buchel et al., 1998; Buchel et al., 1999, Cheng, Knight, Smith, & 
Helmstetter, 2006; Fullana et al., 2016 LaBar et al., 1998) as well as regions 
implicated in CS->CS+ discrimination including hippocampus and vmPFC (Fullana 
et al., 2016). While discrimination was observed in the expected direction for most 
regions, amygdala showed deactivation to both CSs and greater deactivation to 
CS+ than CS-. Additionally, there was no link between discrimination in any region 
of interest and extinction or return of fear as measured by physiological indices or 
vmPFC activation.  
 Each of these studies included several limitations. Study 1 included a small 
sample. Additionally, fear ratings were collected following context renewal and 
spontaneous recovery phases, potentially reflecting fear following re-extinction that 
took place during these phases and not reflecting fear upon initial exposure to 
conditional stimuli. In Study 2, skin conductance findings did not demonstrate a 
clear increase in responsivity to the CS+ from the beginning to the end of 
acquisition. This may reflect a failure of the CS+ to evoke a fear response, however 
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it is more likely that it reflects elevated apprehension at the beginning of the task 
before associative learning took place. Additionally, heart rate did not provide 
evidence of successful fear learning. Finally, physiological indices in Study 3 should 
be interpreted with caution due to failure of these measures to demonstrate clear 
differential acquisition and extinction.   
 Results from this group of studies yield interesting potential clinical 
implications. For example, further investigation of the influences on discrimination 
may inform future interventions and potential training in discrimination for anxious 
individuals. Measures of discrimination may help to identify individuals with a 
predisposition to anxiety disorders. Finally, discrimination may provide an 
informative clinical outcome to assess treatment progress in anxious individuals.  
 Future research should examine other potential influences on discrimination, 
including attentional control and clinical status. Further investigation of potential 
methods to improve discrimination may provide an avenue toward prevention and 
treatment of anxiety disorders.  
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Appendix A: Study 2 Tables 
 
Table 1. Group and Extinction SCR 
 b SE LLCI ULCI sig 
A Path       
     Neg vs Pos à  Discrimination (a1 path)  .03 .07 -.10 .17  
     Neu vs Pos à  Discrimination (a2 path)  .01 .06 -.12 .14  
     Neg vs Neu à  Discrimination (a3 path)  .02 .07 -.11 .15  
Extinction SCR during CS+       
     Discrimination à  Extinction (b path) -.93 .54 -2.01 .15  
     Neg v Pos àDiscrimination à  Extinction (Indirect 1) -.03 .08 -.32 .05  
     Neg v Pos à  Extinction (Direct 1) .50 .31 -.12 1.12  
     Neg v Pos à  Extinction (Total 1) .41 .29 -.16 .99  
     Neu v Pos àDiscrimination à  Extinction (Indirect 2) -.01 .07 -.24 .09  
     Neu v Pos à  Extinction (Direct 2) .44 .30 -.17 1.04  
     Neu v Pos à  Extinction (Total 2) .39 .28 -.17 .96  
     Neg v Neu àDiscrimination à  Extinction (Indirect 3) -.02 .07 -.26 .07  
     Neg v Neu à  Extinction (Direct 3) .06 .31 -.55 .68  
     Neg v Neu à  Extinction (Total 3) -.02 .29 -.59 .55  
Extinction SCR during CS-       	
     Discrimination à  Extinction (b path) -.03 .13 -.28 .23  
     Neg v Pos àDiscrimination à  Extinction (Indirect 1) .00 .01 -.03 .01  
     Neg v Pos à  Extinction (Direct 1) .21 .07 .07 .36 * 
     Neg v Pos à  Extinction (Total 1) .16 .07 .02 .30 * 
     Neu v Pos àDiscrimination à  Extinction (Indirect 2) .00 .01 -.02 .01  
     Neu v Pos à  Extinction (Direct 2) .06 .07 -.08 .20  
     Neu v Pos à  Extinction (Total 2) .03 .07 -.11 .16  
     Neg v Neu àDiscrimination à  Extinction (Indirect 3) .00 .01 -.02 .01  
     Neg v Neu à  Extinction (Direct 3) .16 .07 .01 .30 * 
     Neg v Neu à  Extinction (Total 3) -.13 .07 -.27 .00  
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Table 2. Group and Context Renewal SCR 
 b SE LLCI ULCI sig 
A Path       
     Neg vs Pos à  Discrimination (a1 path)  .03 .07 -.10 .17  
     Neu vs Pos à  Discrimination (a2 path)  .01 .06 -.12 .14  
     Neg vs Neu à  Discrimination (a3 path)  .02 .07 -.11 .15  
SCR during CS+        
First 2 Context Renewal Trials      
     Discrimination à  CR (b path) -.32 .20 -.72 .09  
     Neg v Pos àDiscrimination à  CR (Indirect 1) .03 .03 -.01 .12  
     Neg v Pos à  CR (Direct 1) .08 .12 -.16 .32  
     Neg v Pos à  CR (Total 1) .10 .11 -.13 .33  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .01 .03 -.03 .08  
     Neu v Pos à  CR (Direct 2) .03 .11 -.20 .25  
     Neu v Pos à  CR (Total 2) .04 .11 -.17 .25  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .02 .03 -.02 .11  
     Neg v Neu à  CR (Direct 3) .05 .11 -.17 .27  
     Neg v Neu à  CR (Total 3) -.06 .11 -.27 .15  
All Context Renewal Trials      
     Discrimination à  CR (b path) -.27 .15 -.56 .02  
     Neg v Pos àDiscrimination à  CR (Indirect 1) .02 .03 -.01 .09  
     Neg v Pos à  CR (Direct 1) .04 .09 -.13 .22  
     Neg v Pos à  CR (Total 1) .06 .08 -.10 .23  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .01 .02 -.03 .07  
     Neu v Pos à  CR (Direct 2) .05 .08 -.11 .21  
     Neu v Pos à  CR (Total 2) .06 .08 -.09 .21  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .01 .02 -.02 .08  
     Neg v Neu à  CR (Direct 3) .00 .08 -.16 .15  
     Neg v Neu à  CR (Total 3) .00 .08 -.16 .15  
Context Renewal Trial 1      
     Discrimination à  CR (b path) -.28 .31 -.91 .35  
     Neg v Pos àDiscrimination à  CR (Indirect 1) .02 .03 -.01 .13  
     Neg v Pos à  CR (Direct 1) .12 .18 -.25 .49  
     Neg v Pos à  CR (Total 1) .13 .17 -.21 .48  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .01 .03 -.03 .09  
     Neu v Pos à  CR (Direct 2) .12 .17 -.23 .46  
     Neu v Pos à  CR (Total 2) .12 .16 -.20 .44  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .01 .03 -.02   .12  
     Neg v Neu à  CR (Direct 3) .00 .17 -.34   34  
     Neg v Neu à  CR (Total 3) -.01 .16 -.33 .31  
Context Renewal Trial 2      
     Discrimination à  CR (b path) -.35 .18 -.71 .01  
     Neg v Pos àDiscrimination à  CR (Indirect 1) .03 .04 -.01 .15  
     Neg v Pos à  CR (Direct 1) .04 .11 -.17 .25  
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     Neg v Pos à  CR (Total 1) .07 .10 -14 .27  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .01 .03 -.04 .11  
     Neu v Pos à  CR (Direct 2) -.06 .10 -.26 .13  
     Neu v Pos à  CR (Total 2) -.04 .09 -.23 .15  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .02 .04 -.02 .13  
     Neg v Neu à  CR (Direct 3) .10 .10 -.09 .30  
     Neg v Neu à  CR (Total 3) -.11 .09 -.29 .08  
Context Renewal Trial 3      
     Discrimination à  CR (b path) -.18 .15 -.48 .12  
     Neg v Pos àDiscrimination à  CR (Indirect 1) .01 .02 -.01 .10  
     Neg v Pos à  CR (Direct 1) .08 .09 -.10 .26  
     Neg v Pos à  CR (Total 1) .09 .08 -.08 .26  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .01 .02 -.02 .06  
     Neu v Pos à  CR (Direct 2) .10 .08 -.06 .26  
     Neu v Pos à  CR (Total 2) .12 .08 -.04 .27  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .01 .02 -.01 .09  
     Neg v Neu à  CR (Direct 3) -.10 .08 -.26 .06  
     Neg v Neu à  CR (Total 3) .02 .08 -.13 .18  
Context Renewal Trial 4      
     Discrimination à  CR (b path) .88 .58 -.28 2.03  
     Neg v Pos àDiscrimination à  CR (Indirect 1) -.07 .11 -.51 .05  
     Neg v Pos à  CR (Direct 1) .15 .34 -.54 .83  
     Neg v Pos à  CR (Total 1) .06 .32 -.58 .70  
     Neu v Pos àDiscrimination à  CR (Indirect 2) -.02 .10 -.40 .04  
     Neu v Pos à  CR (Direct 2) .19 .31 -.44 .82  
     Neu v Pos à  CR (Total 2) .14 .30 -.45 .73  
     Neg v Neu àDiscrimination à  CR (Indirect 3) -.05 .12 -.57 .05  
     Neg v Neu à  CR (Direct 3) -.04 .31 -.67 .59  
     Neg v Neu à  CR (Total 3) .08 .30 -.51 .67  
SCR during CS-       	
First 2 Context Renewal Trials      
     Discrimination à  CR (b path) -.76 .23 -1.21 -.31 * 
     Neg v Pos àDiscrimination à  CR (Indirect 1) .06 .06 -.02 .24  
     Neg v Pos à  CR (Direct 1) -.21 .14 -.48 .06  
     Neg v Pos à  CR (Total 1) -.14 .14 -.42 .15  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .02 .06 -.10 .15  
     Neu v Pos à  CR (Direct 2) -.16 .12 -.41 .09  
     Neu v Pos à  CR (Total 2) -.13 .13 -.39 .13  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .04 .07 -.05 .24  
     Neg v Neu à  CR (Direct 3) -.05 .12 -.30 .20  
     Neg v Neu à  CR (Total 3) .01 .13 -.25 .26  
All Context Renewal Trials      
     Discrimination à  CR (b path) -1.14 .36 -1.86 -.42 * 
     Neg v Pos àDiscrimination à  CR (Indirect 1) .09 .10 .00 .46  
     Neg v Pos à  CR (Direct 1) -.34 .21 -.76 .09  
     Neg v Pos à  CR (Total 1) -.23 .21 -.65 .20  
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     Neu v Pos àDiscrimination à  CR (Indirect 2) .03 .10 -.11 .27  
     Neu v Pos à  CR (Direct 2) -.23 .19 -.63 .16  
     Neu v Pos à  CR (Total 2) -.19 .20 -.58 .21  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .06 .11 -.04 .48  
     Neg v Neu à  CR (Direct 3) -.10 .20 -.49 .29  
     Neg v Neu à  CR (Total 3) .04 .20 -.36 .43  
Context Renewal Trial 1      
     Discrimination à  CR (b path) -.81 .28 -1.38 -.24 * 
     Neg v Pos àDiscrimination à  CR (Indirect 1) .06 .06 -.03 .23  
     Neg v Pos à  CR (Direct 1) -.18 .17 -.51 .16  
     Neg v Pos à  CR (Total 1) -.11 .17 -.44 .34  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .02 .06 -.11 .14  
     Neu v Pos à  CR (Direct 2) -.12 .15 -.43 .19  
     Neu v Pos à  CR (Total 2) -.09 .16 -.41 .22  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .04 .07 -.06 .24  
     Neg v Neu à  CR (Direct 3) -.06 .15 -.40 .25  
     Neg v Neu à  CR (Total 3) .01 .16 -.30 .32  
Context Renewal Trial 2      
     Discrimination à  CR (b path) .54 .76 -.98 2.06  
     Neg v Pos àDiscrimination à  CR (Indirect 1) -.04 .14 -.64 .10  
     Neg v Pos à  CR (Direct 1) .47 .45 -.42 1.37  
     Neg v Pos à  CR (Total 1) .41 .41 -.42 1.23  
     Neu v Pos àDiscrimination à  CR (Indirect 2) -.02 .11 -.44 .10  
     Neu v Pos à  CR (Direct 2) -.11 .41 -.93 .72  
     Neu v Pos à  CR (Total 2) -.11 .38 -.87 .65  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .03 .12 -.59 .08  
     Neg v Neu à  CR (Direct 3) .58 .41 -.25 1.41  
     Neg v Neu à  CR (Total 3) -.52 .38 -1.28 .25  
Context Renewal Trial 3      
     Discrimination à  CR (b path) -.31 .16 -.62 .01  
     Neg v Pos àDiscrimination à  CR (Indirect 1) .02 .03 -.01 .12  
     Neg v Pos à  CR (Direct 1) -.04 .09 -.22 .15  
     Neg v Pos à  CR (Total 1) .00 .09 -.18 .18  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .01 .03 -.03 .08  
     Neu v Pos à  CR (Direct 2) .07 .09 -.10 .24  
     Neu v Pos à  CR (Total 2) .07 .08 -.09 .24  
     Neg v Neu àDiscrimination à  CR (Indirect 3) -.01 .03 -.08 .03  
     Neg v Neu à  CR (Direct 3) -.07 .09 -.24 .10  
     Neg v Neu à  CR (Total 3) .07 .08 -.09 .24  
Context Renewal Trial 4      
     Discrimination à  CR (b path) -.25 .23 -.71 .21  
     Neg v Pos àDiscrimination à  CR (Indirect 1) .03 .03 -.01 .13  
     Neg v Pos à  CR (Direct 1) .07 .13 -.20 .33  
     Neg v Pos à  CR (Total 1) .09 .12 -.15 .33  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .02 .02 -.01 .10  
     Neu v Pos à  CR (Direct 2) .13 .12 -.11 .37  
     Neu v Pos à  CR (Total 2) .16 .11 -.06 .38  
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     Neg v Neu àDiscrimination à  CR (Indirect 3) .01 .03 -.02 .11  
     Neg v Neu à  CR (Direct 3) -.07 .12 -.30 .17  
     Neg v Neu à  CR (Total 3) .07 .11 -.15 .29  
 
Table 3. Group and Spontaneous Recovery 
 b SE LLCI ULCI sig 
A Path       
     Neg vs Pos à  Discrimination (a1 path)  .11 .08 -.27 .06  
     Neu vs Pos à  Discrimination (a2 path)  -.03 .07 -.18 .12  
     Neg vs Neu à  Discrimination (a3 path)  -.08 .08 -.23 .07  
SCR during CS+        
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.60 .16 -.92 -.29 * 
     Neg v Pos àDiscrimination à  SR (Indirect 1) .06 .04 -.02 .16  
     Neg v Pos à  SR (Direct 1) -.04 .09 -.22 .15  
     Neg v Pos à  SR (Total 1) .02 .10 -.18 .21  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .02 .05 -.08 .10  
     Neu v Pos à  SR (Direct 2) -.03 .08 -.19 .14  
     Neu v Pos à  SR (Total 2) -.02 .09 -.19 .16  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .05 .05 -.03 .17  
     Neg v Neu à  SR (Direct 3) -.01 .09 -.18 .16  
     Neg v Neu à  SR (Total 3) -.03 .09 -.22 .15  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -1.37 .45 -2.27 -.47 * 
     Neg v Pos àDiscrimination à  SR (Indirect 1) .14 .13 .02 .64 * 
     Neg v Pos à  SR (Direct 1) -.42 .26 -.95 .11  
     Neg v Pos à  SR (Total 1) -.26 .26 -.79 .26  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .04 .12 -.09 .39  
     Neu v Pos à  SR (Direct 2) -.36 .24 -.84 .12  
     Neu v Pos à  SR (Total 2) -.30 .24 -.77 .18  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .11 .15 -.01 .71  
     Neg v Neu à  SR (Direct 3) -.06 .24 -.55 .43  
     Neg v Neu à  SR (Total 3) -.03 .24 -.52 .45  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -1.56 .41 -2.38 -.74 * 
     Neg v Pos àDiscrimination à  SR (Indirect 1) .16 .13 .02 .61 * 
     Neg v Pos à  SR (Direct 1) -.40 .24 -.88 .08  
     Neg v Pos à  SR (Total 1) -.23 .25 -.73 .27  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .04 .13 -.19 .32  
     Neu v Pos à  SR (Direct 2) -.28 .21 -.71 .16  
     Neu v Pos à  SR (Total 2) -.24 .23 -.69 .22  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .12 .15 -.03 .64  
     Neg v Neu à  SR (Direct 3) -.12 .22 -.57 .32  
     Neg v Neu à  SR (Total 3) -.01 .23 -.47 .46  
Spontaneous Recovery Trial 2      
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     Discrimination à  SR (b path) -.58 .24 -1.06 -.10 * 
     Neg v Pos àDiscrimination à  SR (Indirect 1) .06 .05 .003 .21 * 
     Neg v Pos à  SR (Direct 1) -.07 .14 -.35 .21  
     Neg v Pos à  SR (Total 1) .00 .14 -.28 .27  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .02 .05 -.07 .11  
     Neu v Pos à  SR (Direct 2) -.09 .13 -.35 .16  
     Neu v Pos à  SR (Total 2) -.07 .12 -.31 .18  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .05 .06 -.02 .23  
     Neg v Neu à  SR (Direct 3) .03 .13 -.23 .29  
     Neg v Neu à  SR (Total 3) -.06 .13 -.31 .19  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) .23 .17 -.12 .58  
     Neg v Pos àDiscrimination à  SR (Indirect 1) -.02 .03 -.14 .01  
     Neg v Pos à  SR (Direct 1) .12 .10 -.09 .32  
     Neg v Pos à  SR (Total 1) .09 .10 -.10 .28  
     Neu v Pos àDiscrimination à  SR (Indirect 2) -.01 .03 -.09 .02  
     Neu v Pos à  SR (Direct 2) .06 .09 -.13 .24  
     Neu v Pos à  SR (Total 2) .08 .09 -.10 .25  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .01 .03 -.02 .09  
     Neg v Neu à  SR (Direct 3) -.06 .09 -.24 .13  
     Neg v Neu à  SR (Total 3) -.01 .09 -.19 .17  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -.51 .49 -1.50 .48  
     Neg v Pos àDiscrimination à  SR (Indirect 1) .05 .05 .00 .21  
     Neg v Pos à  SR (Direct 1) .27 .29 -.31 .85  
     Neg v Pos à  SR (Total 1) .32 .27 -.22 .85  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .01 .04 -.06 .11  
     Neu v Pos à  SR (Direct 2) .25 .26 -.27 .77  
     Neu v Pos à  SR (Total 2) .26 .24 -.22 .75  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .04 .05 -.01 .24  
     Neg v Neu à  SR (Direct 3) .02 .27 -.51 .56  
     Neg v Neu à  SR (Total 3) -.05 .25 -.55 .44  
SCR during CS-       	
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.27 .51 -1.30 .76  
     Neg v Pos àDiscrimination à  SR (Indirect 1) .04 .03 .00 .14  
     Neg v Pos à  SR (Direct 1) .37 .30 -.23 .96  
     Neg v Pos à  SR (Total 1) .37 .27 -.16 .90  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .02 .02 -.01 .09  
     Neu v Pos à  SR (Direct 2) .36 .27 -.18 .89  
     Neu v Pos à  SR (Total 2) .35 .24 -.14 .84  
     Neg v Neu àDiscrimination à  SR (Indirect 3) -.02 .02 -.09 .01  
     Neg v Neu à  SR (Direct 3) -.36 .27 -.89 .18  
     Neg v Neu à  SR (Total 3) -.02 .24 -.50 .46  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.34 .13 -.61 -.08 * 
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     Neg v Pos àDiscrimination à  SR (Indirect 1) .04 .03 .00 .13  
     Neg v Pos à  SR (Direct 1) -.02 .08 -.17 .14  
     Neg v Pos à  SR (Total 1) .02 .08 -.14 .17  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .01 .03 -.04 .07  
     Neu v Pos à  SR (Direct 2) -.03 .07 -.17 .11  
     Neu v Pos à  SR (Total 2) -.02 .07 -.16 .12  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .03 .03 -.01 .13  
     Neg v Neu à  SR (Direct 3) .01 .07 -.13 .16  
     Neg v Neu à  SR (Total 3) -.03 .07 -.17 .11  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -.42 .18 -.78 -.07 * 
     Neg v Pos àDiscrimination à  SR (Indirect 1) .04 .04 .00 .15  
     Neg v Pos à  SR (Direct 1) -.08 .10 -.29 .13  
     Neg v Pos à  SR (Total 1) -.04 .10 -.24 17  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .01 .03 -.05 .09  
     Neu v Pos à  SR (Direct 2) -.04 .09 -.23 .15  
     Neu v Pos à  SR (Total 2) -.01 .09 -.20 .17  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .03 .04 -.02 .16  
     Neg v Neu à  SR (Direct 3) -.04 .10 -.23 .16  
     Neg v Neu à  SR (Total 3) .03 .09 -.16 .21  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -1.39 .56 -2.52 -.25 * 
     Neg v Pos àDiscrimination à  SR (Indirect 1) .15 .15 .00 .73  
     Neg v Pos à  SR (Direct 1) -.64 .33 -1.30 .03  
     Neg v Pos à  SR (Total 1) -.47 .32 -1.11 .17  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .04 .13 -.05 .51  
     Neu v Pos à  SR (Direct 2) -.59 .30 -1.19 .01  
     Neu v Pos à  SR (Total 2) -.53 .29 -1.12 .05  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .11 .16 -.02 .77  
     Neg v Neu à  SR (Direct 3) -.05 .31 -.67 .57  
     Neg v Neu à  SR (Total 3) -.06 .30 -.66 .53  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) -.39 .20 -.80 .02  
     Neg v Pos àDiscrimination à  SR (Indirect 1) .04 .04 -.01 .20  
     Neg v Pos à  SR (Direct 1) -.06 .12 -.31 .18  
     Neg v Pos à  SR (Total 1) -.01 .12 -.24 .22  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .01 .04 -.02 .14  
     Neu v Pos à  SR (Direct 2) -.10 .11 -.32 .12  
     Neu v Pos à  SR (Total 2) -.08 .11 -.29 .13  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .03 .05 -.01 .23  
     Neg v Neu à  SR (Direct 3) .04 .11 -.18 .26  
     Neg v Neu à  SR (Total 3) -.07 .11 -.28 .14  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -1.93 .68 -3.29 -.56 * 
     Neg v Pos àDiscrimination à  SR (Indirect 1) .20 .19 .01 .97 * 
     Neg v Pos à  SR (Direct 1) -.71 .40 -1.51 .09  
     Neg v Pos à  SR (Total 1) -.47 .39 -1.26 .32  
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     Neu v Pos àDiscrimination à  SR (Indirect 2) .05 .17 -.10 .62  
     Neu v Pos à  SR (Direct 2) -.59 .36 -1.31 .14  
     Neu v Pos à  SR (Total 2) -.50 .36 -1.21 .22  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .15 .21 -.02 1.00  
     Neg v Neu à  SR (Direct 3) -.12 .37 -.86 .62  
     Neg v Neu à  SR (Total 3) -.03 .36 -.75 .70  	
Table 4. Group and Extinction US Expectancy 
 b SE LLCI ULCI sig 
A Path       
     Neg vs Pos à  Discrimination (a1 path)  .01 .24 -.46 .48  
     Neu vs Pos à  Discrimination (a2 path)  .24 .23 -.22 .70  
     Neg vs Neu à  Discrimination (a3 path)  -.23 .24 -.71 .25  
Extinction US Expectancy during CS+       
     Discrimination à  Extinction (b path) .22 .08   .06 .39 * 
     Neg v Pos àDiscrimination à  Extinction (Indirect 1) .00 .02 -.02 .03  
     Neg v Pos à  Extinction (Direct 1) .03 .18 -.38 .33  
     Neg v Pos à  Extinction (Total 1) -.02 .19 -.40 .35  
     Neu v Pos àDiscrimination à  Extinction (Indirect 2) .05 .06 -.02 .23  
     Neu v Pos à  Extinction (Direct 2) -.12 .18 -.47 .24  
     Neu v Pos à  Extinction (Total 2) -.06 .18 -.43 .30  
     Neg v Neu àDiscrimination à  Extinction (Indirect 3) -.05 .06 -.23 .02  
     Neg v Neu à  Extinction (Direct 3) .09 .18 -.28 .46  
     Neg v Neu à  Extinction (Total 3) -.04 .19 -.42 .34  
Extinction US Expectancy during CS-       	
     Discrimination à  Extinction (b path) .24 .06 .13 .35 * 
     Neg v Pos àDiscrimination à  Extinction (Indirect 1) .00 .01 -.02 .03  
     Neg v Pos à  Extinction (Direct 1) .05 .012 -.19 .29  
     Neg v Pos à  Extinction (Total 1) .05 .13 -.21 .32  
     Neu v Pos àDiscrimination à  Extinction (Indirect 2) .06 .07 -.01 .25  
     Neu v Pos à  Extinction (Direct 2) .07 .12 -.16 .31  
     Neu v Pos à  Extinction (Total 2) .13 .13 -.13 .39  
     Neg v Neu àDiscrimination à  Extinction (Indirect 3) -.06 .07 -.25 .01  
     Neg v Neu à  Extinction (Direct 3) -.02 .12 -.27 .22  
     Neg v Neu à  Extinction (Total 3) .08 .13 -.19 .35  
 
Table 5. Group and Context Renewal Expectancy 
 b SE LLCI ULCI sig 
A Path       
     Neg vs Pos à  Discrimination (a1 path)  -.03 .07 -.17 .12  
     Neu vs Pos à  Discrimination (a2 path)  -.07 .07 -.20 .06  
     Neg vs Neu à  Discrimination (a3 path)  .05 .07 -.09 .18  
US Expectancy during CS+        
First 2 Context Renewal Trials      
     Discrimination à  CR (b path) 1.19 .72 -.24 2.63  
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     Neg v Pos àDiscrimination à  CR (Indirect 1) -.03 .11 -.36 .11  
     Neg v Pos à  CR (Direct 1) .20 .39 -.57 .98  
     Neg v Pos à  CR (Total 1) .17 .39 -.61 .96  
     Neu v Pos àDiscrimination à  CR (Indirect 2) -.08 .10 -.41 .05  
     Neu v Pos à  CR (Direct 2) -.08 .36 -.81 .65  
     Neu v Pos à  CR (Total 2) -.16 .37 -.90 .57  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .05 .10 -.08 .33  
     Neg v Neu à  CR (Direct 3) .28 .37 -.45 1.02  
     Neg v Neu à  CR (Total 3) -.34 .37 -1.08 .41  
All Context Renewal Trials      
     Discrimination à  CR (b path) .46 .64 -.83 1.74  
     Neg v Pos àDiscrimination à  CR (Indirect 1) -.01 .06 -.25 .06  
     Neg v Pos à  CR (Direct 1) .12 .34 -.57 .81  
     Neg v Pos à  CR (Total 1) .11 .34 -.58 .80  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .03 .07 -.27 .06  
     Neu v Pos à  CR (Direct 2) -.07 .32 -.72 .58  
     Neu v Pos à  CR (Total 2) -.10 .32 -.74 .54  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .02 .07 -.05 .25  
     Neg v Neu à  CR (Direct 3) .19 .33 -.46 .85  
     Neg v Neu à  CR (Total 3) -.21 .33 -.86 .44  
Context Renewal Trial 1      
     Discrimination à  CR (b path) 1.92 .71 .51 3.34 * 
     Neg v Pos àDiscrimination à  CR (Indirect 1) -.05 .13 -.35 .20  
     Neg v Pos à  CR (Direct 1) .47 .38 -.30 1.23  
     Neg v Pos à  CR (Total 1) .42 .40 -.38 1.22  
     Neu v Pos àDiscrimination à  CR (Indirect 2) -.14 .13 -.40 .11  
     Neu v Pos à  CR (Direct 2) .00 .36 -.71 .72  
     Neu v Pos à  CR (Total 2) -.13 .37 -.88 .62  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .09 .13 -.18 .36  
     Neg v Neu à  CR (Direct 3) .46 .36 -.26 1.19  
     Neg v Neu à  CR (Total 3) -.55 .38 -1.31 .21  
Context Renewal Trial 2      
     Discrimination à  CR (b path) .46 .93 -1.39 2.32  
     Neg v Pos àDiscrimination à  CR (Indirect 1) -.01 .10 -.34 .11  
     Neg v Pos à  CR (Direct 1) -.06 .50 -1.06 .94  
     Neg v Pos à  CR (Total 1) -.07 .50 -1.06 .92  
     Neu v Pos àDiscrimination à  CR (Indirect 2) -.03 .12 -.40 .12  
     Neu v Pos à  CR (Direct 2) -.16 .47 -1.10 .78  
     Neu v Pos à  CR (Total 2) -.20 .46 -1.12 .73  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .02 .10 -.09 .37  
     Neg v Neu à  CR (Direct 3) .10 .47 -.84 1.05  
     Neg v Neu à  CR (Total 3) -.13 .47 -1.07 .81  
Context Renewal Trial 3      
     Discrimination à  CR (b path) .48 .74 -1.00 1.96  
     Neg v Pos àDiscrimination à  CR (Indirect 1) -.01 .05 -.19 .05  
     Neg v Pos à  CR (Direct 1) .17 .40 -.63 .97  
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     Neg v Pos à  CR (Total 1) .16 .40 -.63 .95  
     Neu v Pos àDiscrimination à  CR (Indirect 2) -.03 .07 -.25 .04  
     Neu v Pos à  CR (Direct 2) -.02 .38 -.77 .73  
     Neu v Pos à  CR (Total 2) -.06 .37 -.80 .69  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .02 .06 -.04 .21  
     Neg v Neu à  CR (Direct 3) .19 .38 -.56 .95  
     Neg v Neu à  CR (Total 3) -.22 .38 -.97 .54  
Context Renewal Trial 4      
     Discrimination à  CR (b path) -1.04 .65 -2.34 .26  
     Neg v Pos àDiscrimination à  CR (Indirect 1) .03 .09 -.07 .35  
     Neg v Pos à  CR (Direct 1) -.09 .35 -.79 .61  
     Neg v Pos à  CR (Total 1) .07 .35 -.77 .64  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .07 .14 -.05 .56  
     Neu v Pos à  CR (Direct 2) -.10 .33 -.76 .56  
     Neu v Pos à  CR (Total 2) -.03 .33 -.69 .63  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .05 .12 -.50 .05  
     Neg v Neu à  CR (Direct 3) .01 .33 -.66 .67  
     Neg v Neu à  CR (Total 3) .04 .34 -.63 .71  
US Expectancy during CS-       	
First 2 Context Renewal Trials      
     Discrimination à  CR (b path) .03 .59 -1.14 1.21  
     Neg v Pos àDiscrimination à  CR (Indirect 1) .00 .04 -.09 .06  
     Neg v Pos à  CR (Direct 1) .35 .32 -.28 .99  
     Neg v Pos à  CR (Total 1) .35 .31 -.28 .98  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .00 .05 -.12 .09  
     Neu v Pos à  CR (Direct 2) .47 .30 -.12 1.07  
     Neu v Pos à  CR (Total 2) .47 .29 -.12 1.06  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .00 .04 -.07 .11  
     Neg v Neu à  CR (Direct 3) -.12 .30 -.73 .48  
     Neg v Neu à  CR (Total 3) .12 .30 -.47 .72  
All Context Renewal Trials      
     Discrimination à  CR (b path) -.50 .46 -1.42 .43  
     Neg v Pos àDiscrimination à  CR (Indirect 1) .01 .04 -.04 .16  
     Neg v Pos à  CR (Direct 1) .12 .25 -.38 .62  
     Neg v Pos à  CR (Total 1) .13 .25 -.37 .63  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .04 .06 -.02 .26  
     Neu v Pos à  CR (Direct 2) .31 .23 -.16 .78  
     Neu v Pos à  CR (Total 2) .34 .23 -.12 .81  
     Neg v Neu àDiscrimination à  CR (Indirect 3) -.02 .06 -.22 .03  
     Neg v Neu à  CR (Direct 3) -.19 .24 -.66 .29  
     Neg v Neu à  CR (Total 3) .21 .24 -.26 .68  
Context Renewal Trial 1      
     Discrimination à  CR (b path) .37 .74 -1.12 1.85  
     Neg v Pos àDiscrimination à  CR (Indirect 1) -.01 .05 -.21 .04  
     Neg v Pos à  CR (Direct 1) .72 .38 -.03 1.48  
     Neg v Pos à  CR (Total 1) .78 .40 -.01 1.58  
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     Neu v Pos àDiscrimination à  CR (Indirect 2) -.03 .06 -.24 .05  
     Neu v Pos à  CR (Direct 2) .72 .38 -.03 1.48  
     Neu v Pos à  CR (Total 2) .70 .37 -.04 1.44  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .02 .06 -.05 .24  
     Neg v Neu à  CR (Direct 3) .07 .38 -.69 .83  
     Neg v Neu à  CR (Total 3) -.09 .38 -.84 .67  
Context Renewal Trial 2      
     Discrimination à  CR (b path) -.30 .63 -1.56 .96  
     Neg v Pos àDiscrimination à  CR (Indirect 1) -.09 .34 -.77 .59  
     Neg v Pos à  CR (Direct 1) .01 .05 -.05 .19  
     Neg v Pos à  CR (Total 1) .78 .40 -.01 1.58  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .02 .06 -.05 .25  
     Neu v Pos à  CR (Direct 2) .23 .32 -.41 .86  
     Neu v Pos à  CR (Total 2) .70 .37 -.04 1.44  
     Neg v Neu àDiscrimination à  CR (Indirect 3) -.01 .05 -.21 .04  
     Neg v Neu à  CR (Direct 3) -.31 .32 -.96 .33  
     Neg v Neu à  CR (Total 3) -.09 .38 -.84 .67  
Context Renewal Trial 3      
     Discrimination à  CR (b path) -.77 .46 -1.69 .16  
     Neg v Pos àDiscrimination à  CR (Indirect 1) .02 .06 -.06   .19  
     Neg v Pos à  CR (Direct 1) -.10 .25 -.60   .40  
     Neg v Pos à  CR (Total 1) -.08 .34 -.75 .59  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .05 .08 -.02 .31  
     Neu v Pos à  CR (Direct 2) .18 .23 -.29 .65  
     Neu v Pos à  CR (Total 2) .25 .31 -.38 .87  
     Neg v Neu àDiscrimination à  CR (Indirect 3) -.03 .07 -.28 .03  
     Neg v Neu à  CR (Direct 3) -.28 .24 -.75 .19  
     Neg v Neu à  CR (Total 3) .33 .32 -..31 .96  
Context Renewal Trial 4      
     Discrimination à  CR (b path) -1.28 .52 -2.31 -.25 * 
     Neg v Pos àDiscrimination à  CR (Indirect 1) .03 .10 -.07 .38  
     Neg v Pos à  CR (Direct 1) -.12 .28 -.68 .43  
     Neg v Pos à  CR (Total 1) -.09 .29 -.67 .49  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .09 .15 -.03 .61  
     Neu v Pos à  CR (Direct 2) .10 .26 -.42 .63  
     Neu v Pos à  CR (Total 2) .20 .27 -.35 .74  
     Neg v Neu àDiscrimination à  CR (Indirect 3) -.06 .13 -.54 .04  
     Neg v Neu à  CR (Direct 3) -.23 .26 -.76 .30  
     Neg v Neu à  CR (Total 3) .29 .27 -.26 .84  
 
Table 6. Group and Spontaneous Recovery US Expectancy 
 b SE LLCI ULCI sig 
A Path       
     Neg vs Pos à  Discrimination (a1 path)  -.03 .07 -.17 .12  
     Neu vs Pos à  Discrimination (a2 path)  -.07 .07 -.20 .06  
     Neg vs Neu à  Discrimination (a3 path)  .04 .07 -.09 .18  
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US Expectancy during CS+        
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.48 .76 -2.00 1.03  
     Neg v Pos àDiscrimination à  SR (Indirect 1) .01 .08 -.07 .32  
     Neg v Pos à  SR (Direct 1) -.34 .41 -1.17 .49  
     Neg v Pos à  SR (Total 1) -.32 .41 -1.15 .50  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .03 .09 -.07 .39  
     Neu v Pos à  SR (Direct 2) -.33 .38 -1.10 .44  
     Neu v Pos à  SR (Total 2) -.29 .38 -1.05 .46  
     Neg v Neu àDiscrimination à  SR (Indirect 3) -.02 .08 -.38 .06  
     Neg v Neu à  SR (Direct 3) -.01  .39 -.80 .78  
     Neg v Neu à  SR (Total 3) .03 .39 -.75 .81  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.39 .57 -1.54 .76  
     Neg v Pos àDiscrimination à  SR (Indirect 1) .01 .06 -.05 .23  
     Neg v Pos à  SR (Direct 1) -.18 .31 -.81 .45  
     Neg v Pos à  SR (Total 1) -.17 .31 -.79 .45  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .03 .07 -.05 .28  
     Neu v Pos à  SR (Direct 2) -.23 .29 -.91 .36  
     Neu v Pos à  SR (Total 2) -.20 .29 -.77 .38  
     Neg v Neu àDiscrimination à  SR (Indirect 3) -.02 .06 -.28 .04  
     Neg v Neu à  SR (Direct 3) .05  .30 -.55 .64  
     Neg v Neu à  SR (Total 3) -.03 .30 -.62 .56  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -.04 .30 -1.65 1.57  
     Neg v Pos àDiscrimination à  SR (Indirect 1) .00 .08 -.14 .19  
     Neg v Pos à  SR (Direct 1) -.27 .44 -1.15 .61  
     Neg v Pos à  SR (Total 1) -.27 .44 -1.14 .61  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .00 .10 -.18 .26  
     Neu v Pos à  SR (Direct 2) -.18 .41 -1.00 .63  
     Neu v Pos à  SR (Total 2) -.18 .40 -.98 .62  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .00 .08 -.25 .14  
     Neg v Neu à  SR (Direct 3) -.08 .42 -.92 .75  
     Neg v Neu à  SR (Total 3) .08 .41 -.74 .91  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -.93 .88 -2.69 .84  
     Neg v Pos àDiscrimination à  SR (Indirect 1) .02 .10 -.08 .39  
     Neg v Pos à  SR (Direct 1) -.41 .48 -1.37 .55  
     Neg v Pos à  SR (Total 1) -.38 .48 -1.35 .58  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .07 .11 -.05 .48  
     Neu v Pos à  SR (Direct 2) -.47 .45 -1.36 .42  
     Neu v Pos à  SR (Total 2) -.41 .44 -1.29 .48  
     Neg v Neu àDiscrimination à  SR (Indirect 3) -.04 .10 -.44 .06  
     Neg v Neu à  SR (Direct 3) .06 .46 -.85 .98  
     Neg v Neu à  SR (Total 3) -.02 .46 -.94 .89  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) -.44 .65 -1.74 .86  
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     Neg v Pos àDiscrimination à  SR (Indirect 1) .01 .06 -.05 .23  
     Neg v Pos à  SR (Direct 1) .00 .35 -.71 .71  
     Neg v Pos à  SR (Total 1) .01 .35 -.69 .72  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .03 .07 -.04 .28  
     Neu v Pos à  SR (Direct 2) -.15 .33 -.81 .50  
     Neu v Pos à  SR (Total 2) -.12 .32 -.77 .53  
     Neg v Neu àDiscrimination à  SR (Indirect 3) -.02 .06 -.26 .04  
     Neg v Neu à  SR (Direct 3) .15 .34 -.52 .83  
     Neg v Neu à  SR (Total 3) -.13 .33 -.80 .53  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -.14 .45 -1.04 .75  
     Neg v Pos àDiscrimination à  SR (Indirect 1) .00 .03 -.03 .13  
     Neg v Pos à  SR (Direct 1) -.05 .24 -.54 .44  
     Neg v Pos à  SR (Total 1) -.05 .24 -.53 .44  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .01 .04 -.04 .16  
     Neu v Pos à  SR (Direct 2) -.10 .23 -.55 .36  
     Neu v Pos à  SR (Total 2) -.09 .22 -.53 .36  
     Neg v Neu àDiscrimination à  SR (Indirect 3) -.01 .04 -.15 .03  
     Neg v Neu à  SR (Direct 3) .05 .23 -.42 .51  
     Neg v Neu à  SR (Total 3) -.04 .23 -.50 .42  
US Expectancy during CS-       	
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -1.45 .58 -2.61 -.30 * 
     Neg v Pos àDiscrimination à  SR (Indirect 1) .04 .11 -.15 .33  
     Neg v Pos à  SR (Direct 1) -.01 .31 -.64 .62  
     Neg v Pos à  SR (Total 1) .03 .33 -.63 .68  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .10 .11 -.06 .40  
     Neu v Pos à  SR (Direct 2) .20 .29 -.38 .79  
     Neu v Pos à  SR (Total 2) .31 .30 -.30 .91  
     Neg v Neu àDiscrimination à  SR (Indirect 3) -.06 .11 -.35 .12  
     Neg v Neu à  SR (Direct 3) -.22 .30 -.82 .38  
     Neg v Neu à  SR (Total 3) .28 .31 -.34 .91  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -1.21 .39 -1.99 -.43 * 
     Neg v Pos àDiscrimination à  SR (Indirect 1) .03 .09 -.13 .24  
     Neg v Pos à  SR (Direct 1) .05 .21 -.38 .47  
     Neg v Pos à  SR (Total 1) .08 .23 -.38 .54  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .09 .09 -.06 .30  
     Neu v Pos à  SR (Direct 2) .24 .20 -.16 .63  
     Neu v Pos à  SR (Total 2) .32 .21 -.10 .74  
     Neg v Neu àDiscrimination à  SR (Indirect 3) -.05 .09 -.26 .11  
     Neg v Neu à  SR (Direct 3) -.19 .20 -.59 .22  
     Neg v Neu à  SR (Total 3) .24 .22 -.19 .68  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -.68 .79 -2.27 .92  
     Neg v Pos àDiscrimination à  SR (Indirect 1) .02 .09 -.07 .38  
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     Neg v Pos à  SR (Direct 1) -.03 .43 -.90 .84  
     Neg v Pos à  SR (Total 1) -.02 .43 -.88 .85  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .05 .10 -.07 .44  
     Neu v Pos à  SR (Direct 2) .10 .40 -.71 .90  
     Neu v Pos à  SR (Total 2) .14 .40 -.65 .94  
     Neg v Neu àDiscrimination à  SR (Indirect 3) -.03 .09 -.42 .06  
     Neg v Neu à  SR (Direct 3) -.13 .41 -.96 .70  
     Neg v Neu à  SR (Total 3) .16 .41 -.66 .98  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -2.23 .52 -3.27 -1.19 * 
     Neg v Pos àDiscrimination à  SR (Indirect 1) .06 .15 -.23 .39  
     Neg v Pos à  SR (Direct 1) .01 .28 -.56 .58  
     Neg v Pos à  SR (Total 1) .07 .32 -.58 .72  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .16 .16 -.12 .49  
     Neu v Pos à  SR (Direct 2) .31 .26 -.22 .84  
     Neu v Pos à  SR (Total 2) .47 .30 -.13 1.07  
     Neg v Neu àDiscrimination à  SR (Indirect 3) -.10 .16 -.43 .20  
     Neg v Neu à  SR (Direct 3) -.30 .27 -.84 .24  
     Neg v Neu à  SR (Total 3) .40 .31 -.22 1.02  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) -.95 .42 -1.80 -.11 * 
     Neg v Pos àDiscrimination à  SR (Indirect 1) .03 .08 -.09 .27  
     Neg v Pos à  SR (Direct 1) .17 .23 -.29 .63  
     Neg v Pos à  SR (Total 1) .20 .24 -.28 .67  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .07 .08 -.03 .33  
     Neu v Pos à  SR (Direct 2) .39 .21 -.04 .82  
     Neu v Pos à  SR (Total 2) .46 .22 .02 .89  
     Neg v Neu àDiscrimination à  SR (Indirect 3) -.04 .08 -.27 .07  
     Neg v Neu à  SR (Direct 3) -.22 .22 -.66 .22  
     Neg v Neu à  SR (Total 3) .26 .23 -.19 .71  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -.99 .35 -1.69 -.29 * 
     Neg v Pos àDiscrimination à  SR (Indirect 1) .03 .07 -.08 .22  
     Neg v Pos à  SR (Direct 1) .04 .19 -.34 .42  
     Neg v Pos à  SR (Total 1) .07 .20 -.34 .47  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .07 .09 -.03 .34  
     Neu v Pos à  SR (Direct 2) .15 .18 -.21 .51  
     Neu v Pos à  SR (Total 2) .22 .19 -.15 .59  
     Neg v Neu àDiscrimination à  SR (Indirect 3) -.04 .08 -.31 .05  
     Neg v Neu à  SR (Direct 3) -.11 .18 -.47 .26  
     Neg v Neu à  SR (Total 3) .15 .19 -.23 .54  		
Table 7. Group and Extinction Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     Neg vs Pos à  Discrimination (a1 path)  .00 .01 -.02 .01  
		 118	
     Neu vs Pos à  Discrimination (a2 path)  .00 .01 -.01 .01  
     Neg vs Neu à  Discrimination (a3 path)  .00 .01 -.02 .01  
Extinction Heart Rate during CS+       
     Discrimination à  Extinction (b path) .05 .70 -1.35 1.44  
     Neg v Pos àDiscrimination à  Extinction (Indirect 1) .00 .00 -.01 .02  
     Neg v Pos à  Extinction (Direct 1) -.09 .04 -.16 -.02 * 
     Neg v Pos à  Extinction (Total 1) -.09 .04 -.16 -.02  
     Neu v Pos àDiscrimination à  Extinction (Indirect 2) .00 .00 -.01 .01  
     Neu v Pos à  Extinction (Direct 2) -.07 .04 -.14 .00  
     Neu v Pos à  Extinction (Total 2) -.07 .04 -.14 .00  
     Neg v Neu àDiscrimination à  Extinction (Indirect 3) .00 .00 -.01 .01  
     Neg v Neu à  Extinction (Direct 3) -.02 .04 -.10 .05  
     Neg v Neu à  Extinction (Total 3) .03 .04 -.05 .10  
Extinction Heart Rate during CS-       	
     Discrimination à  Extinction (b path) .21 .72 -1.23 1.65  
     Neg v Pos àDiscrimination à  Extinction (Indirect 1) .00 .01 -.02 .00  
     Neg v Pos à  Extinction (Direct 1) -.06 .04 -.13 .01  
     Neg v Pos à  Extinction (Total 1) -.06 .04 -.14 .01  
     Neu v Pos àDiscrimination à  Extinction (Indirect 2) .00 .01 -.01 .01  
     Neu v Pos à  Extinction (Direct 2) -.04 .04 -.11 .04  
     Neu v Pos à  Extinction (Total 2) -.04 .04 -.11 .04  
     Neg v Neu àDiscrimination à  Extinction (Indirect 3) .00 .00 -.01 .00  
     Neg v Neu à  Extinction (Direct 3) -.02 .04 -.10 .05  
     Neg v Neu à  Extinction (Total 3) .03 .04 -.05 .10  
 
Table 8. Group and Context Renewal Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     Neg vs Pos à  Discrimination (a1 path)  -.01 .01 -.02 .01  
     Neu vs Pos à  Discrimination (a2 path)  .00 .01 -.01 .01  
     Neg vs Neu à  Discrimination (a3 path)  .00 .01 -.02 .01  
Heart Rate during CS+        
First 2 Context Renewal Trials      
     Discrimination à  CR (b path) .78 1.43 -2.09 3.65  
     Neg v Pos àDiscrimination à  CR (Indirect 1) .00 .02 -.03 .02  
     Neg v Pos à  CR (Direct 1) -.07 .07 -.20 .07  
     Neg v Pos à  CR (Total 1) -.07 .07 -.20 .06  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .00 .01 -.04 .01  
     Neu v Pos à  CR (Direct 2) .02 .06 -.10 .15  
     Neu v Pos à  CR (Total 2) .02 .06 -.10 .14  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .00 .01 -.03 .02  
     Neg v Neu à  CR (Direct 3) -.09 .06 -.21 .03  
     Neg v Neu à  CR (Total 3) .09 .06 -.03 .22  
All Context Renewal Trials      
     Discrimination à  CR (b path) .08 1.42 -2.77 2.93  
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     Neg v Pos àDiscrimination à  CR (Indirect 1) .00 .02 -.02 .04  
     Neg v Pos à  CR (Direct 1) -.07 .07 -.20 .06  
     Neg v Pos à  CR (Total 1) -.07 .06 -.20 .06  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .00 .01 -.03 .01  
     Neu v Pos à  CR (Direct 2) .01 .06 -.11 .13  
     Neu v Pos à  CR (Total 2) .01 .06 -.11 .13  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .00 .01 -.02 .03  
     Neg v Neu à  CR (Direct 3) -.08 .06 -.20 .04  
     Neg v Neu à  CR (Total 3) .08 .06 -.04 .20  
Context Renewal Trial 1      
     Discrimination à  CR (b path) -1.02 1.33 -3.67 1.64  
     Neg v Pos àDiscrimination à  CR (Indirect 1) .01 .01 -.01 .05  
     Neg v Pos à  CR (Direct 1) -.06 .06 -.19 .06  
     Neg v Pos à  CR (Total 1) -.06 .06 -.18 .06  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .00 .01 -.01 .05  
     Neu v Pos à  CR (Direct 2) .01 .06 -.10 .13  
     Neu v Pos à  CR (Total 2) .02 .06 -.10 .13  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .00 .01 -.01 .03  
     Neg v Neu à  CR (Direct 3) -.08 .06 -.19 .04  
     Neg v Neu à  CR (Total 3) .07 .06 -.04 .19  
Context Renewal Trial 2      
     Discrimination à  CR (b path) 2.57 1.60 -.63 5.78  
     Neg v Pos àDiscrimination à  CR (Indirect 1) -.02 .02 -.06 .02  
     Neg v Pos à  CR (Direct 1) -.07 .07 -.22 .08  
     Neg v Pos à  CR (Total 1) -.08 .07 -.23 .06  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .00 .02 -.05 .02  
     Neu v Pos à  CR (Direct 2) .03 .07 -.10 .17  
     Neu v Pos à  CR (Total 2) .03 .07 -.11 .17  
     Neg v Neu àDiscrimination à  CR (Indirect 3) -.01 .02 -.09 .02  
     Neg v Neu à  CR (Direct 3) -.10 .07 -.24 .03  
     Neg v Neu à  CR (Total 3) .12 .07 -.02 .25  
Context Renewal Trial 3      
     Discrimination à  CR (b path) -.16 1.50 -3.18 2.85  
     Neg v Pos àDiscrimination à  CR (Indirect 1) .00 .01 -.01 .05  
     Neg v Pos à  CR (Direct 1) -.08 .07 -.22 .06  
     Neg v Pos à  CR (Total 1) -.08 .07 -.21 .06  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .00 .01 -.02 .02  
     Neu v Pos à  CR (Direct 2) .01 .06 -.12 .14  
     Neu v Pos à  CR (Total 2) .01 .06 -.12 .14  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .00 .01 -.01 .04  
     Neg v Neu à  CR (Direct 3) -.09 .06 -.22 .04  
     Neg v Neu à  CR (Total 3) .09 .06 -.04 .21  
Context Renewal Trial 4      
     Discrimination à  CR (b path) -1.07 1.41 -3.90 1.75  
     Neg v Pos àDiscrimination à  CR (Indirect 1) .01 .02 .00 .06  
     Neg v Pos à  CR (Direct 1) -.07 .06 -.20 .06  
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     Neg v Pos à  CR (Total 1) -.07 .06 -.19 .06  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .00 .01 -.01 .05  
     Neu v Pos à  CR (Direct 2) -.02 .06 -.14 .10  
     Neu v Pos à  CR (Total 2) -.02 .06 -.13 .10  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .00 .01 -.01 .04  
     Neg v Neu à  CR (Direct 3) -.05 .06 -.18 .07  
     Neg v Neu à  CR (Total 3) .05 .06 -.07 .17  
Heart Rate during CS-       	
First 2 Context Renewal Trials      
     Discrimination à  CR (b path) .22 1.04 -1.86 2.31  
     Neg v Pos àDiscrimination à  CR (Indirect 1) .00 .01 -.02 .02  
     Neg v Pos à  CR (Direct 1) .01 .05 -.09 .10  
     Neg v Pos à  CR (Total 1) .00 .05 -.09 .10  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .00 .01 -.03 .01  
     Neu v Pos à  CR (Direct 2) .03 .04 -.05 .12  
     Neu v Pos à  CR (Total 2) .04 .04 -.05 .12  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .00 .01 -.02 .01  
     Neg v Neu à  CR (Direct 3) -.03 .04 -.12 .06  
     Neg v Neu à  CR (Total 3) .03 .04 -.06 .12  
All Context Renewal Trials      
     Discrimination à  CR (b path) -.08 1.09 -2.27 2.10  
     Neg v Pos àDiscrimination à  CR (Indirect 1) .00 .01 -.01 .04  
     Neg v Pos à  CR (Direct 1) -.01 .05 -.11 .09  
     Neg v Pos à  CR (Total 1) -.01 .05 -.11 .09  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .00 .01 .02 .02  
     Neu v Pos à  CR (Direct 2) .02 .05 -.07 .11  
     Neu v Pos à  CR (Total 2) .02 .05 -.07 .11  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .00 .01 -.01 .03  
     Neg v Neu à  CR (Direct 3) -.03 .05 -.12 .06  
     Neg v Neu à  CR (Total 3) .03 .05 -.06 .12  
Context Renewal Trial 1      
     Discrimination à  CR (b path) .15 1.08 -2.01 2.32  
     Neg v Pos àDiscrimination à  CR (Indirect 1) .00 .01 -.02 .02  
     Neg v Pos à  CR (Direct 1) .02 .05 -.08 .12  
     Neg v Pos à  CR (Total 1) .02 .05 -.08 .12  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .00 .01 -.03 .01  
     Neu v Pos à  CR (Direct 2) .06 .05 -.03 .15  
     Neu v Pos à  CR (Total 2) .06 .05 -.03 .15  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .00 .01 -.02 .02  
     Neg v Neu à  CR (Direct 3) -.04 .05 -.13 .06  
     Neg v Neu à  CR (Total 3) .04 .05 -.06 .13  
Context Renewal Trial 2      
     Discrimination à  CR (b path) .29 1.04 -1.79 2.37  
     Neg v Pos àDiscrimination à  CR (Indirect 1) .00 .01 -.02 .02  
     Neg v Pos à  CR (Direct 1) -.01 .05 -.11 .09  
     Neg v Pos à  CR (Total 1) -.01 .05 -.11 .08  
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     Neu v Pos àDiscrimination à  CR (Indirect 2) .00 .01 -.03 .01  
     Neu v Pos à  CR (Direct 2) .01 .04 -.07 .10  
     Neu v Pos à  CR (Total 2) .01 .04 -.07 .10  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .00 .01 -.02 .01  
     Neg v Neu à  CR (Direct 3) -.02 .04 -.11 .07  
     Neg v Neu à  CR (Total 3) .02 .04 -.06 .11  
Context Renewal Trial 3      
     Discrimination à  CR (b path) -1.39 1.19 -3.78 .99  
     Neg v Pos àDiscrimination à  CR (Indirect 1) .01 .01 .00 .06  
     Neg v Pos à  CR (Direct 1) -.05 .05 -.16 .06  
     Neg v Pos à  CR (Total 1) -.04 .05 -.15 .07  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .00 .01 -.01 .05  
     Neu v Pos à  CR (Direct 2) -.04 .05 -.14 .06  
     Neu v Pos à  CR (Total 2) -.03 .05 -.13 .07  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .01 .01 -.01 .04  
     Neg v Neu à  CR (Direct 3) -.01 .05 -.12 .09  
     Neg v Neu à  CR (Total 3) .01 .05 -.10 .11  
Context Renewal Trial 4      
     Discrimination à  CR (b path) .63 1.29 -1.97 3.22  
     Neg v Pos àDiscrimination à  CR (Indirect 1) .00 .02 -.03 .03  
     Neg v Pos à  CR (Direct 1) .00 .06 -.12 .12  
     Neg v Pos à  CR (Total 1) .00 .06 -.12 .12  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .00 .01 -.05 .01  
     Neu v Pos à  CR (Direct 2) .05 .05 -.06 .16  
     Neu v Pos à  CR (Total 2) .05 .05 -.06 .16  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .00 .01 -.03 .02  
     Neg v Neu à  CR (Direct 3) -.05 .06 -.16 .07  
     Neg v Neu à  CR (Total 3) .05 .06 -.06 .16  
 
Table 9. Group and Spontaneous Recovery Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     Neg vs Pos à  Discrimination (a1 path)  .00 .01 -.02 .01  
     Neu vs Pos à  Discrimination (a2 path)  .00 .01 -.01 .01  
     Neg vs Neu à  Discrimination (a3 path)  .00 .01 -.01 .01  
Heart Rate during CS+        
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.50 1.35 -3.22 2.22  
     Neg v Pos àDiscrimination à  SR (Indirect 1) .00 .01 -.01 .03  
     Neg v Pos à  SR (Direct 1) -.08 .07 -.21 .05  
     Neg v Pos à  SR (Total 1) -.08 .07 -.21 .05  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .00 .01 -.01 .04  
     Neu v Pos à  SR (Direct 2) -.01 .06 -.13 .11  
     Neu v Pos à  SR (Total 2) -.01 .06 -.13 .11  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .02 .09 -.01 .58  
     Neg v Neu à  SR (Direct 3) -.07 .06 -.19 .06  
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     Neg v Neu à  SR (Total 3) .06 .06 -.06 .19  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.69 1.38 -3.45 2.08  
     Neg v Pos àDiscrimination à  SR (Indirect 1) .00 .01 -.01 .04  
     Neg v Pos à  SR (Direct 1) -.07 .07 -.20 .06  
     Neg v Pos à  SR (Total 1) -.07 .07 -.20 .07  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .00 .01 -.01 .04  
     Neu v Pos à  SR (Direct 2) -.02 .06 -.14 .10  
     Neu v Pos à  SR (Total 2) -.02 .06 -.14 .10  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .00 .01 -.01 .02  
     Neg v Neu à  SR (Direct 3) -.05 .06 -.17 .08  
     Neg v Neu à  SR (Total 3) .05 .06 -.08 .17  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -.12 1.35 -2.83 2.58  
     Neg v Pos àDiscrimination à  SR (Indirect 1) .00 .01 -.01 .02  
     Neg v Pos à  SR (Direct 1) -.07 .07 -.21 ..06  
     Neg v Pos à  SR (Total 1) -.07 .07 -.20 .06  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .00 .01 -.02 .02  
     Neu v Pos à  SR (Direct 2) -.01 .06 -.13 .11  
     Neu v Pos à  SR (Total 2) -.01 .06 -.13 .11  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .00 .01 -.01 .02  
     Neg v Neu à  SR (Direct 3) -.07 .06 -.19 .06  
     Neg v Neu à  SR (Total 3) .07 .06 -.05 .19  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -.88 1.39 -3.66 1.91  
     Neg v Pos àDiscrimination à  SR (Indirect 1) .00 .01 -.01 .04  
     Neg v Pos à  SR (Direct 1) -.08 .07 -.22 .05  
     Neg v Pos à  SR (Total 1) -.08 .07 -.22 .05  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .00 .01 -.01 .05  
     Neu v Pos à  SR (Direct 2) -.02 .06 -.14 .10  
     Neu v Pos à  SR (Total 2) -.02 .06 -.14 .10  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .00 .01 -.02 .03  
     Neg v Neu à  SR (Direct 3) -.06 .06 -.19 .06  
     Neg v Neu à  SR (Total 3) .06 .06 -.06 .19  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) -.73 1.40 -3.54 2.07  
     Neg v Pos àDiscrimination à  SR (Indirect 1) .00 .01 -.01 .04  
     Neg v Pos à  SR (Direct 1) -.06 .07 -.19 .08  
     Neg v Pos à  SR (Total 1) -.06 .07 -.19 .08  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .00 .01 -.01 .05  
     Neu v Pos à  SR (Direct 2) -.03 .06 -.15 .09  
     Neu v Pos à  SR (Total 2) -.03 .06 -.15 .09  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .00 .01 -.05 .01  
     Neg v Neu à  SR (Direct 3) .03 .06 -.09 .15  
     Neg v Neu à  SR (Total 3) .03 .06 -.10 .15  
Spontaneous Recovery Trial 4      
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     Discrimination à  SR (b path) -1.02 1.45 -3.92 1.89  
     Neg v Pos àDiscrimination à  SR (Indirect 1) .00 .01 -.01 .05  
     Neg v Pos à  SR (Direct 1) -.06 .07 -.20 .08  
     Neg v Pos à  SR (Total 1) -.06 .07 -.19 .09  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .00 .01 -.01 .05  
     Neu v Pos à  SR (Direct 2) -.02 .06 -.15 .11  
     Neu v Pos à  SR (Total 2) -.02 .06 -.14 .11  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .00 .01 -.05 .01  
     Neg v Neu à  SR (Direct 3) -.04 .07 -.17 .09  
     Neg v Neu à  SR (Total 3) .04 .07 -.09 .17  
Heart Rate during CS-       	
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.75 1.00 -2.75 1.25  
     Neg v Pos àDiscrimination à  SR (Indirect 1) .00 .01 -.01 .04  
     Neg v Pos à  SR (Direct 1) -.02 .05 -.11 .08  
     Neg v Pos à  SR (Total 1) -.01 .05 -.11 .08  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .00 .01 -.01 .04  
     Neu v Pos à  SR (Direct 2) -.02 .04 -.11 .07  
     Neu v Pos à  SR (Total 2) -.02 .04 -.11 .07  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .00 .01 -.01 .02  
     Neg v Neu à  SR (Direct 3) .01 .05 -.08 .10  
     Neg v Neu à  SR (Total 3) -.01 .05 -.10 .08  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.48 1.01 -2.52 1.56  
     Neg v Pos àDiscrimination à  SR (Indirect 1) .00 .01 -.01 .03  
     Neg v Pos à  SR (Direct 1) -.02 .05 -.12 .08  
     Neg v Pos à  SR (Total 1) -.02 .05 -.12 .08  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .00 .01 -.01 .04  
     Neu v Pos à  SR (Direct 2) -.03 .05 -.12 .06  
     Neu v Pos à  SR (Total 2) -.03 .05 -.12 .06  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .00 .01 -.03 .01  
     Neg v Neu à  SR (Direct 3) .01 .05 -.08 .10  
     Neg v Neu à  SR (Total 3) -.01 .05 -.10 .08  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -.76 .95 -2.67 1.14  
     Neg v Pos àDiscrimination à  SR (Indirect 1) .00 .01 -.01 .03  
     Neg v Pos à  SR (Direct 1) -.01 .05 -.10 .08  
     Neg v Pos à  SR (Total 1) -.01 .05 -.10 .08  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .00 .01 -.01 .04  
     Neu v Pos à  SR (Direct 2) -.01 .04 -.10 .07  
     Neu v Pos à  SR (Total 2) -.01 .04 -.09 .07  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .00 .01 -.01 .02  
     Neg v Neu à  SR (Direct 3) .00 .04 -.08 .09  
     Neg v Neu à  SR (Total 3) .00 .04 -.09 .08  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -.74 1.07 -2.89 1.42  
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     Neg v Pos àDiscrimination à  SR (Indirect 1) .00 .01 -.01 .04  
     Neg v Pos à  SR (Direct 1) -.02 .05 -.13 .08  
     Neg v Pos à  SR (Total 1) -.02 .05 -.13 .08  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .00 .01 -.01 .05  
     Neu v Pos à  SR (Direct 2) -.04 .05 -.13 .06  
     Neu v Pos à  SR (Total 2) -.04 .05 -.13 .06  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .04 .05 -.06 .13  
     Neg v Neu à  SR (Direct 3) .00 .01 -.01 .03  
     Neg v Neu à  SR (Total 3) -.01 .05 -.11 .08  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) .22 1.21 -2.20 2.64  
     Neg v Pos àDiscrimination à  SR (Indirect 1) .00 .01 -.04 .01  
     Neg v Pos à  SR (Direct 1) -.03 .06 -.15 .08  
     Neg v Pos à  SR (Total 1) -.03 .06 -.15 .08  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .00 .01 -.03 .01  
     Neu v Pos à  SR (Direct 2) -.03 .05 -.14 .08  
     Neu v Pos à  SR (Total 2) -.03 .05 -.14 .07  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .00 .01 -.02 .01  
     Neg v Neu à  SR (Direct 3) .00 .05 -.11 .11  
     Neg v Neu à  SR (Total 3) .00 .05 -.11 .11  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -.64 1.00 -2.65 1.36  
     Neg v Pos àDiscrimination à  SR (Indirect 1) .00 .01 -.01 .03  
     Neg v Pos à  SR (Direct 1) -.01 .05 -.11 .09  
     Neg v Pos à  SR (Total 1) -01 .05 -.11 .09  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .00 .01 -.01 .03  
     Neu v Pos à  SR (Direct 2) -.03 .04 -.12 .05  
     Neu v Pos à  SR (Total 2) -.03 .04 -.12 .06  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .00 .01 -.01 .02  
     Neg v Neu à  SR (Direct 3) .02 .05 -.07 .11  
     Neg v Neu à  SR (Total 3) -.02 .05 -.11 .07  
  
Table 10. Group and Extinction Fear Ratings 
 b SE LLCI ULCI sig 
A Path       
     Neg vs Pos à  Discrimination (a1 path)  .02 .04 -.06 .09  
     Neu vs Pos à  Discrimination (a2 path)  .01 .03 -.06 .09  
     Neg vs Neu à  Discrimination (a3 path)       
Extinction Fear Ratings for CS+       
     Discrimination à  Extinction (b path) -1.92 1.20 -4.30 .46  
     Neg v Pos àDiscrimination à  Extinction (Indirect 1) -.03 .09 -.29 .09  
     Neg v Pos à  Extinction (Direct 1) -.27 .43 -1.11 .58  
     Neg v Pos à  Extinction (Total 1) -.30 .43 -1.15 .55  
     Neu v Pos àDiscrimination à  Extinction (Indirect 2) -.02 .09 -.26 .13  
     Neu v Pos à  Extinction (Direct 2) -.21 .42 -1.06 .63  
     Neu v Pos à  Extinction (Total 2) -.23 .43 -1.08 .62  
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     Neg v Neu àDiscrimination à  Extinction (Indirect 3) -.01 .09 -.25 .13  
     Neg v Neu à  Extinction (Direct 3) -.06 .44 -.92 .81  
     Neg v Neu à  Extinction (Total 3) .07 .44 -.80 .94  
Extinction Fear Ratings for CS-       	
     Discrimination à  Extinction (b path) -5.34 .92 -7.18 -3.51 * 
     Neg v Pos àDiscrimination à  Extinction (Indirect 1) -.10 .20 -.50 .28  
     Neg v Pos à  Extinction (Direct 1) -.04 .33 -.69 .61  
     Neg v Pos à  Extinction (Total 1) -.13 .38 -.90 .63  
     Neu v Pos àDiscrimination à  Extinction (Indirect 2) -.06 .23 -.48 .37  
     Neu v Pos à  Extinction (Direct 2) -.04 .33 -.69 .61  
     Neu v Pos à  Extinction (Total 2) -.10 .38 -.86 .66  
     Neg v Neu àDiscrimination à  Extinction (Indirect 3) -.04 .20 -.45 .35  
     Neg v Neu à  Extinction (Direct 3) .00 .34 -.66 .67  
     Neg v Neu à  Extinction (Total 3) .03 .39 -.75 .82  
 
Table 11. Group and Return of Fear Fear Ratings 
 b SE LLCI ULCI sig 
A Path       
     Neg vs Pos à  Discrimination (a1 path)  .02 .04 -.07 .11  
     Neu vs Pos à  Discrimination (a2 path)  -.03 .04 -.11 .06  
     Neg vs Neu à  Discrimination (a3 path)  .05 .04 -.04 .14  
Fear Ratings for CS+        
Context Renewal      
     Discrimination à  CR (b path) -.22 1.33 -2.89 2.44  
     Neg v Pos àDiscrimination à  CR (Indirect 1) -.01 .08 -.21 .11  
     Neg v Pos à  CR (Direct 1) -.22 .48 -1.18 .74  
     Neg v Pos à  CR (Total 1) -.23 .48 -1.18 .73  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .01 .08 -.10 .25  
     Neu v Pos à  CR (Direct 2) .06 .46 -.87 .98  
     Neu v Pos à  CR (Total 2) .06 .46 -.85 .98  
     Neg v Neu àDiscrimination à  CR (Indirect 3) -.01 .10 -.30 .15  
     Neg v Neu à  CR (Direct 3) -.28 .48 -1.24 .68  
     Neg v Neu à  CR (Total 3) .29 .47 -.66 1.23  
Spontaneous Recovery      
     Discrimination à  SR (b path) -1.90 1.33 -4.56 .76  
     Neg v Pos àDiscrimination à  SR (Indirect 1) -.04 .11 -.44 .08  
     Neg v Pos à  SR (Direct 1) -.76 .48 -1.72 .20  
     Neg v Pos à  SR (Total 1) -.80 .49 -1.78 .17  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .05 .11 -.08 .38  
     Neu v Pos à  SR (Direct 2) -.07 .46 -.99 .85  
     Neu v Pos à  SR (Total 2) -.02 .46 -.94 .91  
     Neg v Neu àDiscrimination à  SR (Indirect 3) -.10 .12 -.49 .04  
     Neg v Neu à  SR (Direct 3) -.69 .48 -1.65 .27  
     Neg v Neu à  SR (Total 3) .79 .48 -.17 1.75  
Fear Ratings for CS-       	
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Context Renewal      
     Discrimination à  CR (b path) -2.50 1.13 -4.75 -.25  
     Neg v Pos àDiscrimination à  CR (Indirect 1) -.06 .12 -.39 .14  
     Neg v Pos à  CR (Direct 1) .00 .41 -.82 .81  
     Neg v Pos à  CR (Total 1) -.06 .42 -.89 .78  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .07 .12 -.13 .39  
     Neu v Pos à  CR (Direct 2) .15 .39 -.63 .92  
     Neu v Pos à  CR (Total 2) .22 .40 -.58 1.01  
     Neg v Neu àDiscrimination à  CR (Indirect 3) -.13 .12 -.46 .04  
     Neg v Neu à  CR (Direct 3) -.15 .41 -.96 .66  
     Neg v Neu à  CR (Total 3) .28 .41 -.55 1.10  
Spontaneous Recovery      
     Discrimination à  SR (b path) -4.05 .97 -5.99 -2.11 * 
     Neg v Pos àDiscrimination à  SR (Indirect 1) -.09 .18 -.46 .26  
     Neg v Pos à  SR (Direct 1) .03 .35 -.68 .73  
     Neg v Pos à  SR (Total 1) -.07 .39 -.85 .72  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .11 .18 -.25 .49  
     Neu v Pos à  SR (Direct 2) .20 .34 -.47 .87  
     Neu v Pos à  SR (Total 2) .31 .37 -.44 1.06  
     Neg v Neu àDiscrimination à  SR (Indirect 3) -.21 .17 -.56 .11  
     Neg v Neu à  SR (Direct 3) -.17 .35 -.87 .53  
     Neg v Neu à  SR (Total 3) .38 .39 -.40 1.15  
 
 
Table 12. Group and Extinction Valence Ratings 
 b SE LLCI ULCI sig 
A Path       
     Neg vs Pos à  Discrimination (a1 path)  -.01 .04 -.08 .06  
     Neu vs Pos à  Discrimination (a2 path)  -.03 .04 -.10 .05  
     Neg vs Neu à  Discrimination (a3 path)  .02 .04 -.06 .09  
Extinction Valence Ratings for CS+       
     Discrimination à  Extinction (b path) .45 .70 -.94 1.84  
     Neg v Pos àDiscrimination à  Extinction (Indirect 1) .00 .03 -.10 .04  
     Neg v Pos à  Extinction (Direct 1) .11 .23 -.36 .57  
     Neg v Pos à  Extinction (Total 1) .10 .23 -.36 .56  
     Neu v Pos àDiscrimination à  Extinction (Indirect 2) -.01 .04 -.16 .03  
     Neu v Pos à  Extinction (Direct 2) .15 .23 -.32 .61  
     Neu v Pos à  Extinction (Total 2) .14 .23 -.32 .60  
     Neg v Neu àDiscrimination à  Extinction (Indirect 3) .01 .03 -.03 .12  
     Neg v Neu à  Extinction (Direct 3) -.04 .24 -.52 .43  
     Neg v Neu à  Extinction (Total 3) .03 .24 -.44 .51  
Extinction Valence Ratings for CS-       	
     Discrimination à  Extinction (b path) -1.72 .64 -2.99 -.45 * 
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     Neg v Pos àDiscrimination à  Extinction (Indirect 1) .01 .07 -.10 .18  
     Neg v Pos à  Extinction (Direct 1) .03 .21 -.40 .45  
     Neg v Pos à  Extinction (Total 1) .04 .22 -.40 .48  
     Neu v Pos àDiscrimination à  Extinction (Indirect 2) .04 .07 -.07 .23  
     Neu v Pos à  Extinction (Direct 2) -.04 .21 -.46 .39  
     Neu v Pos à  Extinction (Total 2) .01 .22 -.43 45  
     Neg v Neu àDiscrimination à  Extinction (Indirect 3) .03 .06 -.19 .08  
     Neg v Neu à  Extinction (Direct 3) .06 .22 -.37 .50  
     Neg v Neu à  Extinction (Total 3) -.03 .23 -.48 .42  
 
 
Table 13. Group and Return of Fear Valence Ratings 
 b SE LLCI ULCI sig 
A Path       
     Neg vs Pos à  Discrimination (a1 path)  -.02 .04 -.10 .07  
     Neu vs Pos à  Discrimination (a2 path)  .00 .04 -.07 .08  
     Neg vs Neu à  Discrimination (a3 path)  -.02 .04 -.10 .06  
Valence Ratings for CS+        
Context Renewal      
     Discrimination à  CR (b path) 1.34 .67 .01 2.68 * 
     Neg v Pos àDiscrimination à  CR (Indirect 1) -.02 .06 -.18 .07  
     Neg v Pos à  CR (Direct 1) -.16 .22 -.60 .28  
     Neg v Pos à  CR (Total 1) -.18 .23 -.63 .27  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .00 .06 -.12 .13  
     Neu v Pos à  CR (Direct 2) .01 .21 -.42 .43  
     Neu v Pos à  CR (Total 2) .01 .22 -.42 .44  
     Neg v Neu àDiscrimination à  CR (Indirect 3) -.02 .06 -.18 .07  
     Neg v Neu à  CR (Direct 3) -.16 .22 -.60 .27  
     Neg v Neu à  CR (Total 3) .19 .22 -.26 .64  
Spontaneous Recovery      
     Discrimination à  SR (b path) -.18 .74 -1.67 1.30  
     Neg v Pos àDiscrimination à  SR (Indirect 1) .00 .03 -.04 .12  
     Neg v Pos à  SR (Direct 1) .27 .25 -.22 .76  
     Neg v Pos à  SR (Total 1) .27 .24 -.21 .76  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .00 .03 -.08 .06  
     Neu v Pos à  SR (Direct 2) .22 .23 -.25 .69  
     Neu v Pos à  SR (Total 2) .22 .23 -.25 .68  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .00 .03 -.04 .11  
     Neg v Neu à  SR (Direct 3) .05 .24 -.43 .54  
     Neg v Neu à  SR (Total 3) -.06 .24 -.54 .42  
Valence Ratings for CS-       	
Context Renewal      
     Discrimination à  CR (b path) -.24 .58 -1.41 .93  
     Neg v Pos àDiscrimination à  CR (Indirect 1) .00 .03 -.03 .10  
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     Neg v Pos à  CR (Direct 1) .01 .19 -.38 .39  
     Neg v Pos à  CR (Total 1) .01 .19 -.37 .39  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .00 .18 -.37 .37  
     Neu v Pos à  CR (Direct 2) .00 .03 -.07 .05  
     Neu v Pos à  CR (Total 2) .00 .18 -.40 .36  
     Neg v Neu àDiscrimination à  CR (Indirect 3) .00 .03 -.03 .09  
     Neg v Neu à  CR (Direct 3) .01 .19 -.37 .39  
     Neg v Neu à  CR (Total 3) -.02 .19 -.39 .36  
Spontaneous Recovery      
     Discrimination à  SR (b path) -1.47 .59 -2.65 -.29 * 
     Neg v Pos àDiscrimination à  SR (Indirect 1) .02 .07 -.09 .19  
     Neg v Pos à  SR (Direct 1) -.19 .20 -.58 .20  
     Neg v Pos à  SR (Total 1) -.17 .20 -.57 .24  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .00 .07 -.16 .12  
     Neu v Pos à  SR (Direct 2) .00 .19 -.37 .37  
     Neu v Pos à  SR (Total 2) -.01 .19 -.39 .38  
     Neg v Neu àDiscrimination à  SR (Indirect 3) .03 .06 -.07 .19  
     Neg v Neu à  SR (Direct 3) -.19 .19 -.57 .20  
     Neg v Neu à  SR (Total 3) .16 .20 -.24 .56  
 
 
Table 14. Group and Extinction Arousal Ratings 
 b SE LLCI ULCI sig 
A Path       
     Neg vs Pos à  Discrimination (a1 path)  .02 .03 -.05 .08  
     Neu vs Pos à  Discrimination (a2 path)  .03 .03 -.04 .10  
     Neg vs Neu à  Discrimination (a3 path)       
Extinction Arousal Ratings for CS+       
     Discrimination à  Extinction (b path) -2.56 1.10 -4.75 -.37 * 
     Neg v Pos àDiscrimination à  Extinction (Indirect 1) -.05 .10 -.29 .11  
     Neg v Pos à  Extinction (Direct 1) -.58 .34 -1.26 .10  
     Neg v Pos à  Extinction (Total 1) -.63 .35 -1.32 .07  
     Neu v Pos àDiscrimination à  Extinction (Indirect 2) -.08 .09 -.34 .06  
     Neu v Pos à  Extinction (Direct 2) -.17 .34 -.85 .51  
     Neu v Pos à  Extinction (Total 2) -.25 .35 -.94 .45  
     Neg v Neu àDiscrimination à  Extinction (Indirect 3) .03 .10 -.14 .28  
     Neg v Neu à  Extinction (Direct 3) -.41 .35 -1.11 .29  
     Neg v Neu à  Extinction (Total 3) .38 .36 -.33 1.09  
Extinction Arousal Ratings for CS-       	
     Discrimination à  Extinction (b path) -3.89 .98 -5.84 -1.94 * 
     Neg v Pos àDiscrimination à  Extinction (Indirect 1) -.07 .14 -.36 19  
     Neg v Pos à  Extinction (Direct 1) -.72 .30 -1.33 -.12 * 
     Neg v Pos à  Extinction (Total 1) -.80 .33 -1.45 -.14 * 
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     Neu v Pos àDiscrimination à  Extinction (Indirect 2) -.12 .13 -.43 .11  
     Neu v Pos à  Extinction (Direct 2) -.23 .31 -.84 .38  
     Neu v Pos à  Extinction (Total 2) -.35 .31 -1.00 .31  
     Neg v Neu àDiscrimination à  Extinction (Indirect 3) .05 .14 -.21 .37  
     Neg v Neu à  Extinction (Direct 3) -.50 .31 -1.11 .12  
     Neg v Neu à  Extinction (Total 3) .45 .34 -.22 1.12  
 
 
Table 15. Group and Return of Fear Arousal Ratings 
 b SE LLCI ULCI sig 
A Path       
     Neg vs Pos à  Discrimination (a1 path)  .01 .04 -.07 .09  
     Neu vs Pos à  Discrimination (a2 path)  .00 .04 -.08 .08  
     Neg vs Neu à  Discrimination (a3 path)       
Arousal Ratings for CS+        
Context Renewal      
     Discrimination à  CR (b path) -.70 .97 -2.63 1.23  
     Neg v Pos àDiscrimination à  CR (Indirect 1) -.01 .05 -.19 .06  
     Neg v Pos à  CR (Direct 1) -.23 .32 -.87 .41  
     Neg v Pos à  CR (Total 1) -.24 .32 -.88 .40  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .00 .04 -.09 .09  
     Neu v Pos à  CR (Direct 2) -.28 .31 -.89 .33  
     Neu v Pos à  CR (Total 2) -.28 .31 -.89 .33  
     Neg v Neu àDiscrimination à  CR (Indirect 3) -.01 .05 -.19 .06  
     Neg v Neu à  CR (Direct 3) .05 .32 -.59 .69  
     Neg v Neu à  CR (Total 3) -.04 .32 -.68 .59  
Spontaneous Recovery      
     Discrimination à  SR (b path) -.58 1.24 -3.06 1.90  
     Neg v Pos àDiscrimination à  SR (Indirect 1) -.01 .06 -.22 .08  
     Neg v Pos à  SR (Direct 1) -.26 .41 -1.08 .57  
     Neg v Pos à  SR (Total 1) -.26 .41 -1.08 .56  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .00 .05 -.11 .11  
     Neu v Pos à  SR (Direct 2) -.19 .39 -.98 .59  
     Neu v Pos à  SR (Total 2) -.19 .39 -.98 .59  
     Neg v Neu àDiscrimination à  SR (Indirect 3) -.01 .06 -.22 .08  
     Neg v Neu à  SR (Direct 3) -.06 .41 -.88 .75  
     Neg v Neu à  SR (Total 3) .07 .41 -.74 .88  
Arousal Ratings for CS-       	
Context Renewal      
     Discrimination à  CR (b path) -1.41 1.04 -3.49 .67  
     Neg v Pos àDiscrimination à  CR (Indirect 1) -.02 .08 -.24 .10  
     Neg v Pos à  CR (Direct 1) -.32 .35 -1.02 .37  
     Neg v Pos à  CR (Total 1) -.34 .35 -1.04 .36  
     Neu v Pos àDiscrimination à  CR (Indirect 2) .00 .06 -.14 .12  
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     Neu v Pos à  CR (Direct 2) -.31 .33 -.97 .36  
     Neu v Pos à  CR (Total 2) -.31 .33 -.97 .36  
     Neg v Neu àDiscrimination à  CR (Indirect 3) -.02 .08 -.23 .10  
     Neg v Neu à  CR (Direct 3) -.02 .34 -.70 .67  
     Neg v Neu à  CR (Total 3) .03 .35 -.66 .72  
Spontaneous Recovery      
     Discrimination à  SR (b path) -1.25 1.27 -3.78 1.28  
     Neg v Pos àDiscrimination à  SR (Indirect 1) -.01 .08 -.29 .09  
     Neg v Pos à  SR (Direct 1) -.23 .42 -1.07 .61  
     Neg v Pos à  SR (Total 1) -.24 .42 -1.08 .60  
     Neu v Pos àDiscrimination à  SR (Indirect 2) .00 .07 -.14 .15  
     Neu v Pos à  SR (Direct 2) -.01 .40 -.82 .79  
     Neu v Pos à  SR (Total 2) -.01 .40 -.82 .79  
     Neg v Neu àDiscrimination à  SR (Indirect 3) -.01 .08 -.28 .09  
     Neg v Neu à  SR (Direct 3) -.22 .42 -1.05 .62  
     Neg v Neu à  SR (Total 3) .23 .42 -.60 1.07  
 
 
 
Table 16. Positive Mood Change (PMC) and Extinction SCR 
 b SE LLCI ULCI sig 
A Path       
     PMC à  Discrimination (a path)  .00 .00 .00 .00  
Extinction SCR during CS+       
     Discrimination à  Extinction (b path) -.89 .56 -2.00 .21  
     PMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .01  
     PMC à  Extinction (Direct Effect) .00 .01 -.02 .02  
     PMC à  Extinction (Total Effect) .00 .01 -.02 .02  
Extinction SCR during CS-       	
     Discrimination à  Extinction (b path) -.02 .13 -.29 .25  
     PMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .00  
     PMC à  Extinction (Direct Effect) .00 .00 -.01 .00  
     PMC à  Extinction (Total Effect) .00 .00 -.01   .00  
 
 
Table 17. Positive Mood Change (PMC) and Context Renewal SCR 
 b SE LLCI ULCI sig 
A Path       
     PMC à  Discrimination (a path)  .00 .00 .00 .01  
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SCR during CS+        
First 2 Context Renewal Trials      
     Discrimination à  SR (b path) -.31 .20 -.72 .09  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 -.01 .00  
     PMC à  SR (Total Effect) .00 .00 -.01 .00  
All Context Renewal Trials      
     Discrimination à  SR (b path) -.28 .14 -.57 .01  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .01  
     PMC à  SR (Total Effect) .00 .00 -.01 .00  
Context Renewal Trial 1      
     Discrimination à  SR (b path) -.25 .31 -.87 .37  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) -.01 .01 -.02 .01  
     PMC à  SR (Total Effect) -.01 .01 -.02 .00  
Context Renewal Trial 2      
     Discrimination à  SR (b path) -.38 .18 -.74 -.02 * 
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .01  
     PMC à  SR (Total Effect) .00 .00 -.01 .01  
Context Renewal Trial 3      
     Discrimination à  SR (b path) -.22 .15 -.52 .08  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .01  
     PMC à  SR (Total Effect) .00 .00 .00 .01  
Context Renewal Trial 4      
     Discrimination à  SR (b path) .81 .57 -.23 1.96  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .02  
     PMC à  SR (Direct Effect) .00 .01 -.02 .02  
     PMC à  SR (Total Effect) .01 .01 -.01 .03  
SCR during CS-       	
First 2 Context Renewal Trials      
     Discrimination à  SR (b path) -.69 .23 -1.15 -.23 * 
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     PMC à  SR (Direct Effect) .00 .00 -.01 .00  
     PMC à  SR (Total Effect) -.01 .00 -.01 .00  
All Context Renewal Trials      
     Discrimination à  SR (b path) -1.02 .36 -1.75 -.29 * 
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.02 .00  
     PMC à  SR (Direct Effect) -.01 .01 -.02 .01  
     PMC à  SR (Total Effect) -.01 .01 -.02 .01  
Context Renewal Trial 1      
     Discrimination à  SR (b path) -.75 .28 -1.32 -.18 * 
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .01 .00  
     PMC à  SR (Direct Effect) .00 .00 -.01 .01  
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     PMC à  SR (Total Effect) .00 .01 -.01 .01  
Context Renewal Trial 2      
     Discrimination à  SR (b path) .38 .77 -1.16 1.92  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .02  
     PMC à  SR (Direct Effect) .00 .01 -.02 .03  
     PMC à  SR (Total Effect) .00 .01 -.02 .03  
Context Renewal Trial 3      
     Discrimination à  SR (b path) -.26 .16 -.57 .05  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 -.01 .00  
     PMC à  SR (Total Effect) .00 .00 -.01 .00  
Context Renewal Trial 4      
     Discrimination à  SR (b path) -.24 .22 -.68 .21  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 -.01 .00  
     PMC à  SR (Total Effect) -.01 .00 -.01 .00  
 
 
Table 18. Positive Mood Change (PMC) and Spontaneous Recovery SCR 
 b SE LLCI ULCI sig 
A Path       
     PMC à  Discrimination (a path)  .00 .00 .00 .01  
SCR during CS+        
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.60 .15 -.91 -.29 * 
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .01  
     PMC à  SR (Total Effect) .00 .00 -.01 .01  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.01 .01 -.02 .01  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.02 .00  
     PMC à  SR (Direct Effect) .00 .01 -.02 .01  
     PMC à  SR (Total Effect) -.01 .01 -.02 .01  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -1.42 .41 -2.25 -.59 * 
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.02 .00  
     PMC à  SR (Direct Effect) .00 .01 -.02 .01  
     PMC à  SR (Total Effect) -.01 .01 -.02 .01  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -.58 .23 -1.05 -.11 * 
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     PMC à  SR (Direct Effect) .00 .00 -.01 .01  
     PMC à  SR (Total Effect) .00 .00 -.01 .01  
Spontaneous Recovery Trial 3      
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     Discrimination à  SR (b path) .22 .17 -.13 .56  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 -.01 .00  
     PMC à  SR (Total Effect) .00 .00 -.01 .00  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -.54 .49 -1.52 .44  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     PMC à  SR (Direct Effect) .00 .01 -.02 .01  
     PMC à  SR (Total Effect) -.01 .01 -.02 .01  
SCR during CS-       	
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.42 .50 -1.44 .59  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     PMC à  SR (Direct Effect) .00 .01 -.02 .02  
     PMC à  SR (Total Effect) .00 .01 -.02 .02  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.33 .13 -.59 -.07 * 
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 -.01 .00  
     PMC à  SR (Total Effect) .00 .00 -.01 .00  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -.37 .17 -.71 -.02 * 
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 -.01 .00  
     PMC à  SR (Total Effect) -.01 .00 -.01 .00  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -1.20 .58 -2.37 -.03 * 
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.02 .00  
     PMC à  SR (Direct Effect) .00 .01 -.02 .02  
     PMC à  SR (Total Effect) -.01 .01 -.03 .01  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) -.36 .20 -.76 .05  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     PMC à  SR (Direct Effect) .00 .00 -.01 .00  
     PMC à  SR (Total Effect) .00 .00 -.01 .00  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -1.71 .69 -3.10 -.32 * 
     PMC àDiscrimination à  SR (Indirect Effect) .00 .01 -.03 .00  
     PMC à  SR (Direct Effect) .00 .01 -.03 .02  
     PMC à  SR (Total Effect) -.01 .01 -.03 .02  
 
 
Table 19. Negative Mood Change (NMC) and Extinction SCR 
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 b SE LLCI ULCI si
g 
A Path       
     NMC à  Discrimination (a path)  .00 .00 .00 .01  
Extinction SCR during CS+       
     Discrimination à  Extinction (b path) -.95 .56 -2.06 .16  
     NMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 -.01 .00  
     NMC à  Extinction (Direct Effect) .01 .01 -.01 .03  
     NMC à  Extinction (Total Effect) .01 .01 -.01 .03  
Extinction SCR during CS-       	
     Discrimination à  Extinction (b path) -.05 .13 -.32 .22  
     NMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .00  
     NMC à  Extinction (Direct Effect) .01 .00 .00 .01  
     NMC à  Extinction (Total Effect) .01 .00 .00 .01  
 
 
Table 20. Negative Mood Change (NMC) and Context Renewal SCR 
 b SE LLCI ULCI sig 
A Path       
     NMC à  Discrimination (a path)  .00 .00 .00 .01  
SCR during CS+        
First 2 Context Renewal Trials      
     Discrimination à  SR (b path) -.32 .20 -.73 .08  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 -.01 .01  
     NMC à  SR (Total Effect) .00 .00 -.01 .00  
All Context Renewal Trials      
     Discrimination à  SR (b path) -.27 .14 -.56 .01  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 -.01 .00  
     NMC à  SR (Total Effect) .00 .00 -.01 .00  
Context Renewal Trial 1      
     Discrimination à  SR (b path) -.29 .31 -.91 .33  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .01 -.02 .01  
     NMC à  SR (Total Effect) .00 .01 -.02 .01  
Context Renewal Trial 2      
     Discrimination à  SR (b path) -.36 .18 -.71 -.002 * 
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 -.01 .01  
     NMC à  SR (Total Effect) .00 .00 -.01 .00  
Context Renewal Trial 3      
     Discrimination à  SR (b path) -.20 .15 -.50 .10  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
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     NMC à  SR (Direct Effect) .00 .00 -.01 .01  
     NMC à  SR (Total Effect) .00 .00 -.01 .01  
Context Renewal Trial 4      
     Discrimination à  SR (b path) .88 .57 -.26 2.02  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .02  
     NMC à  SR (Direct Effect) -.01 .01 -.03 .02  
     NMC à  SR (Total Effect) -.01 .01 -.03 .02  
SCR during CS-       	
First 2 Context Renewal Trials      
     Discrimination à  SR (b path) -.70 .23 -1.16 -.25 * 
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NMC à  SR (Direct Effect) .00 .00 -.01 .01  
     NMC à  SR (Total Effect) .00 .00 -.01 .01  
All Context Renewal Trials      
     Discrimination à  SR (b path) -1.07 .36 -1.79 -.34 * 
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NMC à  SR (Direct Effect) .00 .01 -.01 .01  
     NMC à  SR (Total Effect) .00 .01 -.02 .01  
Context Renewal Trial 1      
     Discrimination à  SR (b path) -.75 .28 -1.31 -.19 * 
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NMC à  SR (Direct Effect) .00 .01 -.02 .01  
     NMC à  SR (Total Effect) -.01 .01 -.02 .01  
Context Renewal Trial 2      
     Discrimination à  SR (b path) .26 ..71 -1.17 1.69  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     NMC à  SR (Direct Effect) .04 .01 -.01 .06  
     NMC à  SR (Total Effect) .04 .01 .01 .06  
Context Renewal Trial 3      
     Discrimination à  SR (b path) -.27 .15 -.58 .03  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 -.01 .00  
     NMC à  SR (Total Effect) -.01 .00 -.01 .00  
Context Renewal Trial 4      
     Discrimination à  SR (b path) -.27 .22 -.72 .19  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 -.01 .01  
     NMC à  SR (Total Effect) .00 .00 -.01 .01  
 
 
Table 21. Negative Mood Change (NMC) and Spontaneous Recovery SCR 
 b SE LLCI ULCI sig 
A Path       
     NMC à  Discrimination (a path)  .00 .00 -.01 .01  
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SCR during CS+        
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.59 .15 -.90 -.28 * 
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 -.01 .01  
     NMC à  SR (Total Effect) .00 .00 -.01 .01  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -1.26 .45 -2.16 -.35 * 
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .01  
     NMC à  SR (Direct Effect) .00 .01 -.02 .02  
     NMC à  SR (Total Effect) .00 .01 -.02 .02  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -1.44 .41 -2.26 -.63 * 
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .01  
     NMC à  SR (Direct Effect) .00 .01 -.02 .02  
     NMC à  SR (Total Effect) .00 .01 -.02 .02  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -.57 .23 -1.04 -.10 * 
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 -.01 .01  
     NMC à  SR (Total Effect) .00 .00 -.01 .01  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) .19 .17 -.15 .54  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 -.01 .01  
     NMC à  SR (Total Effect) .00 .00 -.01 .01  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -.58 .48 -1.55 .39  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .01 -.02 .02  
     NMC à  SR (Total Effect) .00 .01 -.02 .02  
SCR during CS-       	
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.42 .50 -1.43 .59  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .01 .-.02 .02  
     NMC à  SR (Total Effect) .00 .01 -.02 .02  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.34 .13 -.60 -.08 * 
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 -.01 .00  
     NMC à  SR (Total Effect) .00 .00 -.01 .00  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -.40 .17 -.75 -.05 * 
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 -.01 .00  
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     NMC à  SR (Total Effect) .00 .00 -.01 .00  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -1.23 .58 -2.38 -.07 * 
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .01  
     NMC à  SR (Direct Effect) .00 .01 -.02 .03  
     NMC à  SR (Total Effect) .00 .01 -.02 .03  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) -.38 .20 -.79 .02  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 -.01 .01  
     NMC à  SR (Total Effect) .00 .00 -.01 .01  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -1.74 .69 -3.12 -.36 * 
     NMC àDiscrimination à  SR (Indirect Effect) .00 .01 -.02 .01  
     NMC à  SR (Direct Effect) .00 .01 -.02 .03  
     NMC à  SR (Total Effect) .00 .01 -.03 .03  
 
 
Table 22. Positive Mood Change (PMC) and Extinction US Expectancy 
 b SE LLCI ULCI sig 
A Path       
     PMC à  Discrimination (a path)  .00 .01 -.01 .01  
Extinction Expectancy during CS+       
     Discrimination à  Extinction (b path) .23 .08 .06 .39 * 
     PMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .00  
     PMC à  Extinction (Direct Effect) .01 .00 .00 .01  
     PMC à  Extinction (Total Effect) .00 .01 -.01 .01  
Extinction Expectancy during CS-       	
     Discrimination à  Extinction (b path) .25 .06 .15 .36 * 
     PMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .00  
     PMC à  Extinction (Direct Effect) .00 .00 .00 .01  
     PMC à  Extinction (Total Effect) .00 .00 .00 .01  
 
 
Table 23. Positive Mood Change (PMC) and Context Renewal US Expectancy 
 b SE LLCI ULCI sig 
A Path       
     PMC à  Discrimination (a path)  .00 .00 .00 .00  
Expectancy during CS+        
First 2 Context Renewal Trials      
     Discrimination à  SR (b path) 1.22 .73 -.24 2.67  
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     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     PMC à  SR (Direct Effect) -.01 .01 -.03 .02  
     PMC à  SR (Total Effect) -.01 .01 -.03 .02  
All Context Renewal Trials      
     Discrimination à  SR (b path) .47 .65 -.83 1.77  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     PMC à  SR (Direct Effect) .00 .01 -.02 .02  
     PMC à  SR (Total Effect) .00 .01 -.02 .02  
Context Renewal Trial 1      
     Discrimination à  SR (b path) 2.04 .72 .60 3.49 * 
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .01  
     PMC à  SR (Direct Effect) -.01 .01 -.03 .02  
     PMC à  SR (Total Effect) -.01 .01 -.03 .02  
Context Renewal Trial 2      
     Discrimination à  SR (b path) .39 .93 -1.48 2.26  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     PMC à  SR (Direct Effect) -.01 .01 -.04 .02  
     PMC à  SR (Total Effect) -.01 .01 -.03 .02  
Context Renewal Trial 3      
     Discrimination à  SR (b path) .49 .75 -1.02 1.99  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .01 -.03 .02  
     PMC à  SR (Total Effect) .00 .01 -.03 .02  
Context Renewal Trial 4      
     Discrimination à  SR (b path) -1.06 .66 -2.38 .25  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     PMC à  SR (Direct Effect) .00 .01 -.02 .02  
     PMC à  SR (Total Effect) .00 .01 -02 .02  
Expectancy during CS-       	
First 2 Context Renewal Trials      
     Discrimination à  SR (b path) -.01 .61 -1.22 1.20  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) -.01 .01 -.03 .01  
     PMC à  SR (Total Effect) -.01 .01 -.03 .01  
All Context Renewal Trials      
     Discrimination à  SR (b path) -.57 .48 -1.52 .38  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .01 -.01 .02  
     PMC à  SR (Total Effect) .00 .01 -.01 .02  
Context Renewal Trial 1      
     Discrimination à  SR (b path) .34 .76 -1.19 1.87  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     PMC à  SR (Direct Effect) -.02 .01 -.04 .01  
     PMC à  SR (Total Effect) -.02 .01 -.04 .01  
Context Renewal Trial 2      
     Discrimination à  SR (b path) -.36 .64 -1.64 .92  
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     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .01 .01 -.01 .03  
     PMC à  SR (Total Effect) .01 .01 -.01 .03  
Context Renewal Trial 3      
     Discrimination à  SR (b path) -.88 .47 -1.82 .06  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .01 .01 -.01 .02  
     PMC à  SR (Total Effect) .01 .01 -.01 .02  
Context Renewal Trial 4      
     Discrimination à  SR (b path) -1.38 .52 -2.43 -.34 * 
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     PMC à  SR (Direct Effect) .01 .01 -.01 .02  
     PMC à  SR (Total Effect) .01 .01 -.01 .02  
 
 
Table 24. Positive Mood Change (PMC) and Spontaneous Recovery US 
Expectancy 
 b SE LLCI ULCI sig 
A Path       
     PMC à  Discrimination (a path)  .00 .00 .00 .00  
Expectancy during CS+        
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.40 .77 -1.95 1.15  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     PMC à  SR (Direct Effect) .00 .01 -.03 .02  
     PMC à  SR (Total Effect) .00 .01 -.03 .02  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.32 .58 -1.49 .85  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .01 -.02 .02  
     PMC à  SR (Total Effect) .00 .01 -.02 .02  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) .11 .81 -1.52 1.74  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .01 -.03 .03  
     PMC à  SR (Total Effect) .00 .01 -.03 .02  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -.91 .90 -2.71 .88  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     PMC à  SR (Direct Effect) .00 .01 -.03 .03  
     PMC à  SR (Total Effect) .00 .01 -.03 .03  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) -.37 .66 -1.69 .94  
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     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .01 -.02 .02  
     PMC à  SR (Total Effect) .00 .01 -.02 .02  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -.12 .45 -1.02 .79  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .01 -.01 .02  
     PMC à  SR (Total Effect) .00 .01 -.01 .02  
Expectancy during CS-       	
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -1.53 .59 -2.70 -.35 * 
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     PMC à  SR (Direct Effect) .00 .01 -.02 .02  
     PMC à  SR (Total Effect) .00 .01 -.02 .02  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -1.30 .40 -2.10 -.51 * 
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     PMC à  SR (Direct Effect) .00 .01 -.01 .02  
     PMC à  SR (Total Effect) .00 .01 -.01 .02  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -.68 .80 -2.29 .93  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     PMC à  SR (Direct Effect) .00 .01 -.02 .03  
     PMC à  SR (Total Effect) .00 .01 -.02 .03  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -2.37 .53 -3.44 -1.30 * 
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .01  
     PMC à  SR (Direct Effect) .00 .01 -.02 .02  
     PMC à  SR (Total Effect) .00 .01 -.02 .02  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) -1.09 .44 -1.96 -.21 * 
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     PMC à  SR (Direct Effect) .01 .01 -.01 .02  
     PMC à  SR (Total Effect) .00 .01 -.01 .02  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -1.07 .35 -1.77 -.36 * 
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .01 .01 .00 .02  
     PMC à  SR (Total Effect) .01 .01 -.01 .02  
 
 
Table 25. Negative Mood Change (NMC) and Extinction US Expectancy 
 b SE LLCI UL
CI 
si
g 
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A Path       
     NMC à  Discrimination (a path)  .00 .01 -.01 .02  
Extinction Expectancy during CS+       
     Discrimination à  Extinction (b path) .22 .08 .05 .39  
     NMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .00  
     NMC à  Extinction (Direct Effect) .00 .01 -.01 .01  
     NMC à  Extinction (Total Effect) .00 .01 -.01 .01  
Extinction Expectancy during CS-       	
     Discrimination à  Extinction (b path) .25 .06 .14 .36  
     NMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 -.01 .00  
     NMC à  Extinction (Direct Effect) .00 .00 -.01 .00  
     NMC à  Extinction (Total Effect) .00 .00 -.01 .01  
 
 
Table 26. Negative Mood Change (NMC) and Context Renewal US Expectancy 
 b SE LLCI ULCI sig 
A Path       
     NMC à  Discrimination (a path)  .00 .00 .00 .01  
Expectancy during CS+        
First 2 Context Renewal Trials      
     Discrimination à  SR (b path) 1.16 .72 -.29 2.61  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     NMC à  SR (Direct Effect) .01 .01 -.01 .04  
     NMC à  SR (Total Effect) .01 .01 -.01 .04  
All Context Renewal Trials      
     Discrimination à  SR (b path) .42 .65 -.87 1.71  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     NMC à  SR (Direct Effect) .01 .01 -.01 .03  
     NMC à  SR (Total Effect) .01 .01 -.01 .03  
Context Renewal Trial 1      
     Discrimination à  SR (b path) 1.98 .72 .54 3.42 * 
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .01  
     NMC à  SR (Direct Effect) .01 .01 -.01 .04  
     NMC à  SR (Total Effect) .02 .01 -.01 .04  
Context Renewal Trial 2      
     Discrimination à  SR (b path) .34 .93 -1.53 2.20  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     NMC à  SR (Direct Effect) .01 .02 -.02 .04  
     NMC à  SR (Total Effect) .01 .02 -.02 .04  
Context Renewal Trial 3      
     Discrimination à  SR (b path) .45 .75 -1.05 1.95  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     NMC à  SR (Direct Effect) .01 .01 -.02 .04  
     NMC à  SR (Total Effect) .01 .01 -.02 .04  
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Context Renewal Trial 4      
     Discrimination à  SR (b path) -1.08 .66 -2.40 .23  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NMC à  SR (Direct Effect) .01 .01 -.02 .03  
     NMC à  SR (Total Effect) .01 .01 -.02 .03  
Expectancy during CS-       	
First 2 Context Renewal Trials      
     Discrimination à  SR (b path) .01 .61 -1.20 1.22  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) -.01 .01 -.03 .01  
     NMC à  SR (Total Effect) -.01 .01 -.03 .01  
All Context Renewal Trials      
     Discrimination à  SR (b path) -.55 .47 -1.50 .40  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NMC à  SR (Direct Effect) -.01 .01 -.02 .01  
     NMC à  SR (Total Effect) -.01 .01 -.02 .01  
Context Renewal Trial 1      
     Discrimination à  SR (b path) .35 .78 -1.21 1.90  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     NMC à  SR (Direct Effect) -.01 .01 -.04 .02  
     NMC à  SR (Total Effect) -.01 .01 -.04 .02  
Context Renewal Trial 2      
     Discrimination à  SR (b path) -.32 .64 -1.60 .96  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NMC à  SR (Direct Effect) -.01 .01 -.03 .02  
     NMC à  SR (Total Effect) -.01 .01 -.03 .01  
Context Renewal Trial 3      
     Discrimination à  SR (b path) -.86 .47 -1.81 .09  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NMC à  SR (Direct Effect) .00 .01 -.02 .01  
     NMC à  SR (Total Effect) .00 .01 -.02 .01  
Context Renewal Trial 4      
     Discrimination à  SR (b path) -1.36 .52 -2.41 -.31 * 
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.02 .00  
     NMC à  SR (Direct Effect) .00 .01 -.02 .02  
     NMC à  SR (Total Effect) .00 .01 -.02 .02  
 
 
Table 27. Negative Mood Change (NMC) and Spontaneous Recovery US 
Expectancy 
 b SE LLCI ULCI sig 
A Path       
     NMC à  Discrimination (a path)  .00 .00 .00 .01  
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Expectancy during CS+        
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.38 .77 -1.92 1.17  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NMC à  SR (Direct Effect) -.01 .01 -.04 .02  
     NMC à  SR (Total Effect) -.01 .01 -.04 .02  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.30 .58 -1.47 .87  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NMC à  SR (Direct Effect) -.01 .01 -.03 .02  
     NMC à  SR (Total Effect) -.01 .01 -.03 .02  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) .18 .80 -1.43 1.79  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     NMC à  SR (Direct Effect) -.02 .02 -.05 .01  
     NMC à  SR (Total Effect) -.02 .01 -.05 .01  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -.93 .90 -2.73 .87  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.02 .00  
     NMC à  SR (Direct Effect) .00 .02 -.03 .04  
     NMC à  SR (Total Effect) .00 .02 -.03 .04  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) -.38 .66 -1.70 .94  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NMC à  SR (Direct Effect) .00 .01 -.02 .03  
     NMC à  SR (Total Effect) .00 .01 -.02 .02  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -.08 .45 -.97 .82  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) -.01 .01 -.03 .01  
     NMC à  SR (Total Effect) -.01 .01 -.03 .01  
Expectancy during CS-       	
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -1.48 .58 -2.65 -.32 * 
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .01  
     NMC à  SR (Direct Effect) -.01 .01 -.03 .01  
     NMC à  SR (Total Effect) -.01 .01 -.04 .01  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -1.27 .40 -2.07 -.48 * 
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .01  
     NMC à  SR (Direct Effect) -.01 .01 -.02 .01  
     NMC à  SR (Total Effect) -.01 .01 -.02 .01  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -.60 .79 -2.19 .98  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NMC à  SR (Direct Effect) -.02 .01 -.05 .01  
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     NMC à  SR (Total Effect) -.02 .01 -.05 .01  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -2.36 .53 -3.43 -1.29 * 
     NMC àDiscrimination à  SR (Indirect Effect) .00 .01 -.01 .01  
     NMC à  SR (Direct Effect) .00 .01 -.02 .02  
     NMC à  SR (Total Effect) .00 .01 -.03 .02  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) -1.08 .44 -1.96 -.20 * 
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NMC à  SR (Direct Effect) .00 .01 -.02 .02  
     NMC à  SR (Total Effect) .00 .01 -.02 .02  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -1.05 .36 -1.77 -.34 * 
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NMC à  SR (Direct Effect) .00 .01 -.02 .01  
     NMC à  SR (Total Effect) .00 .01 -.02 .01  
 
 
Table 28. Positive Mood Change (PMC) and Extinction Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     PMC à  Discrimination (a path)  .00 .00 .00 .00  
Extinction Heart Rate during CS+       
     Discrimination à  Extinction (b path) .12 .72 -1.32 1.55  
     PMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .00  
     PMC à  Extinction (Direct Effect) .00 .00 .00 .00  
     PMC à  Extinction (Total Effect) .00 .00 .00 .00  
Extinction Heart Rate during CS-       	
     Discrimination à  Extinction (b path) .33 .73 -1.14 1.79  
     PMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .00  
     PMC à  Extinction (Direct Effect) .00 .00 .00 .00  
     PMC à  Extinction (Total Effect) .00 .00 .00 .00  
 
 
Table 29. Positive Mood Change (PMC) and Context Renewal Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     PMC à  Discrimination (a path)  .00 .00 .00 .00  
Heart Rate during CS+        
First 2 Context Renewal Trials      
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     Discrimination à  SR (b path) 1.03 1.07 -1.11 3.18  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .01  
     PMC à  SR (Total Effect) .00 .00 .00 .01  
All Context Renewal Trials      
     Discrimination à  SR (b path) .33 1.03 -1.74 2.40  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .01  
     PMC à  SR (Total Effect) .00 .00 .00 .01  
Context Renewal Trial 1      
     Discrimination à  SR (b path) -.78 .99 -2.78 1.21  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .01  
     PMC à  SR (Total Effect) .00 .00 .00 .01  
Context Renewal Trial 2      
     Discrimination à  SR (b path) 2.85 1.22 .40 5.29 * 
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .01  
     PMC à  SR (Total Effect) .00 .00 .00 .01  
Context Renewal Trial 3      
     Discrimination à  SR (b path) .11 1.12 -2.15 2.36  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .01  
     PMC à  SR (Total Effect) .00 .00 .00 .01  
Context Renewal Trial 4      
     Discrimination à  SR (b path) -.84 .98 -2.82 1.13  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .01  
     PMC à  SR (Total Effect) .00 .00 .00 .01  
Heart Rate during CS-       	
First 2 Context Renewal Trials      
     Discrimination à  SR (b path) .25 1.01 -1.80 2.30  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .00  
     PMC à  SR (Total Effect) .00 .00 .00 .00  
All Context Renewal Trials      
     Discrimination à  SR (b path) -.02 1.06 -2.15 2.11  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .00  
     PMC à  SR (Total Effect) .00 .00 .00 .00  
Context Renewal Trial 1      
     Discrimination à  SR (b path) .15 1.08 -2.01 2.32  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .00  
     PMC à  SR (Total Effect) .00 .00 .00 .00  
Context Renewal Trial 2      
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     Discrimination à  SR (b path) .35 1.00 -1.66 2.35  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .01  
     PMC à  SR (Total Effect) .00 .00 .00 .01  
Context Renewal Trial 3      
     Discrimination à  SR (b path) -1.26 1.15 -3.56 1.05  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .01  
     PMC à  SR (Total Effect) .00 .00 .00 .01  
Context Renewal Trial 4      
     Discrimination à  SR (b path) .68 1.27 -1.87 3.23  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .01  
     PMC à  SR (Total Effect) .00 .00 .00 .01  
 
 
Table 30. Positive Mood Change (PMC) and Spontaneous Recovery Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     PMC à  Discrimination (a path)  .00 .00 .00 .00  
Heart Rate during CS+        
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.29 1.02 -2.34 1.77  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .01  
     PMC à  SR (Total Effect) .00 .00 .00 .01  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.52 1.03 -2.59 1.56  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .01  
     PMC à  SR (Total Effect) .00 .00 .00 .01  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) .10 1.05 -2.02 2.21  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .01  
     PMC à  SR (Total Effect) .00 .00 .00 .01  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -.67 1.03 -2.74 1.40  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .01  
     PMC à  SR (Total Effect) .00 .00 .00 .01  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) -.61 1.06 -2.73 1.52  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
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     PMC à  SR (Direct Effect) .00 .00 .00 .01  
     PMC à  SR (Total Effect) .00 .00 .00 .01  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -.88 1.09 -3.06 1.30  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .01  
     PMC à  SR (Total Effect) .00 .00 .00 .01  
Heart Rate during CS-       	
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.64 .98 -2.60 1.32  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .00  
     PMC à  SR (Total Effect) .00 .00 .00 .00  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.37 1.00 -2.37 1.63  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .00  
     PMC à  SR (Total Effect) .00 .00 .00 .00  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -.66 `.93 -2.53 1.20  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .00  
     PMC à  SR (Total Effect) .00 .00 .00 .00  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -.62 1.06 -2.74 1.51  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .01  
     PMC à  SR (Total Effect) .00 .00 .00 .01  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) .34 1.20 -2.06 2.74  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .01  
     PMC à  SR (Total Effect) .00 .00 .00 .01  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -.54 .98 -2.51 1.43  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .00 .00 .00  
     PMC à  SR (Total Effect) .00 .00 .00 .00  
 
 
Table 31. Negative Mood Change (NMC) and Extinction Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     NMC à  Discrimination (a path)  .00 .00  .00 .00  
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Extinction Heart Rate during CS+       
     Discrimination à  Extinction (b path)    .14 .70 -1.27 1.54  
     NMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .00  
     NMC à  Extinction (Direct Effect) .00 .00 -.01 .00  
     NMC à  Extinction (Total Effect) .00 .00 -.01 .00  
Extinction Heart Rate during CS-       	
     Discrimination à  Extinction (b path) .34 .72 -1.10 1.78  
     NMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .00  
     NMC à  Extinction (Direct Effect) .00 .00 .00 .00  
     NMC à  Extinction (Total Effect) .00 .00 .00 .00  
 
 
Table 32. Negative Mood Change (NMC) and Context Renewal Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     NMC à  Discrimination (a path)  .00 .00 .00 .00  
Heart Rate during CS+        
First 2 Context Renewal Trials      
     Discrimination à  SR (b path) 1.02 1.10 -1.19 3.23  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 .00 .00  
All Context Renewal Trials      
     Discrimination à  SR (b path) .32 1.06 -1.82 2.46  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 .00 .00  
Context Renewal Trial 1      
     Discrimination à  SR (b path) -.79 1.02 -2.85 1.26  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 .00 .00  
Context Renewal Trial 2      
     Discrimination à  SR (b path) 2.84 1.25 .33 5.35 * 
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 .00 .00  
Context Renewal Trial 3      
     Discrimination à  SR (b path) .11 1.15 -2.20 2.41  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 .00 .00  
Context Renewal Trial 4      
     Discrimination à  SR (b path) -.87 1.03 -2.94 1.19  
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     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 .00 .00  
Heart Rate during CS-       	
First 2 Context Renewal Trials      
     Discrimination à  SR (b path) .24 1.04 -1.85 2.32  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 .00 .00  
All Context Renewal Trials      
     Discrimination à  SR (b path) -.02 1.08 -2.20 2.15  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 .00 .00  
Context Renewal Trial 1      
     Discrimination à  SR (b path) .16 1.09 -2.02 2.34  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 .00 .00  
Context Renewal Trial 2      
     Discrimination à  SR (b path) .32 1.03 -1.74 2.37  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 .00 .00  
Context Renewal Trial 3      
     Discrimination à  SR (b path) -1.24 1.18 -3.62 1.13  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 -.01 .00  
     NMC à  SR (Total Effect) .00 .00 -.01 .00  
Context Renewal Trial 4      
     Discrimination à  SR (b path) .67 1.28 -1.91 3.24  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 .00 .00  
 
 
Table 33. Negative Mood Change (NMC) and Spontaneous Recovery Heart Rate  
 b SE LLCI ULCI sig 
A Path       
     NMC à  Discrimination (a path)  .00 .00 .00 .00  
Heart Rate during CS+        
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.36 1.07 -2.52 1.79  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
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     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 .00 .00  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.61 1.07 -2.76 1.54  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 .00 .00  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -.01 1.11 -2.24 2.22  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 .00 .00  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -.72 1.07 -2.87 1.43  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 -.01 .00  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) -.73 1.08 -2.90 1.44  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 .00 .00  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -.98 1.11 -3.22 1.25  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 .00 .00  
Heart Rate during CS-       	
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.73 1.00 -2.75 1.28  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 .00 .00  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.45 1.02 -2.50 1.61  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 .00 .00  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -.74 .95 -2.65 1.17  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 .00 .00  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -.72 1.08 -2.90 1.45  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
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     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 .00 .00  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) .26 1.22 -2.18 2.70  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 .00 .00  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -.58 1.01 -2.60 1.45  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .00 .00 .00 .00  
     NMC à  SR (Total Effect) .00 .00 .00 .00  
 
 
Table 34. Positive Mood Change (PMC) and Extinction Fear Ratings 
 b SE LLCI ULCI sig 
A Path       
     PMC à  Discrimination (a path)  .00 .00 .00 .00  
Extinction Fear Ratings for CS+       
     Discrimination à  Extinction (b path) -1.81 1.20 -4.19 .57  
     PMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .01  
     PMC à  Extinction (Direct Effect) .01 .01 -.01 .03  
     PMC à  Extinction (Total Effect) .01 .01 -.01 .03  
Extinction Fear Ratings for CS-       	
     Discrimination à  Extinction (b path) -5.38 .91 -7.20 -3.57 * 
     PMC àDiscrimination à  Extinction (Indirect Effect) .00 .01 -.01 .01  
     PMC à  Extinction (Direct Effect) .01 .01 -.01 .03  
     PMC à  Extinction (Total Effect) .01 .01 -.01 .03  
 
 
Table 35. Positive Mood Change (PMC) and Return of Fear Ratings 
 b SE LLCI ULCI sig 
A Path       
     PMC à  Discrimination (a path)  .00 .00 .00 .00  
Fear Ratings for CS+        
Context Renewal      
     Discrimination à  SR (b path) -.20 1.30 -2.79 2.40  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) -.01 .01 -.04 .02  
     PMC à  SR (Total Effect) -.01 .01 -.04 .02  
Spontaneous Recovery       
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     Discrimination à  SR (b path) -2.04 1.34 -4.70 .63  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .01  
     PMC à  SR (Direct Effect) -.01 .01 -.04 .02  
     PMC à  SR (Total Effect) -.01 .01 -.04 .02  
Fear Ratings for CS-       	
Context Renewal       
     Discrimination à  SR (b path) -2.48 1.11 -4.69 -.27 * 
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .01  
     PMC à  SR (Direct Effect) .01 .01 -.02 .03  
     PMC à  SR (Total Effect) .01 .01 -.02 .03  
Spontaneous Recovery      
     Discrimination à  SR (b path) -4.07 .96 -5.99 -2.15 * 
     PMC àDiscrimination à  SR (Indirect Effect) .00 .01 -.01 .01  
     PMC à  SR (Direct Effect) .00 .01 -.02 .02  
     PMC à  SR (Total Effect) .00 .01 -.02 .02  
 
 
 
Table 36. Negative Mood Change (NMC) and Extinction Fear Ratings 
 b SE LLCI ULC
I 
sig 
A Path       
     NMC à  Discrimination (a path)  .00 .00 .00 .00  
Extinction Fear Ratings for CS+       
     Discrimination à  Extinction (b path) -1.93 1.22 -4.35 .49  
     NMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 -.01 .00  
     NMC à  Extinction (Direct Effect) .01 .01 -.02 .04  
     NMC à  Extinction (Total Effect) .00 .01 -.02 .03  
Extinction Fear Ratings for CS-       	
     Discrimination à  Extinction (b path) -5.44 .93 -7.29 -
3.59 
* 
     NMC àDiscrimination à  Extinction (Indirect Effect) -.01 .01 -.02 .00  
     NMC à  Extinction (Direct Effect) .00 .01 -.02 .03  
     NMC à  Extinction (Total Effect) -.01 .01 -.03 .02  
 
 
Table 37. Negative Mood Change (NMC) and Return of Fear Ratings 
 b SE LLCI ULCI sig 
A Path       
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     NMC à  Discrimination (a path)  .00 .00 .00 .01  
Fear Ratings for CS+        
Context Renewal      
     Discrimination à  SR (b path) -.14 1.36 -2.85 2.57  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .01 -.01 .01  
     NMC à  SR (Direct Effect) .00 .02 -.04 .03  
     NMC à  SR (Total Effect) .00 .02 -.03 .03  
Spontaneous Recovery      
     Discrimination à  SR (b path) -2.22 1.39 -5.00 .55  
     NMC àDiscrimination à  SR (Indirect Effect) -.01 .01 -.03 .00  
     NMC à  SR (Direct Effect) .01 .02 -.03 .04  
     NMC à  SR (Total Effect) .00 .02 -.03 .03  
Fear Ratings for CS-       	
Context Renewal      
     Discrimination à  SR (b path) -2.53 1.15 -4.83 -.22 * 
     NMC àDiscrimination à  SR (Indirect Effect) -.01 .01 -.02 .00  
     NMC à  SR (Direct Effect) .00 .01 -.03 .03  
     NMC à  SR (Total Effect) -.01 .01 -.03 .02  
Spontaneous Recovery      
     Discrimination à  SR (b path) -4.28 1.00 -6.27 -2.29 * 
     NMC àDiscrimination à  SR (Indirect Effect) -.01 .01 -.03 .00  
     NMC à  SR (Direct Effect) .01 .01 -.02 .03  
     NMC à  SR (Total Effect) -.01 .01 -.03 .02  
 
 
Table 38. Positive Mood Change (PMC) and Extinction Valence Ratings 
 b SE LLCI ULCI sig 
A Path       
     PMC à  Discrimination (a path)  .00 .00 .00 .00  
Extinction Valence Ratings for CS+       
     Discrimination à  Extinction (b path) .39 .70 -1.01 1.79  
     PMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .00  
     PMC à  Extinction (Direct Effect) .00 .01 -.01 .01  
     PMC à  Extinction (Total Effect) .00 .01 -.01 .01  
Extinction Valence Ratings for CS-       	
     Discrimination à  Extinction (b path) -1.73 .64 -3.00 -.45 * 
     PMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 -.01 .00  
     PMC à  Extinction (Direct Effect) .00 .01 -.01 .01  
     PMC à  Extinction (Total Effect) .00 .01 -.01 .01  
 
 
Table 39. Positive Mood Change (PMC) and Return of Fear Valence Ratings 
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 b SE LLCI ULCI sig 
A Path       
     PMC à  Discrimination (a path)  .00 .00 .00 .00  
Valence Ratings for CS+        
Context Renewal      
     Discrimination à  SR (b path) 1.32 .68 -.04 2.68  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     PMC à  SR (Direct Effect) .01 .01 -.01 .02  
     PMC à  SR (Total Effect) .01 .01 -.01 .02  
Spontaneous Recovery       
     Discrimination à  SR (b path) -.28 .76 -1.80 1.24  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .01 -.01 .02  
     PMC à  SR (Total Effect) .00 .01 -.01 .02  
Valence Ratings for CS-       	
Context Renewal       
     Discrimination à  SR (b path) -.19 .59 -1.37 .99  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PMC à  SR (Direct Effect) .00 .01 -.02 .01  
     PMC à  SR (Total Effect) .00 .01 -.02 .01  
Spontaneous Recovery      
     Discrimination à  SR (b path) -1.48 .61 -2.69 -.27 * 
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     PMC à  SR (Direct Effect) .00 .01 -.01 .01  
     PMC à  SR (Total Effect) .00 .01 -.01 .01  
 
 
Table 40. Negative Mood Change (NMC) and Extinction Valence Ratings 
 b SE LLCI UL
CI 
sig 
A Path       
     NMC à  Discrimination (a path)  .00 .00 .00 .00  
Extinction Valence Ratings for CS+       
     Discrimination à  Extinction (b path)       .40 .70 -1.00 1.79  
     NMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .00  
     NMC à  Extinction (Direct Effect) .00 .01 -.02 .01  
     NMC à  Extinction (Total Effect) .00 .01 -.02 .01  
Extinction Valence Ratings for CS-       	
     Discrimination à  Extinction (b path) -1.73 .64 -3.00 -.45 * 
     NMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .00  
     NMC à  Extinction (Direct Effect) .00 .01 -.01 .02  
     NMC à  Extinction (Total Effect) .00 .01 -.01 .02  
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Table 41. Negative Mood Change (NMC) and Return of Fear Valence Ratings 
 b SE LLCI ULCI sig 
A Path       
     NMC à  Discrimination (a path)  .00 .00 .00 .00  
Valence Ratings for CS+        
Context Renewal      
     Discrimination à  SR (b path) 1.39 .68 .03 2.75 * 
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NMC à  SR (Direct Effect) .00 .01 -.01 .02  
     NMC à  SR (Total Effect) .00 .01 -.01 .02  
Spontaneous Recovery      
     Discrimination à  SR (b path) -.22 .76 -1.74 1.29  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .01 .01 -.01 .02  
     NMC à  SR (Total Effect) .01 .01 -.01 .02  
Valence Ratings for CS-       	
Context Renewal      
     Discrimination à  SR (b path) -.18 .58 -1.33 .98  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NMC à  SR (Direct Effect) .01 .01 -.00 .02  
     NMC à  SR (Total Effect) .01 .01 .00 .02  
Spontaneous Recovery      
     Discrimination à  SR (b path) -1.48 .60 -2.68 -.28 * 
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     NMC à  SR (Direct Effect) .00 .01 -.02 .01  
     NMC à  SR (Total Effect) .00 .01 -.02 .01  
 
 
Table 42. Positive Mood Change (PMC) and Extinction Arousal Ratings 
 b SE LLCI ULCI sig 
A Path       
     PMC à  Discrimination (a path)  .00 .00 .00 .00  
Extinction Arousal Ratings for CS+       
     Discrimination à  Extinction (b path) -2.71 1.09 -4.89 -.54 * 
     PMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .01  
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     PMC à  Extinction (Direct Effect) .01 .01 -.01 .03  
     PMC à  Extinction (Total Effect) .01 .01 -.01 .03  
Extinction Arousal Ratings for CS-       	
     Discrimination à  Extinction (b path) -4.01 .98 -5.96 -2.07 * 
     PMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .01  
     PMC à  Extinction (Direct Effect) .01 .01 .00 .03  
     PMC à  Extinction (Total Effect) .02 .01 .00 .04  
 
 
Table 43. Positive Mood Change (PMC) and Return of Fear Arousal Ratings 
 b SE LLCI ULCI sig 
A Path       
     PMC à  Discrimination (a path)  .00 .00 .00 .00  
Arousal Ratings for CS+        
Context Renewal      
     Discrimination à  SR (b path) -.66 .98 -2.61 1.29  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     PMC à  SR (Direct Effect) .01 .01 -.01 .03  
     PMC à  SR (Total Effect) .01 .01 -.01 .03  
Spontaneous Recovery       
     Discrimination à  SR (b path) -.55 1.25 -4.06 1.95  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     PMC à  SR (Direct Effect) .00 .01 -.02 .03  
     PMC à  SR (Total Effect) .00 .01 -.02 .03  
Arousal Ratings for CS-       	
Context Renewal       
     Discrimination à  SR (b path) -1.29 1.04 -3.37 .79  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     PMC à  SR (Direct Effect) .01 .01 -.01 .04  
     PMC à  SR (Total Effect) .02 .01 .00 .04  
Spontaneous Recovery      
     Discrimination à  SR (b path) -1.14 1.27 -3.68 1.40  
     PMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     PMC à  SR (Direct Effect) .01 .01 -.01 .04  
     PMC à  SR (Total Effect) .01 .01 -.01 .04  
 
 
 
Table 44. Negative Mood Change (NMC) Extinction Arousal Ratings 
 b SE LLCI ULCI sig 
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A Path       
     NMC à  Discrimination (a path)  .00 .00 .00 .00  
Extinction Arousal Ratings for CS+       
     Discrimination à  Extinction (b path) -3.00 1.09 -5.16 -.83 * 
     NMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 -.01 .00  
     NMC à  Extinction (Direct Effect) .02 .01 .00 .04  
     NMC à  Extinction (Total Effect) .02 .01 -.01 .04  
Extinction Arousal Ratings for CS-       	
     Discrimination à  Extinction (b path) -4.11 1.00 -6.09 -2.13 * 
     NMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 -.01 .00  
     NMC à  Extinction (Direct Effect) .00 .01 -.02 .02  
     NMC à  Extinction (Total Effect) -.01 .01 -.03 .01  
 
 
Table 45. Negative Mood Change (NMC) and Return of Fear Arousal Ratings 
 b SE LLCI ULCI sig 
A Path       
     NMC à  Discrimination (a path)  .00 .00 .00 .00  
Arousal Ratings for CS+        
Context Renewal      
     Discrimination à  SR (b path) -.88 .98 -2.84 1.07  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NMC à  SR (Direct Effect) .01 .01 -.01 .04  
     NMC à  SR (Total Effect) .01 .01 -.01 .03  
Spontaneous Recovery      
     Discrimination à  SR (b path) -.53 1.27 -3.06 2.00  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NMC à  SR (Direct Effect) .00 .01 -.03 .03  
     NMC à  SR (Total Effect) .00 .01 -.03 .02  
Arousal Ratings for CS-       	
Context Renewal      
     Discrimination à  SR (b path) -1.37 1.07 -3.50 .77  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NMC à  SR (Direct Effect) .00 .01 -.03 .02  
     NMC à  SR (Total Effect) .00 .01 -.03 .02  
Spontaneous Recovery      
     Discrimination à  SR (b path) -.98 1.28 -3.53 1.57  
     NMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NMC à  SR (Direct Effect) -.02 .01 -.05 .01  
     NMC à  SR (Total Effect) -.02 .01 -.05 .01  
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Table 46.  Positive Acquisition Mood Change (PAMC) and Extinction SCR 
 b SE LLCI ULCI sig 
A Path       
     PAMC à  Discrimination (a path)  .00 .00 .00 .01  
Extinction SCR during CS+       
     Discrimination à  Extinction (b path) -.93 .56 -2.05 .20  
     PAMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 -.02 .00  
     PAMC à  Extinction (Direct Effect) .01 .01 -.02 .03  
     PAMC à  Extinction (Total Effect) .00 .01 -.02 .03  
Extinction SCR during CS-       	
     Discrimination à  Extinction (b path) -.04 .14 -.31 .24  
     PAMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .00  
     PAMC à  Extinction (Direct Effect) .00 .00 .00 .01  
     PAMC à  Extinction (Total Effect) .00 .00 .00 .01  
 
 
Table 47. Positive Acquisition Mood Change (PAMC) and Context Renewal SCR 
 b SE LLCI ULCI sig 
A Path       
     PAMC à  Discrimination (a path)  .00 .00 -.01 .01  
SCR during CS+        
First 2 Context Renewal Trials      
     Discrimination à  CR (b path) -.34 .20 -.75 .07  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  CR (Direct Effect) .00 .00 -.01 .01  
     PAMC à  CR (Total Effect) .00 .00 -.01 .01  
All Context Renewal Trials      
     Discrimination à  CR (b path) -.27 .14 -.56 .01  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  CR (Direct Effect) .00 .00 -.01 .01  
     PAMC à  CR (Total Effect) .00 .00 -.01 .01  
Context Renewal Trial 1      
     Discrimination à  CR (b path) -.31 .31 -.93 .31  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  CR (Direct Effect) .00 .01 -.01 .01  
     PAMC à  CR (Total Effect) .00 .01 -.01 .01  
Context Renewal Trial 2      
     Discrimination à  CR (b path) -.37 .18 -.73 -.01 * 
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  CR (Direct Effect) .00 .00 -.01 .01  
     PAMC à  CR (Total Effect) .00 .00 -.01 .01  
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Context Renewal Trial 3      
     Discrimination à  CR (b path) -.18 .14 -.47 .11  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  CR (Direct Effect) .00 .00 .00 .01  
     PAMC à  CR (Total Effect) .00 .00 .00 .01  
Context Renewal Trial 4      
     Discrimination à  CR (b path) .85 .57 -.29 2.00  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 -.02 .00  
     PAMC à  CR (Direct Effect) -.01 .01 -.03 .02  
     PAMC à  CR (Total Effect) -.01 .01 -.03 .02  
SCR during CS-       	
First 2 Context Renewal Trials      
     Discrimination à  CR (b path) -.72 .23 -1.18 -.26 * 
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .01  
     PAMC à  CR (Direct Effect) .00 .01 -.01 .01  
     PAMC à  CR (Total Effect) .00 .01 -.01 .01  
All Context Renewal Trials      
     Discrimination à  CR (b path) -1.07 .36 -1.80 -.33 * 
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .01  
     PAMC à  CR (Direct Effect) .00 .01 -.02 .02  
     PAMC à  CR (Total Effect) .00 .01 -.02 .02  
Context Renewal Trial 1      
     Discrimination à  CR (b path) -.76 .28 -1.33 -.19 * 
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .01  
     PAMC à  CR (Direct Effect) .00 .01 -.01 .01  
     PAMC à  CR (Total Effect) .00 .01 -.01 .02  
Context Renewal Trial 2      
     Discrimination à  CR (b path) .40 .76 -1.13 1.94  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 -.01 .00  
     PAMC à  CR (Direct Effect) .00 .02 -.04 .03  
     PAMC à  CR (Total Effect) .00 .02 -.04 .03  
Context Renewal Trial 3      
     Discrimination à  CR (b path) -.30 .16 -.62 .01  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  CR (Direct Effect) .00 .00 -.01 .01  
     PAMC à  CR (Total Effect) .00 .00 -.01 .01  
Context Renewal Trial 4      
     Discrimination à  CR (b path) -.26 .22 -.70 .19  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  CR (Direct Effect) .00 .00 -.01 .01  
     PAMC à  CR (Total Effect) .00 .00 -.01 .01  
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Table 48. Positive Acquisition Mood Change (PAMC) and Spontaneous Recovery 
SCR 
 b SE LLCI ULCI sig 
A Path       
     PAMC à  Discrimination (a path)  .00 .00 -.01 .01  
SCR during CS+        
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.58 .15 -.88 -.28 * 
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  SR (Direct Effect) .00 .00 .00 .01  
     PAMC à  SR (Total Effect) .00 .00 -.01 .01  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -1.26 .46 -2.17 -.34 * 
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .02  
     PAMC à  SR (Direct Effect) .00 .01 -.02 .02  
     PAMC à  SR (Total Effect) .00 .01 -.02 .02  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -1.44 .41 -2.26 -.61 * 
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .01  
     PAMC à  SR (Direct Effect) .00 .01 -.01 .02  
     PAMC à  SR (Total Effect) .00 .01 -.02 .02  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -.56 .23 -1.03 -.09 * 
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     PAMC à  SR (Direct Effect) .00 .01 -.01 .01  
     PAMC à  SR (Total Effect) .00 .01 -.01 .01  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) .18 .17 -.16 .53  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  SR (Direct Effect) .00 .00 -.01 .01  
     PAMC à  SR (Total Effect) .00 .00 -.01 .01  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -.57 .49 -1.55 .41  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     PAMC à  SR (Direct Effect) .01 .01 -.01 .03  
     PAMC à  SR (Total Effect) .01 .01 -.01 .03  
SCR during CS-       	
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.41 .51 -1.43 .61  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  SR (Direct Effect) .00 .01 -.02 .03  
     PAMC  à  SR (Total Effect) .01 .01 -.02 .03  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.34 .13 -.60 -.08 * 
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
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     PAMC à  SR (Direct Effect) .00 .00 -.01 .01  
     PAMC à  SR (Total Effect) .00 .00 -.01 .01  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -.40 .17 -.74 -.05 * 
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  SR (Direct Effect) .00 .00 .00 .01  
     PAMC à  SR (Total Effect) .00 .00 .00 .01  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -1.23 .58 -2.40 -.06 * 
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .02  
     PAMC à  SR (Direct Effect) .00 .01 -.03 .02  
     PAMC à  SR (Total Effect) .00 .01 -.03 .02  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) -.38 .20 -.79 .02  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     PAMC à  SR (Direct Effect) .00 .00 -.01 .01  
     PAMC à  SR (Total Effect) .00 .00 -.01 .01  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -1.74 .69 -3.14 -.35 * 
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .01 .00 .03  
     PAMC à  SR (Direct Effect) .00 .02 -.03 .03  
     PAMC à  SR (Total Effect) .00 .02 -.03 .03  
 
 
 
Table 49.  Negative Acquisition Mood Change (NAMC) and Extinction SCR 
 b SE LLCI ULCI sig 
A Path       
     NAMC à  Discrimination (a path)  .00 .00 .00 .00  
Extinction SCR during CS+       
     Discrimination à  Extinction (b path) -.89 .55 -2.00 .21  
     NAMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .01  
     NAMC à  Extinction (Direct Effect) -.01 .01 -.03 .01  
     P=NAMC à  Extinction (Total Effect) -.01 .01 -.03 .01  
Extinction SCR during CS-       	
     Discrimination à  Extinction (b path) -.02 .13 -.28 .25  
     NAMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .00  
     NAMC à  Extinction (Direct Effect) -.01 .00 -.01 .00  
     NAMC à  Extinction (Total Effect) -.01 .00 -.01 .00  
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Table 50. Negative Acquisition Mood Change (NAMC) and Context Renewal SCR 
 b SE LLCI ULCI sig 
A Path       
     NAMC à  Discrimination (a path)  .00 .00 -.01 .01  
SCR during CS+        
First 2 Context Renewal Trials      
     Discrimination à  CR (b path) -.34 .20 -.74 .07  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  CR (Direct Effect) .00 .00 -.01 .01  
     NAMC à  CR (Total Effect) .00 .00 -.01 .01  
All Context Renewal Trials      
     Discrimination à  CR (b path) -.27 .14 -.56 .01  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  CR (Direct Effect) .00 .00 -.01 .01  
     NAMC à  CR (Total Effect) .00 .00 -.01 .01  
Context Renewal Trial 1      
     Discrimination à  CR (b path) -.31 .31 -.93 .31  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  CR (Direct Effect) .00 .01 -.01 .01  
     NAMC à  CR (Total Effect) .00 .01 -.01 .01  
Context Renewal Trial 2      
     Discrimination à  CR (b path) -.37 .18 -.73 -.01 * 
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  CR (Direct Effect) .00 .00 .00 .01  
     NAMC à  CR (Total Effect) .00 .00 .00 .01  
Context Renewal Trial 3      
     Discrimination à  CR (b path) -.19 .15 -.48 .10  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  CR (Direct Effect) .00 .00 -.01 .01  
     NAMC à  CR (Total Effect) .00 .00 -.01 .01  
Context Renewal Trial 4      
     Discrimination à  CR (b path) .87 .57 -.27 2.01  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .02  
     NAMC à  CR (Direct Effect) .00 .01 -.03 .02  
     NAMC à  CR (Total Effect) .00 .01 -.03 .02  
SCR during CS-       	
First 2 Context Renewal Trials      
     Discrimination à  CR (b path) -.72 .23 -1.18 -.26 * 
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  CR (Direct Effect) .00 .00 -.01 .01  
     NAMC à  CR (Total Effect) .00 .01 -.01 .01  
All Context Renewal Trials      
     Discrimination à  CR (b path) -1.07 .36 -1.80 -.35 * 
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 -.01 .01  
     NAMC à  CR (Direct Effect) .01 .01 -.01 .02  
     NAMC à  CR (Total Effect) .01 .01 -.01 .02  
		 163	
Context Renewal Trial 1      
     Discrimination à  CR (b path) -.77 .28 -1.33 -.20 * 
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  CR (Direct Effect) .00 .01 -.01 .02  
     NAMC à  CR (Total Effect) .00 .01 -.01 .02  
Context Renewal Trial 2      
     Discrimination à  CR (b path) .42 .76 -1.11 1.95  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .01  
     NAMC à  CR (Direct Effect) -.01 .02 -.04 .02  
     NAMC à  CR (Total Effect) -.01 .02 -.04 .02  
Context Renewal Trial 3      
     Discrimination à  CR (b path) -.30 .16 -.61 .01  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  CR (Direct Effect) .00 .00 .00 .01  
     NAMC à  CR (Total Effect) .00 .00 .00 .01  
Context Renewal Trial 4      
     Discrimination à  CR (b path) -.27 .22 -.71 .18  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  CR (Direct Effect) .00 .00 -.01 .01  
     NAMC à  CR (Total Effect) .00 .00 -.01 .01  
 
 
 
Table 51. Negative Acquisition Mood Change (NAMC) and Spontaneous Recovery 
SCR 
 b SE LLCI ULCI sig 
A Path       
     NAMC à  Discrimination (a path)  .00 .00 .00 .01  
SCR during CS+        
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.60 .15 -.89 -.30 * 
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  SR (Direct Effect) .00 .00 .00 .01  
     NAMC à  SR (Total Effect) .00 .00 .00 .01  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -1.28 .45 -2.19 -.37 * 
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.02 .00  
     NAMC à  SR (Direct Effect) .01 .01 -.01 .03  
     NAMC à  SR (Total Effect) .01 .01 -.01 .03  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -1.47 .41 -2.28 -.66 * 
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .01  
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     NAMC à  SR (Direct Effect) .01 .01 -.01 .03  
     NAMC à  SR (Total Effect) .01 .01 -.01 .03  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -.57 .23 -1.03 -.10 * 
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  SR (Direct Effect) .00 .00 -.01 .01  
     NAMC à  SR (Total Effect) .00 .00 -.01 .01  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) .19 .17 -.16 .54  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  SR (Direct Effect) .00 .00 -.01 .01  
     NAMC à  SR (Total Effect) .00 .00 -.01 .01  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -.58 .49 -1.57 .41  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  SR (Direct Effect) .00 .01 -.02 .02  
     NAMC à  SR (Total Effect) .00 .01 -.02 .02  
SCR during CS-       	
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.41 .51 -1.43 .61  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  SR (Direct Effect) .00 .01 -.02 .02  
     NAMC à  SR (Total Effect) .00 .01 -.02 .02  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.35 .13 -.61 -.09 * 
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  SR (Direct Effect) .00 .00 .00 .01  
     NAMC à  SR (Total Effect) .00 .00 .00 .01  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -.41 .17 -.76 -.07 * 
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  SR (Direct Effect) .00 .00 .00 .01  
     NAMC à  SR (Total Effect) .00 .00 .00 .01  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -1.25 .58 -2.42 -.09 * 
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.02 .00  
     NAMC à  SR (Direct Effect) .01 .01 -.01 .03  
     NAMC à  SR (Total Effect) .01 .01 -.02 .03  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) -.39 .20 -.80 .01  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  SR (Direct Effect) .00 .00 -.01 .01  
     NAMC à  SR (Total Effect) .00 .00 -.01 .01  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -1.76 .69 -3.15 -.37 * 
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .01 -.03 .00  
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     NAMC à  SR (Direct Effect) .01 .01 -.02 .04  
     NAMC à  SR (Total Effect) .01 .01 -.02 .04  
 
Table 52. Positive Acquisition Mood Change (PAMC) and Extinction US 
Expectancy 
 b SE LLCI ULCI sig 
A Path       
     PAMC à  Discrimination (a path)  .01 .01 -.01 .02  
Extinction US Expectancy during CS+       
     Discrimination à  Extinction (b path) .23 .08 .06 .40 * 
     PAMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .01  
     PAMC à  Extinction (Direct Effect) -.01 .01 -.02 .01  
     PAMC à  Extinction (Total Effect) .00 .01 -.01 .01  
Extinction US Expectancy during CS-       	
     Discrimination à  Extinction (b path) .26 .06 .15 .37 * 
     PAMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .01  
     PAMC à  Extinction (Direct Effect) .00 .00 -.01 .00  
     PAMC à  Extinction (Total Effect) .00 .00 -.01 .01  
 
 
 
Table 53. Positive Acquisition Mood Change (PAMC) and Context Renewal US 
Expectancy 
 b SE LLCI ULCI sig 
A Path       
     PAMC à  Discrimination (a path)  .00 .00 -.01 .00  
US Expectancy during CS+        
First 2 Context Renewal Trials      
     Discrimination à  CR (b path) 1.20 .74 -.28 2.69  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 -.02 .00  
     PAMC à  CR (Direct Effect) .00 .02 -.03 .03  
     PAMC à  CR (Total Effect) -.01 .02 -.04 .02  
All Context Renewal Trials      
     Discrimination à  CR (b path) .44 .66 -.88 1.76  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 -.01 .00  
     PAMC à  CR (Direct Effect) -.01 .01 -.03 .02  
     PAMC à  CR (Total Effect) -.01 .01 -.03 .02  
Context Renewal Trial 1      
     Discrimination à  CR (b path) 2.10 .74 .62 3.58 * 
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     PAMC àDiscrimination à  CR (Indirect Effect) -.01 .01 -.02 .00  
     PAMC à  CR (Direct Effect) .01 .02 -.02 .04  
     PAMC à  CR (Total Effect) .00 .02 -.03 .04  
Context Renewal Trial 2      
     Discrimination à  CR (b path) .31 .94 -1.57 2.19  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 -.01 .01  
     PAMC à  CR (Direct Effect) -.02 .02 -.06 .02  
     PAMC à  CR (Total Effect) -.02 .02 -.06 .02  
Context Renewal Trial 3      
     Discrimination à  CR (b path) .50 .76 -1.03 2.02  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 -.01 .00  
     PAMC à  CR (Direct Effect) .00 .02 -.03 .03  
     PAMC à  CR (Total Effect) .00 .02 -.03 .03  
Context Renewal Trial 4      
     Discrimination à  CR (b path) -1.15 .66 -2.47 .17  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .02  
     PAMC à  CR (Direct Effect) -.02 .01 -.04 .01  
     PAMC à  CR (Total Effect) -.01 .01 -.04 .01  
US Expectancy during CS-       	
First 2 Context Renewal Trials      
     Discrimination à  CR (b path) .04 .61 -1.19 1.26  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 -.01 .00  
     PAMC à  CR (Direct Effect) .00 .01 -.02 .03  
     PAMC à  CR (Total Effect) .00 .01 -.02 .03  
All Context Renewal Trials      
     Discrimination à  CR (b path) -.59 .48 -1.55 .37  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .01  
     PAMC à  CR (Direct Effect) -.01 .01 -.03 .01  
     PAMC à  CR (Total Effect) .00 .01 -.02 .02  
Context Renewal Trial 1      
     Discrimination à  CR (b path) .52 .77 -1.02 2.06  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 -.01 .00  
     PAMC à  CR (Direct Effect) .02 .02 -.01 .05  
     PAMC à  CR (Total Effect) .02 .02 -.01 .05  
Context Renewal Trial 2      
     Discrimination à  CR (b path) -.44 .64 -1.73 .84  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .01  
     PAMC à  CR (Direct Effect) -.02 .01 -.04 .01  
     PAMC à  CR (Total Effect) -.02 .01 -.04 .01  
Context Renewal Trial 3      
     Discrimination à  CR (b path) -.95 .47 -1.90 -.01 * 
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .01  
     PAMC à  CR (Direct Effect) -.01 .01 -.03 .01  
     PAMC à  CR (Total Effect) -.01 .01 -.03 .01  
Context Renewal Trial 4      
     Discrimination à  CR (b path) -1.48 .52 -2.52 -.43 * 
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     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .02  
     PAMC à  CR (Direct Effect) -.02 .01 -.04 .01  
     PAMC à  CR (Total Effect) -.01 .01 -.03 .01  
 
 
Table 54. Positive Acquisition Mood Change (PAMC) and Spontaneous Recovery 
SCR 
 b SE LLCI ULCI sig 
A Path       
     PAMC à  Discrimination (a path)  .00 .00 -.01 .00  
US Expectancy during CS+        
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.47 .78 -2.04 1.09  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .02  
     PAMC à  SR (Direct Effect) -.01 .02 -.04 .03  
     PAMC à  SR (Total Effect) .00 .02 -.04 .03  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.39 .59 -1.58 .80  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     PAMC à  SR (Direct Effect) -.01 .01 -.03 .02  
     PAMC à  SR (Total Effect) -.01 .01 -.03 .02  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) .07 .83 -1.59 1.72  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .01  
     PAMC à  SR (Direct Effect) .00 .02 -.04 .03  
     PAMC à  SR (Total Effect) .00 .02 -.04 .03  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -1.01 .91 -2.83 .81  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .02  
     PAMC à  SR (Direct Effect) -.01 .02 -.05 .03  
     PAMC à  SR (Total Effect) -.01 .02 -.04 .03  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) -.41 .66 -1.75 .92  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     PAMC à  SR (Direct Effect) -.01 .01 -.04 .02  
     PAMC à  SR (Total Effect) -.01 .01 -.03 .02  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -.19 .45 -1.10 .72  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     PAMC à  SR (Direct Effect) -.01 .01 -.03 .01  
     PAMC à  SR (Total Effect) -.01 .01 -.03 .01  
US Expectancy during CS-       	
First 2 Spontaneous Recovery Trials      
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     Discrimination à  SR (b path) -1.56 .59 -2.75 -.37 * 
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .02  
     PAMC à  SR (Direct Effect) .00 .01 -.03 .02  
     PAMC à  SR (Total Effect) .00 .01 -.02 .03  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -1.33 .41 -2.14 -.52 * 
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     PAMC à  SR (Direct Effect) .00 .01 -.02 .01  
     PAMC à  SR (Total Effect) .00 .01 -.02 .02  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -.72 .80 -2.32 .89  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .02  
     PAMC à  SR (Direct Effect) .00 .02 -.03 .04  
     PAMC à  SR (Total Effect) .01 .02 -.03 .04  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -2.41 .54 -3.49 -1.33 * 
     PAMC àDiscrimination à  SR (Indirect Effect) .01 .01 .00 .02  
     PAMC à  SR (Direct Effect) -.01 .01 -.03 .01  
     PAMC à  SR (Total Effect) .00 .01 -.03 .02  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) -1.07 .45 -1.96 -.17 * 
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     PAMC à  SR (Direct Effect) .00 .01 -.02 .02  
     PAMC à  SR (Total Effect) .00 .01 -.02 .02  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -1.13 .36 -1.84 -.42 * 
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     PAMC à  SR (Direct Effect) -.01 .01 -.03 .00  
     PAMC à  SR (Total Effect) -.01 .01 -.02 .01  
 
 
Table 55.  Negative Acquisition Mood Change (NAMC) and Extinction US 
Expectancy 
 b SE LLCI ULCI sig 
A Path       
     NAMC à  Discrimination (a path)  .02 .01 -.01 .04  
Extinction Expectancy during CS+       
     Discrimination à  Extinction (b path) .19 .09 .01 .36 * 
     NAMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .01  
     NAMC à  Extinction (Direct Effect) .01 .01 .00 .02  
     P=NAMC à  Extinction (Total Effect) .01 .01 .00 .02  
Extinction Expectancy during CS-       	
     Discrimination à  Extinction (b path) .22 .06 .11 .34 * 
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     NAMC àDiscrimination à  Extinction (Indirect Effect) .01 .00 .00 .02  
     NAMC à  Extinction (Direct Effect) .01 .00 .00 .01  
     NAMC à  Extinction (Total Effect) .01 .00 .00 .02  
 
 
 
Table 56. Negative Acquisition Mood Change (NAMC) and Context Renewal US 
Expectancy 
 b SE LLCI ULCI sig 
A Path       
     NAMC à  Discrimination (a path)  .00 .00 .00 .01  
Expectancy during CS+        
First 2 Context Renewal Trials      
     Discrimination à  CR (b path) 1.15 .73 -.31 2.61  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .02  
     NAMC à  CR (Direct Effect) .01 .01 -.01 .04  
     NAMC à  CR (Total Effect) .02 .01 -.01 .05  
All Context Renewal Trials      
     Discrimination à  CR (b path) .39 .65 -.91 1.69  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .01  
     NAMC à  CR (Direct Effect) .02 .01 -.01 .04  
     NAMC à  CR (Total Effect) .02 .01 -.01 .04  
Context Renewal Trial 1      
     Discrimination à  CR (b path) 1.93 .73 .48 3.38 * 
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .01 -.01 .02  
     NAMC à  CR (Direct Effect) .02 .01 -.01 .05  
     NAMC à  CR (Total Effect) .02 .02 -.01 .05  
Context Renewal Trial 2      
     Discrimination à  CR (b path) .37 .94 -1.51 2.26  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 -.01 .02  
     NAMC à  CR (Direct Effect) .01 .02 -.03 .05  
     NAMC à  CR (Total Effect) .01 .02 -.03 .05  
Context Renewal Trial 3      
     Discrimination à  CR (b path) .41 .75 -1.09 1.92  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .01  
     NAMC à  CR (Direct Effect) .02 .01 -.01 .05  
     NAMC à  CR (Total Effect) .02 .01 -.01 .05  
Context Renewal Trial 4      
     Discrimination à  CR (b path) -1.15 .65 -2.45 .16  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .01 -.02 .00  
     NAMC à  CR (Direct Effect) .02 .01 -.01 .05  
     NAMC à  CR (Total Effect) .02 .01 -.01 .04  
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Expectancy during CS-       	
First 2 Context Renewal Trials      
     Discrimination à  CR (b path) -.02 .61 -1.24 1.19  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  CR (Direct Effect) .01 .01 -.02 .03  
     NAMC à  CR (Total Effect) .01 .01 -.02 .03  
All Context Renewal Trials      
     Discrimination à  CR (b path) -.59 .48 -1.54 .37  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  CR (Direct Effect) .01 .01 -.01 .03  
     NAMC à  CR (Total Effect) .01 .01 -.01 .03  
Context Renewal Trial 1      
     Discrimination à  CR (b path) .32 .78 -1.24 1.88  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .01  
     NAMC à  CR (Direct Effect) .01 .02 -.02 .04  
     NAMC à  CR (Total Effect) .01 .02 -.02 .04  
Context Renewal Trial 2      
     Discrimination à  CR (b path) -.36 .65 -1.66 .93  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  CR (Direct Effect) .01 .01 -.02 .03  
     NAMC à  CR (Total Effect) .01 .01 -.02 .03  
Context Renewal Trial 3      
     Discrimination à  CR (b path) -.89 .48 -1.85 .06  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  CR (Direct Effect) .01 .01 -.01 .03  
     NAMC à  CR (Total Effect) .00 .01 -.01 .02  
Context Renewal Trial 4      
     Discrimination à  CR (b path) -1.41 .53 -2.47 -.35 * 
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .01 -.02 .00  
     NAMC à  CR (Direct Effect) .01 .01 -.01 .03  
     NAMC à  CR (Total Effect) .01 .01 -.02 .03  
 
 
Table 57. Negative Acquisition Mood Change (NAMC) and Spontaneous 
Recovery US Expectancy 
 b SE LLCI ULCI sig 
A Path       
     NAMC à  Discrimination (a path)  .00 .00 .00 .01  
Expectancy during CS+        
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.67 .72 -2.12 .78  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  SR (Direct Effect) .04 .01 -.01 .07  
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     NAMC à  SR (Total Effect) .04 .01 -.01 .07  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.49 .56 -1.62 .63  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  SR (Direct Effect) .03 .01 -.01 .05  
     NAMC à  SR (Total Effect) .03 .01 -.01 .05  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -.19 .76 -1.71 1.34  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  SR (Direct Effect) .05 .02 .02 .08 * 
     NAMC à  SR (Total Effect) .05 .02 .02 .08 * 
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -1.16 .87 -2.90 .59  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.02 .00  
     NAMC à  SR (Direct Effect) .04 .02 .003 .07 * 
     NAMC à  SR (Total Effect) .04 .02 .0004 .07 * 
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) -.45 .65 -1.77 .86  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  SR (Direct Effect) .02 .01 -.01 .04  
     NAMC à  SR (Total Effect) .02 .01 -.01 .04  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) .01 .01 -.01 .03  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  SR (Direct Effect) .01 .01 -.01 .03  
     NAMC à  SR (Total Effect) .01 .01 -.01 .03  
Expectancy during CS-       	
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -1.55 .59 -2.74 -.37 * 
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  SR (Direct Effect) .00 .01 -.02 .02  
     NAMC à  SR (Total Effect) .00 .01 -.03 .02  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -1.32 .40 -2.13 -.51 * 
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  SR (Direct Effect) .00 .01 -.01 .02  
     NAMC à  SR (Total Effect) .00 .01 -.02 .02  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -.73 .80 -2.33 .86  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.02 .00  
     NAMC à  SR (Direct Effect) .00 .02 -.03 .03  
     NAMC à  SR (Total Effect) .00 .02 -.03 .03  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -2.37 .54 -3.45 -1.28 * 
     NAMC àDiscrimination à  SR (Indirect Effect) -.01 .01 -.02 .01  
     NAMC à  SR (Direct Effect) .00 .01 -.02 .02  
		 172	
     NAMC à  SR (Total Effect) .00 .01 -.03 .02  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) -1.12 .44 -2.00 -.23 * 
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  SR (Direct Effect) .01 .01 -.01 .03  
     NAMC à  SR (Total Effect) .01 .01 -.01 .02  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -1.07 .36 -1.79 -.35 * 
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  SR (Direct Effect) .00 .01 -.01 .02  
     NAMC à  SR (Total Effect) .00 .01 -.01 .02  
 
 
 
Table 58. Positive Acquisition Mood Change (PAMC) and Extinction Heart Rate  
 b SE LLCI ULCI sig 
A Path       
     PAMC à  Discrimination (a path)  .00 .00 .00 .01  
Extinction Heart Rate during CS+       
     Discrimination à  Extinction (b path) -1.07 .36 -1.79 -.35 * 
     PAMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 -.01 .00  
     PAMC à  Extinction (Direct Effect) .00 .01 -.01 .02  
     PAMC à  Extinction (Total Effect) .00 .01 -.01 .02  
Extinction Heart Rate during CS-       	
     Discrimination à  Extinction (b path) .12 .75 -1.37 1.61  
     PAMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .00  
     PAMC à  Extinction (Direct Effect) .00 .00 .00 .00  
     PAMC à  Extinction (Total Effect) .00 .00 .00 .00  
 
 
Table 59. Positive Acquisition Mood Change (PAMC) and Context Renewal Heart 
Rate 
 b SE LLCI ULCI sig 
A Path       
     PAMC à  Discrimination (a path)  .00 .00 .00 .00  
Heart Rate during CS+        
First 2 Context Renewal Trials      
     Discrimination à  CR (b path) .30 .76 -1.22 1.82  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
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     PAMC à  CR (Direct Effect) .00 .00 .00 .00  
     PAMC à  CR (Total Effect) .00 .00 .00 .00  
All Context Renewal Trials      
     Discrimination à  CR (b path) 1.20 1.10 -1.00 3.40  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  CR (Direct Effect) .00 .00 -.01 .00  
     PAMC à  CR (Total Effect) .00 .00 -.01 .00  
Context Renewal Trial 1      
     Discrimination à  CR (b path) .49 1.06 -1.64 2.61  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  CR (Direct Effect) .00 .00 -.01 .00  
     PAMC à  CR (Total Effect) .00 .00 -.01 .00  
Context Renewal Trial 2      
     Discrimination à  CR (b path) -.67 1.03 -2.73 1.40  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  CR (Direct Effect) .00 .00 -.01 .00  
     PAMC à  CR (Total Effect) .00 .00 -.01 .00  
Context Renewal Trial 3      
     Discrimination à  CR (b path) 3.06 1.24 .57 5.55 * 
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  CR (Direct Effect) .00 .00 -.01 .00  
     PAMC à  CR (Total Effect) .00 .00 -.01 .00  
Context Renewal Trial 4      
     Discrimination à  CR (b path) .32 1.13 -1.95 2.60  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  CR (Direct Effect) .00 .00 -.01 .00  
     PAMC à  CR (Total Effect) .00 .00 -.01 .00  
Heart Rate during CS-       	
First 2 Context Renewal Trials      
     Discrimination à  CR (b path) -.77 1.02 -2.83 1.29  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  CR (Direct Effect) .00 .00 -.01 .00  
     PAMC à  CR (Total Effect) .00 .00 -.01 .00  
All Context Renewal Trials      
     Discrimination à  CR (b path) .40 1.04 -1.67 2.48  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  CR (Direct Effect) .00 .00 .00 .00  
     PAMC à  CR (Total Effect) .00 .00 .00 .00  
Context Renewal Trial 1      
     Discrimination à  CR (b path) .13 1.08 -2.04 2.30  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  CR (Direct Effect) .00 .00 -.01 .00  
     PAMC à  CR (Total Effect) .00 .00 -.01 .00  
Context Renewal Trial 2      
     Discrimination à  CR (b path) .29 1.09 -1.90 2.48  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
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     PAMC à  CR (Direct Effect) .00 .00 .00 .00  
     PAMC à  CR (Total Effect) .00 .00 .00 .00  
Context Renewal Trial 3      
     Discrimination à  CR (b path) .52 1.02 -1.52 2.57  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  CR (Direct Effect) .00 .00 .00 .00  
     PAMC à  CR (Total Effect) .00 .00 .00 .00  
Context Renewal Trial 4      
     Discrimination à  CR (b path) -1.10 1.17 -3.46 1.25  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  CR (Direct Effect) .00 .00 -.01 .00  
     PAMC à  CR (Total Effect) .00 .00 -.01 .00  
 
 
Table 60. Positive Acquisition Mood Change (PAMC) and Spontaneous Recovery 
Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     PAMC à  Discrimination (a path)  .00 .00 .00 .00  
Heart Rate during CS+        
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.21 1.06 -2.34 1.93  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  SR (Direct Effect) .00 .00 -.01 .00  
     PAMC à  SR (Total Effect) .00 .00 -.01 .00  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.47 1.07 -2.61 1.68  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  SR (Direct Effect) .00 .00 -.01 .00  
     PAMC à  SR (Total Effect) .00 .00 -.01 .00  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) .23 1.09 -1.95 2.41  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  SR (Direct Effect) .00 .00 -.01 .00  
     PAMC à  SR (Total Effect) .00 .00 -.01 .00  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -.64 1.07 -2.79 1.51  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  SR (Direct Effect) .00 .00 -.01 .00  
     PAMC à  SR (Total Effect) .00 .00 -.01 .00  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) -.61 1.09 -2.80 1.59  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
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     PAMC à  SR (Direct Effect) .00 .00 -.01 .00  
     PAMC à  SR (Total Effect) .00 .00 -.01 .00  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -.84 1.12 -3.08 1.40  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  SR (Direct Effect) .00 .00 -.01 .00  
     PAMC à  SR (Total Effect) .00 .00 -.01 .00  
Heart Rate during CS-       	
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.64 1.01 -2.66 1.38  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  SR (Direct Effect) .00 .00 -.01 .00  
     PAMC à  SR (Total Effect) .00 .00 -.01 .00  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.37 1.03 -2.44 1.70  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  SR (Direct Effect) .00 .00 -.01 .00  
     PAMC à  SR (Total Effect) .00 .00 -.01 .00  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -.63 .96 -2.55 1.28  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  SR (Direct Effect) .00 .00 -.01 .00  
     PAMC à  SR (Total Effect) .00 .00 -.01 .00  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -.64 1.08 -2.82 1.54  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  SR (Direct Effect) .00 .00 -.01 .00  
     PAMC à  SR (Total Effect) .00 .00 -.01 .00  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) .35 1.23 -2.11 2.81  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  SR (Direct Effect) .00 .00 -.01 .00  
     PAMC à  SR (Total Effect) .00 .00 -.01 .00  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -.56 1.02 -2.60 1.48  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     PAMC à  SR (Direct Effect) .00 .00 .00 .00  
     PAMC à  SR (Total Effect) .00 .00 .00 .00  
  
 
Table 61.  Negative Acquisition Mood Change (NAMC) and Extinction Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     NAMC à  Discrimination (a path)  .00 .00 .00 .00  
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Extinction Heart Rate during CS+       
     Discrimination à  Extinction (b path)      .03 .70 -1.37 1.44  
     NAMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .00  
     NAMC à  Extinction (Direct Effect) .00 .0 .00 .01  
     P=NAMC à  Extinction (Total Effect) .00 .00 .00 .01  
Extinction Heart Rate during CS-       	
     Discrimination à  Extinction (b path) .26 .73 -1.19 1.72  
     NAMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .00  
     NAMC à  Extinction (Direct Effect) .00 .00 .00 .00  
     NAMC à  Extinction (Total Effect) .00 .00 .00 .00  
 
 
 
Table 62. Negative Acquisition Mood Change (NAMC) and Context Renewal Heart 
Rate 
 b SE LLCI ULCI sig 
A Path       
     NAMC à  Discrimination (a path)  .00 .00 .00 .00  
Heart Rate during CS+        
First 2 Context Renewal Trials      
     Discrimination à  CR (b path) 1.14 1.09 -1.06 3.34  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  CR (Direct Effect) .00 .00 .01 .00  
     NAMC à  CR (Total Effect) .00 .00 .01 .00  
All Context Renewal Trials      
     Discrimination à  CR (b path) .42 1.06 -1.70 2.55  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  CR (Direct Effect) .00 .00 -.01 .00  
     NAMC à  CR (Total Effect) .00 .00 -.01 .00  
Context Renewal Trial 1      
     Discrimination à  CR (b path) -.72 1.02 -2.77 1.33  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  CR (Direct Effect) .00 .00 -.01 .00  
     NAMC à  CR (Total Effect) .00 .00 -.01 .00  
Context Renewal Trial 2      
     Discrimination à  CR (b path) 3.00 1.24 .51 5.48 * 
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  CR (Direct Effect) .00 .00 -.01 .00  
     NAMC à  CR (Total Effect) .00 .00 -.01 .00  
Context Renewal Trial 3      
     Discrimination à  CR (b path) .27 1.13 -1.99 2.53  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
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     NAMC à  CR (Direct Effect) .00 .00 -.01 .00  
     NAMC à  CR (Total Effect) .00 .00 -.01 .00  
Context Renewal Trial 4      
     Discrimination à  CR (b path) -.85 1.03 -2.92 1.22  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  CR (Direct Effect) .00 .00 -.01 .00  
     NAMC à  CR (Total Effect) .00 .00 -.01 .00  
Heart Rate during CS-       	
First 2 Context Renewal Trials      
     Discrimination à  CR (b path) .38 1.02 -1.67 2.42  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  CR (Direct Effect) .00 .00 -.01 .00  
     NAMC à  CR (Total Effect) .00 .00 -.01 .00  
All Context Renewal Trials      
     Discrimination à  CR (b path) .07 1.08 -2.09 2.24  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  CR (Direct Effect) .00 .00 -.01 .00  
     NAMC à  CR (Total Effect) .00 .00 -.01 .00  
Context Renewal Trial 1      
     Discrimination à  CR (b path) .27 1.07 -1.88 2.42  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  CR (Direct Effect) .00 .00 -.01 .00  
     NAMC à  CR (Total Effect) .00 .00 -.01 .00  
Context Renewal Trial 2      
     Discrimination à  CR (b path) .49 1.01 -1.53 2.51  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  CR (Direct Effect) .00 .00 -.01 .00  
     NAMC à  CR (Total Effect) .00 .00 -.01 .00  
Context Renewal Trial 3      
     Discrimination à  CR (b path) -1.22 1.20 -3.63 1.18  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  CR (Direct Effect) .00 .00 -.01 .00  
     NAMC à  CR (Total Effect) .00 .00 -.01 .00  
Context Renewal Trial 4      
     Discrimination à  CR (b path) .77 1.29 -1.81 3.34  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  CR (Direct Effect) .00 .00 -.01 .00  
     NAMC à  CR (Total Effect) .00 .00 -.01 .00  
 
 
Table 63. Negative Acquisition Mood Change (NAMC) and Spontaneous 
Recovery Heart Rate  
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 b SE LLCI ULCI sig 
A Path       
     NAMC à  Discrimination (a path)  .00 .00 .00 .00  
Heart Rate during CS+        
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.36 1.07 -2.51 1.79  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  SR (Direct Effect) .00 .00 -.01 .00  
     NAMC à  SR (Total Effect) .00 .00 -.01 .00  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.61 1.07 -2.76 1.54  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  SR (Direct Effect) .00 .00 -.01 .00  
     NAMC à  SR (Total Effect) .00 .00 -.01 .00  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) .06 1.09 -2.14 2.25  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  SR (Direct Effect) .00 .00 -.01 .00  
     NAMC à  SR (Total Effect) .00 .00 -.01 .00  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -.78 1.08 -2.94 1.39  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  SR (Direct Effect) .00 .00 -.01 .00  
     NAMC à  SR (Total Effect) .00 .00 -.01 .00  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) -.73 1.08 -2.90 1.44  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  SR (Direct Effect) .00 .00 -.01 .00  
     NAMC à  SR (Total Effect) .00 .00 -.01 .00  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -1.00 1.11 -3.23 1.24  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  SR (Direct Effect) .00 .00 -.01 .00  
     NAMC à  SR (Total Effect) .00 .00 -.01 .00  
Heart Rate during CS-       	
First 2 Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.77 1.01 -2.79 1.24  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  SR (Direct Effect) .00 .00 -.01 .00  
     NAMC à  SR (Total Effect) .00 .00 -.01 .00  
All Spontaneous Recovery Trials      
     Discrimination à  SR (b path) -.47 1.03 -2.54 1.59  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  SR (Direct Effect) .00 .00 -.01 .00  
     NAMC à  SR (Total Effect) .00 .00 -.01 .00  
Spontaneous Recovery Trial 1      
     Discrimination à  SR (b path) -.77 .95 -2.68 1.14  
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     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  SR (Direct Effect) .00 .00 -.01 .00  
     NAMC à  SR (Total Effect) .00 .00 -.01 .00  
Spontaneous Recovery Trial 2      
     Discrimination à  SR (b path) -.78 1.09 -2.96 1.40  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  SR (Direct Effect) .00 .00 -.01 .00  
     NAMC à  SR (Total Effect) .00 .00 -.01 .00  
Spontaneous Recovery Trial 3      
     Discrimination à  SR (b path) .29 1.22 -2.17 2.74  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  SR (Direct Effect) .00 .00 -.01 .00  
     NAMC à  SR (Total Effect) .00 .00 -.01 .00  
Spontaneous Recovery Trial 4      
     Discrimination à  SR (b path) -.63 1.01 -2.67 1.41  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  SR (Direct Effect) .00 .00 .00 .00  
     NAMC à  SR (Total Effect) .00 .00 .00 .00  
 
Table 64. Positive Acquisition Mood Change (PAMC) and Extinction Fear Ratings 
 b SE LLCI ULCI sig 
A Path       
     PAMC à  Discrimination (a path)  .00 .00 .00 .00  
Extinction Fear Ratings for CS+       
     Discrimination à  Extinction (b path) -1.80 1.21 -4.21 .60  
     PAMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 -.01 .01  
     PAMC à  Extinction (Direct Effect) -.01 .01 -.04 .02  
     PAMC à  Extinction (Total Effect) -.01 .01 -.04 .02  
Extinction Fear Ratings for CS-       	
     Discrimination à  Extinction (b path) -5.32 .92 -7.15 -3.49 * 
     PAMC àDiscrimination à  Extinction (Indirect Effect) .00 .01 -.01 .02  
     PAMC à  Extinction (Direct Effect) -.01 .01 -.03 .01  
     PAMC à  Extinction (Total Effect) -.01 .01 -.03 .02  
 
 
Table 65. Positive Acquisition Mood Change (PAMC) and Return of Fear Fear 
Ratings 
 b SE LLCI ULCI sig 
A Path       
     PAMC à  Discrimination (a path)  .00 .00 .00 .00  
Fear Ratings for CS+        
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Context Renewal      
     Discrimination à  CR (b path) -.12 1.32 -2.75 2.52  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .01  
     PAMC à  CR (Direct Effect) .01 .02 -.03 .04  
     PAMC à  CR (Total Effect) .01 .02 -.03 .04  
Spontaneous Recovery      
     Discrimination à  SR (b path) -1.90 1.34 -4.59 .78  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     PAMC à  SR (Direct Effect) .00 .02 -.03 .04  
     PAMC à  SR (Total Effect) .00 .02 -.03 .04  
Fear Ratings for CS-       	
Context Renewal      
     Discrimination à  CR (b path) -2.39 1.12 -4.62 -.16 * 
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .01 -.01 .02  
     PAMC à  CR (Direct Effect) .00 .02 -.03 .03  
     PAMC à  CR (Total Effect) .01 .02 -.03 .04  
Spontaneous Recovery      
     Discrimination à  SR (b path) -3.93 .96 -5.84 -2.01 * 
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .01 -.01 .02  
     PAMC à  SR (Direct Effect) .01 .01 -.01 .04  
     PAMC à  SR (Total Effect) .02 .01 -.01 .05  
 
 
Table 66. Negative Acquisition Mood Change (NAMC) and Extinction Fear Ratings 
 b SE LLCI ULCI sig 
A Path       
     NAMC à  Discrimination (a path)  .00 .00 .00 .00  
Extinction Fear Ratings for CS+       
     Discrimination à  Extinction (b path) -1.87 1.20 -4.25 .51  
     NAMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  Extinction (Direct Effect) .02 .01 -.01 .05  
     NAMC à  Extinction (Total Effect) .02 .01 -.01 .05  
Extinction Fear Ratings for CS-       	
     Discrimination à  Extinction (b path) -5.34 .92 -7.17 -3.51 * 
     NAMC àDiscrimination à  Extinction (Indirect Effect) .00 .01 -.02 .01  
     NAMC à  Extinction (Direct Effect) .00 .01 -.02 .03  
     NAMC à  Extinction (Total Effect) .00 .01 -.02 .03  
 
 
Table 67. Negative Acquisition Mood Change (NAMC) and Return of Fear Ratings 
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 b SE LLCI ULCI sig 
A Path       
     NAMC à  Discrimination (a path)  .00 .00 .00 .00  
Fear Ratings for CS+        
Context Renewal      
     Discrimination à  CR (b path) -.12 1.32 -2.77 2.52  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  CR (Direct Effect) .00 .02 -.04 .03  
     NAMC à  CR (Total Effect) .00 .02 -.04 .03  
Spontaneous Recovery      
     Discrimination à  SR (b path) -1.96 1.35 -4.65 .72  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  SR (Direct Effect) .01 .02 -.03 .04  
     NAMC à  SR (Total Effect) .01 .02 -.03 .04  
Fear Ratings for CS-       	
Context Renewal      
     Discrimination à  CR (b path) -2.35 1.12 -4.59 -.12 * 
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  CR (Direct Effect) -.01 .01 -.04 .02  
     NAMC à  CR (Total Effect) -.01 .01 -.04 .02  
Spontaneous Recovery      
     Discrimination à  SR (b path) -3.85 .95 -5.74 -1.96 * 
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .01 -.02 .01  
     NAMC à  SR (Direct Effect) -.02 .01 -.05 .00  
     NAMC à  SR (Total Effect) -.02 .01 -.05 .00  
 
 
Table 68. Positive Acquisition Mood Change (PAMC) and Extinction Valence 
Ratings 
 b SE LLCI ULCI sig 
A Path       
     PAMC à  Discrimination (a path)  .00 .00 .00 .00  
Extinction Valence Ratings for CS+       
     Discrimination à  Extinction (b path) .39 .70 -1.01 1.79  
     PAMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .00  
     PAMC à  Extinction (Direct Effect) .00 .01 -.02 .01  
     PAMC à  Extinction (Total Effect) .00 .01 -.02 .01  
Extinction Valence Ratings for CS-       	
     Discrimination à  Extinction (b path) -1.73 .64 -3.01 -.45 * 
     PAMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 -.01 .02  
     PAMC à  Extinction (Direct Effect) .00 .01 -.01 .02  
     PAMC à  Extinction (Total Effect) .00 .01 -.01 .02  
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Table 69. Positive Acquisition Mood Change (PAMC) and Return of Fear Valence 
Ratings 
 b SE LLCI ULCI sig 
A Path       
     PAMC à  Discrimination (a path)  .00 .00 .00 .00  
Valence Ratings for CS+        
Context Renewal      
     Discrimination à  CR (b path) 1.44 .69 .07 2.81 * 
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .01  
     PAMC à  CR (Direct Effect) -.01 .01 -.02 .01  
     PAMC à  CR (Total Effect) -.01 .01 -.02 .01  
Spontaneous Recovery      
     Discrimination à  SR (b path) -.30 .77 -1.83 1.24  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     PAMC à  SR (Direct Effect) .00 .01 -.01 .02  
     PAMC à  SR (Total Effect) .00 .01 -.01 .02  
Valence Ratings for CS-       	
Context Renewal      
     Discrimination à  CR (b path) -.31 .59 -1.50 .87  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 -.01 .00  
     PAMC à  CR (Direct Effect) .01 .01 -.01 .02  
     PAMC à  CR (Total Effect) .01 .01 -.01 .02  
Spontaneous Recovery      
     Discrimination à  SR (b path) -1.39 .61 -2.61 -.18 * 
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     PAMC à  SR (Direct Effect) -.01 .01 -.02 .01  
     PAMC à  SR (Total Effect) -.01 .01 -.02 .01  
 
 
Table 70. Negative Acquisition Mood Change (NAMC) and Extinction Valence 
Ratings 
 b SE LLCI ULCI sig 
A Path       
     NAMC à  Discrimination (a path)  .00 .00 .00 .00  
Extinction Valence Ratings for CS+       
     Discrimination à  Extinction (b path) .23 .71 -1.19 1.64  
     NAMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  Extinction (Direct Effect) -.01 .01 -.03 .01  
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     NAMC à  Extinction (Total Effect) -.01 .01 -.03 .01  
Extinction Valence Ratings for CS-       	
     Discrimination à  Extinction (b path) -1.72 .66 -3.03 -.42 * 
     NAMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 .00 .01  
     NAMC à  Extinction (Direct Effect) .00 .01 -.01 .01  
     NAMC à  Extinction (Total Effect) .00 .01 -01 .02  
 
 
Table 71. Negative Acquisition Mood Change (NAMC) and Return of Fear Valence 
Ratings 
 b SE LLCI ULCI sig 
A Path       
     NAMC à  Discrimination (a path)  .00 .00 -.01 .00  
Valence Ratings for CS+        
Context Renewal      
     Discrimination à  CR (b path) 1.26 .72 -.18 2.71  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 -.02 .00  
     NAMC à  CR (Direct Effect) .00 .01 -.02 .01  
     NAMC à  CR (Total Effect) -.01 .01 -.02 .01  
Spontaneous Recovery      
     Discrimination à  SR (b path) -.46 .80 -2.07 1.14  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .00  
     NAMC à  SR (Direct Effect) -.01 .01 -.03 .01  
     NAMC à  SR (Total Effect) -.01 .01 -.02 .01  
Valence Ratings for CS-       	
Context Renewal      
     Discrimination à  CR (b path) -.55 .62 -1.78 .69  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .01  
     NAMC à  CR (Direct Effect) -.01 .01 -.03 .00  
     NAMC à  CR (Total Effect) -.01 .01 -.02 .00  
Spontaneous Recovery      
     Discrimination à  SR (b path) -1.32 .64 -2.60 -.04 * 
     NAMC àDiscrimination à  SR (Indirect Effect) .01 .00 .00 .02  
     NAMC à  SR (Direct Effect) -.01 .01 -.01 .02  
     NAMC à  SR (Total Effect) .01 .01 .00 .02  
 
 
Table 72. Positive Acquisition Mood Change (PAMC) and Extinction Arousal 
Ratings 
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 b SE LLCI ULCI sig 
A Path       
     PAMC à  Discrimination (a path)  .00 .00 .00 .00  
Extinction Arousal Ratings for CS+       
     Discrimination à  Extinction (b path) -2.80 1.11 -5.01 -.58 * 
     PAMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 -.01 .01  
     PAMC à  Extinction (Direct Effect) .00 .01 -.02 .02  
     PAMC à  Extinction (Total Effect) .00 .01 -.03 .02  
Extinction Arousal Ratings for CS-       	
     Discrimination à  Extinction (b path) -4.08 1.00 -6.06 -2.09 * 
     PAMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 -.01 .01  
     PAMC à  Extinction (Direct Effect) -.01 .01 -.03 .01  
     PAMC à  Extinction (Total Effect) -.01 .01 -.03 .01  
 
Table 73. Positive Acquisition Mood Change (PAMC) and Return of Fear Arousal 
Ratings 
 b SE LLCI ULCI sig 
A Path       
     PAMC à  Discrimination (a path)  .00 .00 .00 .00  
Arousal Ratings for CS+        
Context Renewal      
     Discrimination à  CR (b path) -.77 .99 -2.74 1.21  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .01  
     PAMC à  CR (Direct Effect) .01 .01 -.02 .03  
     PAMC à  CR (Total Effect) .01 .01 -.02 .03  
Spontaneous Recovery      
     Discrimination à  SR (b path) -.57 1.27 -3.11 1.98  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     PAMC à  SR (Direct Effect) .00 .02 -.03 .03  
     PAMC à  SR (Total Effect) .00 .02 -.03 .03  
Arousal Ratings for CS-       	
Context Renewal      
     Discrimination à  CR (b path) -1.46 1.07 -3.60 .69  
     PAMC àDiscrimination à  CR (Indirect Effect) .00 .00 .00 .01  
     PAMC à  CR (Direct Effect) .00 .01 -.03 .03  
     PAMC à  CR (Total Effect) .00 .01 -.03 .03  
Spontaneous Recovery      
     Discrimination à  SR (b path) -1.19 1.29 -3.77 1.39  
     PAMC àDiscrimination à  SR (Indirect Effect) .00 .00 .00 .01  
     PAMC à  SR (Direct Effect) -.01 .02 -.04 .03  
     PAMC à  SR (Total Effect) -.01 .03 -.04 .03  
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Table 74. Negative Acquisition Mood Change (NAMC) and Extinction Arousal 
Ratings 
 b SE LLCI ULCI sig 
A Path       
     NAMC à  Discrimination (a path)  .00 .00 .00 .00  
Extinction Arousal Ratings for CS+       
     Discrimination à  Extinction (b path) .02 .01 -.01 .04  
     NAMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 -.01 .01  
     NAMC à  Extinction (Direct Effect) .02 .01 -.01 .04  
     NAMC à  Extinction (Total Effect) .02 .01 -.01 .04  
Extinction Arousal Ratings for CS-       	
     Discrimination à  Extinction (b path) -4.10 1.00 -6.09 -2.12 * 
     NAMC àDiscrimination à  Extinction (Indirect Effect) .00 .00 -.01 .01  
     NAMC à  Extinction (Direct Effect) .01 .01 -.01 .03  
     NAMC à  Extinction (Total Effect) .01 .01 -.01 .03  
 
Table 75. Negative Acquisition Mood Change (NAMC) and Return of Fear Arousal 
Ratings 
 b SE LLCI ULCI sig 
A Path       
     NAMC à  Discrimination (a path)  .00 .00 .00 .00  
Arousal Ratings for CS+        
Context Renewal      
     Discrimination à  CR (b path) .00 .01 -.02 .02  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  CR (Direct Effect) .00 .01 -.02 .02  
     NAMC à  CR (Total Effect) .00 .01 -.02 .02  
Spontaneous Recovery      
     Discrimination à  SR (b path) -.58 1.26 -3.10 1.95  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  SR (Direct Effect) .01 .01 -.02 .04  
     NAMC à  SR (Total Effect) .01 .01 -.02 .04  
Arousal Ratings for CS-       	
Context Renewal      
     Discrimination à  CR (b path) -1.44 1.07 -3.57 .70  
     NAMC àDiscrimination à  CR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  CR (Direct Effect) -.01 .01 -.03 .02  
     NAMC à  CR (Total Effect) -.01 .01 -.03 .02  
Spontaneous Recovery      
     Discrimination à  SR (b path) -1.17 1.28 -3.74 1.39  
     NAMC àDiscrimination à  SR (Indirect Effect) .00 .00 -.01 .00  
     NAMC à  SR (Direct Effect) .01 .02 -.02 .04  
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     NAMC à  SR (Total Effect) .01 .02 -.02 .04  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix B: Study 3 Tables 
 
 
Table 1: Left Insula Discrimination and SCR 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 .00 .00  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .51 .79 -1.08 2.09  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .01  
     Fear à  Recall (Direct) .00 .01 -.02 .03  
     Fear à  Recall (Total) .00 .01 -.02 .03  
Recall      
     Discrimination à  Recall (b path) -.24 1.30 -2.84 2.35  
     Fear àDiscrimination à  Recall (Indirect) .00 .00 -.01 .00  
     Fear à  Recall (Direct) -.01 .02 -.05 .03  
     Fear à  Recall (Total) -.01 .02 -.05 .03  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.14 .37 -.88 .60  
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     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Fear à  Recall (Direct) .00 .01 -.01 .01  
     Fear à  Recall (Total) .00 .01 -.01 .01  
Recall      
     Discrimination à  Recall (b path) .52 .93 -1.34 2.38  
     Fear àDiscrimination à  Recall (Indirect) .00 .00 .00 .01  
     Fear à  Recall (Direct) .00 .01 -.03 .05  
     Fear à  Recall (Total) .00 .01 -.03 .03  
	
Table 2: Right Insula Discrimination and SCR 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 .00 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.02 .83 -1.67 1.63  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Fear à  Recall (Direct) .00 .01 -.02 .03  
     Fear à  Recall (Total) .00 .01 -.02 .03  
Recall      
     Discrimination à  Recall (b path) -.27 1.28 -2.83 2.28  
     Fear àDiscrimination à  Recall (Indirect) .00 .00 -.01 .00  
     Fear à  Recall (Direct) -.01 .02 -.05 .03  
     Fear à  Recall (Total) -.01 .02 -.05 .03  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.23 .40 -1.02 .56  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Fear à  Recall (Direct) .00 .01 -.01 .01  
     Fear à  Recall (Total) .00 .01 -.01 .01  
Recall      
     Discrimination à  Recall (b path) -.24 .91 -2.06 1.58  
     Fear àDiscrimination à  Recall (Indirect) .00 .00 -.01 .00  
     Fear à  Recall (Direct) .00 .01 -.03 .03  
     Fear à  Recall (Total) .00 .01 -.03 .03  	
Table 3: dACC Discrimination and SCR 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 .00 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .21 .73 -1.25 1.67  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .01  
     Fear à  Recall (Direct) .00 .01 -.02 .03  
     Fear à  Recall (Total) .00 .01 -.02 .03  
Recall      
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     Discrimination à  Recall (b path) .75 1.16 -1.57 3.07  
     Fear àDiscrimination à  Recall (Indirect) .00 .00 .00 .02  
     Fear à  Recall (Direct) -.01 .03 -.05 .03  
     Fear à  Recall (Total) -.01 .02 -.05 .03  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.03 .34 -.71 .65  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Fear à  Recall (Direct) .00 .01 -.01 .01  
     Fear à  Recall (Total) .00 .01 -.01 .01  
Recall      
     Discrimination à  Recall (b path) .40 -.84 -1.28 2.07  
     Fear àDiscrimination à  Recall (Indirect) .00 .00 -.01 .01  
     Fear à  Recall (Direct) .00 .01 -.03 .03  
     Fear à  Recall (Total) .00 .01 -.03 .03  
 
Table 4: Left Hippocampus CS->CS+ Discrimination and SCR 	
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 -.01 .00  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .46 1.07 -1.67 2.59  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 -.01 .00  
     Fear à  Recall (Direct) .00 .01 -.02 .03  
     Fear à  Recall (Total) .00 .01 -.02 .03  
Recall      
     Discrimination à  Recall (b path) .05 1.70 -3.34 3.44  
     Fear àDiscrimination à  Recall (Indirect) .00 .00 -.01 .01  
     Fear à  Recall (Direct) -.01 .02 -.05 .03  
     Fear à  Recall (Total) -.01 .02 -.05 .03  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .11 .53 -.96 1.17  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Fear à  Recall (Direct) .00 .01 -.01 .01  
     Fear à  Recall (Total) .00 .01 -.01 .01  
Recall      
     Discrimination à  Recall (b path) .61 1.21 -1.80 3.02  
     Fear àDiscrimination à  Recall (Indirect) .00 .00 -.01 .00  
     Fear à  Recall (Direct) .00 .01 -.03 .03  
     Fear à  Recall (Total) .00 .01 -.03 .03  	
Table 5: Right Hippocampus CS->CS+ Discrimination and SCR 
 b SE LLCI ULCI sig 
A Path       
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     Fear à  Discrimination (a path)  .00 .00 -.01 .00  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.34 1.22 -2.77 2.09  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Fear à  Recall (Direct) .00 .01 -.02 .03  
     Fear à  Recall (Total) .00 .01 -.02 .03  
Recall      
     Discrimination à  Recall (b path) -1.00 1.84 -4.69 2.68  
     Fear àDiscrimination à  Recall (Indirect) .00 .01 .00 .02  
     Fear à  Recall (Direct) -.01 .02 -.05 .03  
     Fear à  Recall (Total) -.01 .02 -.05 .03  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .10 .57 -1.03 1.23  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Fear à  Recall (Direct) .00 .01 -.01 .01  
     Fear à  Recall (Total) .00 .01 -.01 .01  
Recall      
     Discrimination à  Recall (b path) -.09 1.32 -2.73 2.56  
     Fear àDiscrimination à  Recall (Indirect) .00 .00 .00 .01  
     Fear à  Recall (Direct) .00 .01 -.03 .03  
     Fear à  Recall (Total) .00 .01 -.03 .03  		
Table 6: 5mm vmPFC CS->CS+ Discrimination and SCR 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 -.01 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.11 .47 -1.06 .84  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Fear à  Recall (Direct) .00 .01 -.02 .03  
     Fear à  Recall (Total) .00 .01 -.02 .03  
Recall      
     Discrimination à  Recall (b path) 1.81 .74 .34 3.28 * 
     Fear àDiscrimination à  Recall (Indirect) .00 .01 -.01 .02  
     Fear à  Recall (Direct) -.01 .02 -.05 .03  
     Fear à  Recall (Total) -.01 .02 -.05 .03  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.19 .23 -.65 .28  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Fear à  Recall (Direct) .00 .01 -.01 .01  
     Fear à  Recall (Total) .00 .01 -.01 .01  
Recall      
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     Discrimination à  Recall (b path) 1.18 .55 .08 2.28 * 
     Fear àDiscrimination à  Recall (Indirect) .00 .00 -.01 .01  
     Fear à  Recall (Direct) .00 .01 -.03 .02  
     Fear à  Recall (Total) .00 .01 -.03 .03  	
Table 7: 10mm vmPFC CS->CS+ Discrimination and SCR 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 -.01 .00  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) 26.10 34.84 -43.46 95.66  
     Fear àDiscrimination à  Extinction (Indirect) -.02 .10 -.40 .08  
     Fear à  Recall (Direct) -.99 .71 -2.41 .42  
     Fear à  Recall (Total) -1.02 .70 -2.42 .39  
Recall      
     Discrimination à  Recall (b path) -3.90 16.80 -37.43 29.64  
     Fear àDiscrimination à  Recall (Indirect) .00 .05 -.15 .07  
     Fear à  Recall (Direct) .20 .38 -.55 .96  
     Fear à  Recall (Total) .20 .37 -.55 .95  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 9.21 25.79 -42.28 60.69  
     Fear àDiscrimination à  Extinction (Indirect) -.01 .06 -.23 .05  
     Fear à  Recall (Direct) -.36 .52 -1.39 .67  
     Fear à  Recall (Total) -.27 .51 -1.40 .65  
Recall      
     Discrimination à  Recall (b path) -.90 21.02 -42.84 41.05  
     Fear àDiscrimination à  Recall (Indirect) .00 .06 -.16 .11  
     Fear à  Recall (Direct) -.82 .47 -1.76 .12  
     Fear à  Recall (Total) -.82 .47 -1.76 .11  		
Table 8: Left Insula Discrimination and Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 .00 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -28.20 43.19 -114.43 58.03  
     Fear àDiscrimination à  Extinction (Indirect) -.05 .12 -.54 .08  
     Fear à  Recall (Direct) -.97 .71 -2.39 .45  
     Fear à  Recall (Total) -1.02 .70 -2.42 .39  
Recall      
     Discrimination à  Recall (b path) 4.74 20.74 -36.65 46.13  
     Fear àDiscrimination à  Recall (Indirect) .01 .06 -.06 .20  
     Fear à  Recall (Direct) .19 .38 -.57 .95  
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     Fear à  Recall (Total) .20 .37 -.55 .95  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -3.58 31.45 -66.37 59.21  
     Fear àDiscrimination à  Extinction (Indirect) .00 .07 -.20 .10  
     Fear à  Recall (Direct) -.37 .52 -1.40 .66  
     Fear à  Recall (Total) -.37 .51 -1.40 .65  
Recall      
     Discrimination à  Recall (b path) 22.37 25.79 -29.10 73.85  
     Fear àDiscrimination à  Recall (Indirect) .04 .09 -.05 .36  
     Fear à  Recall (Direct) -.86 .47 -1.80 .08  
     Fear à  Recall (Total) -.82 .47 -1.76 .11  	
Table 9: Right Insula Discrimination and Heart Rate 
 b SE LLCI ULCI Sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 .00 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -57.27 45.79 -148.70 34.16  
     Fear àDiscrimination à  Extinction (Indirect) -.09 .15 -.64 .08  
     Fear à  Recall (Direct) -.93 .70 -2.34 .48  
     Fear à  Recall (Total) -1.02 .70 -2.42 .39  
Recall      
     Discrimination à  Recall (b path) 5.16 22.02 -38.80 49.12  
     Fear àDiscrimination à  Recall (Indirect) .01 .06 -.06 .21  
     Fear à  Recall (Direct) .19 .38 -.56 .95  
     Fear à  Recall (Total) .20 .37 -.55 .95  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -13.57 34.01 -81.47 54.32  
     Fear àDiscrimination à  Extinction (Indirect) -.01 .08 -.31 .07  
     Fear à  Recall (Direct) -.36 .52 -1.39 .67  
     Fear à  Recall (Total) -.37 .51 -1.40 .65  
Recall      
     Discrimination à  Recall (b path) 42.28 27.06 -11.73 96.29  
     Fear àDiscrimination à  Recall (Indirect) .06 .10 -.08 .37  
     Fear à  Recall (Direct) -.88 .46 -1.81 .05  
     Fear à  Recall (Total) -.82 .47 -1.76 .11  	
Table 10: dACC Discrimination and Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 .00 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) 5.05 37.70 -70.21 80.31  
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     Fear àDiscrimination à  Extinction (Indirect) .02 .18 -.28 .46  
     Fear à  Recall (Direct) -1.04 .73 -2.49 .41  
     Fear à  Recall (Total) -1.02 .70 -2.42 .39  
Recall      
     Discrimination à  Recall (b path) -8.69 18.88 -46.37 29.00  
     Fear àDiscrimination à  Recall (Indirect) -.04 .10 -.33 .09  
     Fear à  Recall (Direct) .24 .39 -.53 1.01  
     Fear à  Recall (Total) .20 .37 -.55 .95  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 48.20 26.92 -5.54 101.94  
     Fear àDiscrimination à  Extinction (Indirect) .16 .14 -.01 .58  
     Fear à  Recall (Direct) -.54 .51 -1.56 .49  
     Fear à  Recall (Total) -.37 .51 -1.40 .65  
Recall      
     Discrimination à  Recall (b path) 3.35 23.64 -43.84 50.53  
     Fear àDiscrimination à  Recall (Indirect) .01 .10 -.17 .24  
     Fear à  Recall (Direct) -.84 .48 -1.80 .13  
     Fear à  Recall (Total) -.82 .47 -1.76 .11  	
Table 11: Left Hippocampus CS->CS+ Discrimination and Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 -.01 .00  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) 69.93 59.72 -49.32 189.17  
     Fear àDiscrimination à  Extinction (Indirect) -.23 .34 -1.31 .13  
     Fear à  Recall (Direct) -.78 .73 -2.24 .67  
     Fear à  Recall (Total) -1.02 .70 -2.42 .39  
Recall      
     Discrimination à  Recall (b path) -52.80 31.30 -115.28 9.68  
     Fear àDiscrimination à  Recall (Indirect) .15 .16 -.05 .61  
     Fear à  Recall (Direct) .05 .38 -.71 .81  
     Fear à  Recall (Total) .20 .37 -.55 .95  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -10.04 43.63 -97.16 77.07  
     Fear àDiscrimination à  Extinction (Indirect) .03 .15 -.21 .43  
     Fear à  Recall (Direct) -.41 .53 -1.47 .66  
     Fear à  Recall (Total) -.37 .51 -1.40 .65  
Recall      
     Discrimination à  Recall (b path) -36.74 39.71 -116.00 42.52  
     Fear àDiscrimination à  Recall (Indirect) .10 .11 -.05 .39  
     Fear à  Recall (Direct) -.93 .48 -1.89 .04  
     Fear à  Recall (Total) -.82 .47 -1.76 .11  	
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Table 12: Right Hippocampus CS->CS+ Discrimination and Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 -.01 .00  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) 119.53 67.73 -15.70 254.76  
     Fear àDiscrimination à  Extinction (Indirect) -.34 .31 -1.23 .07  
     Fear à  Recall (Direct) -.68 .72 -2.12 .75  
     Fear à  Recall (Total) -1.02 .70 -2.42 .39  
Recall      
     Discrimination à  Recall (b path) -39.00 32.86 -104.59 26.58  
     Fear àDiscrimination à  Recall (Indirect) .06 .08 -.05 .32  
     Fear à  Recall (Direct) .14 .38 -.61 .89  
     Fear à  Recall (Total) .20 .37 -.55 .95  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 47.32 50.10 -52.70 147.35  
     Fear àDiscrimination à  Extinction (Indirect) -.12 .14 -.52 .08  
     Fear à  Recall (Direct) -.25 .53 -1.31 .81  
     Fear à  Recall (Total) -.37 .51 -1.40 .65  
Recall      
     Discrimination à  Recall (b path) -27.06 41.38 -109.66 55.53  
     Fear àDiscrimination à  Recall (Indirect) .04 .09 -.06 .33  
     Fear à  Recall (Direct) -.86 .47 -1.81 .08  
     Fear à  Recall (Total) -.82 .47 -1.76 .11  	
Table 13: 5mm vmPFC CS->CS+ Discrimination and Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 -.01 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) 22.46 25.64 -28.72 73.65  
     Fear àDiscrimination à  Extinction (Indirect) -.02 .10 -.34 .11  
     Fear à  Recall (Direct) -1.00 .71 -2.41 .41  
     Fear à  Recall (Total) -1.02 .70 -2.42 .39  
Recall      
     Discrimination à  Recall (b path) -4.49 12.59 -29.63 20.65  
     Fear àDiscrimination à  Recall (Indirect) -.01 .05 -.17 .07  
     Fear à  Recall (Direct) .20 .38 -.55 .96  
     Fear à  Recall (Total) .20 .37 -.55 .95  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 20.08 19.03 -.17.92 58.08  
     Fear àDiscrimination à  Extinction (Indirect) -.04 .08 -.29 .05  
     Fear à  Recall (Direct) -.34 .51 -1.36 .69  
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     Fear à  Recall (Total) -.37 .51 -1.40 .65  
Recall      
     Discrimination à  Recall (b path) -2.46 15.76 -33.91 29.00  
     Fear àDiscrimination à  Recall (Indirect) .00 .06 -.16 .09  
     Fear à  Recall (Direct) -.82 .47 -1.76 .12  
     Fear à  Recall (Total) -.82 .47 -1.76 .11  		
Table 14: 10mm vmPFC CS->CS+ Discrimination and Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 -.01 .00  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) 26.10 34.84 -43.46 95.66  
     Fear àDiscrimination à  Extinction (Indirect) -.02 .10 -.40 .08  
     Fear à  Recall (Direct) -.99 .71 -2.41 .42  
     Fear à  Recall (Total) -1.02 .70 -2.42 .39  
Recall      
     Discrimination à  Recall (b path) -3.90 16.80 -37.43 29.64  
     Fear àDiscrimination à  Recall (Indirect) .00 .06 -.16 .07  
     Fear à  Recall (Direct) .20 .38 -.55 .96  
     Fear à  Recall (Total) .20 .37 -.55 .95  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 9.21 25.79 -42.28 60.69  
     Fear àDiscrimination à  Extinction (Indirect) -.01 .06 -.23 .05  
     Fear à  Recall (Direct) -.36 .52 -1.39 .67  
     Fear à  Recall (Total) -.37 .51 -1.40 .65  
Recall      
     Discrimination à  Recall (b path) -.90 21.02 -42.84 41.05  
     Fear àDiscrimination à  Recall (Indirect) .00 .06 -.16 .12  
     Fear à  Recall (Direct) -.82 .47 -1.76 .12  
     Fear à  Recall (Total) -.82 .47 -1.76 .11  		
Table 15: Left Insula Contrasts Discrimination and SCR 
 b SE LLCI ULCI Sig 
A Path       
     Fear à  Discrimination (a path)  .05 .09 -.11 .22  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .01 .02 -.02 .04  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .01  
     Fear à  Recall (Direct) .00 .01 -.02 .03  
     Fear à  Recall (Total) .00 .01 -.02 .03  
Recall      
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     Discrimination à  Recall (b path) -.01 .03 -.06 .05  
     Fear àDiscrimination à  Recall (Indirect) .00 .00 -.01 .00  
     Fear à  Recall (Direct) -.01 .02 -.05 .03  
     Fear à  Recall (Total) -.01 .02 -.05 .03  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .00 .01 -.02 .01  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Fear à  Recall (Direct) .00 .01 -.01 .01  
     Fear à  Recall (Total) .00 .01 -.01 .01  
Recall      
     Discrimination à  Recall (b path) .01 .01 -.03 .05  
     Fear àDiscrimination à  Recall (Indirect) .00 .00 .00 .01  
     Fear à  Recall (Direct) .00 .01 -.03 .03  
     Fear à  Recall (Total) .00 .01 -.03 .03  		
Table 16: Right Insula Contrasts Discrimination and SCR 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .09 .08 -.07 .26  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .00 .02 -.04 .03  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Fear à  Recall (Direct) .00 .01 -.02 .03  
     Fear à  Recall (Total) .00 .01 -.02 .03  
Recall      
     Discrimination à  Recall (b path) .00 .03 -.06 .05  
     Fear àDiscrimination à  Recall (Indirect) .00 .00 -.01 .00  
     Fear à  Recall (Direct) -.01 .02 -.05 .03  
     Fear à  Recall (Total) -.01 .02 -.05 .03  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.01 .01 -.02 .01  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Fear à  Recall (Direct) .00 .01 -.01 .01  
     Fear à  Recall (Total) .00 .01 -.01 .01  
Recall      
     Discrimination à  Recall (b path) .00 .02 -.04 .04  
     Fear àDiscrimination à  Recall (Indirect) .00 .00 -.01 .00  
     Fear à  Recall (Direct) .00 .01 -.03 .03  
     Fear à  Recall (Total) .00 .01 -.03 .03  		
Table 17: dACC Contrasts Discrimination and SCR 
 b SE LLCI ULCI sig 
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A Path       
     Fear à  Discrimination (a path)  .19 .10 -.00 .38  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .00 .02 -.03 .03  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .01  
     Fear à  Recall (Direct) .00 .01 -.02 .03  
     Fear à  Recall (Total) .00 .01 -.02 .03  
Recall      
     Discrimination à  Recall (b path) .02 .02 -.03 .06  
     Fear àDiscrimination à  Recall (Indirect) .00 .00 .00 .02  
     Fear à  Recall (Direct) -.01 .02 -.05 .03  
     Fear à  Recall (Total) -.01 .02 -.05 .03  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .00 .01 -.02 .01  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Fear à  Recall (Direct) .00 .01 -.01 .01  
     Fear à  Recall (Total) .00 .01 -.01 .01  
Recall      
     Discrimination à  Recall (b path) .01 .02 -.03 .04  
     Fear àDiscrimination à  Recall (Indirect) .00 .00 -.01 .01  
     Fear à  Recall (Direct) .00 .01 -.03 .03  
     Fear à  Recall (Total) .00 .01 -.03 .03  	
Table 18: Left Hippocampus Contrasts Discrimination and SCR 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  -.11 .06 -.23 .02  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .01 .02 -.04 .05  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 -.01 .00  
     Fear à  Recall (Direct) .00 .01 -.02 .03  
     Fear à  Recall (Total) .00 .01 -.02 .03  
Recall      
     Discrimination à  Recall (b path) .00 .04 -.07 .08  
     Fear àDiscrimination à  Recall (Indirect) .00 .00 -.01 .01  
     Fear à  Recall (Direct) -.01 .02 -.05 .03  
     Fear à  Recall (Total) -.01 .02 -.05 .03  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .00 .01 -.02 .03  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 -.01 .00  
     Fear à  Recall (Direct) .00 .01 -.01 .01  
     Fear à  Recall (Total) .00 .01 -.01 .01  
Recall      
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     Discrimination à  Recall (b path) .02 .03 -.03 .07  
     Fear àDiscrimination à  Recall (Indirect) .00 .00 -.01 .00  
     Fear à  Recall (Direct) .00 .01 -.03 .03  
     Fear à  Recall (Total) .00 .01 -.03 .03  	
Table 19: Right Hippocampus Contrasts Discrimination and SCR 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  -.12 .06 -.22 -.01 * 
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.01 .03 -.06 .04  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Fear à  Recall (Direct) .00 .01 -.02 .03  
     Fear à  Recall (Total) .00 .01 -.02 .03  
Recall      
     Discrimination à  Recall (b path) -.02 .04 -.10 .07  
     Fear àDiscrimination à  Recall (Indirect) .00 .01 .00 .02  
     Fear à  Recall (Direct) -.01 .02 -.05 .03  
     Fear à  Recall (Total) -.01 .02 -.05 .03  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .00 .01 -.02 .03  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Fear à  Recall (Direct) .00 .01 -.01 .01  
     Fear à  Recall (Total) .00 .01 -.01 .01  
Recall      
     Discrimination à  Recall (b path) .00 .03 -.05 .06  
     Fear àDiscrimination à  Recall (Indirect) .00 .00 .00 .00  
     Fear à  Recall (Direct) .00 .01 -.03 .03  
     Fear à  Recall (Total) .00 .01 -.03 .03  	
Table 20: 5mm vmPFC Contrasts Discrimination and SCR 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  -.05 .12 -.29 .19  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .00 .01 -.03 .02  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Fear à  Recall (Direct) .00 .01 -.02 .03  
     Fear à  Recall (Total) .00 .01 -.02 .03  
Recall      
     Discrimination à  Recall (b path) .04 .02 .01 .08 * 
     Fear àDiscrimination à  Recall (Indirect) .00 .01 -.01 .01  
     Fear à  Recall (Direct) -.01 .02 -.05 .03  
     Fear à  Recall (Total) -.01 .02 -.05 .03  
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SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .00 .01 -.02 .01  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Fear à  Recall (Direct) .00 .01 -.01 .01  
     Fear à  Recall (Total) .00 .01 -.01 .01  
Recall      
     Discrimination à  Recall (b path) .03 .01 .00 .06  
     Fear àDiscrimination à  Recall (Indirect) .00 .00 -.01 .00  
     Fear à  Recall (Direct) .00 .01 -.03 .03  
     Fear à  Recall (Total) .00 .01 -.03 .03  	
Table 21: 10mm vmPFC Contrasts Discrimination and SCR 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .00 .09 -.18 .18  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.01 .02 -.04 .03  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Fear à  Recall (Direct) .00 .01 -.02 .03  
     Fear à  Recall (Total) .00 .01 -.02 .03  
Recall      
     Discrimination à  Recall (b path) .06 .03 .01 .11 * 
     Fear àDiscrimination à  Recall (Indirect) .00 .01 -.01 .01  
     Fear à  Recall (Direct) -.01 .02 -.05 .03  
     Fear à  Recall (Total) -.01 .02 -.05 .03  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .00 .01 -.02 .01  
     Fear àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Fear à  Recall (Direct) .00 .01 -.01 .01  
     Fear à  Recall (Total) .00 .01 -.01 .01  
Recall      
     Discrimination à  Recall (b path) .04 .02 .004 .08 * 
     Fear àDiscrimination à  Recall (Indirect) .00 .00 -.01 .01  
     Fear à  Recall (Direct) .00 .01 -.03 .02  
     Fear à  Recall (Total) .00 .01 -.03 .03  		
Table 22: Left Insula Contrasts Discrimination and Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .07 .09 -.12 .25  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.68 .93 -2.54 1.18  
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     Fear àDiscrimination à  Extinction (Indirect) -.05 .13 -.54 .08  
     Fear à  Recall (Direct) -.97 .71 -2.39 .45  
     Fear à  Recall (Total) -1.02 .70 -2.42 .39  
Recall      
     Discrimination à  Recall (b path) .09 .44 -.79 .98  
     Fear àDiscrimination à  Recall (Indirect) .01 .06 -.07 .19  
     Fear à  Recall (Direct) .19 .38 -.57 .95  
     Fear à  Recall (Total) .20 .37 -.55 .95  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.06 .68 -1.42 1.29  
     Fear àDiscrimination à  Extinction (Indirect) .00 .07 -.18 .11  
     Fear à  Recall (Direct) -.37 .52 -1.40 .66  
     Fear à  Recall (Total) -.37 .51 -1.40 .65  
Recall      
     Discrimination à  Recall (b path) .44 .55 -.67 1.54  
     Fear àDiscrimination à  Recall (Indirect) .03 .08 -.05 .34  
     Fear à  Recall (Direct) -.86 .47 -1.80 .08  
     Fear à  Recall (Total) -.82 .47 -1.76 .11  
	
Table 23: Right Insula Contrasts Discrimination and Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .07 .09 -.10 .25  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -1.38 .97 -3.32 .56  
     Fear àDiscrimination à  Extinction (Indirect) .10 .17 -.71 .08  
     Fear à  Recall (Direct) -.02 .70 -2.32 .48  
     Fear à  Recall (Total) -1.02 .70 -2.42 .39  
Recall      
     Discrimination à  Recall (b path) .04 .47 -.90 .97  
     Fear àDiscrimination à  Recall (Indirect) .00 .06 -.09 .17  
     Fear à  Recall (Direct) .20 .38 -.56 .95  
     Fear à  Recall (Total) .20 .37 -.55 .95  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.12 .72 -1.56 1.33  
     Fear àDiscrimination à  Extinction (Indirect) -.01 .07 -.24 .10  
     Fear à  Recall (Direct) -.37 .52 -1.40 .66  
     Fear à  Recall (Total) -.37 .51 -1.40 .65  
Recall      
     Discrimination à  Recall (b path) .79 .58 -.36 1.95  
     Fear àDiscrimination à  Recall (Indirect) .06 .10 -.06 .37  
     Fear à  Recall (Direct) -.88 .47 -1.82 .05  
     Fear à  Recall (Total) -.82 .47 -1.76 .11  	
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Table 24: dACC Contrasts Discrimination and Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .17 .11 -.04 .39  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .24 .81 -1.37 1.86  
     Fear àDiscrimination à  Extinction (Indirect) .04 .19 -.25 .57  
     Fear à  Recall (Direct) -1.06 .72 -2.50 .38  
     Fear à  Recall (Total) -1.02 .70 -2.42 .39  
Recall      
     Discrimination à  Recall (b path) -.12 .42 -.95 .72  
     Fear àDiscrimination à  Recall (Indirect) -.02 .10 -.31 .11  
     Fear à  Recall (Direct) .22 .39 -.55 .99  
     Fear à  Recall (Total) .20 .37 -.55 .95  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 1.08 .58 -.07 2.23  
     Fear àDiscrimination à  Extinction (Indirect) .16 .15 -.02 .59  
     Fear à  Recall (Direct) -.53 .51 -1.55 .49  
     Fear à  Recall (Total) -.37 .51 -1.40 .65  
Recall      
     Discrimination à  Recall (b path) .07 .52 -.97 1.11  
     Fear àDiscrimination à  Recall (Indirect) .01 .10 -.18 .24  
     Fear à  Recall (Direct) -.84 .48 -1.80 .13  
     Fear à  Recall (Total) -.82 .47 -1.76 .11  	
Table 25: Left Hippocampus Contrasts Discrimination and Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  -.17 .06 -.30 -.04 * 
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) 1.63 1.33 -1.02 4.28  
     Fear àDiscrimination à  Extinction (Indirect) -.28 .38 -1.44 .16  
     Fear à  Recall (Direct) -.74 .74 -2.21 .73  
     Fear à  Recall (Total) -1.02 .70 -2.42 .39  
Recall      
     Discrimination à  Recall (b path) -1.12 .67 -2.46 .23  
     Fear àDiscrimination à  Recall (Indirect) .14 .15 -.05 .59  
     Fear à  Recall (Direct) .05 .38 -.71 .81  
     Fear à  Recall (Total) .20 .37 -.55 .95  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.42 .97 -2.36 1.51  
     Fear àDiscrimination à  Extinction (Indirect) .07 .17 -.20 .52  
     Fear à  Recall (Direct) -.44 .54 -1.52 .63  
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     Fear à  Recall (Total) -.37 .51 -1.40 .65  
Recall      
     Discrimination à  Recall (b path) -.73 .86 -2.44 .98  
     Fear àDiscrimination à  Recall (Indirect) .09 .11 -.06 .39  
     Fear à  Recall (Direct) -.92 .48 -1.88 .04  
     Fear à  Recall (Total) -.82 .47 -1.76 .11  	
Table 26: Right Hippocampus Contrasts Discrimination and Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  -.14 .06 -.25 -.02 * 
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) 2.56 1.45 -.32 5.47  
     Fear àDiscrimination à  Extinction (Indirect) -.35 .31 -1.26 .07  
     Fear à  Recall (Direct) -.67 .72 -2.10 .77  
     Fear à  Recall (Total) -1.02 .70 -2.42 .39  
Recall      
     Discrimination à  Recall (b path) -.83 .70 -2.22 .56  
     Fear àDiscrimination à  Recall (Indirect) .06 .08 -.05 .33  
     Fear à  Recall (Direct) .14 .38 -.61 .89  
     Fear à  Recall (Total) .20 .37 -.55 .95  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .94 1.07 -1.21 3.08  
     Fear àDiscrimination à  Extinction (Indirect) -.12 .15 -.52 .09  
     Fear à  Recall (Direct) -.25 .53 -1.31 .81  
     Fear à  Recall (Total) -.37 .51 -1.40 .65  
Recall      
     Discrimination à  Recall (b path) -.51 .88 -2.26 1.25  
     Fear àDiscrimination à  Recall (Indirect) .04 .09 -.07 .31  
     Fear à  Recall (Direct) -.86 .47 -1.81 .09  
     Fear à  Recall (Total) -.82 .47 -1.81 .09  	
Table 27: 5mm vmPFC Contrasts Discrimination and Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  -.07 .13 -.33 .19  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .62 .66 -.70 1.93  
     Fear àDiscrimination à  Extinction (Indirect) -.04 .11 -.43 .07  
     Fear à  Recall (Direct) -.98 .71 -2.39 .43  
     Fear à  Recall (Total) -1.02 .70 -2.42 .39  
Recall      
     Discrimination à  Recall (b path) -.12 .32 -.76 .53  
     Fear àDiscrimination à  Recall (Indirect) .00 .05 -.11 .10  
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     Fear à  Recall (Direct) -.20 .38 -.55 .95  
     Fear à  Recall (Total) -.20 .37 -.55 .95  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .45 .49 -.53 1.43  
     Fear àDiscrimination à  Extinction (Indirect) -.05 .08 -.33 .03  
     Fear à  Recall (Direct) -.33 .52 -1.35 .70  
     Fear à  Recall (Total) -.37 .51 -1.40 .65  
Recall      
     Discrimination à  Recall (b path) -.14 .40 -.94 .66  
     Fear àDiscrimination à  Recall (Indirect) .00 .05 -.13 .11  
     Fear à  Recall (Direct) -.82 .47 -1.76 .12  
     Fear à  Recall (Total) -.82 .47 -1.76 .11  	
Table 28: 10mm vmPFC Contrasts Discrimination and Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  -.08 .10 -.27 .11  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .73 .90 -1.06 2.53  
     Fear àDiscrimination à  Extinction (Indirect) -.06 .11 -.49 .06  
     Fear à  Recall (Direct) -.96 .71 -2.38 .45  
     Fear à  Recall (Total) -1.02 .70 -2.42 .39  
Recall      
     Discrimination à  Recall (b path) -.17 .44 -1.04 .70  
     Fear àDiscrimination à  Recall (Indirect) .00 .05 -.11 .09  
     Fear à  Recall (Direct) .20 .38 -.55 .95  
     Fear à  Recall (Total) .20 .37 -.55 .95  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .11 .67 -1.22 1.44  
     Fear àDiscrimination à  Extinction (Indirect) -.01 .07 -.23 .09  
     Fear à  Recall (Direct) -.36 .52 -1.40 .67  
     Fear à  Recall (Total) -.37 .51 -1.40 .65  
Recall      
     Discrimination à  Recall (b path) -.15 .54 -1.23 .94  
     Fear àDiscrimination à  Recall (Indirect) .00 .05 -.13 .10  
     Fear à  Recall (Direct) -.82 .47 -1.76 .12  
     Fear à  Recall (Total) -.82 .47 -1.76 .11  		
Table 29: Left Insula Discrimination and 5mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 .00 .00  
SCR during CS+        
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End of Extinction      
     Discrimination à  Extinction (b path) -1.83 6.97 -15.65 11.99  
     Fear àDiscrimination à  Extinction (Indirect) .00 .01 -.05 .02  
     Fear à  Recall (Direct) -.11 .11 -.33 .12  
     Fear à  Recall (Total) -.11 .11 -.33 .12  
Recall      
     Discrimination à  Recall (b path) -6.39 7.17 -20.61 7.83  
     Fear àDiscrimination à  Recall (Indirect) .00 .02 -.06 .01  
     Fear à  Recall (Direct) -.10 .12 -.13 .33  
     Fear à  Recall (Total) .09 .12 -.14 .32  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 9.52 7.22 -4.79 23.84  
     Fear àDiscrimination à  Extinction (Indirect) .01 .02 -.02 .07  
     Fear à  Recall (Direct) .10 .12 -.13 .33  
     Fear à  Recall (Total) .11 .12 -.13 .34  
Recall      
     Discrimination à  Recall (b path) -7.46 7.49 -22.32 7.40  
     Fear àDiscrimination à  Recall (Indirect) -.01 .02 .06 .01  
     Fear à  Recall (Direct) -.13 .12 -.37 .11  
     Fear à  Recall (Total) -.14 .12 -.38 .11  	
Table 30: Right Insula Discrimination and 5mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 .00 .00  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -11.35 7.42 -26.07 3.37  
     Fear àDiscrimination à  Extinction (Indirect) -.01 .02 -.08 .01  
     Fear à  Recall (Direct) -.10 .11 -.32 .13  
     Fear à  Recall (Total) -.11 .11 -.33 .12  
Recall      
     Discrimination à  Recall (b path) -12.45 7.65 -27.63 2.73  
     Fear àDiscrimination à  Recall (Indirect) -.01 .02 -.10 .01  
     Fear à  Recall (Direct) .11 .12 -.12 .33  
     Fear à  Recall (Total) .09 .12 -.14 .32  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 9.67 7.78 -5.76 25.11  
     Fear àDiscrimination à  Extinction (Indirect) .01 .02 -.01 .08  
     Fear à  Recall (Direct) .10 .12 -.14 .33  
     Fear à  Recall (Total) .11 .12 -.13 .34  
Recall      
     Discrimination à  Recall (b path) -11.40 8.03 -27.32 4.53  
     Fear àDiscrimination à  Recall (Indirect) -.01 .02 -.08 .01  
     Fear à  Recall (Direct) -.12 .12 -.36 .12  
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     Fear à  Recall (Total) -.14 .12 -.38 .11  	
Table 31: dACC Discrimination and 5mm vmPFC 
 b SE LLCI ULCI Sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 .00 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) 5.68 5.98 -6.19 17.55  
     Fear àDiscrimination à  Extinction (Indirect) .02 .03 -.02 .11  
     Fear à  Recall (Direct) -.13 .11 -.35 .10  
     Fear à  Recall (Total) -.11 .11 -.33 .12  
Recall      
     Discrimination à  Recall (b path) -8.39 6.15 -20.59 3.81  
     Fear àDiscrimination à  Recall (Indirect) -.03 .03 -.11 .00  
     Fear à  Recall (Direct) .12 .12 -.11 .36  
     Fear à  Recall (Total) .09 .12 -.14 .32  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 11.18 6.18 -1.08 23.43  
     Fear àDiscrimination à  Extinction (Indirect) .04 .03 .00 .13  
     Fear à  Recall (Direct) .06 .12 -.17 .30  
     Fear à  Recall (Total) .11 .12 -.13 .34  
Recall      
     Discrimination à  Recall (b path) -12.28 6.37 -24.93 .36  
     Fear àDiscrimination à  Recall (Indirect) -.05 .03 -.14 .00  
     Fear à  Recall (Direct) -.09 .12 -.33 .15  
     Fear à  Recall (Total) -.14 .12 -.38 .11  	
Table 32: Left Hippocampus Discrimination and 5mm vmPFC 
 b SE LLCI ULCI Sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 .00 .00  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .75 8.86 -16.84 18.33  
     Fear àDiscrimination à  Extinction (Indirect) .00 .01 -.04 .02  
     Fear à  Recall (Direct) -.11 .11 -.33 .12  
     Fear à  Recall (Total) -.11 .11 -.33 .12  
Recall      
     Discrimination à  Recall (b path) 3.42 9.15 -14.73 21.57  
     Fear àDiscrimination à  Recall (Indirect) -.01 .02 -.06 .02  
     Fear à  Recall (Direct) .10 .12 -.13 .33  
     Fear à  Recall (Total) .09 .12 -.14 .43  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -5.99 9.24 -24.32 12.34  
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     Fear àDiscrimination à  Extinction (Indirect) .01 .02 -.01 .08  
     Fear à  Recall (Direct) .10 .12 -.14 .33  
     Fear à  Recall (Total) -.11 .12 -.13 .34  
Recall      
     Discrimination à  Recall (b path) -4.94 9.56 -23.91 14.03  
     Fear àDiscrimination à  Recall (Indirect) .01 .02 -.02 .08  
     Fear à  Recall (Direct) -.14 .12 -.39 .10  
     Fear à  Recall (Total) -.14 .12 -.38 .11  	
Table 33: Right Hippocampus Discrimination and 5mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 .00 .00  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) 1.18 9.30 -17.28 19.65  
     Fear àDiscrimination à  Extinction (Indirect) .00 .01 -.04 .02  
     Fear à  Recall (Direct) -.11 .11 -.33 .12  
     Fear à  Recall (Total) -.11 .11 -.33 .12  
Recall      
     Discrimination à  Recall (b path) -1.26 9.61 -20.33 17.81  
     Fear àDiscrimination à  Recall (Indirect) .00 .02 -.02 .05  
     Fear à  Recall (Direct) .09 .12 -.14 .32  
     Fear à  Recall (Total) .09 .12 -.14 .33  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -8.19 9.69 -27.40 11.03  
     Fear àDiscrimination à  Extinction (Indirect) .01 .02 -.01 .08  
     Fear à  Recall (Direct) .10 .12 -.14 .33  
     Fear à  Recall (Total) .11 .12 -.13 .34  
Recall      
     Discrimination à  Recall (b path) -2.05 10.05 -21.99 17.89  
     Fear àDiscrimination à  Recall (Indirect) .00 .01 -.02 .05  
     Fear à  Recall (Direct) -.14 .12 -.38 .11  
     Fear à  Recall (Total) -.14 .12 -.38 .11  	
Table 34: 5mm vmPFC Discrimination and 5mm vmPFC 
 b SE LLCI ULCI Sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 .00 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -1.36 4.12 -9.55 6.82  
     Fear àDiscrimination à  Extinction (Indirect) .00 .01 -.03 .02  
     Fear à  Recall (Direct) -.11 .11 -.33 .12  
     Fear à  Recall (Total) -.11 .11 -.33 .12  
Recall      
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     Discrimination à  Recall (b path) -8.11 4.18 -16.41 .18  
     Fear àDiscrimination à  Recall (Indirect) .00 .02 -.07 .03  
     Fear à  Recall (Direct) .10 .11 -.13 .32  
     Fear à  Recall (Total) .09 .12 -.14 .32  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .15 4.31 -8.40 8.70  
     Fear àDiscrimination à  Extinction (Indirect) .00 .01 -.02 .03  
     Fear à  Recall (Direct) .11 .12 -.13 .34  
     Fear à  Recall (Total) .11 .12 -.13 .34  
Recall      
     Discrimination à  Recall (b path) -7.04 4.40 -15.77 1.69  
     Fear àDiscrimination à  Recall (Indirect) .00 .02 -.06 .03  
     Fear à  Recall (Direct) -.13 .12 -.37 .11  
     Fear à  Recall (Total) -.14 .12 -.38 .11  	
Table 35: Left Insula Discrimination and 10mm vmPFC 
 b SE LLCI ULCI Sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 .00 .00  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) 2.91 5.19 -7.38 13.21  
     Fear àDiscrimination à  Extinction (Indirect) .00 .01 -.01 .04  
     Fear à  Recall (Direct) -.04 .08 -.21 .13  
     Fear à  Recall (Total) -.04 .08 -.20 .13  
Recall      
     Discrimination à  Recall (b path) -2.10 5.35 -12.71 8.50  
     Fear àDiscrimination à  Recall (Indirect) .00 .01 -.04 .01  
     Fear à  Recall (Direct) .01 .09 -.16 .18  
     Fear à  Recall (Total) .01 .09 -.16 .18  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 9.48 5.59 -1.61 20.57  
     Fear àDiscrimination à  Extinction (Indirect) .01 .02 -.02 .06  
     Fear à  Recall (Direct) .08 .09 -.10 .26  
     Fear à  Recall (Total) .09 .09 -.09 .27  
Recall      
     Discrimination à  Recall (b path) -5.66 5.37 -16.31 4.98  
     Fear àDiscrimination à  Recall (Indirect) .00 .01 -.05 .01  
     Fear à  Recall (Direct) -.07 .09 -.24 .10  
     Fear à  Recall (Total) -.07 .09 -.25 .10  	
Table 36: Right Insula Discrimination and 10mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 .00 .00  
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SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -4.06 5.58 -15.14 7.02  
     Fear àDiscrimination à  Extinction (Indirect) .00 .01 -.05 .01  
     Fear à  Recall (Direct) -.03 .08 -.20 .13  
     Fear à  Recall (Total) -.04 .09 -.20 .13  
Recall      
     Discrimination à  Recall (b path) -7.05 5.72 -18.40 4.30  
     Fear àDiscrimination à  Recall (Indirect) -.01 .01 -.06 .01  
     Fear à  Recall (Direct) -.02 .09 -.15 .19  
     Fear à  Recall (Total) .01 .09 -.16 .18  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 10.58 6.01 -1.35 22.51  
     Fear àDiscrimination à  Extinction (Indirect) .01 .02 -.01 .07  
     Fear à  Recall (Direct) .08 .09 -.10 .26  
     Fear à  Recall (Total) .09 .09 -.09 .27  
Recall      
     Discrimination à  Recall (b path) -7.57 5.76 -19.00 3.87  
     Fear àDiscrimination à  Recall (Indirect) -.01 .01 -.06 .01  
     Fear à  Recall (Direct) -.07 .09 -.24 .11  
     Fear à  Recall (Total) -.07 .09 -.25 .10  	
Table 37: dACC Discrimination and 10mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 .00 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) 5.72 4.45 -3.10 14.54  
     Fear àDiscrimination à  Extinction (Indirect) .02 .02 -.01 .09  
     Fear à  Recall (Direct) -.06 .09 -.23 .11  
     Fear à  Recall (Total) -.04 .08 -.20 .13  
Recall      
     Discrimination à  Recall (b path) -5.22 4.58 -14.32 3.87  
     Fear àDiscrimination à  Recall (Indirect) -.02 .02 -.07 .01  
     Fear à  Recall (Direct) .03 .09 -.14 .20  
     Fear à  Recall (Total) .01 .09 -.16 .18  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 8.61 4.81 -.94 18.16  
     Fear àDiscrimination à  Extinction (Indirect) .03 .03 .00 .11  
     Fear à  Recall (Direct) .06 .09 -.12 .24  
     Fear à  Recall (Total) .09 .09 -.09 .27  
Recall      
     Discrimination à  Recall (b path) -9.43 4.56 -18.48 -.39 * 
     Fear àDiscrimination à  Recall (Indirect) -.03 .02 -.10 .00  
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     Fear à  Recall (Direct) -.04 .09 -.21 .13  
     Fear à  Recall (Total) -.07 .09 -.25 .10  	
Table 38: Left Hippocampus Discrimination and 10mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 .00 .00  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -3.47 6.60 -16.57 9.62  
     Fear àDiscrimination à  Extinction (Indirect) .01 .01 -.01 .05  
     Fear à  Recall (Direct) -.04 .08 -.21 .13  
     Fear à  Recall (Total) -.04 .08 -.20 .13  
Recall      
     Discrimination à  Recall (b path) 1.59 6.80 -11.90 15.09  
     Fear àDiscrimination à  Recall (Indirect) .00 .01 -.04 .02  
     Fear à  Recall (Direct) .01 .09 -.16 .19  
     Fear à  Recall (Total) .01 .09 -.16 .18  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -5.89 7.19 -20.15 8.37  
     Fear àDiscrimination à  Extinction (Indirect) .01 .02 -.01 .07  
     Fear à  Recall (Direct) .08 .09 -.10 .26  
     Fear à  Recall (Total) .09 .09 -.09 .27  
Recall      
     Discrimination à  Recall (b path) -2.63 6.86 -16.24 10.98  
     Fear àDiscrimination à  Recall (Indirect) .00 .02 -.02 .06  
     Fear à  Recall (Direct) -.08 .09 -.25 .10  
     Fear à  Recall (Total) -.07 .09 -.25 .10  	
Table 39: Right Hippocampus Discrimination and 10mm vmPFC 
 b SE LLCI ULCI Sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 .00 .00  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -3.91 6.93 -17.66 9.84  
     Fear àDiscrimination à  Extinction (Indirect) .00 .01 -.01 .04  
     Fear à  Recall (Direct) -.04 .08 -.21 .13  
     Fear à  Recall (Total) -.04 .08 -.20 .13  
Recall      
     Discrimination à  Recall (b path) -1.71 7.14 -15.89 12.46  
     Fear àDiscrimination à  Recall (Indirect) .00 .01 -.01 .04  
     Fear à  Recall (Direct) .01 .09 -.16 .18  
     Fear à  Recall (Total) .01 .09 -.16 .18  
SCR during CS-       	
End of Extinction      
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     Discrimination à  Extinction (b path) -8.29 7.53 -23.22 6.64  
     Fear àDiscrimination à  Extinction (Indirect) .01 .02 -.01 .07  
     Fear à  Recall (Direct) .08 .09 -.10 .26  
     Fear à  Recall (Total) .09 .09 -.09 .27  
Recall      
     Discrimination à  Recall (b path) .89 7.21 -13.40 15.19  
     Fear àDiscrimination à  Recall (Indirect) .00 .01 -.03 .02  
     Fear à  Recall (Direct) -.07 .09 -.25 .10  
     Fear à  Recall (Total) -.07 .09 -.25 .10  	
Table 40: 10mm vmPFC Discrimination and 10mm vmPFC 
 b SE LLCI ULCI Sig 
A Path       
     Fear à  Discrimination (a path)  .00 .00 .00 .00  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -5.59 4.13 -13.79 2.60  
     Fear àDiscrimination à  Extinction (Indirect) .00 .01 -.04 .01  
     Fear à  Recall (Direct) -.03 .08 -.20 .13  
     Fear à  Recall (Total) -.04 .08 -.20 .13  
Recall      
     Discrimination à  Recall (b path) -8.56 4.20 -16.90 -22.42 * 
     Fear àDiscrimination à  Recall (Indirect) -.01 .02 -.06 .02  
     Fear à  Recall (Direct) .02 .08 -.15 .18  
     Fear à  Recall (Total) .01 .09 -.16 .18  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -1.21 4.54 -10.23 7.80  
     Fear àDiscrimination à  Extinction (Indirect) .00 .01 -.03 .01  
     Fear à  Recall (Direct) .09 .09 -.09 .27  
     Fear à  Recall (Total) .09 .09 -.09 .27  
Recall      
     Discrimination à  Recall (b path) -4.70 4.30 -13.23 3.84  
     Fear àDiscrimination à  Recall (Indirect) .00 .01 -.05 .01  
     Fear à  Recall (Direct) -.07 .09 -.24 .10  
     Fear à  Recall (Total) -.07 .09 -.25 .10  		
Table 41: Left Insula Contrast and 5mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .03 .07 -.11 .18  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.03 .15 -.33 .27  
     Fear àDiscrimination à  Extinction (Indirect) .00 .01 -.04 .02  
     Fear à  Recall (Direct) -.11 .11 -.33 .12  
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     Fear à  Recall (Total) -.11 .11 -.33 .12  
Recall      
     Discrimination à  Recall (b path) -.14 .15 -.45 .17  
     Fear àDiscrimination à  Recall (Indirect) .00 .02 -.06 .01  
     Fear à  Recall (Direct) .10 .12 -.13 .33  
     Fear à  Recall (Total) .09 .12 -.14 .32  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .19 .16 -.12 .50  
     Fear àDiscrimination à  Extinction (Indirect) .01 .02 -.02 .07  
     Fear à  Recall (Direct) .10 .12 -.13 .33  
     Fear à  Recall (Total) .11 .12 -.13 .34  
Recall      
     Discrimination à  Recall (b path) -.16 .16 -.48 .16  
     Fear àDiscrimination à  Recall (Indirect) -.01 .02 -.06 .01  
     Fear à  Recall (Direct) -.13 .12 -.37 .11  
     Fear à  Recall (Total) -.14 .12 -.38 .11  	
Table 42: Right Insula Contrast and 5mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .06 .07 -.08 .20  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.20 .16 -.51 .12  
     Fear àDiscrimination à  Extinction (Indirect) -.01 .02 -.08 .01  
     Fear à  Recall (Direct) -.10 .11 -.32 .13  
     Fear à  Recall (Total) -.11 .11 -.33 .12  
Recall      
     Discrimination à  Recall (b path) -.30 .16 -.62 .03  
     Fear àDiscrimination à  Recall (Indirect) -.02 .03 -.10 .01  
     Fear à  Recall (Direct) .11 .12 -.12 .34  
     Fear à  Recall (Total) .09 .12 -.14 .32  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .16 .17 -.17 .49  
     Fear àDiscrimination à  Extinction (Indirect) .01 .02 -.01 .08  
     Fear à  Recall (Direct) .10 .12 -.14 .33  
     Fear à  Recall (Total) .11 .12 -.13 .34  
Recall      
     Discrimination à  Recall (b path) -.27 .17 -.61 .07  
     Fear àDiscrimination à  Recall (Indirect) -.02 .02 -.09 .01  
     Fear à  Recall (Direct) -.12 .12 -36 .12  
     Fear à  Recall (Total) -.14 12 -.38 .11  	
 
Table 43: dACC Contrast and 5mm vmPFC 
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 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .17 .09 .001 .34 * 
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .15 .13 -.11. 41  
     Fear àDiscrimination à  Extinction (Indirect) .03 .03 -.01 .12  
     Fear à  Recall (Direct) -.13 .11 -.36 .09  
     Fear à  Recall (Total) -.11 .11 -.33 .12  
Recall      
     Discrimination à  Recall (b path) -.13 .13 -.39 .14  
     Fear àDiscrimination à  Recall (Indirect) -.02 .03 -.09 .01  
     Fear à  Recall (Direct) .11 .12 -.12 .35  
     Fear à  Recall (Total) .09 .12 -.14 .32  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .23 .13 -.04 .49  
     Fear àDiscrimination à  Extinction (Indirect) .04 .03 .00 .13  
     Fear à  Recall (Direct) .07 .12 -.17 .30  
     Fear à  Recall (Total) .11 .12 -.13 .34  
Recall      
     Discrimination à  Recall (b path) -.21 .14 -.49 .06  
     Fear àDiscrimination à  Recall (Indirect) -.04 .03 -.13 .00  
     Fear à  Recall (Direct) -.10 .12 -.34 .15  
     Fear à  Recall (Total) -.14 .12 -.38 .11  	
Table 44: Left Hippocampus Contrast and 5mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  -.08 .06 -.19 .04  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .01 .20 -.38 .40  
     Fear àDiscrimination à  Extinction (Indirect) .00 .01 -.04 .03  
     Fear à  Recall (Direct) -.11 .11 -.33 .12  
     Fear à  Recall (Total) -.11 .11 -.33 .12  
Recall      
     Discrimination à  Recall (b path) .09 .20 -.31 .49  
     Fear àDiscrimination à  Recall (Indirect) -.01 .02 -.06 .02  
     Fear à  Recall (Direct) .10 .12 -.13 .33  
     Fear à  Recall (Total) .09 .12 -.14 .32  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.13 .20 -.53 .28  
     Fear àDiscrimination à  Extinction (Indirect) .01 .02 -.01 .08  
     Fear à  Recall (Direct) .10 .12 -.14 .33  
     Fear à  Recall (Total) .11 .12 -.13 .34  
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Recall      
     Discrimination à  Recall (b path) -.07 .21 -.49 .35  
     Fear àDiscrimination à  Recall (Indirect) .01 .02 -.02 .07  
     Fear à  Recall (Direct) -.14 .12 -.38 .10  
     Fear à  Recall (Total) -.14 .12 -.38 .11  	
Table 45: Right Hippocampus Contrast and 5mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  -.05 .06 -.16 .06  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .02 .20 -.39 .42  
     Fear àDiscrimination à  Extinction (Indirect) .00 .01 -.04 .02  
     Fear à  Recall (Direct) -.11 .11 -.33 .12  
     Fear à  Recall (Total) -.11 .11 -.33 .12  
Recall      
     Discrimination à  Recall (b path) -.06 .21 -.48 .36  
     Fear àDiscrimination à  Recall (Indirect) .00 .02 -.02 .05  
     Fear à  Recall (Direct) .09 .12 -.14 .32  
     Fear à  Recall (Total) .09 .12 -.14 .32  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.19 .21 -.61 .23  
     Fear àDiscrimination à  Extinction (Indirect) .01 .02 -.01 .08  
     Fear à  Recall (Direct) .10 .12 -.14 .33  
     Fear à  Recall (Total) .11 .12 -.13 .34  
Recall      
     Discrimination à  Recall (b path) -.04 .22 -.48 .39  
     Fear àDiscrimination à  Recall (Indirect) .00 .01 -.02 .05  
     Fear à  Recall (Direct) -.14 .12 -.38 .11  
     Fear à  Recall (Total) -.14 .12 -.38 .11  	
Table 46: 5mm vmPFC Contrast and 5mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  -.01 .11 -.22 .20  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.05 .11 -.26 .16  
     Fear àDiscrimination à  Extinction (Indirect) .00 .01 -.02 .03  
     Fear à  Recall (Direct) -.11 .11 -.33 .12  
     Fear à  Recall (Total) -.11 .11 -.33 .12  
Recall      
     Discrimination à  Recall (b path) -.21 .11 -.42 .00  
     Fear àDiscrimination à  Recall (Indirect) .00 .02 -.05 .04  
     Fear à  Recall (Direct) .09 .11 -.13 .32  
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     Fear à  Recall (Total) .09 .12 -.14 .32  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.01 .11 -.23 .21  
     Fear àDiscrimination à  Extinction (Indirect) .00 .01 -.02 .03  
     Fear à  Recall (Direct) .11 .12 -.13 .34  
     Fear à  Recall (Total) .11 .12 -.13 .34  
Recall      
     Discrimination à  Recall (b path) -.18 .11 -.40 .05  
     Fear àDiscrimination à  Recall (Indirect) .00 .02 -.04 .05  
     Fear à  Recall (Direct) -.14 .12 -.38 .10  
     Fear à  Recall (Total) -.14 .12 -.38 .11  	
Table 47: Left Insula Contrast and 10mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .03 .07 -.11 .18  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .06 .11 -.16 .29  
     Fear àDiscrimination à  Extinction (Indirect) .00 .01 -.01 .04  
     Fear à  Recall (Direct) -.04 .08 -.21 .13  
     Fear à  Recall (Total) -.04 .08 -.20 .13  
Recall      
     Discrimination à  Recall (b path) -.04 .12 -.27 .19  
     Fear àDiscrimination à  Recall (Indirect) .00 .01 -.03 .01  
     Fear à  Recall (Direct) .01 .09 -.16 .18  
     Fear à  Recall (Total) .01 .09 -.16 .18  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .19 .12 -.05 .43  
     Fear àDiscrimination à  Extinction (Indirect) .01 .02 -.02 .06  
     Fear à  Recall (Direct) .08 .09 -.10 .26  
     Fear à  Recall (Total) .09 .09 -.09 .27  
Recall      
     Discrimination à  Recall (b path) -.11 .12 -.34 .12  
     Fear àDiscrimination à  Recall (Indirect) .00 .01 -.04 .01  
     Fear à  Recall (Direct) -.07 .09 -.24 .10  
     Fear à  Recall (Total) -.07 .09 -.25 .10  	
Table 48: Right Insula Contrast and 10mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .06 .07 -.08 .20  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.05 .12 -.29 .19  
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     Fear àDiscrimination à  Extinction (Indirect) .00 .01 -.04 .01  
     Fear à  Recall (Direct) -.03 .08 -.20 .13  
     Fear à  Recall (Total) -.04 .08 -.20 .13  
Recall      
     Discrimination à  Recall (b path) -.17 .12 -.41 .08  
     Fear àDiscrimination à  Recall (Indirect) -.01 .02 -.07 .01  
     Fear à  Recall (Direct) .02 .09 -.15 .19  
     Fear à  Recall (Total) .01 .09 -.16 .18  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .19 .13 -.07 .44  
     Fear àDiscrimination à  Extinction (Indirect) .01 .02 -.01 .07  
     Fear à  Recall (Direct) .08 .09 -.10 .26  
     Fear à  Recall (Total) .09 .09 -.09 .27  
Recall      
     Discrimination à  Recall (b path) -.17 .12 -.42 .07  
     Fear àDiscrimination à  Recall (Indirect) -.01 .02 -.06 .01  
     Fear à  Recall (Direct) -.06 .09 -.24 .11  
     Fear à  Recall (Total) -.08 .09 -.25 .10  	
Table 49: dACC Contrast and 10mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .17 .09 .001 .34 * 
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .13 .10 -.06 .33  
     Fear àDiscrimination à  Extinction (Indirect) .02 .02 -.01 .10  
     Fear à  Recall (Direct) -.06 .09 -.23 .11  
     Fear à  Recall (Total) -.04 .08 -.20 .13  
Recall      
     Discrimination à  Recall (b path) -.07 .10 -.27 .13  
     Fear àDiscrimination à  Recall (Indirect) -.01 .02 -.06 .01  
     Fear à  Recall (Direct) .02 .09 -.15 .20  
     Fear à  Recall (Total) .01 .09 -.16 .18  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .18 .10 -.03 .39  
     Fear àDiscrimination à  Extinction (Indirect) .03 .02 .00 .10  
     Fear à  Recall (Direct) .06 .09 -.12 .24  
     Fear à  Recall (Total) .09 .09 -.09 .27  
Recall      
     Discrimination à  Recall (b path) -.17 .10 -.37 .03  
     Fear àDiscrimination à  Recall (Indirect) -.03 .02 -.09 .00  
     Fear à  Recall (Direct) -.04 .09 -.22 .13  
     Fear à  Recall (Total) -.07 .09 -.25 .10  	
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Table 50: Left Hippocampus Contrast and 10mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  -.08 .06 -.19 .04  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.08 .15 -.37 .21  
     Fear àDiscrimination à  Extinction (Indirect) .01 .01 -.01 .05  
     Fear à  Recall (Direct) -.04 .08 -.21 .13  
     Fear à  Recall (Total) -.04 .08 -.20 .13  
Recall      
     Discrimination à  Recall (b path) .04 .15 -.25 .34  
     Fear àDiscrimination à  Recall (Indirect) .00 .01 -.04 .02  
     Fear à  Recall (Direct) .01 .09 -.16 .19  
     Fear à  Recall (Total) .01 .09 -.16 .18  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.13 .16 -.44 .19  
     Fear àDiscrimination à  Extinction (Indirect) .01 .02 -.01 .07  
     Fear à  Recall (Direct) .08 .09 -.10 .26  
     Fear à  Recall (Total) .09 .09 -.10 .26  
Recall      
     Discrimination à  Recall (b path) -.04 .15 -.34 .26  
     Fear àDiscrimination à  Recall (Indirect) .00 .02 -.02 .05  
     Fear à  Recall (Direct) -.08 .09 -.25 .10  
     Fear à  Recall (Total) -.07 .09 -.25 .10  	
Table 51: Right Hippocampus Contrast and 10mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  -.05 .06 -.16 .06  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.09 .15 -.39 .22  
     Fear àDiscrimination à  Extinction (Indirect) .00 .01 -.01 .04  
     Fear à  Recall (Direct) -.04 .08 -.21 .13  
     Fear à  Recall (Total) -.04 .08 -.20 .13  
Recall      
     Discrimination à  Recall (b path) -.06 .16 -.37 .25  
     Fear àDiscrimination à  Recall (Indirect) .00 .01 -.01 .04  
     Fear à  Recall (Direct) .01 .09 -.17 .18  
     Fear à  Recall (Total) .01 .09 -.16 .18  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.19 .16 -.52 .14  
     Fear àDiscrimination à  Extinction (Indirect) .01 .02 -.01 .07  
     Fear à  Recall (Direct) .08 .09 -.10 .26  
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     Fear à  Recall (Total) .09 .09 -.09 .27  
Recall      
     Discrimination à  Recall (b path) .02 .16 -.29 .33  
     Fear àDiscrimination à  Recall (Indirect) .00 .01 -.03 .02  
     Fear à  Recall (Direct) -.07 .09 -.25 .10  
     Fear à  Recall (Total) -.07 .09 -.25 .10  	
Table 52: 10mm vmPFC Contrast and 10mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Fear à  Discrimination (a path)  .00 .08 -.16 .15  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.14 .11 -.35 .07  
     Fear àDiscrimination à  Extinction (Indirect) .00 .01 -.02 .03  
     Fear à  Recall (Direct) -.04 .08 -.20 .13  
     Fear à  Recall (Total) -.04 .08 -.20 .13  
Recall      
     Discrimination à  Recall (b path) -.24 .11 -.45 -.03 * 
     Fear àDiscrimination à  Recall (Indirect) .00 .02 -.04 .04  
     Fear à  Recall (Direct) .01 .09 -.16 .18  
     Fear à  Recall (Total) .01 .09 -.16 .18  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.05 .12 -.28 .18  
     Fear àDiscrimination à  Extinction (Indirect) .00 .01 -.02 .02  
     Fear à  Recall (Direct) .09 .09 -.09 .27  
     Fear à  Recall (Total) .09 .09 -.09 .27  
Recall      
     Discrimination à  Recall (b path) -14 .11 -.36 .08  
     Fear àDiscrimination à  Recall (Indirect) .00 .01 -.02 .03  
     Fear à  Recall (Direct) -.07 .09 -.15 .10  
     Fear à  Recall (Total) -.08 .09 -.25 .10  	
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Appendix C: Study 3 Supplementary Mediation Analyses with MASQ-Anxious 
Arousal 
 
Table	1:	Left	Insula	Discrimination,	and	SCR	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .00 -.01 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .50 .81 -1.12 2.12  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 -.02 .00  
     Anx à  Recall (Direct) .00 .03 -.06 .05  
     Anx à  Recall (Total) .00 .03 -.06 .05  
Recall      
     Discrimination à  Recall (b path) .07 1.24 -2.42 2.56  
     Anx àDiscrimination à  Recall (Indirect) .00 .00 -.01 .01  
     Anx à  Recall (Direct) -.01 .04 -.10 .07  
     Anx à  Recall (Total) -.01 .04 -.09 .07  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.18 .38 -.93 .57  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Anx à  Recall (Direct) .00 .01 -.03 .03  
     Anx à  Recall (Total) .00 .01 -.03 .03  
Recall      
     Discrimination à  Recall (b path) .78 .88 -.98 2.53  
     Anx àDiscrimination à  Recall (Indirect) .00 .01 -.02 .00  
     Anx à  Recall (Direct) .01 .03 -.05 .06  
     Anx à  Recall (Total) .00 .03 -.05 .06  	
Table	2:	Right	Insula	Discrimination	and	SCR	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .00 -.01 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.01 .84 -1.69 1.68  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Anx à  Recall (Direct) .00 .03 -.06 .05  
     Anx à  Recall (Total) .00 .03 -.06 .05  
Recall      
     Discrimination à  Recall (b path) .22 1.22 -2.23 2.67  
     Anx àDiscrimination à  Recall (Indirect) .00 .00 -.01 .01  
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     Anx à  Recall (Direct) -.01 .04 -.10 .07  
     Anx à  Recall (Total) -.01 .04 -.09 .07  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.28 .40 -1.08 .52  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Anx à  Recall (Direct) .00 .01 -.03 .03  
     Anx à  Recall (Total) .00 .01 -.03 .03  
Recall      
     Discrimination à  Recall (b path) .15 .86 -1.57 1.88  
     Anx àDiscrimination à  Recall (Indirect) .00 .00 -.01 .01  
     Anx à  Recall (Direct) .00 .03 -.05 .06  
     Anx à  Recall (Total) .00 .03 -.05 .06  	
Table	3:	dACC	Discrimination	and	SCR	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .00 -.01 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .23 .72 -1.21 1.68  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 -.01 .00  
     Anx à  Recall (Direct) .00 .03 -.06 .05  
     Anx à  Recall (Total) .00 .03 -.06 .05  
Recall      
     Discrimination à  Recall (b path) .67 1.07 -1.47 2.81  
     Anx àDiscrimination à  Recall (Indirect) .00 .01 -.02 .01  
     Anx à  Recall (Direct) -.01 .04 -.09 .07  
     Anx à  Recall (Total) -.01 .04 -.09 .07  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.07 .34 -.74 .60  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Anx à  Recall (Direct) .00 .01 -.03 .03  
     Anx à  Recall (Total) .00 .01 -.03 .03  
Recall      
     Discrimination à  Recall (b path) .41 .76 -1.11 1.93  
     Anx àDiscrimination à  Recall (Indirect) .00 .01 -.02 .01  
     Anx à  Recall (Direct) .01 .03 -.05 .06  
     Anx à  Recall (Total) .00 .03 -.05 .06  	
Table	4:	Left	Hippocampus	CS->CS+	Discrimination	and	SCR	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .00 -.01 .01  
SCR during CS+        
End of Extinction      
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     Discrimination à  Extinction (b path) .00 .03 -.06 .05  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 .00 .01  
     Anx à  Recall (Direct) .00 .03 -.06 .05  
     Anx à  Recall (Total) .00 .03 -.06 .05  
Recall      
     Discrimination à  Recall (b path) -.52 1.61 -3.73 2.70  
     Anx àDiscrimination à  Recall (Indirect) .00 .00 -.01 .01  
     Anx à  Recall (Direct) -.01 .04 -.10 .07  
     Anx à  Recall (Total) -.01 .04 -.09 .07  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .19 .54 -.88 1.26  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 .00 .01  
     Anx à  Recall (Direct) .00 .01 -.03 .03  
     Anx à  Recall (Total) .00 .01 -.03 .03  
Recall      
     Discrimination à  Recall (b path) .12 1.14 -2.15 2.39  
     Anx àDiscrimination à  Recall (Indirect) .00 .00 -.01 .00  
     Anx à  Recall (Direct) .01 .03 -.05 .06  
     Anx à  Recall (Total) .00 .03 -.05 .06  	
Table	5:	Right	Hippocampus	CS->CS+	Discrimination	and	SCR	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .00 .00 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.37 1.20 -2.78 2.03  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 -.01 .00  
     Anx à  Recall (Direct) .00 .03 -.06 .05  
     Anx à  Recall (Total) .00 .03 -.06 .05  
Recall      
     Discrimination à  Recall (b path) -.73 1.72 -4.17 2.71  
     Anx àDiscrimination à  Recall (Indirect) .00 .01 -.03 .00  
     Anx à  Recall (Direct) -.01 .04 -.09 .07  
     Anx à  Recall (Total) -.01 .04 -.09 .07  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .18 .55 -.93 1.28  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 .00 .01  
     Anx à  Recall (Direct) .00 .01 -.03 .03  
     Anx à  Recall (Total) .00 .01 -.03 .03  
Recall      
     Discrimination à  Recall (b path) -.01 1.23 -2.51 2.37  
     Anx àDiscrimination à  Recall (Indirect) .00 .00 -.01 .00  
     Anx à  Recall (Direct) .01 .03 -.05 .06  
     Anx à  Recall (Total) .00 .03 -.05 .06  
		 220	
	
Table	6:	5mm	vmPFC	CS->CS+	Discrimination	and	SCR	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .01 -.01 .02  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.11 .49 -1.09 .86  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 -.01 .00  
     Anx à  Recall (Direct) .00 .03 -.06 .05  
     Anx à  Recall (Total) .00 .03 -.06 .05  
Recall      
     Discrimination à  Recall (b path) 1.54 .71 .11 2.97 * 
     Anx àDiscrimination à  Recall (Indirect) .01 .01 -.02 .04  
     Anx à  Recall (Direct) -.02 .04 -.10 .06  
     Anx à  Recall (Total) -.01 .04 -.09 .07  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.17 .24 -.65 .31  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 -.01 .00  
     Anx à  Recall (Direct) .00 .01 -.03 .03  
     Anx à  Recall (Total) .00 .01 -.03 .03  
Recall      
     Discrimination à  Recall (b path) .96 .53 -.10 2.03  
     Anx àDiscrimination à  Recall (Indirect) .01 .01 .00 .03  
     Anx à  Recall (Direct) .00 .03 -.06 .06  
     Anx à  Recall (Total) .00 .03 -.05 .06  	
Table	7:	10mm	vmPFC	CS->CS+	Discrimination	and	SCR	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .01 -.01 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.06 .67 -1.40 1.28  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Anx à  Recall (Direct) .00 .03 -.06 .05  
     Anx à  Recall (Total) .00 .03 -.06 .05  
Recall      
     Discrimination à  Recall (b path) 2.17 .94 .30 4.04 * 
     Anx àDiscrimination à  Recall (Indirect) .01 .01 -.02 .04  
     Anx à  Recall (Direct) -.02 .04 -.10 .06  
     Anx à  Recall (Total) -.01 .04 -.09 .07  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.26 .32 -.90 .38  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 -.01 .00  
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     Anx à  Recall (Direct) .00 .01 -.03 .03  
     Anx à  Recall (Total) .00 .01 -.03 .03  
Recall      
     Discrimination à  Recall (b path) 1.47 .68 .11 2.83 * 
     Anx àDiscrimination à  Recall (Indirect) .01 .01 -.01 .03  
     Anx à  Recall (Direct) .00 .03 -.06 .05  
     Anx à  Recall (Total) .00 .03 -.05 .06  	
Table	8:	Left	Insula	Discrimination	and	Heart	Rate	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .01 -.01 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -27.83 43.73 -115.19 59.54  
     Anx àDiscrimination à  Extinction (Indirect) .11 .36 -.19 1.59  
     Anx à  Recall (Direct) 1.70 1.70 -1.90 5.30  
     Anx à  Recall (Total) 1.81 1.78 -1.75 5.38  
Recall      
     Discrimination à  Recall (b path) 4.44 20.52 -36.54 45.42  
     Anx àDiscrimination à  Recall (Indirect) -.01 .10 -.28 .15  
     Anx à  Recall (Direct) -1.14 .79 02.73 .44  
     Anx à  Recall (Total) -1.15 .79 -2.72 .42  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -4.38 31.65 -67.59 58.82  
     Anx àDiscrimination à  Extinction (Indirect) .02 .22 -.29 .72  
     Anx à  Recall (Direct) 1.41 1.30 -1.19 4.01  
     Anx à  Recall (Total) 1.43 1.28 -1.13 3.99  
Recall      
     Discrimination à  Recall (b path) 18.22 26.51 -34.71 71.15  
     Anx àDiscrimination à  Recall (Indirect) -.03 .15 -.56 .14  
     Anx à  Recall (Direct) .00 1.03 -2.05 2.04  
     Anx à  Recall (Total) -.03 1.02 -2.07 2.01  	
Table	9:	Right	Insula	Discrimination	and	Heart	Rate	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .00 -.01 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -65.24 46.21 -157.56 27.08  
     Anx àDiscrimination à  Extinction (Indirect) .07 .37 -.45 1.14  
     Anx à  Recall (Direct) 1.79 1.77 -1.79 5.28  
     Anx à  Recall (Total) 1.81 1.78 -1.75 5.38  
Recall      
     Discrimination à  Recall (b path) 3.72 21.93 -40.07 47.51  
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     Anx àDiscrimination à  Recall (Indirect) -.01 .09 -.25 .13  
     Anx à  Recall (Direct) -1.14 .79 -2.73 .44  
     Anx à  Recall (Total) -1.15 .79 -2.72 .42  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -16.75 34.09 -84.83 51.34  
     Anx àDiscrimination à  Extinction (Indirect) .03 .18 -.18 .66  
     Anx à  Recall (Direct) 1.40 1.29 -1.18 3.98  
     Anx à  Recall (Total) 1.43 1.28 -1.13 3.99  
Recall      
     Discrimination à  Recall (b path) 39.53 29.01 -16.39 95.45  
     Anx àDiscrimination à  Recall (Indirect) -.08 .18 -.64 .17  
     Anx à  Recall (Direct) .05 1.01 -1.98 2.07  
     Anx à  Recall (Total) -.03 1.02 -2.07 2.01  	
Table	10:	dACC	Discrimination	and	Heart	Rate	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .01 -.01 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -6.29 37.13 -80.47 67.89  
     Anx àDiscrimination à  Extinction (Indirect) -.01 .27 -.64 .46  
     Anx à  Recall (Direct) 1.82 1.80 -1.77 5.40  
     Anx à  Recall (Total) 1.81 1.78 -1.75 5.38  
Recall      
     Discrimination à  Recall (b path) -5.04 18.34 -41.66 31.57  
     Anx àDiscrimination à  Recall (Indirect) -.01 .10 -.30 .14  
     Anx à  Recall (Direct) -1.14 .79 -2.73 .44  
     Anx à  Recall (Total) -1.15 .79 -2.72 .42  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 42.57 26.55 -10.45 95.59  
     Anx àDiscrimination à  Extinction (Indirect) .01 .35 -.62 .81  
     Anx à  Recall (Direct) 1.42 1.27 -1.12 3.95  
     Anx à  Recall (Total) 1.43 1.28 -1.13 3.99  
Recall      
     Discrimination à  Recall (b path) -5.55 23.77 -53.01 41.92  
     Anx àDiscrimination à  Recall (Indirect) -.01 .12 -.40 .16  
     Anx à  Recall (Direct) -.02 1.03 -2.07 2.03  
     Anx à  Recall (Total) -.03 .1.02 -2.07 2.01  	
Table	11:	Left	Hippocampus	CS->CS+	Discrimination	and	Heart	Rate	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .00 -.01 .01  
SCR during CS+        
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End of Extinction      
     Discrimination à  Extinction (b path) 95.99 58.09 -20.07 212.04  
     Anx àDiscrimination à  Extinction (Indirect) -.23 .61 -2.55 .22  
     Anx à  Recall (Direct) 2.04 1.77 -1.49 5.57  
     Anx à  Recall (Total) 1.81 1.78 -1.75 5.38  
Recall      
     Discrimination à  Recall (b path) -51.06 30.48 -111.93 9.80  
     Anx àDiscrimination à  Recall (Indirect) -.07 .24 -.77 .28  
     Anx à  Recall (Direct) -1.08 .78 -2.64 .47  
     Anx à  Recall (Total) -1.15 .79 -2.72 .42  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 5.83 42.45 -78.95 90.61  
     Anx àDiscrimination à  Extinction (Indirect) -.01 .21 -.62 .33  
     Anx à  Recall (Direct) 1.44 1.30 -1.15 4.02  
     Anx à  Recall (Total) 1.43 1.28 -1.13 3.99  
Recall      
     Discrimination à  Recall (b path) -21.07 40.25 -101.43 59.29  
     Anx àDiscrimination à  Recall (Indirect) -.03 .14 -.48 .16  
     Anx à  Recall (Direct) .00 1.03 -2.05 2.05  
     Anx à  Recall (Total) -.03 1.02 -2.07 2.01  	
Table	12:	Right	Hippocampus	CS->CS+	Discrimination	and	Heart	Rate	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .00 -.01 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) 135.29 65.24 4.95 265.62 * 
     Anx àDiscrimination à  Extinction (Indirect) .18 .54 -.54 1.88  
     Anx à  Recall (Direct) 1.64 1.74 -1.84 5.12  
     Anx à  Recall (Total) 1.81 1.78 -1.75 5.38  
Recall      
     Discrimination à  Recall (b path) -31.73 33.23 -98.09 34.62  
     Anx àDiscrimination à  Recall (Indirect) -.16 .81 -2.60 .62  
     Anx à  Recall (Direct) -.99 .81 -2.60 .62  
     Anx à  Recall (Total) -1.15 .79 -2.72 .42  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 50.38 48.39 -46.27 147.02  
     Anx àDiscrimination à  Extinction (Indirect) .07 .23 -.20 .88  
     Anx à  Recall (Direct) 1.36 1.28 -1.21 3.92  
     Anx à  Recall (Total) 1.43 1.28 -1.13 3.99  
Recall      
     Discrimination à  Recall (b path) -18.52 43.30 -104.97 67.94  
     Anx àDiscrimination à  Recall (Indirect) -.09 .29 -.94 .32  
     Anx à  Recall (Direct) -.06 1.05 -2.03 2.16  
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     Anx à  Recall (Total) -.03 1.02 -2.07 2.01  	
Table	13:	5mm	vmPFC	CS->CS+	Discrimination	and	Heart	Rate	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .01 -.02 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) 27.09 25.96 -24.77 78.95  
     Anx àDiscrimination à  Extinction (Indirect) -.06 .33 -1.20 .32  
     Anx à  Recall (Direct) 1.87 1.78 -1.69 5.43  
     Anx à  Recall (Total) 1.81 1.78 -1.75 5.38  
Recall      
     Discrimination à  Recall (b path) -1.80 12.66 -27.07 23.47  
     Anx àDiscrimination à  Recall (Indirect) -.01 .16 -.44 .22  
     Anx à  Recall (Direct) -1.14 .80 -2.73 .46  
     Anx à  Recall (Total) -1.15 .79 -2.72 .42  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 23.01 18.95 -14.94 60.85  
     Anx àDiscrimination à  Extinction (Indirect) -.07 .26 -.91 .22  
     Anx à  Recall (Direct) 1.50 1.28 -1.06 4.06  
     Anx à  Recall (Total) 1.43 1.28 -1.13 3.99  
Recall      
     Discrimination à  Recall (b path) -4.15 16.39 -36.89 28.58  
     Anx àDiscrimination à  Recall (Indirect) -.03 .21 -.71 .21  
     Anx à  Recall (Direct) .00 1.03 -2.07 2.06  
     Anx à  Recall (Total) -.03 1.02 -2.07 2.01  	
Table	14:	10mm	vmPFC	CS->CS+	Discrimination	and	Heart	Rate	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .01 -.02 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) 31.16 35.22 -39.21 101.52  
     Anx àDiscrimination à  Extinction (Indirect) -.09 .35 -1.46 .24  
     Anx à  Recall (Direct) 1.91 1.79 -1.67 5.48  
     Anx à  Recall (Total) 1.81 1.78 -1.75 5.38  
Recall      
     Discrimination à  Recall (b path) -1.19 16.75 -34.63 32.25  
     Anx àDiscrimination à  Recall (Indirect) .00 .14 -.30 .23  
     Anx à  Recall (Direct) -1.15 .80 -2.74 .44  
     Anx à  Recall (Total) -1.15 .79 -2.72 .42  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 14.12 25.78 -37.37 65.61  
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     Anx àDiscrimination à  Extinction (Indirect) -.05 .21 -.82 .15  
     Anx à  Recall (Direct) 1.47 1.29 -1.11 4.05  
     Anx à  Recall (Total) 1.43 1.28 -1.13 3.99  
Recall      
     Discrimination à  Recall (b path) -3.12 21.70 -46.46 40.21  
     Anx àDiscrimination à  Recall (Indirect) -.01 .19 -.56 .26  
     Anx à  Recall (Direct) -.02 1.03 -2.08 2.04  
     Anx à  Recall (Total) -.03 1.02 -2.07 2.01  	
Table	15:	Left	Insula	Contrasts	Discrimination	and	SCR	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  -.09 .20 -.48 .30  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .01 .02 -.02 .04  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 -.02 .00  
     Anx à  Recall (Direct) .00 .03 -.06 .05  
     Anx à  Recall (Total) .00 .03 -.06 .05  
Recall      
     Discrimination à  Recall (b path) .00 .03 -.05 .05  
     Anx àDiscrimination à  Recall (Indirect) .00 .01 -.01 .01  
     Anx à  Recall (Direct) -.01 .04 -.10 .07  
     Anx à  Recall (Total) -.01 .04 -.09 .07  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .00 .01 -.02 .01  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 .00 .01  
     Anx à  Recall (Direct) .00 .01 -.03 .03  
     Anx à  Recall (Total) .00 .01 -.03 .03  
Recall      
     Discrimination à  Recall (b path) .02 .02 -.02 .06  
     Anx àDiscrimination à  Recall (Indirect) .00 .01 -.02 .01  
     Anx à  Recall (Direct) .01 .03 -.05 .06  
     Anx à  Recall (Total) .00 .03 -.05 .06  	
Table	16:	Right	Insula	Contrasts	Discrimination	and	SCR	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  -.02 .19 -.40 .36  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .00 .02 -.04 .04  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Anx à  Recall (Direct) .00 .03 -.06 .05  
     Anx à  Recall (Total) .00 .03 -.06 .05  
Recall      
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     Discrimination à  Recall (b path) .01 .03 -.04 .06  
     Anx àDiscrimination à  Recall (Indirect) .00 .00 -.01 .01  
     Anx à  Recall (Direct) -.01 .04 -.10 .07  
     Anx à  Recall (Total) -.01 .04 -.09 .07  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.01 .01 -.02 .01  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Anx à  Recall (Direct) .00 .01 -.03 .03  
     Anx à  Recall (Total) .00 .01 -.03 .03  
Recall      
     Discrimination à  Recall (b path) .01 .02 -.03 .04  
     Anx àDiscrimination à  Recall (Indirect) .00 .00 -.01 .01  
     Anx à  Recall (Direct) .00 .03 -.05 .06  
     Anx à  Recall (Total) .00 .03 -.05 .06  	
Table	17:	dACC	Contrasts	Discrimination	and	SCR	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  -.08 .23 -.54 .37  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .00 .02 -.03 .03  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 -.01 .00  
     Anx à  Recall (Direct) .00 .03 -.06 .05  
     Anx à  Recall (Total) .00 .03 -.06 .05  
Recall      
     Discrimination à  Recall (b path) .01 .02 -.03 .06  
     Anx àDiscrimination à  Recall (Indirect) .00 .01 -.02 .01  
     Anx à  Recall (Direct) -.01 .04 -.09 .07  
     Anx à  Recall (Total) -.01 .04 -.09 .07  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .00 .01 -.02 .01  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 .00 .00  
     Anx à  Recall (Direct) .00 .01 -.03 .03  
     Anx à  Recall (Total) .00 .01 -.03 .03  
Recall      
     Discrimination à  Recall (b path) .01 .02 -.02 .04  
     Anx àDiscrimination à  Recall (Indirect) .00 .01 -.02 .01  
     Anx à  Recall (Direct) .01 .03 .05 .06  
     Anx à  Recall (Total) .00 .03 -.05 .06  	
Table	18:	Left	Hippocampus	Contrasts	Discrimination	and	SCR	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .03 .15 -.26 .32  
		 227	
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .01 .02 -.04 .05  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 .00 .01  
     Anx à  Recall (Direct) .00 .03 -.06 .05  
     Anx à  Recall (Total) .00 .03 -.06 .05  
Recall      
     Discrimination à  Recall (b path) -.01 .04 -.08 .06  
     Anx àDiscrimination à  Recall (Indirect) .00 .00 -.01 .01  
     Anx à  Recall (Direct) -.01 .04 -.10 .07  
     Anx à  Recall (Total) -.01 .04 -.09 .07  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .01 .01 -.02 .03  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 .00 .01  
     Anx à  Recall (Direct) .00 .01 -.03 .03  
     Anx à  Recall (Total) .00 .01 -.03 .03  
Recall      
     Discrimination à  Recall (b path) .01 .02 -.04 .06  
     Anx àDiscrimination à  Recall (Indirect) .00 .00 -.01 .00  
     Anx à  Recall (Direct) .01 .03 -.05 .06  
     Anx à  Recall (Total) .00 .03 -.05 .06  	
Table	19:	Right	Hippocampus	Contrasts	Discrimination	and	SCR	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .13 .13 -.13 .38  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.01 .03 -.06 .04  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 -.01 .00  
     Anx à  Recall (Direct) .00 .03 -.06 .05  
     Anx à  Recall (Total) .00 .03 -.06 .05  
Recall      
     Discrimination à  Recall (b path) -.01 .04 -.08 .07  
     Anx àDiscrimination à  Recall (Indirect) .00 .01 -.02 .01  
     Anx à  Recall (Direct) -.01 .04 -.10 .07  
     Anx à  Recall (Total) -.01 .04 -.09 .07  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .01 .01 -.02 .03  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 .00 .01  
     Anx à  Recall (Direct) .00 .01 -.03 .03  
     Anx à  Recall (Total) .00 .01 -.03 .03  
Recall      
     Discrimination à  Recall (b path) .01 .03 -.05 .06  
     Anx àDiscrimination à  Recall (Indirect) .00 .00 .00 .01  
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     Anx à  Recall (Direct) .00 .03 -.05 .06  
     Anx à  Recall (Total) .00 .03 -.05 .06  	
Table	20:	5mm	vmPFC	Contrasts	Discrimination	and	SCR	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .11 .28 -.45 .66  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .00 .01 -.03 .02  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 -.01 .00  
     Anx à  Recall (Direct) .00 .03 -.06 .05  
     Anx à  Recall (Total) .00 .03 -.06 .05  
Recall      
     Discrimination à  Recall (b path) .04 .02 .002 .08 * 
     Anx àDiscrimination à  Recall (Indirect) .00 .01 -.02 .04  
     Anx à  Recall (Direct) -.02 .04 -.10 .06  
     Anx à  Recall (Total) -.01 .04 -.09 .07  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .00 .01 -.01 .01  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 -.01 .00  
     Anx à  Recall (Direct) .00 .01 -.03 .03  
     Anx à  Recall (Total) .00 .01 -.03 .03  
Recall      
     Discrimination à  Recall (b path) .02 .01 .00 .05  
     Anx àDiscrimination à  Recall (Indirect) .01 .01 .00 .03  
     Anx à  Recall (Direct) .00 .03 -.06 .06  
     Anx à  Recall (Total) .00 .03 -.05 .06  	
Table	21:	10mm	vmPFC	Contrasts	Discrimination	and	SCR	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .06 .20 -.34 .47  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.01 .02 -.04 .03  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 -.01 .00  
     Anx à  Recall (Direct) .00 .03 -.06 .05  
     Anx à  Recall (Total) .00 .03 -.06    .05  
Recall      
     Discrimination à  Recall (b path) .05 .02 .006 .10 * 
     Anx àDiscrimination à  Recall (Indirect) .00 .01 -.02 .04  
     Anx à  Recall (Direct) -.02 .04 -.10 .06  
     Anx à  Recall (Total) -.01 .04 -.09 .07  
SCR during CS-       	
End of Extinction      
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     Discrimination à  Extinction (b path) .00 .01 -.02 .01  
     Anx àDiscrimination à  Extinction (Indirect) .00 .00 -.01 .00  
     Anx à  Recall (Direct) .00 .01 -.03 .03  
     Anx à  Recall (Total) .00 .01 -.03 .03  
Recall      
     Discrimination à  Recall (b path) .04 .02 .001 .07 * 
     Anx àDiscrimination à  Recall (Indirect) .01 .01 -.01 .03  
     Anx à  Recall (Direct) .00 .03 -.06 .06  
     Anx à  Recall (Total) .00 .03 -.05 .06  	
Table	22:	Left	Insula	Contrasts	Discrimination	and	Heart	Rate	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  -.22 .24 -.69 .25  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.66 .94 -2.55 1.22  
     Anx àDiscrimination à  Extinction (Indirect) .14 .39 -.20 1.67  
     Anx à  Recall (Direct) 1.67 1.80 -1.93 5.26  
     Anx à  Recall (Total) 1.81 1.78 -1.75 5.38  
Recall      
     Discrimination à  Recall (b path) .09 .44 -.79 .97  
     Anx àDiscrimination à  Recall (Indirect) -.01 .10 -.27 .15  
     Anx à  Recall (Direct) -1.15 .79 -2.73 .44  
     Anx à  Recall (Total) -1.15 .79 -2.72 .42  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.05 .68 -1.41 1.31  
     Anx àDiscrimination à  Extinction (Indirect) .01 .24 -.40 .62  
     Anx à  Recall (Direct) 1.42 1.30 -1.19 4.02  
     Anx à  Recall (Total) 1.43 1.28 -1.13 3.99  
Recall      
     Discrimination à  Recall (b path) .35 .57 -.79 1.48  
     Anx àDiscrimination à  Recall (Indirect) -.02 .15 -.55 .15  
     Anx à  Recall (Direct) -.01 1.03 -2.06 2.04  
     Anx à  Recall (Total) -.03 1.02 -2.07 2.01  	
Table	23:	Right	Insula	Contrasts	Discrimination	and	Heart	Rate	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  -.07 .22 -.51 .38  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -1.55 .98 -3.50 .41  
     Anx àDiscrimination à  Extinction (Indirect) .11 .43 -.47 1.46  
     Anx à  Recall (Direct) 1.71 1.76 -1.82 5.23  
     Anx à  Recall (Total) 1.81 1.78 -1.75 5.38  
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Recall      
     Discrimination à  Recall (b path) .02 .47 -.91 .95  
     Anx àDiscrimination à  Recall (Indirect) .00 .09 -.20 .18  
     Anx à  Recall (Direct) -1.15 .79 -2.74 .44  
     Anx à  Recall (Total) -1.15 .79 -2.72 .42  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.16 .73 -1.61 1.29  
     Anx àDiscrimination à  Extinction (Indirect) .02 .19 -.25 .59  
     Anx à  Recall (Direct) 1.41 1.30 -1.18 4.00  
     Anx à  Recall (Total) 1.43 1.28 -1.13 3.99  
Recall      
     Discrimination à  Recall (b path) .72 .60 -.47 1.91  
     Anx àDiscrimination à  Recall (Indirect) -.04 .18 -.56 .22  
     Anx à  Recall (Direct) .01 1.02 -2.02 2.04  
     Anx à  Recall (Total) -.03 1.02 -2.07 2.01  
	
Table	24:	dACC	Contrasts	Discrimination	and	Heart	Rate	
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .05 .28 -.51 .61  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .02 .80 -1.58 1.62  
     Anx àDiscrimination à  Extinction (Indirect) .00 .30 -.57 .68  
     Anx à  Recall (Direct) 1.81 1.80 -1.78 5.40  
     Anx à  Recall (Total) 1.81 1.78 -1.75 5.38  
Recall      
     Discrimination à  Recall (b path) -.03 .40 -.84 .78  
     Anx àDiscrimination à  Recall (Indirect) .00 .10 -.24 .19  
     Anx à  Recall (Direct) -1.15 .79 -2.74 .44  
     Anx à  Recall (Total) -1.15 .79 -2.72 .42  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .96 .57 -.18 2.10  
     Anx àDiscrimination à  Extinction (Indirect) .01 .35 -.64 .83  
     Anx à  Recall (Direct) 1.42 1.27 -1.11 3.95  
     Anx à  Recall (Total) 1.43 1.28 -1.13 3.99  
Recall      
     Discrimination à  Recall (b path) -.14 .52 -1.18 .91  
     Anx àDiscrimination à  Recall (Indirect) -.01 .12 -.41 .14  
     Anx à  Recall (Direct) -.02 1.03 -2.07 2.04  
     Anx à  Recall (Total) -.03 1.02 -2.07 2.01  
 
Table 25: Left Hippocampus Contrasts Discrimination and Heart Rate 
 b SE LLCI ULCI sig 
A Path       
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     Anx à  Discrimination (a path)  -.10 .17 -.44 .24  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) 2.28 1.27 -.26 4.83  
     Anx àDiscrimination à  Extinction (Indirect) -.23 .61 -2.55 .23  
     Anx à  Recall (Direct) 2.04 1.76 -1.47 5.56  
     Anx à  Recall (Total) 1.81 1.78 -1.75 5.38  
Recall      
     Discrimination à  Recall (b path) -1.07 .66 -2.38 .25  
     Anx àDiscrimination à  Recall (Indirect) -.08 .24 -.79 .22  
     Anx à  Recall (Direct) -1.07 .78 -2.62 .49  
     Anx à  Recall (Total) -1.15 .79 -2.72 .42  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.06 .93 -1.92 1.80  
     Anx àDiscrimination à  Extinction (Indirect) .00 .21 -.34 .60  
     Anx à  Recall (Direct) 1.42 1.30 -1.16 4.01  
     Anx à  Recall (Total) 1.43 1.28 -1.13 3.99  
Recall      
     Discrimination à  Recall (b path) -.40 .87 -2.14 1.33  
     Anx àDiscrimination à  Recall (Indirect) -.03 .14 -.49 .14  
     Anx à  Recall (Direct) .00 1.03 -2.05 2.06  
     Anx à  Recall (Total) -.03 1.02 -2.07 2.01  
 
Table 26: Right Hippocampus Contrasts Discrimination and Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .07 .15 -.24 .38  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) 2.97 1.39 .19 5.76  
     Anx àDiscrimination à  Extinction (Indirect) .22 .56 -.52 1.90  
     Anx à  Recall (Direct) 1.60 1.74 -1.88 5.07  
     Anx à  Recall (Total) 1.81 1.78 -1.75 5.38  
Recall      
     Discrimination à  Recall (b path) -.66 .71 -2.07 .75  
     Anx àDiscrimination à  Recall (Indirect) -.17 .29 -.99 .14  
     Anx à  Recall (Direct) -.98 .81 -2.60 .63  
     Anx à  Recall (Total) -1.15 .79 -2.72 .42  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .97 1.04 -1.10 3.04  
     Anx àDiscrimination à  Extinction (Indirect) .08 .22 -.16 .80  
     Anx à  Recall (Direct) 1.35 1.29 -1.22 3.92  
     Anx à  Recall (Total) 1.43 1.28 -1.13 3.99  
Recall      
     Discrimination à  Recall (b path) -.33 .92 -2.17 1.51  
		 232	
     Anx àDiscrimination à  Recall (Indirect) -.08 .30 -.92 .36  
     Anx à  Recall (Direct) .05 1.05 -2.05 2.16  
     Anx à  Recall (Total) -.03 1.02 -2.07 2.01  
 
Table 27: 5mm vmPFC Contrasts Discrimination and Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  -.11 .33 -.77 .55  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .79 .66 -.54 2.11  
     Anx àDiscrimination à  Extinction (Indirect) -.09 .35 -1.16 .32  
     Anx à  Recall (Direct) 1.90 1.78 -1.65 5.46  
     Anx à  Recall (Total) 1.81 1.78 -1.75 5.38  
Recall      
     Discrimination à  Recall (b path) -.05 .32 -.70 .59  
     Anx àDiscrimination à  Recall (Indirect) -.01 .16 -.48 .20  
     Anx à  Recall (Direct) -1.14 .80 -2.73 .46  
     Anx à  Recall (Total) -1.15 .79 -2.72 .42  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .53 .49 -.45 1.50  
     Anx àDiscrimination à  Extinction (Indirect) -.08 .25 -.94 .18  
     Anx à  Recall (Direct) 1.51 1.28 -1.06 4.07  
     Anx à  Recall (Total) 1.43 1.28 -1.13 3.99  
Recall      
     Discrimination à  Recall (b path) -.16 .42 -1.00 .68  
     Anx àDiscrimination à  Recall (Indirect) -.04 .22 -.81 .19  
     Anx à  Recall (Direct) .01 1.03 -2.05 2.08  
     Anx à  Recall (Total) -.03 1.02 -2.07 2.01  
 
Table 28: 10mm vmPFC Contrasts Discrimination and Heart Rate 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  -.13 .24 -.62 .26  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .94 .90 -.86 2.75  
     Anx àDiscrimination à  Extinction (Indirect) -.13 .37 -1.57 .23  
     Anx à  Recall (Direct) 1.94 1.79 -1.63 5.51  
     Anx à  Recall (Total) 1.81 1.78 -1.75 5.38  
Recall      
     Discrimination à  Recall (b path) -.11 .43 -.97 .76  
     Anx àDiscrimination à  Recall (Indirect) -.02 .16 -.46 .16  
     Anx à  Recall (Direct) -1.13 .80 -2.72 .46  
     Anx à  Recall (Total) -1.15 .79 -2.72 .42  
SCR during CS-       	
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End of Extinction      
     Discrimination à  Extinction (b path) .25 .66 -1.07 1.57  
     Anx àDiscrimination à  Extinction (Indirect) -.04 .20 -.75 .18  
     Anx à  Recall (Direct) 1.47 1.30 -1.12 4.05  
     Anx à  Recall (Total) 1.43 1.28 -1.13 3.99  
Recall      
     Discrimination à  Recall (b path) -.16 .56 -1.29 .96  
     Anx àDiscrimination à  Recall (Indirect) -.03 .20 -.73 .20  
     Anx à  Recall (Direct) .00 1.03 -2.06 2.06  
     Anx à  Recall (Total) -.03 1.02 -2.07 2.01  
 
Table 29: Left Insula Discrimination and 5mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .00 -.01 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -1.31 7.05 -15.30 12.68  
     Anx àDiscrimination à  Extinction (Indirect) .00 .04 -.05 .12  
     Anx à  Recall (Direct) .18 .28 -.38 .74  
     Anx à  Recall (Total) .18 .28 -.37 .74  
Recall      
     Discrimination à  Recall (b path) -6.86 7.23 -21.21 7.49  
     Anx àDiscrimination à  Recall (Indirect) .01 .04 -.03 .16  
     Anx à  Recall (Direct) -.35 .29 -.92 .22  
     Anx à  Recall (Total) -.34 .29 -.91 .23  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 9.58 7.34 -4.98 24.14  
     Anx àDiscrimination à  Extinction (Indirect) -.02 .05 -.19 .04  
     Anx à  Recall (Direct) .01 .29 -.57 .59  
     Anx à  Recall (Total) -.01 .29 -.59 .57  
Recall      
     Discrimination à  Recall (b path) -7.21 7.47 -22.04 7.61  
     Anx àDiscrimination à  Recall (Indirect) .01 .04 -.03 .16  
     Anx à  Recall (Direct) .27 .30 -.32 .86  
     Anx à  Recall (Total) .29 .30 -.30 .88  
 
Table 30: Right Insula Discrimination and 5mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .00 -.01 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -11.19 7.52 -26.11 3.73  
     Anx àDiscrimination à  Extinction (Indirect) .01 .04 -.05 .14  
     Anx à  Recall (Direct) .17 .28 -.38 .72  
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     Anx à  Recall (Total) .18 .28 -.37 .74  
Recall      
     Discrimination à  Recall (b path) -12.67 7.73 -28.01 2.67  
     Anx àDiscrimination à  Recall (Indirect) .01 .05 -.06 .14  
     Anx à  Recall (Direct) -.35 .29 -.92 -.21  
     Anx à  Recall (Total) -.34 .29 -.91 .23  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 9.72 7.92 -6.00 25.44  
     Anx àDiscrimination à  Extinction (Indirect) -.01 .04 -.14 .04  
     Anx à  Recall (Direct) .00 .29 -.58 .58  
     Anx à  Recall (Total) -.01 .29 -.59 .57  
Recall      
     Discrimination à  Recall (b path) -10.50 8.02 -26.42 5.42  
     Anx àDiscrimination à  Recall (Indirect) .01 .04 -.05 .14  
     Anx à  Recall (Direct) .28 .30 -.31 .86  
     Anx à  Recall (Total) .29 .30 -.30 .88  
 
Table 31: dACC Discrimination and 5mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .00 -.01 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) 4.29 5.94 -7.50 16.07  
     Anx àDiscrimination à  Extinction (Indirect) .01 .04 -.03 .17  
     Anx à  Recall (Direct) .17 .28 -.38 .73  
     Anx à  Recall (Total) .18 .28 -.37 .74  
Recall      
     Discrimination à  Recall (b path) -6.80 6.10 -18.90 5.30  
     Anx àDiscrimination à  Recall (Indirect) -.02 .04 -.17 .03  
     Anx à  Recall (Direct) -.32 .29 -.89 .25  
     Anx à  Recall (Total) -.34 .29 -.91 .23  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 11.84 6.13 -.33 24.01  
     Anx àDiscrimination à  Extinction (Indirect) .03 .07 -.06 .21  
     Anx à  Recall (Direct) -.04 .29 -.62 .53  
     Anx à  Recall (Total) -.01 .29 -.59 .57  
Recall      
     Discrimination à  Recall (b path) -13.59 6.19 -25.86 -1.31 * 
     Anx àDiscrimination à  Recall (Indirect) -.04 .07 -.24 .07  
     Anx à  Recall (Direct) .32 .29 -.25 .90  
     Anx à  Recall (Total) .29 .30 -.30 .88  
 
Table 32: Left Hippocampus Discrimination and 5mm vmPFC 
 b SE LLCI ULCI sig 
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A Path       
     Anx à  Discrimination (a path)  .00 .00 -.01 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .99 8.92 -16.73 18.70  
     Anx àDiscrimination à  Extinction (Indirect) .00 .02 -.05 .05  
     Anx à  Recall (Direct) .18 .28 -.37 .74  
     Anx à  Recall (Total) .18 .28 -.37 .74  
Recall      
     Discrimination à  Recall (b path) 2.83 9.19 -15.42 21.07  
     Anx àDiscrimination à  Recall (Indirect) .00 .03 -.06 .05  
     Anx à  Recall (Direct) -.34 .29 -.91 .23  
     Anx à  Recall (Total) -.34 .29 -.91 .23  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -6.39 9.35 -24.93 12.17  
     Anx àDiscrimination à  Extinction (Indirect) .00 .03 -.05 .09  
     Anx à  Recall (Direct) -.01 .29 -.59 .57  
     Anx à  Recall (Total) -.01 .29 -.59 .57  
Recall      
     Discrimination à  Recall (b path) -5.10 9.49 -23.93 13.72  
     Anx àDiscrimination à  Recall (Indirect) .00 .03 -.06 .10  
     Anx à  Recall (Direct) .29 .30 -.30 .88  
     Anx à  Recall (Total) .29 .30 -.30 .88  
 
Table 33: Right Hippocampus Discrimination and 5mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .00 .00 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) 1.28 9.41 -17.40 19.96  
     Anx àDiscrimination à  Extinction (Indirect) .01 .03 -.05 .09  
     Anx à  Recall (Direct) .18 .28 -.38 .74  
     Anx à  Recall (Total) .18 .28 -.37 .74  
Recall      
     Discrimination à  Recall (b path) -.54 9.70 -19.79 18.71  
     Anx àDiscrimination à  Recall (Indirect) .00 .04 -.11 .07  
     Anx à  Recall (Direct) -.34 .29 -.92 .24  
     Anx à  Recall (Total) -.34 .29 -.91 .23  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -9.02 9.84 -28.54 10.51  
     Anx àDiscrimination à  Extinction (Indirect) -.04 .05 -.22 .03  
     Anx à  Recall (Direct) .02 .30 -.56 .61  
     Anx à  Recall (Total) -.01 .29 -.59 .57  
Recall      
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     Discrimination à  Recall (b path) -2.50 10.02 -22.37 17.38  
     Anx àDiscrimination à  Recall (Indirect) -.01 .04 -.13 .05  
     Anx à  Recall (Direct) .30 .30 -.30 .89  
     Anx à  Recall (Total) .29 .30 -.30 .88  
 
Table 34: 5mm vmPFC Discrimination and 5mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .01 -.01 .02  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -1.73 4.18 -10.02 6.55  
     Anx àDiscrimination à  Extinction (Indirect) .00 .04 -.11 .05  
     Anx à  Recall (Direct) .19 .28 -.37 .74  
     Anx à  Recall (Total) .18 .28 -.37 .74  
Recall      
     Discrimination à  Recall (b path) -7.95 4.23 -16.35 .45  
     Anx àDiscrimination à  Recall (Indirect) -.01 .07 -.19 .10  
     Anx à  Recall (Direct) -.33 .28 -.90 .24  
     Anx à  Recall (Total) -.34 .29 -.91 .23  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .49 4.39 -8.22 9.20  
     Anx àDiscrimination à  Extinction (Indirect) .00 .04 -.08 .08  
     Anx à  Recall (Direct) -.01 .29 -.60 .57  
     Anx à  Recall (Total) -.01 .29 -.59 .57  
Recall      
     Discrimination à  Recall (b path) -8.21 4.37 -16.89 .47  
     Anx àDiscrimination à  Recall (Indirect) -.01 .07 -.19 .11  
     Anx à  Recall (Direct) .30 .29 -.28 .88  
     Anx à  Recall (Total) .29 .30 -.30 .88  
 
Table 35: Left Insula Discrimination and 10mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .00 -.01 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) 3.22 5.25 -7.21 13.64  
     Anx àDiscrimination à  Extinction (Indirect) -.01 .03 -.11 .02  
     Anx à  Recall (Direct) .07 .21 -.34 .49  
     Anx à  Recall (Total) .06 .21 -.35 .48  
Recall      
     Discrimination à  Recall (b path) -2.76 5.37 -13.42 7.89  
     Anx àDiscrimination à  Recall (Indirect) .01 .03 -.02 .11  
     Anx à  Recall (Direct) -.24 .21 -.67 .18  
     Anx à  Recall (Total) -.24 .21 -.66 .18  
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SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 9.31 5.68 -1.96 20.57  
     Anx àDiscrimination à  Extinction (Indirect) -.02 .04 -.15 .04  
     Anx à  Recall (Direct) -.03 .23 -.48 .42  
     Anx à  Recall (Total) -.05 .23 -.50 .40  
Recall      
     Discrimination à  Recall (b path) -5.43 5.36 -16.06 5.19  
     Anx àDiscrimination à  Recall (Indirect) .01 .03 -.02 .13  
     Anx à  Recall (Direct) .19 .21 -.24 .61  
     Anx à  Recall (Total) .20 .21 -.23 .62  
 
Table 36: Right Insula Discrimination and 10mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .00 -.01 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -3.92 5.66 -15.15 7.32  
     Anx àDiscrimination à  Extinction (Indirect) .00 .02 -.02 .08  
     Anx à  Recall (Direct) .06 .21 -.35 .47  
     Anx à  Recall (Total) .06 .21 -.35 .48  
Recall      
     Discrimination à  Recall (b path) -7.81 -5.74 -19.20 3.59  
     Anx àDiscrimination à  Recall (Indirect) .01 .03 -.04 .10  
     Anx à  Recall (Direct) -.25 .21 -.67 .17  
     Anx à  Recall (Total) -.24 .21 -.66 .18  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 10.44 6.11 -1.69 22.58  
     Anx àDiscrimination à  Extinction (Indirect) -.01 .04 -.13 .05  
     Anx à  Recall (Direct) -.04 .23 -.49 .41  
     Anx à  Recall (Total) -.05 .23 -.50 .40  
Recall      
     Discrimination à  Recall (b path) -6.88 5.76 -18.32 4.56  
     Anx àDiscrimination à  Recall (Indirect) .01 .03 -.03 .11  
     Anx à  Recall (Direct) .19 .21 -.23 .61  
     Anx à  Recall (Total) .20 .21 -.23 .62  
 
Table 37: dACC Discrimination and 10mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .00 -.01 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) 5.13 4.41 -3.63 13.89  
     Anx àDiscrimination à  Extinction (Indirect) .01 .03 -.02 .14  
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     Anx à  Recall (Direct) .05 .21 -.36 .46  
     Anx à  Recall (Total) .06 .21 -.35 .48  
Recall      
     Discrimination à  Recall (b path) -4.71 4.51 -13.67 4.24  
     Anx àDiscrimination à  Recall (Indirect) -.01 .03 -.12 .02  
     Anx à  Recall (Direct) -.22 .21 -.65 .20  
     Anx à  Recall (Total) -.24 .21 -.66 .18  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) 9.22 4.77 -.24 18.68  
     Anx àDiscrimination à  Extinction (Indirect) .03 .05 -.05 .17  
     Anx à  Recall (Direct) -.08 .22 -.52 .37  
     Anx à  Recall (Total) -.05 .23 -.50 .40  
Recall      
     Discrimination à  Recall (b path) -10.10 4.43 -18.89 -1.30 * 
     Anx àDiscrimination à  Recall (Indirect) -.03 .05 -.16 .05  
     Anx à  Recall (Direct) .22 .21 -.19 .64  
     Anx à  Recall (Total) .20 .21 -.23 .62  
 
Table 38: Left Hippocampus Discrimination and 10mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .00 -.01 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -3.50 6.65 -16.71 9.70  
     Anx àDiscrimination à  Extinction (Indirect) .00 .02 -.03 .06  
     Anx à  Recall (Direct) .06 .21 -.35 .48  
     Anx à  Recall (Total) .06 .21 -.35 .48  
Recall      
     Discrimination à  Recall (b path) 2.12 6.80 -11.38 15.62  
     Anx àDiscrimination à  Recall (Indirect) .00 .02 -.05 .04  
     Anx à  Recall (Direct) -.24 .21 -.66 .19  
     Anx à  Recall (Total) -.24 .22 -.66 .18  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -6.00 7.26 -20.41 8.40  
     Anx àDiscrimination à  Extinction (Indirect) .00 .03 -.04 .09  
     Anx à  Recall (Direct) -.05 .23 -.50 .40  
     Anx à  Recall (Total) -.05 .23 -.50 .40  
Recall      
     Discrimination à  Recall (b path) -2.92 6.81 -16.43 10.60  
     Anx àDiscrimination à  Recall (Indirect) .00 .02 -.04 .06  
     Anx à  Recall (Direct) .20 .21 -.23 .62  
     Anx à  Recall (Total) .20 .21 -.23 .62  
 
Table 39: Right Hippocampus Discrimination and 10mm vmPFC 
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 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .00 .00 .01  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -3.92 7.02 -17.84 10.01  
     Anx àDiscrimination à  Extinction (Indirect) -.02 .03 -.10 .01  
     Anx à  Recall (Direct) .08 .21 -.34 .50  
     Anx à  Recall (Total) .06 .21 -.35 .48  
Recall      
     Discrimination à  Recall (b path) -.75 7.18 -14.99 13.50  
     Anx àDiscrimination à  Recall (Indirect) .00 .03 -.09 .05  
     Anx à  Recall (Direct) -.23 .22 -.66 .19  
     Anx à  Recall (Total) -.24 .22 -.66 .18  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -8.83 7.63 -23.98 6.31  
     Anx àDiscrimination à  Extinction (Indirect) -.03 .04 -.18 .01  
     Anx à  Recall (Direct) -.02 .23 -.47 .44  
     Anx à  Recall (Total) -.05 .23 -.50 .40  
Recall      
     Discrimination à  Recall (b path) .46 7.19 -13.81 14.72  
     Anx àDiscrimination à  Recall (Indirect) .00 .03 -.05 .08  
     Anx à  Recall (Direct) .20 .22 -.23 .62  
     Anx à  Recall (Total) .20 .21 -.23 .62  
 
Table 40: 10mm vmPFC Discrimination and 10mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .00 .01 -.01 .02  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -2.21 3.11 -8.39 3.97  
     Anx àDiscrimination à  Extinction (Indirect) .00 .03 -.10 .04  
     Anx à  Recall (Direct) .07 .21 -.35 .48  
     Anx à  Recall (Total) .06 .21 -.35 .48  
Recall      
     Discrimination à  Recall (b path) -5.83 3.13 -12.05 .39  
     Anx àDiscrimination à  Recall (Indirect) -.01 .05 -.15 .07  
     Anx à  Recall (Direct) -.23 .21 -.64 .19  
     Anx à  Recall (Total) -.24 .21 -.66 .18  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.73 3.41 -7.50 6.05  
     Anx àDiscrimination à  Extinction (Indirect) .00 .03 -.09 .04  
     Anx à  Recall (Direct) -.05 .23 -.50 .41  
     Anx à  Recall (Total) -.05 .23 -.50 .40  
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Recall      
     Discrimination à  Recall (b path) -4.80 3.16 -11.06 1.47  
     Anx àDiscrimination à  Recall (Indirect) -.01 .05 -.13 .06  
     Anx à  Recall (Direct) .21 .21 -.21 .62  
     Anx à  Recall (Total) .20 .21 -.23 .62  
 
Table 41: Left Insula Contrast and 5mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  -.09 .19 -.46 .28  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.02 .15 -.32 .28  
     Anx àDiscrimination à  Extinction (Indirect) .00 .04 -.06 .11  
     Anx à  Recall (Direct) .18 .28 -.37 .74  
     Anx à  Recall (Total) .18 .28 -.37 .74  
Recall      
     Discrimination à  Recall (b path) -.15 .16 -.46 .16  
     Anx àDiscrimination à  Recall (Indirect) .01 .04 -.03 .18  
     Anx à  Recall (Direct) -.35 .29 -.93 .22  
     Anx à  Recall (Total) -.34 .29 -.93 .22  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .19 .16 -.13 .50  
     Anx àDiscrimination à  Extinction (Indirect) -.02 .05 -.18 .04  
     Anx à  Recall (Direct) -.01 .29 -.57 .59  
     Anx à  Recall (Total) -.01 .29 -.59 .57  
Recall      
     Discrimination à  Recall (b path) -.15 .16 -.47 .17  
     Anx àDiscrimination à  Recall (Indirect) .01 .04 -.03 .17  
     Anx à  Recall (Direct) .27 .30 -.32 .86  
     Anx à  Recall (Total) .29 .30 -.30 .88  
 
Table 42: Right Insula Contrast and 5mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  -.05 .17 -.39 .29  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.20 .16 -.52 .13  
     Anx àDiscrimination à  Extinction (Indirect) .01 .04 -.05 .14  
     Anx à  Recall (Direct) .17 .28 -.38 .73  
     Anx à  Recall (Total) .18 .28 -.37 .74  
Recall      
     Discrimination à  Recall (b path) -.30 .17 -.63 .03  
     Anx àDiscrimination à  Recall (Indirect) .01 .05 -.08 .16  
     Anx à  Recall (Direct) -.35 .28 -.92 .21  
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     Anx à  Recall (Total) -.34 .29 -.91 .23  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .16 .17 -.18 .50  
     Anx àDiscrimination à  Extinction (Indirect) -.01 .04 -.13 .04  
     Anx à  Recall (Direct) .00 .29 -.58 .58  
     Anx à  Recall (Total) -.01 .29 -.59 .57  
Recall      
     Discrimination à  Recall (b path) -.25 .17 -.59 .09  
     Anx àDiscrimination à  Recall (Indirect) .01 .05 -.06 .15  
     Anx à  Recall (Direct) .28 .30 -.31 .86  
     Anx à  Recall (Total) .29 .30 -.30 .88  
 
Table 43: dACC Contrast and 5mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .12 .22 -.31 .55  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .12 .13 -.14 .38  
     Anx àDiscrimination à  Extinction (Indirect) .01 .04 -.03 .18  
     Anx à  Recall (Direct) .17 .28 -.39 .72  
     Anx à  Recall (Total) .18 .28 -.37 .74  
Recall      
     Discrimination à  Recall (b path) -.09 .13 -.36 .17  
     Anx àDiscrimination à  Recall (Indirect) -.01 .04 -.16 .03  
     Anx à  Recall (Direct) -.33 .29 -.90 .24  
     Anx à  Recall (Total) -.34 .29 -.91 .23  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .24 .13 -.02 .51  
     Anx àDiscrimination à  Extinction (Indirect) .03 .06 -.06 .20  
     Anx à  Recall (Direct) -.04 .29 -.61 .54  
     Anx à  Recall (Total) -.01 .29 -.59 .57  
Recall      
     Discrimination à  Recall (b path) -.24 .14 -.51 .02  
     Anx àDiscrimination à  Recall (Indirect) -.03 .06 -.22 .05  
     Anx à  Recall (Direct) .32 .29 -.27 .90  
     Anx à  Recall (Total) .29 .30 -.30 .88  
 
Table 44: Left Hippocampus Contrast and 5mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .02 .14 -.27 .30  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .02 .20 -.37 .41  
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     Anx àDiscrimination à  Extinction (Indirect) .00 .02 -.04 .05  
     Anx à  Recall (Direct) .18 .28 -.37 .74  
     Anx à  Recall (Total) .18 .28 -.37 .74  
Recall      
     Discrimination à  Recall (b path) .07 .20 -.33 .47  
     Anx àDiscrimination à  Recall (Indirect) .00 .03 -.05 .07  
     Anx à  Recall (Direct) -.34 .29 -.91 .23  
     Anx à  Recall (Total) -.34 .29 -.91 .23  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.14 .21 -.55 .27  
     Anx àDiscrimination à  Extinction (Indirect) .00 .03 -.09 .05  
     Anx à  Recall (Direct) -.01 .29 -.59 .57  
     Anx à  Recall (Total) -.01 .29 -.59 .57  
Recall      
     Discrimination à  Recall (b path) -.08 .21 -.49 .33  
     Anx àDiscrimination à  Recall (Indirect) .00 .03 -.08 .06  
     Anx à  Recall (Direct) .29 .30 -.30 .88  
     Anx à  Recall (Total) .29 .30 -.30 .88  
 
 
Table 45: Right Hippocampus Contrast and 5mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .19 .14 -.08 .46  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .02 .21 -.39 .43  
     Anx àDiscrimination à  Extinction (Indirect) .00 .03 -.06 .09  
     Anx à  Recall (Direct) .18 .28 -.38 .74  
     Anx à  Recall (Total) .18 .28 -.37 .74  
Recall      
     Discrimination à  Recall (b path) -.04 .21 -.46 .38  
     Anx àDiscrimination à  Recall (Indirect) -.01 .05 .14 .06  
     Anx à  Recall (Direct) -.33 .29 -.91 .25  
     Anx à  Recall (Total) -.34 .29 -.91 .23  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.21 .22 -.64 .22  
     Anx àDiscrimination à  Extinction (Indirect) -.04 .06 -.23 .03  
     Anx à  Recall (Direct) .03 .20 -.56 .62  
     Anx à  Recall (Total) -.01 .29 -.59 .57  
Recall      
     Discrimination à  Recall (b path) -.06 .22 -.50 .38  
     Anx àDiscrimination à  Recall (Indirect) -.01 .05 -.14 .06  
     Anx à  Recall (Direct) .30 .30 -.30 .90  
     Anx à  Recall (Total) .29 .30 -.30 .88  
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Table 46: 5mm vmPFC Contrast and 5mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .07 .26 -.45 .59  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.05 .11 -.27 .16  
     Anx àDiscrimination à  Extinction (Indirect) .00 .04 -.12 .05  
     Anx à  Recall (Direct) .19 .28 -.37 .74  
     Anx à  Recall (Total) .18 .28 -.37 .74  
Recall      
     Discrimination à  Recall (b path) -.21 .11 -.42 .01  
     Anx àDiscrimination à  Recall (Indirect) -.01 .07 -.20 .11  
     Anx à  Recall (Direct) -.33 .28 -.89 .24  
     Anx à  Recall (Total) -.34 .29 -.91 .23  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.20 .11 -.42 .02  
     Anx àDiscrimination à  Extinction (Indirect) -.01 .07 -.18 .11  
     Anx à  Recall (Direct) .30 .29 -.28 .88  
     Anx à  Recall (Total) -.29 .30 -.30 .88  
Recall      
     Discrimination à  Recall (b path) -.01 .11 -.23 .22  
     Anx àDiscrimination à  Recall (Indirect) .00 .04 -.09 .06  
     Anx à  Recall (Direct) -.01 .29 -.59 .57  
     Anx à  Recall (Total) -.01 .29 -.59 .57  
 
Table 47: Left Insula Contrast and 10mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  -.09 .19 -.46 .28  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .07 .11 -.16 .29  
     Anx àDiscrimination à  Extinction (Indirect) -.01 .03 -.11 .02  
     Anx à  Recall (Direct) .07 .21 -.34 .49  
     Anx à  Recall (Total) -.06 .21 -.35 .48  
Recall      
     Discrimination à  Recall (b path) -.06 .12 -.29 .17  
     Anx àDiscrimination à  Recall (Indirect) .01 .03 -.02 .10  
     Anx à  Recall (Direct) -.24 .21 -.67 .18  
     Anx à  Recall (Total) -.24 .21 -.66 .18  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .18 .12 -.06 .43  
     Anx àDiscrimination à  Extinction (Indirect) -.02 .04 -.16 .04  
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     Anx à  Recall (Direct) -.03 .23 -.48 .42  
     Anx à  Recall (Total) -.05 .23 -.50 .40  
Recall      
     Discrimination à  Recall (b path) -.11 .12 -.34 .12  
     Anx àDiscrimination à  Recall (Indirect) .01 .03 -.02 .12  
     Anx à  Recall (Direct) .19 .21 -.24 .61  
     Anx à  Recall (Total) .20 .21 -.23 .62  
 
Table 48: Right Insula Contrast and 10mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  -.05 .17 -.39 .29  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.05 .12 -.29 .19  
     Anx àDiscrimination à  Extinction (Indirect) .00 .02 -.03 .07  
     Anx à  Recall (Direct) .06 .21 -.35 .48  
     Anx à  Recall (Total) .06 .21 -.35 .48  
Recall      
     Discrimination à  Recall (b path) -.18 .12 -.42 .07  
     Anx àDiscrimination à  Recall (Indirect) .01 .04 -.04 .11  
     Anx à  Recall (Direct) -.25 .21 -.67 .17  
     Anx à  Recall (Total) -.24 .21 -.66 .18  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .18 .13 -.08 .45  
     Anx àDiscrimination à  Extinction (Indirect) -.01 .04 -.13 .04  
     Anx à  Recall (Direct) -.04 .23 -.49 .41  
     Anx à  Recall (Total) -.05 .23 -.50 .40  
Recall      
     Discrimination à  Recall (b path) -.16 .12 -.40 .09  
     Anx àDiscrimination à  Recall (Indirect) .01 .03 -.04 .12  
     Anx à  Recall (Direct) .19 .21 -.23 .61  
     Anx à  Recall (Total) .20 .21 -.23 .62  
 
Table 49: dACC Contrast and 10mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .12 .22 -.31 .55  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) .12 .10 -.07 .31  
     Anx àDiscrimination à  Extinction (Indirect) .01 .04 -.03 .14  
     Anx à  Recall (Direct) .05 .21 -.36 .46  
     Anx à  Recall (Total) .06 .21 -.35 .48  
Recall      
     Discrimination à  Recall (b path) -.06 .10 -.25 .14  
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     Anx àDiscrimination à  Recall (Indirect) -.01 .03 -.11 .02  
     Anx à  Recall (Direct) -.23 .21 -.65 .19  
     Anx à  Recall (Total) -.24 .21 -.66 .18  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) .19 .10 -.02 .40  
     Anx àDiscrimination à  Extinction (Indirect) .02 .05 -.05 .16  
     Anx à  Recall (Direct) -.07 .23 -.52 .37  
     Anx à  Recall (Total) -.05 .23 -.50 .40  
Recall      
     Discrimination à  Recall (b path) -.18 .10 -.38 .01  
     Anx àDiscrimination à  Recall (Indirect) -.02 .05 -.16 .04  
     Anx à  Recall (Direct) .22 .21 -.20 .64  
     Anx à  Recall (Total) .20 .21 -.23 .62  
 
Table 50: Left Hippocampus Contrast and 10mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .02 .14 -.27 .30  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.08 .15 -.37 .21  
     Anx àDiscrimination à  Extinction (Indirect) .00 .02 -.05 .04  
     Anx à  Recall (Direct) .07 .21 -.35 .48  
     Anx à  Recall (Total) .06 .21 -.35 .48  
Recall      
     Discrimination à  Recall (b path) .06 .15 -.24 .35  
     Anx àDiscrimination à  Recall (Indirect) .00 .02 -.03 .06  
     Anx à  Recall (Direct) -.24 .21 -.66 .18  
     Anx à  Recall (Total) -.24 .21 -.66 .18  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.13 .16 -.45 .18  
     Anx àDiscrimination à  Extinction (Indirect) .00 .03 -.07 .04  
     Anx à  Recall (Direct) -.05 .23 -.50 .40  
     Anx à  Recall (Total) -.05 .23 -.50 .40  
Recall      
     Discrimination à  Recall (b path) -.05 .15 -.35 .24  
     Anx àDiscrimination à  Recall (Indirect) .00 .02 -.06 .04  
     Anx à  Recall (Direct) -.20 .21 -.23 .62  
     Anx à  Recall (Total) .20 .21 -.23 .62  
 
Table 51: Right Hippocampus Contrast and 10mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .19 .14 -.08 .46  
SCR during CS+        
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End of Extinction      
     Discrimination à  Extinction (b path) -.08 .15 -.39 .22  
     Anx àDiscrimination à  Extinction (Indirect) -.02 .03 -.11 .01  
     Anx à  Recall (Direct) .08 .21 -.34 .50  
     Anx à  Recall (Total) .06 .21 -.35 .48  
Recall      
     Discrimination à  Recall (b path) -.04 .16 -.35 -.27  
     Anx àDiscrimination à  Recall (Indirect) -.01 .04 -.11 .04  
     Anx à  Recall (Direct) -.23 .22 -.66 .20  
     Anx à  Recall (Total) -.24 .21 -.66 .18  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.20 .17 -.54 .13  
     Anx àDiscrimination à  Extinction (Indirect) -.04 .05 -.19 .02  
     Anx à  Recall (Direct) -.01 .23 -.47 .44  
     Anx à  Recall (Total) -.05 .23 -.50 .40  
Recall      
     Discrimination à  Recall (b path) .00 .16 -.31 .32  
     Anx àDiscrimination à  Recall (Indirect) .00 .03 -.07 .08  
     Anx à  Recall (Direct) .20 .22 -.23 .63  
     Anx à  Recall (Total) -.20 .21 -.23 .62  
 
Table 52: 10mm vmPFC Contrast and 10mm vmPFC 
 b SE LLCI ULCI sig 
A Path       
     Anx à  Discrimination (a path)  .05 .19 -.34 .43  
SCR during CS+        
End of Extinction      
     Discrimination à  Extinction (b path) -.15 .11 -.36 .07  
     Anx àDiscrimination à  Extinction (Indirect) -.01 .04 -.14 .06  
     Anx à  Recall (Direct) .07 .21 -.34 .48  
     Anx à  Recall (Total) .06 .21 -.35 .48  
Recall      
     Discrimination à  Recall (b path) -.23 .11 -.45 .02  
     Anx àDiscrimination à  Recall (Indirect) -.01 .06 .17 .09  
     Anx à  Recall (Direct) -.23 .21 -.64 .19  
     Anx à  Recall (Total) -.24 .21 -.66 .18  
SCR during CS-       	
End of Extinction      
     Discrimination à  Extinction (b path) -.04 .12 -.28 .19  
     Anx àDiscrimination à  Extinction (Indirect) .00 .03 -.09 .04  
     Anx à  Recall (Direct) -.05 .23 -.50 .41  
     Anx à  Recall (Total) -.05 .23 -.50 .40  
Recall      
     Discrimination à  Recall (b path) -.15 .11 -.37 .06  
     Anx àDiscrimination à  Recall (Indirect) -.01 .04 -.13 .06  
     Anx à  Recall (Direct) .20 .21 -.22 .62  
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     Anx à  Recall (Total) -.20 .21 -.23 .62  
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